NIH Grant Search by PI — Funded Principal Investigator Finder

Search NIH grants by PI name or research area. Look up funded principal investigators, see their NIH RePORTER awards, institutions, and project details.

Search NIH grants by research area to find funded PIs

Enter a research topic, disease, or technology to find principal investigators with NIH funding in that area. To look up a specific PI by name, use the PI Funding Status check.

Search Results

Found 337 principal investigators from 200 displayed projects for "U54" (2021–2026)

Note: 616 projects matched but only the first 200 were analyzed. Try narrowing your search with a more specific term or selecting "Project title only".

Opportunity Digest

Heuristic scoring to help trainees and job seekers prioritize which labs to inspect first.

1

High-opportunity leads

54

Likely hiring signals

10

Training-friendly awards

35

Average opportunity score

Prioritize records with strong opportunity signals, then validate fit using abstracts, institution pages, and lab websites.

Filter for opportunity type

Lauren Hersch Nicholas

UNIVERSITY OF COLORADO DENVER, Aurora, CO

High-opportunity lead · 74/100
Likely hiring
Above-average budget
Very recent
Active award
$626,499
FY 2026

Project Title

Care for Persons with Dementia in Medicare Advantage and Traditional Medicare: Family Spillovers and Disparities

Grant Number:

5R01AG089058-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2024

End Date:

4/30/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.
  • • Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary Medicare beneficiaries with Alzheimer's Disease and Related Dementias (ADRD) typically require significant amounts of formal and informal healthcare. These treatments often lack coordination, conflict with patient and family preferences, and are costly to patients, families, and publ...

Research Terms

<0-11 years old><AD and related dementia><AD patients><AD related dementia><ADRD><Abnormal coordination><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease patient><Alzheimer's disease related dementia><Alzheimer's patient><Amentia><Black><Black race><Care Manager><Caring><Case Manager><Cessation of life><Characteristics><Child><Child Youth><Children (0-21)><Co-ordination disorder><Code><Coding System><Complex><Computer software><Conflict><Conflict (Psychology)><Coordination Disorder><Data><Death><Decision Making><Dementia><Department of Health and Human Services><Disparities><Disparity><Dyscoordination><Economic Income><Economical Income><Education><Educational aspects><Emotional well being><Enrollment><Ethnic Origin><Ethnicity><Family><Family member><Feels well><Friends><Generations><Grant><Health><Health Care><Health Care Utilization><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Health and Retirement Study><Home><Home Care><Hospices><Hospital Admission><Hospitalization><Household><Housing><Incentives><Income><Incoordination><Informal care giver><Intergenerational transfer><Lack of Coordination><Life><Low income><Managed Care><Medicaid eligibility><Medicare><Minority><Minority Enrollment><Normal mental condition><Normal mental state><Normal psyche><Outcome><Palliative Care><Palliative Therapy><Palliative Treatment><Patient Care><Patient Care Delivery><Patients><Persons><Policy Maker><Psychological Well Being><Race><Races><Reporting><Research><Research Resources><Resources><SES disparity><Sense of well-being><Services><Site><Software><Survey Instrument><Surveys><Time><Title 18><Translating><United States Department of Health and Human Services><United States Dept. of Health and Human Services><Well in self><Work><access disparities><accessibility disparities><beneficiary><care burden><care coordination><care for patients><care giving><care of patients><caregiving><caring for patients><cohort><comfort care><coordinating care><cost><dementia care><design><designing><disparities in access><disparities in income><disparities in race><disparity due to race><disparity in care><disparity in ethnic><disparity in health><disparity in health care><dual eligible><emotional wellbeing><emotional wellness><enroll><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnic minority><ethnicity disparity><experience><flexibility><flexible><grandchild><health care disparity><health care inequality><health care inequity><health care service use><health care service utilization><health disparity><health insurance for disabled><high school><homes><hospice environment><improved><income disparities><incomes><inequality due to race><inequality in access><inequity due to race><inequity in access><inequity in accessibility><informal care><informal caregiver><intergenerational><kids><mental well-being><mental wellbeing><mental wellness><nursing skill><palliative><palliative intervention><patient home care><patient homecare><patient living with Alzheimer's disease><patient suffering from Alzheimer's disease><patient with Alzheimer's><patient with Alzheimer's disease><patients with AD><payment><posthospitalization care><preference><psychological wellbeing><psychological wellness><race based disparity><race based inequality><race based inequity><race disparity><race related disparity><race related inequality><race related inequity><racial><racial background><racial disparity><racial inequality><racial inequity><racial minority><racial origin><racially unequal><satisfaction><self wellness><sense of wellbeing><social><social health determinants><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><tool><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM L. BOXER

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$16,947,844
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

2U19AG063911-06

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley F Boeve

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$16,947,844
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

2U19AG063911-06

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HOWARD J ROSEN

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$16,947,844
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

2U19AG063911-06

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LEONIDAS C. PLATANIAS

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$6,423,784
FY 2025

Project Title

The Robert H. Lurie Comprehensive Cancer Center

Grant Number:

2P30CA060553-31

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/1997

End Date:

7/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (NU) is an NCI-designated, comprehensive matrix cancer center conducting a broad range of multidisciplinary clinical, basic, translational and population science research. The Lurie Cancer Center (LCC) integrates the expertis...

Research Terms

<Address><Ambulatory Care><Basic Research><Basic Science><Biophysics><Brain Cancer><CCSG><Cancer Burden><Cancer Center><Cancer Center Support Grant><Cancer Control><Cancer Control Science><Cancer Patient><Cancer Science><Cancer Survivorship><Cancers><Catchment Area><Chemistry><Chicago><Clinic><Clinical><Clinical Investigator><Clinical Research><Clinical Sciences><Clinical Study><Clinical Trials><Communities><Community Outreach><Community Physician><Comprehensive Cancer Center><Data Science><Dedications><Development><Developmental Therapeutics><Developmental Therapeutics Program><Developmental Therapy><Disparities><Disparity><Educational Activities><Engineering><Environment><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Faculty><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Fostering><Funding><Generalized Growth><Genetics-Mutagenesis><Goals><Grant><Growth><Health><Health Care Facility><Health Care Professional><Health Facilities><Health Professional><Histology><Hospitals><Illinois><Immune><Immunes><Infrastructure><Institution><International><Investigators><Knowledge><Laboratories><Leadership><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Brain><Malignant neoplasm of brain><Malignant neoplasm of prostate><Malignant prostatic tumor><Measurement><Medical><Medicine><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Mice><Mice Mammals><Microscopy><Mission><Murine><Mus><Mutagenesis><Mutagenesis Molecular Biology><NIH><National Cancer Burden><National Institutes of Health><Neoplasm Metastasis><Nuclear><Organization administrative structures><Organizational Unit><Outcome><Outpatient Care><Pathology><Peer Review><Phenotype><Play><Population><Population Research><Population Sciences><Population-based research><Population-level research><Prevention><Process><Prostate CA><Prostate Cancer><Prostate malignancy><Proteomics><Research><Research Activity><Research Personnel><Research Resources><Researchers><Resource Sharing><Resources><Schools><Science><Scientist><Secondary Neoplasm><Secondary Tumor><Side><Site><Strategic Planning><Tissue Growth><Training><Training Programs><Transgenic Organisms><Translating><Translational Research><Translational Science><Translations><United States National Institutes of Health><Universities><Work><anti-cancer research><authority><biophysical foundation><biophysical principles><biophysical sciences><cancer care><cancer disparity><cancer education><cancer health disparity><cancer metastasis><cancer prevention><cancer research><cancer-related health disparity><care facilities><clinical applicability><clinical application><clinical practice><community center><community centers><developmental><disparity elimination><disparity in cancer><eliminate disparities><eliminating disparities><epigenetically><flow cytophotometry><innovate><innovation><innovative><malignancy><medical college><medical schools><member><metabolism measurement><metabolomics><metabonomics><molecular imaging><molecule imaging><multidisciplinary><neoplasm/cancer><next generation><ontogeny><outpatient treatment><outreach program><patient centered><patient oriented><physical science><programs><recruit><school of medicine><structural biology><survivorship><transgenic><translation><translation research><translational investigation><tumor><tumor cell metastasis>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

William Stewart

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$2,032,044
FY 2024

Project Title

Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)

Grant Number:

1U01NS137500-01

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Traumatic brain injury (TBI) is recognized as a modifiable risk factor for neurodegenerative diseases, including Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). As such, there has been an explosion of interest in the link between TBI and the development of late neurodegenera...

Research Terms

<AD dementia><AD pathology><AD related dementia><ADRD><Acceleration><Adopted><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amentia><Archives><Armed Forces Personnel><Automobile Driving><Body Tissues><Brain><Brain Nervous System><Brain Trauma><Characteristics><Clinical><Clinical Data><Communities><Complex><Computer software><Country><Data Set><Degenerative Neurologic Disorders><Dementia><Democracy><Development><Diagnosis><Encephalon><Environment><Event><Evolution><Explosion><Exposure to><Heterogeneity><Histology><History><Image><Individual><Injury><Institution><International><Investigation><Investigators><Link><MT-bound tau><MTBI><Mediating><Military><Military Personnel><NINDS><National Institute of Neurological Diseases and Stroke><National Institute of Neurological Disorders and Stroke><Natural History><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Outcome><Pathologic><Pathology><Phase><Pilot Projects><Prevalence><Primary Senile Degenerative Dementia><Process><Publishing><Recording of previous events><Research><Research Methodology><Research Methods><Research Personnel><Research Resources><Researchers><Resources><Risk Factors><Scanning><Schedule><Secure><Severities><Site><Slide><Software><Sports><Symptoms><Time><Tissue Banks><Tissue Collection><Tissue repository><Tissues><Traumatic Brain Injury><Traumatic encephalopathy><chronic traumatic encephalopathy><clinical phenotype><co-morbid><co-morbidity><comorbidity><data archive><data archives><data resource><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><digital><driving><histories><imaging><injuries><innovate><innovation><innovative><interest><intimate partner violence><malleable risk><microtubule bound tau><microtubule-bound tau><mild TBI><mild brain trauma><mild traumatic brain injury><military population><modifiable risk><multidisciplinary><neural degeneration><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neurological degeneration><neuronal degeneration><neuropathologic><neuropathological><neuropathology><pilot study><primary degenerative dementia><prospective><research and methods><research study><senile dementia of the Alzheimer type><socio-demographics><sociodemographics><success><tangle><tau><tau Proteins><tau factor><tissue archive><traumatic brain damage><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Edward Byung-Ha Lee

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$1,919,827
FY 2025

Project Title

Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)

Grant Number:

5U01NS137500-02

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Traumatic brain injury (TBI) is recognized as a modifiable risk factor for neurodegenerative diseases, including Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). As such, there has been an explosion of interest in the link between TBI and the development of late neurodegenera...

Research Terms

<AD dementia><AD pathology><AD related dementia><ADRD><Acceleration><Adopted><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amentia><Archives><Armed Forces Personnel><Automobile Driving><Body Tissues><Brain><Brain Nervous System><Brain Trauma><Characteristics><Clinical><Clinical Data><Communities><Complex><Computer software><Country><Data Set><Degenerative Neurologic Disorders><Dementia><Democracy><Development><Diagnosis><Encephalon><Environment><Event><Evolution><Explosion><Exposure to><Heterogeneity><Histology><History><Image><Individual><Injury><Institution><International><Investigation><Investigators><Link><MT-bound tau><MTBI><Mediating><Military><Military Personnel><NINDS><National Institute of Neurological Diseases and Stroke><National Institute of Neurological Disorders and Stroke><Natural History><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Outcome><Pathologic><Pathology><Phase><Pilot Projects><Prevalence><Primary Senile Degenerative Dementia><Process><Publishing><Recording of previous events><Research><Research Methodology><Research Methods><Research Personnel><Research Resources><Researchers><Resources><Risk Factors><Scanning><Schedule><Secure><Severities><Site><Slide><Software><Sports><Symptoms><Time><Tissue Banks><Tissue Collection><Tissue repository><Tissues><Traumatic Brain Injury><Traumatic encephalopathy><chronic traumatic encephalopathy><clinical phenotype><co-morbid><co-morbidity><comorbidity><data archive><data archives><data resource><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><digital><driving><histories><imaging><injuries><innovate><innovation><innovative><interest><intimate partner violence><malleable risk><microtubule bound tau><microtubule-bound tau><mild TBI><mild brain trauma><mild traumatic brain injury><military population><modifiable risk><multidisciplinary><neural degeneration><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neurological degeneration><neuronal degeneration><neuropathologic><neuropathological><neuropathology><pilot study><primary degenerative dementia><prospective><research and methods><research study><senile dementia of the Alzheimer type><socio-demographics><sociodemographics><success><tangle><tau><tau Proteins><tau factor><tissue archive><traumatic brain damage><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Douglas Hamilton Smith

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$1,919,827
FY 2025

Project Title

Transdisciplinary Research Accelerating Neuropathology Studies and Facilitating Open Research Methods in TBI (TRANSFORM-TBI)

Grant Number:

5U01NS137500-02

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Traumatic brain injury (TBI) is recognized as a modifiable risk factor for neurodegenerative diseases, including Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). As such, there has been an explosion of interest in the link between TBI and the development of late neurodegenera...

Research Terms

<AD dementia><AD pathology><AD related dementia><ADRD><Acceleration><Adopted><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amentia><Archives><Armed Forces Personnel><Automobile Driving><Body Tissues><Brain><Brain Nervous System><Brain Trauma><Characteristics><Clinical><Clinical Data><Communities><Complex><Computer software><Country><Data Set><Degenerative Neurologic Disorders><Dementia><Democracy><Development><Diagnosis><Encephalon><Environment><Event><Evolution><Explosion><Exposure to><Heterogeneity><Histology><History><Image><Individual><Injury><Institution><International><Investigation><Investigators><Link><MT-bound tau><MTBI><Mediating><Military><Military Personnel><NINDS><National Institute of Neurological Diseases and Stroke><National Institute of Neurological Disorders and Stroke><Natural History><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Outcome><Pathologic><Pathology><Phase><Pilot Projects><Prevalence><Primary Senile Degenerative Dementia><Process><Publishing><Recording of previous events><Research><Research Methodology><Research Methods><Research Personnel><Research Resources><Researchers><Resources><Risk Factors><Scanning><Schedule><Secure><Severities><Site><Slide><Software><Sports><Symptoms><Time><Tissue Banks><Tissue Collection><Tissue repository><Tissues><Traumatic Brain Injury><Traumatic encephalopathy><chronic traumatic encephalopathy><clinical phenotype><co-morbid><co-morbidity><comorbidity><data archive><data archives><data resource><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><digital><driving><histories><imaging><injuries><innovate><innovation><innovative><interest><intimate partner violence><malleable risk><microtubule bound tau><microtubule-bound tau><mild TBI><mild brain trauma><mild traumatic brain injury><military population><modifiable risk><multidisciplinary><neural degeneration><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neurological degeneration><neuronal degeneration><neuropathologic><neuropathological><neuropathology><pilot study><primary degenerative dementia><prospective><research and methods><research study><senile dementia of the Alzheimer type><socio-demographics><sociodemographics><success><tangle><tau><tau Proteins><tau factor><tissue archive><traumatic brain damage><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephen T Higgins

UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, BURLINGTON, VT

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$1,113,044
FY 2025

Project Title

Vermont Center on Behavior and Health

Grant Number:

5P30GM149331-03

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY Overall Plan The overarching goal of this application for a Phase 3 Center of Biomedical Research Excellence (COBRE) award is to firmly establish the Vermont Center on Behavior and Health (VCBH) at the University of Vermont (UVM) as a sustainable center of research excellence. This m...

Research Terms

<Advisory Committees><Applications Grants><Area><Award><Behavior><COBRE><Center of Biomedical Research Excellence><Centers of Research Excellence><Cessation of life><Chronic Disease><Chronic Illness><Clinical><Clinical Research><Clinical Study><Collaborations><Complex><Data><Death><Drug Therapy><Education><Educational aspects><Environment><Faculty><Fostering><Foundations><Funding><Funding Opportunities><Generalized Growth><Goals><Grant><Grant Proposals><Growth><HRSA><Health><Health Promotion><Health Resources and Services Administration><Individual><Industry><Institution><Interdisciplinary Research><Interdisciplinary Study><International><Intervention><Investigators><Journals><Knowledge><Learning><Life Style><Lifestyle><Magazine><Medical><Mentors><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Nebraska><Neurobiology><Obesity><Pattern><Peer Review><Periodicals><Personal Behavior><Personal Conduct><Pharmacological Treatment><Pharmacotherapy><Phase><Pilot Projects><Policies><Position><Positioning Attribute><Preventive Medicine><Publications><Regimen><Research><Research Personnel><Researchers><Risk><Risk Behaviors><Risky Behavior><Role><Rural><Salutogenesis><Schedule><Science><Scientific Advances and Accomplishments><Scientific Publication><Scientist><Series><Structure><Substance abuse problem><System><Task Forces><Tissue Growth><Tobacco><Training><United States Health Resources and Services Administration><United States National Institutes of Health><Universities><Vermont><Vulnerable Populations><abuse of substances><addiction><addictive disorder><adiposity><advisory team><at risk behavior><behavior change><behavioral economics><behavioral health><brain research><career><chronic disorder><clinical care><college><collegiate><conference><contingency management><convention><corpulence><cost effective><disease risk><disorder risk><drug intervention><drug treatment><early-career faculty><evidence base><full professor><improved><innovate><innovation><innovative><lack of physical activity><lectures><member><multidisciplinary><neurobiological><next generation><ontogeny><periodic><periodical><pharmaceutical intervention><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><physical inactivity><pilot study><premature><prematurity><preventative medicine><programs><promoting health><scientific accomplishments><scientific advances><senior faculty><social role><sound><substance abuse><substance misuse><success><summit><symposia><symposium><vulnerable group><vulnerable individual><vulnerable people><work group><working group>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexandra K. Adams

MONTANA STATE UNIVERSITY - BOZEMAN, BOZEMAN, MT

Good lead · 68/100
Likely hiring
Large award
Active award
Team-scale grant
$1,087,500
FY 2025

Project Title

Center for American Indian and Rural Health Excellence (CAIRHE)

Grant Number:

5P30GM154593-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The mission of the Center for American Indian and Rural Health Excellence (CAIRHE) is to improve health in American Indian and rural communities across Montana while developing early-career faculty into a multidisciplinary cohort of independent health investigators. The Center achieves its mission t...

Research Terms

<Achievement><Achievement Attainment><Affect><Agriculture><American Indian><American Indian community><Applications Grants><Award><Belief><Biological Markers><Biomedical Research><COBRE><Cancers><Cardiac Diseases><Cardiac Disorders><Career Counseling><Career Guidance><Caring><Cause of Death><Center of Biomedical Research Excellence><Centers of Research Excellence><Clinic><Clinical><Collaborations><Communities><County><Death Rate><Development><Diabetes Mellitus><Dissemination and Implementation><Employment Opportunities><Face><Faculty><Foundations><Funding><Funding Agency><Funding Source><Geography><Grant><Grant Proposals><Health><Health Care><Health Care Providers><Health Instruction><Health Personnel><Health Science Library><Health Tutoring><Health education><Health system><Heart Diseases><Hepatic Cirrhosis><Idaho><Indigenous><Individual><Institution><Institutionalization><Interdisciplinary Research><Interdisciplinary Study><Intervention><Intervention Studies><Investigators><Liver Cirrhosis><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><Montana><Multidisciplinary Collaboration><Multidisciplinary Research><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><North Dakota><Occupational Guidance><Outcome><Paper><Peer Review><Phase><Pilot Projects><Population Density><Position><Positioning Attribute><Public Health><Publishing><QOL><Quality of life><Randomized, Controlled Trials><Research><Research Design><Research Infrastructure><Research Personnel><Researchers><Resource Sharing><Risk Behaviors><Risk Factors><Risky Behavior><Rural><Rural Community><Rural Health><Science><South Dakota><Study Type><System><Training><Training Programs><Translational Research><Translational Science><Trauma Research><Unhealthy Diet><United States><United States National Institutes of Health><Universities><Utah><Vocational Counseling><Vocational Guidance><Washington><Work><Wyoming><at risk behavior><binge alcohol consumption><binge drinking><bio-markers><biologic marker><biomarker><career><career counselor><catalyst><chronic hepatic disease><chronic hepatic disorder><chronic liver disease><chronic liver disorder><cohort><collaboration with communities><community based participatory research><community based practice><community collaboration><community engaged participatory research><community engaged research><community engagement><community led research><community participatory research><community partnered participatory research><community partnered research><community-based collaboration><community-engaged study><community-partnered study><developmental><diabetes><driving under influence><early-career faculty><engagement with communities><episodic drinking><executive coaching><faces><facial><falls><frontier><health care personnel><health care worker><health provider><health workforce><heart disorder><improved><innovate><innovation><innovative><intervention research><interventional research><interventional study><interventions research><low SES><low socio-economic position><low socio-economic status><low socioeconomic position><low socioeconomic status><malignancy><medical college><medical personnel><medical schools><mentoring community><mortality rate><mortality ratio><multidisciplinary><neoplasm/cancer><next generation><operation><operations><participatory action research><pilot study><poor diet><programs><public health intervention><randomized control trial><research on resilience><research on resiliency><resilience research><resiliency research><rural area><rural dwellers><rural location><rural region><rural resident><school of medicine><study design><translation research><translational health research><translational health science><translational investigation><treatment provider>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ryan Bruce Corcoran

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 66/100
Likely hiring
Above-average budget
Recent
Active award
$711,990
FY 2026

Project Title

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Grant Number:

5R01CA262805-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2022

End Date:

3/31/2027

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract Although KRAS is mutated in 20% of all cancers and 40% of colorectal cancer (CRC), it has long been considered an “undruggable” target 1. Recently, novel covalent inhibitors selective for KRASG12C have entered the clinic, offering the unprecedented opportunity to target KRAS...

Research Terms

<Antibodies><Assay><Automobile Driving><B-raf-1><BRAF><BRAF gene><Bioassay><Biological Assay><Biopsy><C-K-RAS><Cancer Model><CancerModel><Cancers><Cell Communication and Signaling><Cell Signaling><Clinic><Clinical><Clinical Data><Clinical Trials><Collaborations><Collection><Colorectal Cancer><Combined Modality Therapy><Complex><DNA mutation><Data><Development><EGF Receptor><EGFR><ERBB Protein><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Evolution><Extracellular Signal-Regulated Kinase Gene><FDA approved><Feedback><Genetic Change><Genetic defect><Genetic mutation><Genomics><Goals><Grant><HER1><Heterogeneity><Heterograft><Heterologous Transplantation><Immunofluorescence><Immunofluorescence Immunologic><In vivo analysis><Intracellular Communication and Signaling><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS(G12D)><KRAS2><KRAS2 gene><KRASG12D><Ki-RAS><Lead><MAP Kinase Gene><MAPK><MDACC><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Lung><Malignant neoplasm of lung><Maps><Mediating><Mediator><Melanoma><Methods><Mitogen-Activated Protein Kinase Gene><Modeling><Multimodal Therapy><Multimodal Treatment><Mutate><Mutation><Non-Receptor Type 11 Protein Tyrosine Phosphatase><Oncogene K-Ras><Organoids><Outcome><PTP-2 enzyme><PTP2C><PTPN11><PTPN11 gene><Pathway interactions><Patients><Pb element><Pharmacodynamics><Protein Tyrosine Phosphatase 2C><Protein-Tyrosine Phosphatase 2C><Proteomics><Pulmonary Cancer><Pulmonary malignant Neoplasm><RAFB1><RASK2><Resistance><Role><SHP2><SHP2 Phosphatase><SHPTP2><Shp-2 tyrosine phosphatase><Signal Transduction><Signal Transduction Systems><Signaling><TGF-alpha Receptor><Testing><Therapeutic><Time><Transforming Growth Factor alpha Receptor><Translations><Tyrosine Phosphatase SHP2><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Urogastrone Receptor><Xenograft><Xenograft Model><Xenograft procedure><Xenotransplantation><biological signal transduction><c-erbB-1><c-erbB-1 Protein><cancer progression><candidate identification><clinical relevance><clinically relevant><colon cancer patients><colorectal cancer patients><combination therapy><combined modality treatment><combined treatment><determine efficacy><developmental><driving><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><evaluate efficacy><examine efficacy><genome mutation><heavy metal Pb><heavy metal lead><improved><in vitro Model><in vivo><in vivo Model><in vivo evaluation><in vivo testing><inhibitor><lung cancer><malignancy><multi-modal therapy><multi-modal treatment><mutant><neoplasm progression><neoplasm/cancer><neoplastic progression><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><pathway><pre-clinical><preclinical><proto-oncogene protein c-erbB-1><resistance mechanism><resistant><resistant mechanism><response><scRNA sequencing><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell analysis><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><tool><transcriptomics><translation><tumor><tumor progression><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog><v-raf Murine Sarcoma Viral Oncogene Homolog B1><xeno-transplant><xeno-transplantation><xenograft transplant model><xenotransplant model>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Scott Kopetz

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 66/100
Likely hiring
Above-average budget
Recent
Active award
$711,990
FY 2026

Project Title

Overcoming adaptive feedback resistance to KRAS inhibition in colorectal cancer

Grant Number:

5R01CA262805-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2022

End Date:

3/31/2027

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract Although KRAS is mutated in 20% of all cancers and 40% of colorectal cancer (CRC), it has long been considered an “undruggable” target 1. Recently, novel covalent inhibitors selective for KRASG12C have entered the clinic, offering the unprecedented opportunity to target KRAS...

Research Terms

<Antibodies><Assay><Automobile Driving><B-raf-1><BRAF><BRAF gene><Bioassay><Biological Assay><Biopsy><C-K-RAS><Cancer Model><CancerModel><Cancers><Cell Communication and Signaling><Cell Signaling><Clinic><Clinical><Clinical Data><Clinical Trials><Collaborations><Collection><Colorectal Cancer><Combined Modality Therapy><Complex><DNA mutation><Data><Development><EGF Receptor><EGFR><ERBB Protein><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Evolution><Extracellular Signal-Regulated Kinase Gene><FDA approved><Feedback><Genetic Change><Genetic defect><Genetic mutation><Genomics><Goals><Grant><HER1><Heterogeneity><Heterograft><Heterologous Transplantation><Immunofluorescence><Immunofluorescence Immunologic><In vivo analysis><Intracellular Communication and Signaling><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS(G12D)><KRAS2><KRAS2 gene><KRASG12D><Ki-RAS><Lead><MAP Kinase Gene><MAPK><MDACC><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Lung><Malignant neoplasm of lung><Maps><Mediating><Mediator><Melanoma><Methods><Mitogen-Activated Protein Kinase Gene><Modeling><Multimodal Therapy><Multimodal Treatment><Mutate><Mutation><Non-Receptor Type 11 Protein Tyrosine Phosphatase><Oncogene K-Ras><Organoids><Outcome><PTP-2 enzyme><PTP2C><PTPN11><PTPN11 gene><Pathway interactions><Patients><Pb element><Pharmacodynamics><Protein Tyrosine Phosphatase 2C><Protein-Tyrosine Phosphatase 2C><Proteomics><Pulmonary Cancer><Pulmonary malignant Neoplasm><RAFB1><RASK2><Resistance><Role><SHP2><SHP2 Phosphatase><SHPTP2><Shp-2 tyrosine phosphatase><Signal Transduction><Signal Transduction Systems><Signaling><TGF-alpha Receptor><Testing><Therapeutic><Time><Transforming Growth Factor alpha Receptor><Translations><Tyrosine Phosphatase SHP2><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Urogastrone Receptor><Xenograft><Xenograft Model><Xenograft procedure><Xenotransplantation><biological signal transduction><c-erbB-1><c-erbB-1 Protein><cancer progression><candidate identification><clinical relevance><clinically relevant><colon cancer patients><colorectal cancer patients><combination therapy><combined modality treatment><combined treatment><determine efficacy><developmental><driving><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><evaluate efficacy><examine efficacy><genome mutation><heavy metal Pb><heavy metal lead><improved><in vitro Model><in vivo><in vivo Model><in vivo evaluation><in vivo testing><inhibitor><lung cancer><malignancy><multi-modal therapy><multi-modal treatment><mutant><neoplasm progression><neoplasm/cancer><neoplastic progression><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><novel><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><pathway><pre-clinical><preclinical><proto-oncogene protein c-erbB-1><resistance mechanism><resistant><resistant mechanism><response><scRNA sequencing><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell analysis><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><tool><transcriptomics><translation><tumor><tumor progression><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog><v-raf Murine Sarcoma Viral Oncogene Homolog B1><xeno-transplant><xeno-transplantation><xenograft transplant model><xenotransplant model>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexander M Friedman

ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, SCOTTSDALE, AZ

Good lead · 66/100
Likely hiring
Solid budget
Very recent
Active award
$427,356
FY 2025

Project Title

Using Multimodal Clinical and SDOH Data to Develop Risk Models for Predicting Severe Maternal Morbidity

Grant Number:

7R01HD116103-02

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/10/2025

End Date:

12/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT ABSTRACT Severe maternal morbidity (SMM) is defined as an unexpected adverse outcome during pregnancy or postpartum (PP) with significant short- or long-term negative consequences to a woman’s health. Rates of SMM have risen substantially in the past decades and are >50% higher for non-Hispa...

View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jyotishman Pathak

ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, SCOTTSDALE, AZ

Good lead · 66/100
Likely hiring
Solid budget
Very recent
Active award
$427,356
FY 2025

Project Title

Using Multimodal Clinical and SDOH Data to Develop Risk Models for Predicting Severe Maternal Morbidity

Grant Number:

7R01HD116103-02

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/10/2025

End Date:

12/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT ABSTRACT Severe maternal morbidity (SMM) is defined as an unexpected adverse outcome during pregnancy or postpartum (PP) with significant short- or long-term negative consequences to a woman’s health. Rates of SMM have risen substantially in the past decades and are >50% higher for non-Hispa...

View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Subhash C. Chauhan

UNIVERSITY OF TEXAS RIO GRANDE VALLEY, EDINBURG, TX

Good lead · 62/100
Large award
Very recent
Active award
Team-scale grant
$3,229,138
FY 2026

Project Title

Rio Grande Valley Cancer Health Disparity Research Center

Grant Number:

5U54MD019970-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/18/2024

End Date:

3/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.
  • • Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Overall Project Summary: The Rio Grande Valley (RGV), located in South Texas along the US-Mexico region, is home to Hispanic/Latino American (HA/LA) populations who disproportionately suffer from several cancers despite improvements in the last several years in overall health care (diagnosis and tre...

Research Terms

<Accountability><American><Area><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Research><Behavioral Therapy><Behavioral Treatment><Biologic Factor><Biological><Biological Factors><Biomedical Research><Cancer Burden><Cancer Patient><Cancers><Causality><Cervical Cancer><Cervix Cancer><Chronic Disease><Chronic Illness><Clinical><Clinical Services><Collaborations><Communication><Complement><Complement Proteins><Conditioning Therapy><Core Facility><Data><Development><Diagnosis><Disparities><Disparity><Early Diagnosis><Education><Educational Achievement><Educational Status><Educational aspects><Ensure><Environment><Etiology><Faculty><Fellowship><Fostering><Funding><Goals><HPV screening><Health Care><Health Disparities Research><Health Services Evaluation><Health Services Research><Health disparities related research><Hepatic Cancer><Hispanic><Hispanic Populations><Hispanic group><Hispanic individual><Hispanic people><Hispanics><Home><Human Papilloma Virus screening><Individual><Infrastructure><Institution><Intervention Strategies><Investigators><Knowledge><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Leadership><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Medical><Medical Care Research><Medicine><Mentors><Mexico><Mission><Modeling><Molecular><NCMHD><NIMHD><National Cancer Burden><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Psychosocial Stress><QOL improvement><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Services><Social Behavior><South Texas><Structure><Students><Texas><Training Programs><Translational Research><Translational Science><United States><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Work><behavior intervention><behavioral intervention><biologic><burden of chronic disease><burden of chronic illness><cancer diagnosis><cancer disparity><cancer health disparity><cancer-related health disparity><causation><chemotherapy><chronic disorder><clinical translation><clinically translatable><college><collegiate><community engagement><community partners><community-based partners><complementation><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disease causation><disease disparity><disparity in cancer><disparity in health><early detection><educational level><engagement with communities><flexibility><flexible><graduate student><health determinants><health disparities science><health disparity><homes><improved><improvements in QOL><improvements in quality of life><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><member><multidisciplinary><neoplasm/cancer><notch><notch protein><notch receptors><patient population><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><quality of life improvement><recruit><research associates><research facility><services research><social><sociobehavior><sociobehavioral><successful intervention><therapeutic outcome><therapy outcome><training achievement><training level><training status><translation research><translational investigation><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Everardo Cobos

UNIVERSITY OF TEXAS RIO GRANDE VALLEY, EDINBURG, TX

Good lead · 62/100
Large award
Very recent
Active award
Team-scale grant
$3,229,138
FY 2026

Project Title

Rio Grande Valley Cancer Health Disparity Research Center

Grant Number:

5U54MD019970-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/18/2024

End Date:

3/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.
  • • Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Overall Project Summary: The Rio Grande Valley (RGV), located in South Texas along the US-Mexico region, is home to Hispanic/Latino American (HA/LA) populations who disproportionately suffer from several cancers despite improvements in the last several years in overall health care (diagnosis and tre...

Research Terms

<Accountability><American><Area><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Research><Behavioral Therapy><Behavioral Treatment><Biologic Factor><Biological><Biological Factors><Biomedical Research><Cancer Burden><Cancer Patient><Cancers><Causality><Cervical Cancer><Cervix Cancer><Chronic Disease><Chronic Illness><Clinical><Clinical Services><Collaborations><Communication><Complement><Complement Proteins><Conditioning Therapy><Core Facility><Data><Development><Diagnosis><Disparities><Disparity><Early Diagnosis><Education><Educational Achievement><Educational Status><Educational aspects><Ensure><Environment><Etiology><Faculty><Fellowship><Fostering><Funding><Goals><HPV screening><Health Care><Health Disparities Research><Health Services Evaluation><Health Services Research><Health disparities related research><Hepatic Cancer><Hispanic><Hispanic Populations><Hispanic group><Hispanic individual><Hispanic people><Hispanics><Home><Human Papilloma Virus screening><Individual><Infrastructure><Institution><Intervention Strategies><Investigators><Knowledge><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Leadership><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Medical><Medical Care Research><Medicine><Mentors><Mexico><Mission><Modeling><Molecular><NCMHD><NIMHD><National Cancer Burden><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Psychosocial Stress><QOL improvement><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Services><Social Behavior><South Texas><Structure><Students><Texas><Training Programs><Translational Research><Translational Science><United States><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Work><behavior intervention><behavioral intervention><biologic><burden of chronic disease><burden of chronic illness><cancer diagnosis><cancer disparity><cancer health disparity><cancer-related health disparity><causation><chemotherapy><chronic disorder><clinical translation><clinically translatable><college><collegiate><community engagement><community partners><community-based partners><complementation><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disease causation><disease disparity><disparity in cancer><disparity in health><early detection><educational level><engagement with communities><flexibility><flexible><graduate student><health determinants><health disparities science><health disparity><homes><improved><improvements in QOL><improvements in quality of life><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><member><multidisciplinary><neoplasm/cancer><notch><notch protein><notch receptors><patient population><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><quality of life improvement><recruit><research associates><research facility><services research><social><sociobehavior><sociobehavioral><successful intervention><therapeutic outcome><therapy outcome><training achievement><training level><training status><translation research><translational investigation><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jianfu Chen

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Good lead · 62/100
Likely hiring
Above-average budget
Active award
Team-scale grant
$896,543
FY 2025

Project Title

Broader Evaluation of TMD Treatment Efficacy and Response (BETTER TMD)

Grant Number:

1U01DE036113-01

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/11/2025

End Date:

6/30/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ ABSTRACT (Project 1 BETTER TMD) C-TMD IMPACT Research Project 1 refers to Broader Evaluation of TMD Treatment Efficacy & Response (BETTER-TMD) and will address the misdiagnosis and suboptimal treatment decision gaps in the TMDs. The overall goal of this project is to define and pred...

Research Terms

<Academic Medical Centers><Address><Adherence><Algorithms><Catalogs><Causality><Characteristics><Chronic><Clinic><Clinic Visits><Clinical><Collection><Common Data Element><Custom><Data><Data Analyses><Data Analysis><Data Analytics><Data Banks><Data Bases><Data Collection><Data Set><Data Systems><Databanks><Databases><Decision Making><Diagnosis><Diagnostic Errors><Diagnostic Findings><Diagnostic Method><Diagnostic Procedure><Diagnostic Technique><Disease><Disorder><Dysfunction><Effectiveness><Etiology><Evaluation><FaceBase><Functional disorder><Goals><HEAL Initiative><HIPAA><Health Insurance Portability and Accountability Act><Helping End Addiction Long-term><Helping to End Addiction Long-term><IT Systems><Image><Information Systems><Information Technology Systems><Investigators><Kennedy Kassebaum Act><Measurement><Measures><Methodology><Modality><Muscle><Muscle Tissue><NIH><Names><National Institutes of Health><Nature><Neurologic><Neurological><Orofacial Pain><Outcome><Outcome Measure><PL 104-191><PL104-191><Pain><Painful><Patient Care><Patient Care Delivery><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Performance><Persons><Phase><Phenotype><Physiopathology><Point-of-Care Systems><Prediction of Response to Therapy><Private Practice><Process><Public Law 104-191><R-Series Research Projects><R01 Mechanism><R01 Program><Reader><Reporting><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Serology><Signs and Symptoms><Site><Specialist><Structure><Symptoms><TMD pain><TMD treatment><TMJ Diseases><TMJ Disorders><TMJD><Temporomandibular Disorders><Temporomandibular Joint Diseases><Temporomandibular Joint Disorders><Temporomandibular Joint and Muscle Disorder><Temporomandibular disorder pain><Temporomandibular joint disease pain><Temporomandibular joint disorder pain><Testing><Time><Treatment Efficacy><Treatment Protocols><Treatment Regimen><Treatment Schedule><Treatment outcome><United States Health Insurance Portability and Accountability Act><United States National Institutes of Health><University Medical Centers><Visit><Work><care for patients><care of patients><caring for patients><catalog><causation><clinical research site><clinical site><customized therapy><customized treatment><customs><data base><data base structure><data depository><data interpretation><data repository><data set repository><database structure><dataset repository><decision making algorithm><determine efficacy><diagnosis errors><diagnostic algorithm><disease causation><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><evidence base><examine efficacy><help seeking><help-seeking behavior><human subject protection><imaging><imaging biomarker><imaging marker><imaging-based biological marker><imaging-based biomarker><imaging-based marker><improved><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><interest><intervention efficacy><machine learning based method><machine learning method><machine learning methodologies><measurable outcome><mobile app><mobile application><mobile device application><muscular><name><named><naming><oral facial pain><oral motor><outcome measurement><pathophysiology><patient advocacy group><patient specific therapies><patient specific treatment><patient stratification><predict therapeutic response><predict therapy response><psychosocial><response><response to therapy><response to treatment><scale up><stratified patient><structured data><tailored medical treatment><tailored therapy><tailored treatment><temporomandibular disorder treatment><therapeutic efficacy><therapeutic response><therapy efficacy><therapy prediction><therapy response><trait><treatment planning><treatment prediction><treatment response><treatment response prediction><treatment responsiveness><unique treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Glenn Thomas Clark

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Good lead · 62/100
Likely hiring
Above-average budget
Active award
Team-scale grant
$896,543
FY 2025

Project Title

Broader Evaluation of TMD Treatment Efficacy and Response (BETTER TMD)

Grant Number:

1U01DE036113-01

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/11/2025

End Date:

6/30/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ ABSTRACT (Project 1 BETTER TMD) C-TMD IMPACT Research Project 1 refers to Broader Evaluation of TMD Treatment Efficacy & Response (BETTER-TMD) and will address the misdiagnosis and suboptimal treatment decision gaps in the TMDs. The overall goal of this project is to define and pred...

Research Terms

<Academic Medical Centers><Address><Adherence><Algorithms><Catalogs><Causality><Characteristics><Chronic><Clinic><Clinic Visits><Clinical><Collection><Common Data Element><Custom><Data><Data Analyses><Data Analysis><Data Analytics><Data Banks><Data Bases><Data Collection><Data Set><Data Systems><Databanks><Databases><Decision Making><Diagnosis><Diagnostic Errors><Diagnostic Findings><Diagnostic Method><Diagnostic Procedure><Diagnostic Technique><Disease><Disorder><Dysfunction><Effectiveness><Etiology><Evaluation><FaceBase><Functional disorder><Goals><HEAL Initiative><HIPAA><Health Insurance Portability and Accountability Act><Helping End Addiction Long-term><Helping to End Addiction Long-term><IT Systems><Image><Information Systems><Information Technology Systems><Investigators><Kennedy Kassebaum Act><Measurement><Measures><Methodology><Modality><Muscle><Muscle Tissue><NIH><Names><National Institutes of Health><Nature><Neurologic><Neurological><Orofacial Pain><Outcome><Outcome Measure><PL 104-191><PL104-191><Pain><Painful><Patient Care><Patient Care Delivery><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Performance><Persons><Phase><Phenotype><Physiopathology><Point-of-Care Systems><Prediction of Response to Therapy><Private Practice><Process><Public Law 104-191><R-Series Research Projects><R01 Mechanism><R01 Program><Reader><Reporting><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Serology><Signs and Symptoms><Site><Specialist><Structure><Symptoms><TMD pain><TMD treatment><TMJ Diseases><TMJ Disorders><TMJD><Temporomandibular Disorders><Temporomandibular Joint Diseases><Temporomandibular Joint Disorders><Temporomandibular Joint and Muscle Disorder><Temporomandibular disorder pain><Temporomandibular joint disease pain><Temporomandibular joint disorder pain><Testing><Time><Treatment Efficacy><Treatment Protocols><Treatment Regimen><Treatment Schedule><Treatment outcome><United States Health Insurance Portability and Accountability Act><United States National Institutes of Health><University Medical Centers><Visit><Work><care for patients><care of patients><caring for patients><catalog><causation><clinical research site><clinical site><customized therapy><customized treatment><customs><data base><data base structure><data depository><data interpretation><data repository><data set repository><database structure><dataset repository><decision making algorithm><determine efficacy><diagnosis errors><diagnostic algorithm><disease causation><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><evidence base><examine efficacy><help seeking><help-seeking behavior><human subject protection><imaging><imaging biomarker><imaging marker><imaging-based biological marker><imaging-based biomarker><imaging-based marker><improved><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><interest><intervention efficacy><machine learning based method><machine learning method><machine learning methodologies><measurable outcome><mobile app><mobile application><mobile device application><muscular><name><named><naming><oral facial pain><oral motor><outcome measurement><pathophysiology><patient advocacy group><patient specific therapies><patient specific treatment><patient stratification><predict therapeutic response><predict therapy response><psychosocial><response><response to therapy><response to treatment><scale up><stratified patient><structured data><tailored medical treatment><tailored therapy><tailored treatment><temporomandibular disorder treatment><therapeutic efficacy><therapeutic response><therapy efficacy><therapy prediction><therapy response><trait><treatment planning><treatment prediction><treatment response><treatment response prediction><treatment responsiveness><unique treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ann C. McKee

BOSTON UNIVERSITY MEDICAL CAMPUS, BOSTON, MA

Good lead · 60/100
Likely hiring
Large award
Active award
$4,269,339
FY 2025

Project Title

Consequences of Exposure to Repetitive Head Impacts Across the Lifespan

Grant Number:

1RF1NS143015-01

Activity Code:

RF1

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2025

End Date:

5/31/2027

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Each year, millions of people are exposed to repetitive head impacts (RHI) from contact sports, military service, and interpersonal violence. Although RHI typically occurs early in life, the health consequences of RHI evolve over the lifespan and include neurobehavioral symptoms, cognitive impairmen...

Research Terms

<21+ years old><3-D Imaging><3D imaging><AD dementia><AD related dementia><ADRD><APOE e4><APOE-ε4><APOEε4><Address><Adult><Adult Human><Age><Age related pathologies><Aging><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimers Dementia><Amentia><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Autopsy><Aβ><Blood Vessels><Body Tissues><Brain><Brain Mapping><Brain Nervous System><Brain Vascular><Brain Vascular Disorders><Brain region><Cardiovascular Diseases><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Cognitive Disturbance><Cognitive Impairment><Cognitive Manifestations><Cognitive Symptoms><Cognitive decline><Cognitive function abnormal><DWI (diffusion weighted imaging)><DWI-MRI><Data><Dementia><Development><Diffusion><Diffusion MRI><Diffusion Magnetic Resonance Imaging><Diffusion Weighted MRI><Diffusion weighted imaging><Diffusion-weighted Magnetic Resonance Imaging><Disturbance in cognition><Dose><Early identification><Emotional><Encephalon><Encephalopathies><Exposure to><Female Groups><Funding><Gene Expression><Genetic><Genetic Diversity><Genetic Variation><Goals><Grant><Haplotypes><Health><Hemosiderin><Histology><Human><Image><Imaging technology><Immunofluorescence><Immunofluorescence Immunologic><Impaired cognition><Impulsivity><Inflammation><Infrastructure><Interpersonal Violence><Interruption><Intervention Strategies><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Knowledge><LB disease><LB disorder><Leanness><Lesion><Lewy Body Disease><Lewy body disorder><Lewy disease><Lewy disorder><Libraries><Life><Life Cycle><Life Cycle Stages><Life Style><Lifestyle><MR Imaging><MR Tomography><MRI><MRIs><Machine Learning><Macrophage><Magnetic Resonance Imaging><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Metabolic><Metabolic Diseases><Metabolic Disorder><Methods><Modern Man><Molecular><Mφ><NAC precursor><NMR Imaging><NMR Tomography><Nerve Cells><Nerve Degeneration><Nerve Unit><Nervous System Injuries><Nervous System Trauma><Nervous System damage><Neural Cell><Neurobehavioral Manifestations><Neurobehavioral Signs and Symptoms><Neurocyte><Neurological Damage><Neurological Injury><Neurological trauma><Neuron Degeneration><Neurons><Nuclear Magnetic Resonance Imaging><Optics><Outcome><PARK1 protein><PARK4 protein><Parkinsonian><Parkinsonian Condition><Parkinsonian Diseases><Parkinsonian Disorders><Parkinsonian Syndrome><Parkinsonism><Pathologic><Pathology><Pathway interactions><Persons><Phenotype><Premature Aging><Premature aging syndrome><Primary Senile Degenerative Dementia><Race><Races><Registries><Research><Resistance><Risk><Risk Factors><SNCA><SNCA protein><Secure><Single-Nucleus Sequencing><Slide><Staining method><Stains><Symptoms><Synapses><Synaptic><TAR DNA-binding protein 43><TDP-43><TDP43><Tauopathies><Thesaurismosis><Thinness><Three-Dimensional Imaging><Time><Tissue Banks><Tissue Collection><Tissue repository><Tissues><Traumatic encephalopathy><Underrepresented Groups><Underrepresented Populations><Variant><Variation><Vascular Diseases><Vascular Disorder><Women's Group><Zeugmatography><a beta peptide><a-syn><a-synuclein><abeta><adult youth><adulthood><age associated pathologies><age dependent pathologies><age induced pathologies><ages><aging associated pathologies><aging dependent pathologies><aging induced pathologies><aging pathologies><aging related pathologies><alpha synuclein><alpha synuclein gene><alphaSP22><alzheimer risk><amyloid beta><amyloid-b protein><apo E-4><apo E4><apo epsilon4><apoE epsilon 4><apoE-4><apoE4><apolipoprotein E epsilon 4><apolipoprotein E-4><apolipoprotein E4><asyn><beta amyloid fibril><blood vessel disorder><brain tissue><brain vascular disease><brain vascular dysfunction><cardiovascular disorder><cell type><cerebral vascular><cerebral vascular disease><cerebral vascular dysfunction><cerebro-vascular><cerebrovascular><cerebrovascular dysfunction><chronic traumatic encephalopathy><cognitive change><cognitive dysfunction><cognitive loss><cohort><collision sports><connectome><contact sports><dMRI><developmental><diagnostic criteria><diagnostic development><diffused><diffuses><diffusing><diffusion tensor imaging><diffusions><digital><early biomarkers><early detection biomarkers><early detection markers><early experience><ex vivo imaging><fluorescence imaging><fluorescent imaging><head impact><hippocampal sclerosis><imaging><innovate><innovation><innovative><innovative technologies><insight><intracranial vascular dysfunction><large data sets><large datasets><late in life><late life><later in life><later life><life course><life span><life-style factor><lifespan><lifestyle factors><machine based learning><metabolism disorder><microscope imaging><microscopic imaging><microscopy imaging><mid life><mid-life><middle age><middle aged><midlife><military service><necropsy><neural degeneration><neural inflammation><neurobehavioral><neurobehavioral symptom><neurodegeneration><neurodegenerative><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal><neuronal degeneration><neuropathologic><neuropathologic tau><neuropathological><neuropathological tau><neuropathology><neurotrauma><non A-beta component of AD amyloid><non A4 component of amyloid precursor><non-genetic><nongenetic><novel><optical><p-tau><p-τ><pathway><phospho-tau><phospho-τ><phosphorylated tau><post-translational modification of tau><postmortem><posttranslational modification of tau><premature><prematurity><primary degenerative dementia><programs><protein TDP-43><protein TDP43><racial><racial background><racial origin><resilience><resilient><resistant><sNuc-Seq><senile dementia of the Alzheimer type><sex><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><socio-economic><socio-economically><socioeconomically><socioeconomics><soluble amyloid precursor protein><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><substantia alba><synapse><tau associated neurodegeneration><tau associated neurodegenerative process><tau driven neurodegeneration><tau induced degeneration><tau induced neurodegeneration><tau mediated neurodegeneration><tau neurodegenerative disease><tau neuropathology><tau pathology><tau pathophysiology><tau phosphorylation><tau posttranslational modification><tau proteinopathy><tau related neurodegeneration><tau-1><tau-induced pathology><tauopathic neurodegenerative disorder><tauopathy><therapeutic target><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><vascular><vascular dysfunction><vasculopathy><white matter><young adult><young adult age><young adulthood><α synuclein gene><α-syn><α-synuclein><τ phosphorylation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Douglas Hamilton Smith

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 60/100
Likely hiring
Above-average budget
Active award
$556,119
FY 2026

Project Title

Axonal Pathology and TBI-Related Neurodegeneration (TReND)

Grant Number:

5R01NS094003-09

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2016

End Date:

12/31/2027

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Axonal Pathology and TBI-Related Neurodegeneration (TReND) Over the last decade there has been an explosion of interest in the link between traumatic brain injury (TBI) and the development of late neurodegenerative pathologies, particularly chronic traumatic encephalopathy neuropathologic change (CT...

Research Terms

<AD and related dementia><AD dementia><AD pathology><AD related dementia><ADRD><Acute><Adopted><Aging><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amyloid><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid Substance><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Appearance><Atrophic><Atrophy><Automobile Driving><Award><Axon><Axonal Transport><Axoplasmic Transport><Aβ><Binding><Blood Vessels><Brain Trauma><Clinical Data><Cognitive><Complex><Data><Data Set><Degenerative Neurologic Disorders><Development><Diameter><Differences between sexes><Differs between sexes><Diffuse Axonal Injury><Dissociation><Event><Evolution><Explosion><Exposure to><Female><Gliosis><Grant><History><Injury><Interruption><Investigation><Link><MT-bound tau><MTBI><Micro-tubule><Microtubule Stabilization><Microtubule-Associated Proteins><Microtubules><Molecular Interaction><Morphology><NIH><National Institutes of Health><Natural History><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Outcome><Pathology><Pattern><Phenotype><Phosphorylation><Primary Senile Degenerative Dementia><Process><Production><Protein Phosphorylation><Recording of previous events><Recovery><Risk><Risk Factors><Severities><Sex Differences><Sexual differences><Spectrin><Tauopathies><Time><Traumatic Brain Injury><Traumatic encephalopathy><United States National Institutes of Health><a beta peptide><abeta><abeta accumulation><abeta aggregation><aging associated><aging related><amyloid beta><amyloid beta accumulation><amyloid beta aggregation><amyloid β accumulation><amyloid β aggregation><amyloid-b protein><astrogliosis><axon damage><axon injury><axonal damage><axonal degeneration><axonal injury><aβ accumulation><aβ aggregation><beta amyloid fibril><chronic traumatic encephalopathy><degenerative axon><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><driving><histories><injuries><interest><male><malleable risk><microtubule bound tau><microtubule-bound tau><mild TBI><mild brain trauma><mild traumatic brain injury><modifiable risk><natural aging><neural degeneration><neural inflammation><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal degeneration><neuropathologic><neuropathologic tau><neuropathological><neuropathological tau><neuropathology><normal aging><normative aging><p-tau><p-τ><phospho-tau><phospho-τ><phosphorylated tau><post-translational modification of tau><posttranslational modification of tau><primary degenerative dementia><repair><repaired><response><senile dementia of the Alzheimer type><sex><sex based differences><sex-dependent differences><sex-related differences><sex-specific differences><soluble amyloid precursor protein><substantia alba><tangle><tau><tau Proteins><tau associated neurodegeneration><tau associated neurodegenerative process><tau driven neurodegeneration><tau factor><tau induced degeneration><tau induced neurodegeneration><tau mediated neurodegeneration><tau neurodegenerative disease><tau neuropathology><tau pathology><tau pathophysiology><tau phosphorylation><tau posttranslational modification><tau proteinopathy><tau related neurodegeneration><tau-1><tau-induced pathology><tauopathic neurodegenerative disorder><tauopathy><tissue archive><traumatic brain damage><vascular><white matter><τ Proteins><τ phosphorylation><♀><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

William Stewart

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 60/100
Likely hiring
Above-average budget
Active award
$556,119
FY 2026

Project Title

Axonal Pathology and TBI-Related Neurodegeneration (TReND)

Grant Number:

5R01NS094003-09

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/1/2016

End Date:

12/31/2027

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Axonal Pathology and TBI-Related Neurodegeneration (TReND) Over the last decade there has been an explosion of interest in the link between traumatic brain injury (TBI) and the development of late neurodegenerative pathologies, particularly chronic traumatic encephalopathy neuropathologic change (CT...

Research Terms

<AD and related dementia><AD dementia><AD pathology><AD related dementia><ADRD><Acute><Adopted><Aging><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimers Dementia><Amyloid><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid Substance><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Appearance><Atrophic><Atrophy><Automobile Driving><Award><Axon><Axonal Transport><Axoplasmic Transport><Aβ><Binding><Blood Vessels><Brain Trauma><Clinical Data><Cognitive><Complex><Data><Data Set><Degenerative Neurologic Disorders><Development><Diameter><Differences between sexes><Differs between sexes><Diffuse Axonal Injury><Dissociation><Event><Evolution><Explosion><Exposure to><Female><Gliosis><Grant><History><Injury><Interruption><Investigation><Link><MT-bound tau><MTBI><Micro-tubule><Microtubule Stabilization><Microtubule-Associated Proteins><Microtubules><Molecular Interaction><Morphology><NIH><National Institutes of Health><Natural History><Nerve Degeneration><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurofibrillary Tangles><Neurologic Degenerative Conditions><Neuron Degeneration><Outcome><Pathology><Pattern><Phenotype><Phosphorylation><Primary Senile Degenerative Dementia><Process><Production><Protein Phosphorylation><Recording of previous events><Recovery><Risk><Risk Factors><Severities><Sex Differences><Sexual differences><Spectrin><Tauopathies><Time><Traumatic Brain Injury><Traumatic encephalopathy><United States National Institutes of Health><a beta peptide><abeta><abeta accumulation><abeta aggregation><aging associated><aging related><amyloid beta><amyloid beta accumulation><amyloid beta aggregation><amyloid β accumulation><amyloid β aggregation><amyloid-b protein><astrogliosis><axon damage><axon injury><axonal damage><axonal degeneration><axonal injury><aβ accumulation><aβ aggregation><beta amyloid fibril><chronic traumatic encephalopathy><degenerative axon><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><driving><histories><injuries><interest><male><malleable risk><microtubule bound tau><microtubule-bound tau><mild TBI><mild brain trauma><mild traumatic brain injury><modifiable risk><natural aging><neural degeneration><neural inflammation><neurodegeneration><neurodegenerative><neurodegenerative illness><neurofibrillary degeneration><neurofibrillary lesion><neurofibrillary pathology><neuroinflammation><neuroinflammatory><neurological degeneration><neuronal degeneration><neuropathologic><neuropathologic tau><neuropathological><neuropathological tau><neuropathology><normal aging><normative aging><p-tau><p-τ><phospho-tau><phospho-τ><phosphorylated tau><post-translational modification of tau><posttranslational modification of tau><primary degenerative dementia><repair><repaired><response><senile dementia of the Alzheimer type><sex><sex based differences><sex-dependent differences><sex-related differences><sex-specific differences><soluble amyloid precursor protein><substantia alba><tangle><tau><tau Proteins><tau associated neurodegeneration><tau associated neurodegenerative process><tau driven neurodegeneration><tau factor><tau induced degeneration><tau induced neurodegeneration><tau mediated neurodegeneration><tau neurodegenerative disease><tau neuropathology><tau pathology><tau pathophysiology><tau phosphorylation><tau posttranslational modification><tau proteinopathy><tau related neurodegeneration><tau-1><tau-induced pathology><tauopathic neurodegenerative disorder><tauopathy><tissue archive><traumatic brain damage><vascular><white matter><τ Proteins><τ phosphorylation><♀><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael Alosco

BOSTON UNIVERSITY MEDICAL CAMPUS, BOSTON, MA

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$809,373
FY 2025

Project Title

Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms

Grant Number:

5R01NS122854-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Each year, millions of Americans are exposed to repetitive head impacts (RHI) through contact sport participation and may be at risk for chronic traumatic encephalopathy (CTE). The clinical presentation of CTE is ill-defined and includes deficits in executive function and memory, dementia, neurobeha...

Research Terms

<AD dementia><AD related dementia><ADRD><Adverse Late Effects><Affect><Age><Agreement><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><American><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Anterior><Arterioloscleroses><Axon><Aβ><BBB disruption><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Blood Vessels><Boston><Brain><Brain Nervous System><Brain Trauma><Brain Vascular Disorders><CD106><CD106 Antigens><California><Causality><Cerebral Amyloid Angiopathy><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinico-Pathologic Conference><Clinico-Pathological Conference><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Collaborations><Congophilic Angiopathy><DWI (diffusion weighted imaging)><DWI-MRI><Data><Data Set><Degenerative Neurologic Disorders><Dementia><Deposit><Deposition><Diffusion MRI><Diffusion Magnetic Resonance Imaging><Diffusion Weighted MRI><Diffusion weighted imaging><Diffusion-weighted Magnetic Resonance Imaging><Disturbance in cognition><Dose><ELISA><Encephalon><Enrollment><Enzyme-Linked Immunosorbent Assay><Etiology><Evaluation><Executive Dysfunction><Executive Function Deficit><Executive Impairment><Exposure to><Fe element><Female><Football><Frequencies><History><INCAM-110><Immunofluorescence><Immunofluorescence Immunologic><Impaired cognition><Impairment><Inducible Cell Adhesion Molecule 110><Injury><Intervention><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Iron><Late Effects><Light><Literature><Lumbar Puncture><MR Imaging><MR Tomography><MRI><MRIs><MT-bound tau><Magnetic Resonance Imaging><Manufactured football><Maps><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Memory><Mental Depression><Myelin><Myelin Basic Proteins><NMR Imaging><NMR Tomography><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Nuclear Magnetic Resonance Imaging><Oligodendrocytes><Oligodendrocytus><Oligodendroglia><Oligodendroglia Cell><Outcome><PARK5><Parkinson disease 5 gene><Participant><Pathologic><Pathology><Persons><Phone><Photoradiation><Plasma><Plasma Serum><Play><Position><Positioning Attribute><Predisposition><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Race><Races><Recording of previous events><Reporting><Research><Reticuloendothelial System, Serum, Plasma><Risk><Risk Factors><Sampling><San Francisco><Severities><Spinal Puncture><Sports><Subgroup><Susceptibility><Symptoms><Syndrome><Telephone><Testing><Thick><Thickness><Traumatic Brain Injury><Traumatic encephalopathy><UCHL1><UCHL1 gene><Universities><VCAM><VCAM-1><VEGF><VEGFs><Vascular Cell Adhesion Molecule><Vascular Cell Adhesion Molecule-1><Vascular Cognitive Impairment><Vascular Endothelial Growth Factors><White Matter Hyperintensity><Zeugmatography><a beta peptide><abeta><ages><amyloid beta><amyloid-b protein><arterial spin labeling><arterial spin tagging><axon damage><axon injury><axonal damage><axonal injury><beta amyloid fibril><bio-markers><biologic marker><biomarker><biomarker identification><blood-brain barrier disruption><bloodbrain barrier disruption><brain vascular disease><brain vascular dysfunction><causation><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular amyloidosis><cerebrovascular contribution to cognitive impairment><cerebrovascular contributions to cognitive dysfunction><cerebrovascular dysfunction><chronic traumatic encephalopathy><clinical conference><cognitive defects><cognitive dysfunction><cognitive loss><cohort><collision sports><contact sports><dMRI><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><dementia risk><density><depression><diffusion tensor imaging><disease causation><dosage><enroll><enzyme linked immunoassay><executive control><executive function><focus on male><focused on men><head impact><histories><hypoperfusion><identification of biomarkers><identification of new biomarkers><in vivo><indexing><informant><injuries><intracranial vascular dysfunction><later in life><later life><male><male focused><male specific><male targeted><marker identification><microtubule bound tau><microtubule-bound tau><microvascular pathology><neurobehavioral><neurodegenerative illness><neurofilament><neuropsychiatric><neuropsychiatric symptom><neuropsychiatry><novel><p-tau><p-τ><phospho-tau><phospho-τ><phosphorylated tau><post-translational modification of tau><posttranslational modification of tau><primary degenerative dementia><racial><racial background><racial origin><recruit><resilience factor><resiliency factor><response><risk factor for dementia><risk for dementia><senile dementia of the Alzheimer type><sex><soluble amyloid precursor protein><substantia alba><targeted to men><tau><tau Proteins><tau factor><tau phosphorylation><tau posttranslational modification><tau-1><traumatic brain damage><vascular><vascular and cognitive impairment><vascular cognition impairment><vascular cognitive decline><vascular cognitive disease><vascular cognitive disorder><vascular cognitive dysfunction><vascular contributions><vascular contributions to cognitive decline><vascular contributions to cognitive impairment><vascular disease and impaired cognition><vascular dysfunction resulting in cognitive decline><vascular related cognitive decline><vascular related cognitive impairment><vascular risk factor><white matter><τ Proteins><τ phosphorylation><♀><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ann C. McKee

BOSTON UNIVERSITY MEDICAL CAMPUS, BOSTON, MA

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$809,373
FY 2025

Project Title

Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric Symptoms

Grant Number:

5R01NS122854-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Each year, millions of Americans are exposed to repetitive head impacts (RHI) through contact sport participation and may be at risk for chronic traumatic encephalopathy (CTE). The clinical presentation of CTE is ill-defined and includes deficits in executive function and memory, dementia, neurobeha...

Research Terms

<AD dementia><AD related dementia><ADRD><Adverse Late Effects><Affect><Age><Agreement><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's amyloid><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Amentia><American><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Anterior><Arterioloscleroses><Axon><Aβ><BBB disruption><Biological Markers><Blood><Blood Plasma><Blood Reticuloendothelial System><Blood Vessels><Boston><Brain><Brain Nervous System><Brain Trauma><Brain Vascular Disorders><CD106><CD106 Antigens><California><Causality><Cerebral Amyloid Angiopathy><Cerebrovascular Disease><Cerebrovascular Disorders><Clinical><Clinico-Pathologic Conference><Clinico-Pathological Conference><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Collaborations><Congophilic Angiopathy><DWI (diffusion weighted imaging)><DWI-MRI><Data><Data Set><Degenerative Neurologic Disorders><Dementia><Deposit><Deposition><Diffusion MRI><Diffusion Magnetic Resonance Imaging><Diffusion Weighted MRI><Diffusion weighted imaging><Diffusion-weighted Magnetic Resonance Imaging><Disturbance in cognition><Dose><ELISA><Encephalon><Enrollment><Enzyme-Linked Immunosorbent Assay><Etiology><Evaluation><Executive Dysfunction><Executive Function Deficit><Executive Impairment><Exposure to><Fe element><Female><Football><Frequencies><History><INCAM-110><Immunofluorescence><Immunofluorescence Immunologic><Impaired cognition><Impairment><Inducible Cell Adhesion Molecule 110><Injury><Intervention><Interview><Intracranial Vascular Diseases><Intracranial Vascular Disorders><Iron><Late Effects><Light><Literature><Lumbar Puncture><MR Imaging><MR Tomography><MRI><MRIs><MT-bound tau><Magnetic Resonance Imaging><Manufactured football><Maps><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Memory><Mental Depression><Myelin><Myelin Basic Proteins><NMR Imaging><NMR Tomography><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Nuclear Magnetic Resonance Imaging><Oligodendrocytes><Oligodendrocytus><Oligodendroglia><Oligodendroglia Cell><Outcome><PARK5><Parkinson disease 5 gene><Participant><Pathologic><Pathology><Persons><Phone><Photoradiation><Plasma><Plasma Serum><Play><Position><Positioning Attribute><Predisposition><Primary Senile Degenerative Dementia><Protocol><Protocols documentation><Race><Races><Recording of previous events><Reporting><Research><Reticuloendothelial System, Serum, Plasma><Risk><Risk Factors><Sampling><San Francisco><Severities><Spinal Puncture><Sports><Subgroup><Susceptibility><Symptoms><Syndrome><Telephone><Testing><Thick><Thickness><Traumatic Brain Injury><Traumatic encephalopathy><UCHL1><UCHL1 gene><Universities><VCAM><VCAM-1><VEGF><VEGFs><Vascular Cell Adhesion Molecule><Vascular Cell Adhesion Molecule-1><Vascular Cognitive Impairment><Vascular Endothelial Growth Factors><White Matter Hyperintensity><Zeugmatography><a beta peptide><abeta><ages><amyloid beta><amyloid-b protein><arterial spin labeling><arterial spin tagging><axon damage><axon injury><axonal damage><axonal injury><beta amyloid fibril><bio-markers><biologic marker><biomarker><biomarker identification><blood-brain barrier disruption><bloodbrain barrier disruption><brain vascular disease><brain vascular dysfunction><causation><cerebral vascular disease><cerebral vascular dysfunction><cerebrovascular amyloidosis><cerebrovascular contribution to cognitive impairment><cerebrovascular contributions to cognitive dysfunction><cerebrovascular dysfunction><chronic traumatic encephalopathy><clinical conference><cognitive defects><cognitive dysfunction><cognitive loss><cohort><collision sports><contact sports><dMRI><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><dementia risk><density><depression><diffusion tensor imaging><disease causation><dosage><enroll><enzyme linked immunoassay><executive control><executive function><focus on male><focused on men><head impact><histories><hypoperfusion><identification of biomarkers><identification of new biomarkers><in vivo><indexing><informant><injuries><intracranial vascular dysfunction><later in life><later life><male><male focused><male specific><male targeted><marker identification><microtubule bound tau><microtubule-bound tau><microvascular pathology><neurobehavioral><neurodegenerative illness><neurofilament><neuropsychiatric><neuropsychiatric symptom><neuropsychiatry><novel><p-tau><p-τ><phospho-tau><phospho-τ><phosphorylated tau><post-translational modification of tau><posttranslational modification of tau><primary degenerative dementia><racial><racial background><racial origin><recruit><resilience factor><resiliency factor><response><risk factor for dementia><risk for dementia><senile dementia of the Alzheimer type><sex><soluble amyloid precursor protein><substantia alba><targeted to men><tau><tau Proteins><tau factor><tau phosphorylation><tau posttranslational modification><tau-1><traumatic brain damage><vascular><vascular and cognitive impairment><vascular cognition impairment><vascular cognitive decline><vascular cognitive disease><vascular cognitive disorder><vascular cognitive dysfunction><vascular contributions><vascular contributions to cognitive decline><vascular contributions to cognitive impairment><vascular disease and impaired cognition><vascular dysfunction resulting in cognitive decline><vascular related cognitive decline><vascular related cognitive impairment><vascular risk factor><white matter><τ Proteins><τ phosphorylation><♀><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christopher Ethan Cox

DUKE UNIVERSITY, DURHAM, NC

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$640,087
FY 2025

Project Title

Improving needs among older adults: the ICUconnect 2 primary palliative care RCT

Grant Number:

5R01AG084572-02

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/15/2024

End Date:

7/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Millions of older adults receive care in intensive care units (ICUs) annually. However, the quality and accessibility of ICU-based palliative care is highly variable across hospitals and clinicians, due in part to specialists’ limited workforce and geographic inconsistency. Furthermore, there are fe...

Research Terms

<Active Follow-up><Address><Adherence><Admission><Admission activity><Affect><Age><Alabama><Area><Black><Black race><Caring><Characteristics><Clinical><Clinical Trials><Communication><Complex><Critical Care><Critical Illness><Critically Ill><Data><Decrease disparity><Effectiveness of Interventions><Eligibility><Eligibility Determination><Ensure><Environment><Espanol><Ethnic Origin><Ethnicity><Evidence based intervention><Family><Family member><Financial Hardship><Future><Geography><Geriatrics><Goals><Health><Health Care><Health Care Technology><Health Technology><Heterogeneity><Hospitals><Hybrids><Implementation readiness><Infrastructure><Intensive Care Units><Intervention><Interview><Language><Lower disparity><Measurement><Medical><Methods><Modeling><Outcome><Palliative Care><Palliative Therapy><Palliative Treatment><Participant><Patient Self-Report><Patients><Population><Population Characteristics><Population Heterogeneity><Preparedness><Protocol Screening><QOC><Quality of Care><RE-AIM><Race><Races><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Readiness><Reporting><Research><Role><Rural><Sampling><Self Efficacy><Self-Report><Severity of illness><Site><Social support><South Carolina><Spanish><Specialist><Structure><Subgroup><Symptoms><Target Populations><Testing><Treatment Efficacy><Universities><Work><active followup><ages><care as usual><care delivery><care outcomes><clinical care><clinician communication><clinician factors><clinician-level factors><co-morbid><co-morbidity><comfort care><communicate to clinicians><communicate to providers><communicate with clinicians><communicate with doctors><communicate with providers><comorbidity><deprivation><design><designing><determine efficacy><digital><disadvantaged background><disease severity><disparity in care><disparity in health care><disparity reduction><diverse populations><doctor communication><effectiveness/implementation design><effectiveness/implementation hybrid design><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><efficacy testing><ethnic minority><evaluate efficacy><examine efficacy><experience><financial adversity><financial burden><financial distress><financial insecurity><financial strain><financial stress><follow up><follow-up><followed up><followup><future implementation><geriatric medicine><health care disparity><health care inequality><health care inequity><health care outcomes><health care settings><health equity><heterogeneous population><implementation framework><implementation intervention><implementation measures><implementation research framework><implementation science framework><improved><indexing><innovate><innovation><innovative><intervention delivery><intervention design><intervention efficacy><marginalized background><meeting><meetings><mitigate disparity><mobile app><mobile application><mobile device application><multidisciplinary><older adult><older adulthood><palliative intervention><participant interview><person centered><physician factors><physician-level factors><pilot trial><population diversity><post intervention><primary outcome><provider communication><provider factors><provider-level factors><psychological distress><racial><racial background><racial minority group><racial minority individual><racial minority people><racial minority population><racial origin><reach, efficacy, adoption, implementation, and maintenance><reduce disparity><reduction in disparity><response to therapy><response to treatment><routine care><rurality><secondary outcome><social><social factors><social role><social support network><success><therapeutic efficacy><therapeutic response><therapy design><therapy efficacy><therapy response><treatment as usual><treatment design><treatment effect><treatment response><treatment responsiveness><usual care>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley K. Yoder

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$602,956
FY 2025

Project Title

Mechanisms of ciliopathy associated structural birth defects

Grant Number:

5R01HD111399-02

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/6/2024

End Date:

7/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT Cilia are complex structures with more than 1,300 proteins involved in their formation and function. During development, disruption of cilia function causes gestational lethality and mild to severe birth defects. Variants in cilia proteins are causally associated with more t...

Research Terms

<Affect><Animal Model><Animal Models and Related Studies><Animals><Automobile Driving><Biochemistry><Bioinformatics><Biological Chemistry><Biology><Birth Defects><Body System><Brachydanio rerio><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><Cardiac Malformation><Cas nuclease technology><Cell Communication and Signaling><Cell Signaling><Cellular biology><Cerebellar hypoplasia><Cilia><Classification><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Communities><Complex><Computational Biology><Congenital Abnormality><Congenital Anatomical Abnormality><Congenital Defects><Congenital Deformity><Congenital Malformation><Congenital cerebellar hypoplasia><Cystic kidney><Danio rerio><Data><Data Banks><Data Science><Data Set><Databanks><Defect><Development><Diagnosis><Diagnostic><Disease><Disorder><Dysfunction><Dysplasia><Engineering><Erinaceidae><Evaluation><Exhibits><Explosion><FK506 Binding Protein 12-Rapamycin Associated Protein 1><FKBP12 Rapamycin Complex Associated Protein 1><FRAP1><FRAP1 gene><FRAP2><Functional disorder><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G-Protein-Coupled Receptors><GPCR><Gene variant><Generations><Genes><Genetic Diseases><Genomics><Gestation><Goals><Health><Heart Malformation><Hedgehogs><Human Development><Hydrocephalus><Hydrocephaly><Hypogonadism><Individual><International><Intracellular Communication and Signaling><KO mice><Kidney Cyst><Knock-out Mice><Knockout Mice><Late pregnancy><Liver><Machine Learning><Maintenance><Mechanistic Target of Rapamycin><Medicine><Methods><Microcephaly><Modeling><Molecular><Morphology><Mutant Strains Mice><Network Analysis><Neural Tube Closure><Neural Tube Defects><Neural Tube Developmental Defects><Null Mouse><Organ System><Orphan Disease><Outcome><PDGF><Pancreas><Pancreatic><Pathogenicity><Pathway Analysis><Pathway interactions><Patients><Phenotype><Physiopathology><Platelet-Derived Growth Factor><Position><Positioning Attribute><Pregnancy><Process><Protein Trafficking><Proteins><Proteome><Protocol><Protocols documentation><Publications><RAFT1><RNA Seq><RNA sequencing><RNAseq><Rapid screening><Rare Diseases><Rare Disorder><Regulation><Renal Cyst><Retinal Diseases><Retinal Disorder><Role><Scientific Publication><Sensory><Severities><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Situs Inversus><Source><Structural Birth Defect><Structural Congenital Anomalies><Structure><Symptoms><Syndrome><Systematics><Testing><Therapeutic><Translating><Variant><Variation><Work><Xenopus><Xenopus sp.><Zebra Danio><Zebra Fish><Zebrafish><abnormal heart development><allelic variant><bio-informatics tool><bioinformatics tool><biological signal transduction><birthing individual><birthing patient><birthing people><candidate identification><cell biology><ciliogenesis><ciliopathy><cilium biogenesis><cilium motility><clawed frog><computer biology><congenital cardiac abnormality><congenital cardiac anomalies><congenital cardiac disease><congenital cardiac disorder><congenital cardiac malformation><congenital heart abnormality><congenital heart anomaly><congenital heart disease><congenital heart disorder><congenital heart malformation><congenital structural malformation><craniofacial><craniofacies><data depository><data repository><data set repository><dataset repository><depository><developmental><developmental disease><developmental disorder><diagnostic tool><disease diagnostic><driving><drug discovery><dyscrasia><early in pregnancy><early pregnancies><early pregnancy><early stage of pregnancy><gene null><gene testing><gene-based diagnostics><gene-based testing><genetic condition><genetic diagnostics><genetic disorder><genetic testing><genetic variant><genetic-focused diagnostic><genomic variant><hepatic body system><hepatic organ system><heterotaxia syndrome><heterotaxy><hydrocephalic><improved><indexing><individual who gives birth><inversion of viscera><laterality sequence><mTOR><machine based learning><malformation><mammalian target of rapamycin><meeting><meetings><micrencephaly><microencephaly><model of animal><molecular diagnostics><mouse model><mouse mutant><murine model><mutant><notch><notch protein><notch receptors><novel><null mutation><orphan disorder><pathophysiology><pathway><patient who gives birth><people giving birth><people who birth><people who give birth><protein expression><protein transport><repository><response><retina disease><retina disorder><retinopathy><situs abnormality><situs inversus viscerum><skeletal><social role><tool><trafficking><transcriptome sequencing><transcriptomic sequencing><transposition of viscera><unclassified variant><variant of interest><variant of uncertain clinical significance><variant of uncertain significance><variant of undetermined significance><variant of unknown significance><visceral heterotaxy><visceral transposition>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lifang Hou

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$539,229
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

5R01CA274952-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROBERT Leo MURPHY

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$539,229
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

5R01CA274952-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Imran Morhason - Bello

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$539,229
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

5R01CA274952-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY, SEATTLE, WA

Good lead · 54/100
Likely hiring
Above-average budget
Active award
$523,564
FY 2025

Project Title

Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization

Grant Number:

5R01CA264090-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2021

End Date:

6/30/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.
  • • Award size is strong enough to merit immediate review.

Project Abstract

Project summary Much of cancer immunotherapy is focused on engineering or activating tumor-antigen specific CD8+ T cells and, to a lesser extent, CD4+ T cells. In particular, neoantigen-specific T cells are attractive because they can kill cancer cells with high specificity. 1 A general approach sta...

Research Terms

<Address><Algorithms><Antigen Presentation><Antigens><Antioncogene Protein p53><Antitumor Response><Artificial nano particles><Artificial nanoparticles><Binding><Blood><Blood Reticuloendothelial System><Bypass><C-K-RAS><CCNE><CCNE1><CCNE1 gene><CCOP><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><COVID infected patient><COVID patient><COVID positive patient><COVID-19 infected patient><COVID-19 patient><COVID-19 positive patient><COVID19 patient><COVID19 positive patient><Cancer Genes><Cancer-Promoting Gene><Cell Body><Cells><Cellular Tumor Antigen P53><Class II Antigens><Class II Genes><Class II Major Histocompatibility Antigens><Clinic><Clinical><Clone Cells><Community Clinical Oncology Program><Community Oncology><Cost Savings><Cyclin E><Cyclin-E1><DNA mutation><Data><Data Set><Disadvantaged><Engineering><Exhibits><Funding><Genes><Genetic Change><Genetic Engineering><Genetic Engineering Biotechnology><Genetic Engineering Molecular Biology><Genetic defect><Genetic mutation><Grant><HLA Class II Genes><Haplotypes><Histocompatibility Antigens Class II><I-A Antigen><Ia Antigens><Ia-Like Antigens><Immune Response Antigens><Immune mediated therapy><Immune-Response-Associated Antigens><Immunologically Directed Therapy><Immunooncology><Immunotherapy><Infusion><Infusion procedures><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS2><KRAS2 gene><Ki-RAS><Length><Libraries><MHC Class II><MHC Class II Genes><MHC Class II Molecule><MHC Class II Protein><MHC Receptor><MHC class II antigen><Major Histocompatibility Complex Class II><Major Histocompatibility Complex Receptor><Malignant Cell><Malignant Ovarian Neoplasm><Malignant Ovarian Tumor><Malignant Tumor of the Ovary><Malignant neoplasm of ovary><Methodology><Methods><Molecular Interaction><Mutate><Mutation><Nanotechnology><Oncogene K-Ras><Oncogenes><Oncoprotein p53><Ovary Cancer><P53><PBMC><Patients><Peptides><Peripheral Blood Mononuclear Cell><Phosphoprotein P53><Phosphoprotein pp53><Population><Preparation><Protein Engineering><Protein TP53><Proteins><Protocol><Protocols documentation><RASK2><Reagent><Receptors, Antigen, T-Cell, alpha-beta><Recombinant DNA Technology><Reporting><Research Resources><Resources><SARS-CoV-2 infected patient><SARS-CoV-2 patient><SARS-CoV-2 positive patient><Specificity><T cell based immune therapy><T cell based therapeutics><T cell based therapy><T cell directed therapies><T cell immune therapy><T cell immunotherapy><T cell receptor based immunotherapy><T cell receptor cellular immunotherapy><T cell receptor engineered therapy><T cell receptor immunotherapy><T cell response><T cell targeted therapeutics><T cell therapy><T cell treatment><T cell-based immunotherapy><T cell-based treatment><T cellular immunotherapy><T cellular therapy><T lymphocyte based immunotherapy><T lymphocyte based therapy><T lymphocyte therapeutic><T lymphocyte treatment><T-Cell Antigen Receptors><T-Cell Receptor><T-Cell Receptor Genes><T-Cell Receptor Therapy><T-Cell Receptor Treatment><T-Cell Receptor based Therapy><T-Cell Receptor based Treatment><T-Cell Subsets><T-Cells><T-Lymphocyte><T-Lymphocyte Subsets><T-cell therapeutics><T-cell transfer therapy><T4 Cells><T4 Lymphocytes><T8 Cells><T8 Lymphocytes><TCR T cell immunotherapy><TCR T cell therapy><TCR Therapy><TCR based T cell immunotherapy><TCR based Therapy><TCR based immune therapy><TCR based immunotherapy><TCR based treatment><TCR immunotherapy><TP53><TP53 gene><TRP53><TcR Genes><TcR alpha-beta><TcR αβ><Technology><Therapeutic><Time><Transfection><Transforming Genes><Tumor Antigens><Tumor Protein p53><Tumor Protein p53 Gene><Tumor-Associated Antigen><Validation><Work><adoptive T cell transfer><adoptive T lymphocyte transfer><adoptive T-cell therapy><alpha-beta T-Cell Receptor><anti-cancer immunotherapy><anti-tumor effect><anti-tumor response><anticancer immunotherapy><antigen-specific T cells><antitumor effect><cancer antigens><cancer cell><cancer immunotherapy><colon cancer patients><colorectal cancer patients><computer chip><coronavirus disease 2019 infected patient><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19 patient><coronavirus patient><cost><current pandemic><design><design and construct><design and construction><designing><engineered nano particle><engineered nanoparticle><genetic protein engineering><genetically engineered><genome mutation><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immune-oncology><immuno oncology><immuno therapy><immunogen><immunology oncology><immunotherapy for cancer><immunotherapy of cancer><infusions><innovate><innovation><innovative><invention><microchip><mutant><nano><nano tech><nano technology><nano-technological><nanotech><nanotechnological><neo-antigen><neo-epitopes><neoantigens><neoepitopes><oncoimmunology><ovarian cancer><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pandemic><pandemic disease><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><prediction algorithm><preparations><present pandemic><protein design><protein p53><public data base><public database><publicly accessible data base><publicly accessible database><publicly available data base><publicly available database><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><therapeutic T-cell platform><thymus derived lymphocyte><tool><tumor><tumor-specific antigen><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog><validations><αβ T-Cell Receptor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stefan David Baral

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$337,004
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

5U01CA275117-02

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory D Kirk

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$337,004
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

5U01CA275117-02

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ponsiano Ocama

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$337,004
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

5U01CA275117-02

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM L. BOXER

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$331,127
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S2

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley F Boeve

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$331,127
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S2

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HOWARD J ROSEN

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 54/100
Likely hiring
Solid budget
Active award
Team-scale grant
$331,127
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S2

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kevin William Eliceiri

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Good lead · 48/100
Large award
Active award
Team-scale grant
$1,349,589
FY 2026

Project Title

Center for Multiparametric Imaging of Tumor Immune Microenvironments

Grant Number:

5U54CA268069-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

12/9/2021

End Date:

11/30/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This project proposes an integrated suite of microscopy and data analysis advances that would enable quantitative, mechanistic analysis of immune-microenvironment dynamics in poor prognosis solid tumors. While immunotherapies are showing remarkable clinical responses in some advanced cancers, to dat...

Research Terms

<Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Biologic Models><Biological Models><Body Tissues><Brain Cancer><Cancer Biology><Cancer Patient><Cancer Treatment><Cancers><Cell Body><Cell Function><Cell Physiology><Cell Process><Cell-Extracellular Matrix><Cells><Cellular Function><Cellular Immune Function><Cellular Physiology><Cellular Process><Cellular immunotherapy><Clinical><Collaborations><Complex><Computer Analysis><Data><Data Analyses><Data Analysis><Development><Dimensions><ECM><Effectiveness><Engineering><Environment><Extracellular Matrix><FLIM imaging><Fingerprint><GEM model><GEMM model><Genetically Engineered Mouse><Genome engineering><Goals><Image><Imaging technology><Immune mediated therapy><Immune response><Immunologically Directed Therapy><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Infrastructure><Institution><Leadership><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant Tumor of the Brain><Malignant neoplasm of brain><Malignant neoplasm of pancreas><Microfabrication><Microscopy><Model System><Modeling><Molecular><Oncology><Oncology Cancer><Optics><Pancreas Cancer><Pancreatic Cancer><Persons><Play><Prognosis><Publishing><Regimen><Research><Resolution><Seminal><Sight><Solid Neoplasm><Solid Tumor><Spectroscopy><Spectrum Analyses><Spectrum Analysis><Subcellular Process><Sum><T cell based immune therapy><T cell based therapeutics><T cell based therapy><T cell directed therapies><T cell immune therapy><T cell immunotherapy><T cell infiltration><T cell targeted therapeutics><T cell therapy><T cell treatment><T cell-based immunotherapy><T cell-based treatment><T cellular immunotherapy><T cellular therapy><T lymphocyte based immunotherapy><T lymphocyte based therapy><T lymphocyte therapeutic><T lymphocyte treatment><T-Cells><T-Lymphocyte><T-cell therapeutics><T-cell transfer therapy><Technology><Testing><Time><Tissue imaging><Tissues><Tumor Immunity><Vision><Work><adoptive T cell transfer><adoptive T lymphocyte transfer><adoptive T-cell therapy><anti-cancer immunotherapy><anti-cancer therapy><anti-tumor immune response><anti-tumor immune therapy><anti-tumor immunity><anti-tumor immunotherapy><anticancer immunotherapy><antitumor immunity><biophysical model><cancer imaging><cancer immunity><cancer immunology><cancer immunotherapy><cancer microenvironment><cancer therapy><cancer-directed therapy><cell behavior><cell engineering><cell imaging><cell-based immunotherapy><cellular behavior><cellular engineering><cellular imaging><check point blockade><checkpoint blockade><computational analyses><computational analysis><computer analyses><crosslink><data interpretation><data modeling><design><designing><developmental><engineered T cells><experience><fluorescence life-time imaging><fluorescence life-time imaging microscopy><fluorescence lifetime imaging><fluorescence lifetime imaging microscopy><genetically engineered T-cells><genetically engineered mouse model><genetically engineered murine model><host response><imaging><imaging platform><immune cell therapy><immune check point blockade><immune checkpoint blockade><immune function><immune microenvironment><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive microenvironment><immunosuppressive response><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><improved><instrumentation><malignancy><meeting><meetings><member><migration><model of data><model the data><modeling of the data><molecular imaging><molecule imaging><multi-modality><multi-photon><multimodality><multiparametric imaging><multiphoton excitation microscopy><multiphoton microscopy><nanofabricate><nanofabrication><neoplasm immunology><neoplasm immunotherapy><neoplasm/cancer><new technology><next generation><novel><novel technologies><oncologic imaging><oncology imaging><optic imaging><optical><optical imaging><pancreatic malignancy><resolutions><response><tech development><technology development><therapeutic T-cell platform><thymus derived lymphocyte><tool><transgenic T- cells><tumor><tumor imaging><tumor immune microenvironment><tumor immune therapy><tumor immunology><tumor immunotherapy><tumor microenvironment><tumor-immune system interactions><virtual><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paolo Provenzano

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Good lead · 48/100
Large award
Active award
Team-scale grant
$1,349,589
FY 2026

Project Title

Center for Multiparametric Imaging of Tumor Immune Microenvironments

Grant Number:

5U54CA268069-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

12/9/2021

End Date:

11/30/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This project proposes an integrated suite of microscopy and data analysis advances that would enable quantitative, mechanistic analysis of immune-microenvironment dynamics in poor prognosis solid tumors. While immunotherapies are showing remarkable clinical responses in some advanced cancers, to dat...

Research Terms

<Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Biologic Models><Biological Models><Body Tissues><Brain Cancer><Cancer Biology><Cancer Patient><Cancer Treatment><Cancers><Cell Body><Cell Function><Cell Physiology><Cell Process><Cell-Extracellular Matrix><Cells><Cellular Function><Cellular Immune Function><Cellular Physiology><Cellular Process><Cellular immunotherapy><Clinical><Collaborations><Complex><Computer Analysis><Data><Data Analyses><Data Analysis><Development><Dimensions><ECM><Effectiveness><Engineering><Environment><Extracellular Matrix><FLIM imaging><Fingerprint><GEM model><GEMM model><Genetically Engineered Mouse><Genome engineering><Goals><Image><Imaging technology><Immune mediated therapy><Immune response><Immunologically Directed Therapy><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Infrastructure><Institution><Leadership><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant Tumor of the Brain><Malignant neoplasm of brain><Malignant neoplasm of pancreas><Microfabrication><Microscopy><Model System><Modeling><Molecular><Oncology><Oncology Cancer><Optics><Pancreas Cancer><Pancreatic Cancer><Persons><Play><Prognosis><Publishing><Regimen><Research><Resolution><Seminal><Sight><Solid Neoplasm><Solid Tumor><Spectroscopy><Spectrum Analyses><Spectrum Analysis><Subcellular Process><Sum><T cell based immune therapy><T cell based therapeutics><T cell based therapy><T cell directed therapies><T cell immune therapy><T cell immunotherapy><T cell infiltration><T cell targeted therapeutics><T cell therapy><T cell treatment><T cell-based immunotherapy><T cell-based treatment><T cellular immunotherapy><T cellular therapy><T lymphocyte based immunotherapy><T lymphocyte based therapy><T lymphocyte therapeutic><T lymphocyte treatment><T-Cells><T-Lymphocyte><T-cell therapeutics><T-cell transfer therapy><Technology><Testing><Time><Tissue imaging><Tissues><Tumor Immunity><Vision><Work><adoptive T cell transfer><adoptive T lymphocyte transfer><adoptive T-cell therapy><anti-cancer immunotherapy><anti-cancer therapy><anti-tumor immune response><anti-tumor immune therapy><anti-tumor immunity><anti-tumor immunotherapy><anticancer immunotherapy><antitumor immunity><biophysical model><cancer imaging><cancer immunity><cancer immunology><cancer immunotherapy><cancer microenvironment><cancer therapy><cancer-directed therapy><cell behavior><cell engineering><cell imaging><cell-based immunotherapy><cellular behavior><cellular engineering><cellular imaging><check point blockade><checkpoint blockade><computational analyses><computational analysis><computer analyses><crosslink><data interpretation><data modeling><design><designing><developmental><engineered T cells><experience><fluorescence life-time imaging><fluorescence life-time imaging microscopy><fluorescence lifetime imaging><fluorescence lifetime imaging microscopy><genetically engineered T-cells><genetically engineered mouse model><genetically engineered murine model><host response><imaging><imaging platform><immune cell therapy><immune check point blockade><immune checkpoint blockade><immune function><immune microenvironment><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive microenvironment><immunosuppressive response><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><improved><instrumentation><malignancy><meeting><meetings><member><migration><model of data><model the data><modeling of the data><molecular imaging><molecule imaging><multi-modality><multi-photon><multimodality><multiparametric imaging><multiphoton excitation microscopy><multiphoton microscopy><nanofabricate><nanofabrication><neoplasm immunology><neoplasm immunotherapy><neoplasm/cancer><new technology><next generation><novel><novel technologies><oncologic imaging><oncology imaging><optic imaging><optical><optical imaging><pancreatic malignancy><resolutions><response><tech development><technology development><therapeutic T-cell platform><thymus derived lymphocyte><tool><transgenic T- cells><tumor><tumor imaging><tumor immune microenvironment><tumor immune therapy><tumor immunology><tumor immunotherapy><tumor microenvironment><tumor-immune system interactions><virtual><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DIANNA M MILEWICZ

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, HOUSTON, TX

Good lead · 46/100
Training-friendly
Above-average budget
Active award
$528,040
FY 2025

Project Title

Medical Scientist Training Program

Grant Number:

5T32GM150524-03

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

8/23/2023

End Date:

6/30/2028

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.
  • • Award size is strong enough to merit immediate review.

Project Abstract

The mission of our multi-institutional MSTP, comprised of The University of Texas Health Science Center at Houston (UTHealth Houston), The University of Texas MD Anderson Cancer Center (MDACC), and in conjunction with The University of Puerto Rico Medical Sciences Campus School of Medicine (UPR), is...

Research Terms

<Medical><Scientist><Training Programs>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anna R. Giuliano

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Good lead · 46/100
Likely hiring
Solid budget
Active award
$337,724
FY 2025

Project Title

Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study)

Grant Number:

5R01CA274950-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/12/2022

End Date:

8/31/2028

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT Oropharyngeal cancer (OPC) is predominantly caused by HPV 16 and other oncogenic HPV types and disproportionately impacts men and people living with HIV (PLWH). There is no reliable method to detect OPC pre-cancerous lesions for secondary prevention. Trials assessing efficacy of the 9vHPV v...

Research Terms

<AIDS Virus><Aberrant DNA Methylation><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Age><Aging><Alcohol Chemical Class><Alcohols><Americas><Anal Cancer><Anatomic Sites><Anatomic structures><Anatomy><Anti-Oncogenes><Antioncogenes><Anus Cancer><Area><Behavioral><Biological Aging><Biological Markers><Burkitt Herpesvirus><Burkitt Lymphoma Virus><CD4 Lymphocyte Count><CD4+ Cell Counts><CD4+ Counts><Cancer Induction><Cancer Suppressor Genes><Cancers><Cervical Cancer><Cervix Cancer><Chronic><Clinical><Clinical Data><Collaborations><Country><Data><Dental Care><Dental Hygiene><Dental Procedure><Development><Disproportionate number of men><Disproportionately impacts males><Disproportionately in men><EB virus><EBV><Early Diagnosis><Emerogenes><Epstein Barr Virus><Exclusion><Funding><Future><Goals><Grant><Gum Disease><HHV-4><HHV4><HIV><HIV infected men><HIV positive men><HIV therapy><HIV+ men><HPV><HPV + oropharyngeal carcinoma><HPV 16><HPV Vaccination><HPV Vaccine><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV detection><HPV driven cancers><HPV induced Oral Cancer><HPV induced cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV prevention><HPV related cancer of the mouth><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-16><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HPV16><History><Host Factor><Host Factor Protein><Human Herpesvirus 4><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus detection><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papilloma virus infection><Human papilloma virus type 16><Human papillomavirus 16><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus type 16><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immunes><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Incidence><Infection><Infectious Human Wart Virus><Infectious Mononucleosis Virus><Inflammation><Infrastructure><Integration Host Factors><Knowledge><LAV-HTLV-III><Latin America><Latin American><Literature><Location><Lymphadenopathy-Associated Virus><Males living with HIV><Malignant Anal Neoplasm><Malignant Anal Tumor><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Malignant Tumor of the Anus><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of anus><Malignant neoplasm of cervix uteri><Measures><Men with HIV><Methods><Methylation><Mouth Cancer><Natural History><Nested Case-Control Study><Onco-Suppressor Genes><Oncogenes-Tumor Suppressors><Oncogenic><Oral><Oral Cancer><Oral Hygiene><Oral health><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Parodontosis><Patients><Periodontal Diseases><Persons><Policies><Population><Predictive Factor><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Prospective Studies><Recessive Oncogenes><Recording of previous events><Reproducibility><Research><Research Specimen><Risk><Risk Factors><Secondary Lesion><Secondary Prevention><Services><Sex Behavior><Sexual Activity><Sexual Behavior><Specimen><T4 Lymphocyte Count><Testing><Tobacco Consumption><Tobacco use><Tooth Loss><Tumor Suppressing Genes><Tumor Suppressor Genes><Uterine Cervix Cancer><Vaccination><Vaccines><Viral><Virus-HIV><Visit><Woman><accelerated aging><accelerated biological age><accelerated biological aging><active followup><age acceleration><ages><anal squamous cell carcinoma><bio-markers><biologic marker><biological age><biological process of age><biomarker><biomarker identification><cancer risk><carcinogenesis><care utilization><co-infection><coinfection><dental health><dental service><determine efficacy><developmental><disease risk><disorder risk><disproportionately affects males><disproportionately affects men><disproportionately concentrated among men><disproportionately distributed among men><disproportionately higher among men><disproportionately impacts men><disproportionately occurs in men><early detection><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><epigenetic biomarker><epigenetic marker><evaluate efficacy><examine efficacy><follow up><follow-up><followed up><followup><high risk><histories><human papilloma virus 16><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><identification of biomarkers><identification of new biomarkers><infection mouth><male><male bias><male predominance><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><malleable risk><man living with HIV><marker identification><men><men diagnosed with HIV><men disproportionately diagnosed><men disproportionately experience><men experience disproportionate rates><men infected with HIV><men living with HIV><modifiable risk><multidisciplinary><neoplasm/cancer><novel><old age><oncosuppressor gene><oral HPV><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus><oral human papillomavirus infection><oral infection><oral infectious><oral oncogenic HPV><oral papillomavirus infection><periodontal disorder><periodontium disease><periodontium disorder><precancer><precancerous><predominantly affecting men><premalignant><prevent><prevent HPV><prevent human papillomavirus><preventing><programs><screening><screenings><sex activity><sexual activities><social factors><tobacco product use><type 16 Human papilloma virus><type 16 Human papillomavirus><wart virus><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lifang Hou

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 46/100
Likely hiring
Solid budget
Active award
$289,303
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

3R01CA274952-04S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROBERT Leo MURPHY

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 46/100
Likely hiring
Solid budget
Active award
$289,303
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

3R01CA274952-04S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Imran Morhason - Bello

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Good lead · 46/100
Likely hiring
Solid budget
Active award
$289,303
FY 2025

Project Title

Epigenetic study of oral HPV infection-associated oral cancer in people living with HIV in Nigeria

Grant Number:

3R01CA274952-04S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2026

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT The long-term goals of this project are to a) understand the epidemiology of Human papillomavirus virus (HPV)- associated oral and oropharyngeal cancers (OOPC) among people living with HIV (PLWH) as well as the role of epigenetic biomarkers in OOPC, and b) to develop potenti...

Research Terms

<AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Africa><Africa South of the Sahara><Age><Area><Assay><Benign><Bioassay><Biological Assay><Biology><Biopsy><Biopsy Sample><Biopsy Specimen><Body Tissues><Branch Hospitals><Buccal Cavity><Buccal Cavity Head and Neck><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8><CD8B><CD8B1><CD8B1 gene><Cancer Patient><Cancers><Cavitas Oris><Cell Count><Cell Number><Chronic><Clinical><Code><Coding System><Collaborations><Country><Cytology><DNA><DNA Methylation><DNA methylation profiling><Data><Deoxyribonucleic Acid><Development><Diagnosis><Disease><Disorder><Early Diagnosis><Epidemiology><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><Exogenous Factors><Funding><Future><Gene Expression><Genotype><Goals><HIV><HIV Infections><HPV><HPV + oropharyngeal carcinoma><HPV [-]><HPV associated cervical cancer><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV cervical cancer><HPV driven cancers><HPV driven cervical cancer><HPV induced Oral Cancer><HPV induced cancer><HPV induced cervical cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV negative><HPV oropharyngeal cancer><HPV positive><HPV positive cervical cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV related cancer of the mouth><HPV related cervical cancer><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV(+)><HPV(-)><HPV+><HPV+ OPC><HPV+ cancer><HPV+ cervical cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-High Risk><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health Care Facility><Health Facilities><Hereditary><High Prevalence><High Risk Oncogenic HPV><High risk HPV><High risk Human Papillomavirus><High risk Human papilloma virus><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immune system><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Individual><Infectious Human Wart Virus><Inflammation><Inherited><Intervention><LAV-HTLV-III><LYT3><Lesion><Literature><Longitudinal Studies><Lymphadenopathy-Associated Virus><Malignant><Malignant - descriptor><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Medicine><Methyl-Seq><MethylSeq><Methylation sequencing><Modification><Mouth><Mouth Cancer><Mouthwash><Nigeria><Nigerian><Oncogenic><Oral><Oral Cancer><Oral Sex><Oral cavity><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Outcome><Participant><Patients><Persons><Predisposition><Prevalence><Prevention><Preventive><Public Health><Radiation Oncology><Research><Research Resources><Resources><Risk><Risk Factors><Role><Sampling><Satellite Hospitals><Screening for cancer><Sex Behavior><Sexual Activity><Sexual Behavior><Site><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><Swab><T4 Cells><T4 Lymphocytes><Testing><Tissues><Transmission><United States><Universities><Viral><Viral Burden><Viral Load><Viral Load result><Virus><Virus-HIV><absence of HPV><absence of human papillomavirus><active followup><adult youth><ages><antiretroviral therapy><antiretroviral treatment><biomarker development><cancer biomarkers><cancer markers><care facilities><co-infection><cohort><coinfection><college><collegiate><cost effective><developmental><early biomarkers><early cancer detection><early detection><early detection biomarkers><early detection markers><epidemiologic><epidemiological><epigenetic biomarker><epigenetic marker><epigenetically><experience><follow up><follow-up><followed up><followup><genome scale><genome-wide><genomewide><hazard><hrHPV><human papillomavirus +><human papillomavirus associated cervical cancer><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus cervical cancer><human papillomavirus driven cancers><human papillomavirus driven cervical cancer><human papillomavirus induced cervical cancer><human papillomavirus mediated oropharynx cancer><human papillomavirus negative><human papillomavirus positive><human papillomavirus positive cervical cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus related cervical cancer><human papillomavirus+ cervical cancer><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><hypoimmunity><immune deficiency><immunodeficiency><improved><long-term study><longitudinal outcome studies><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><methylation biomarker><methylation marker><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><oncology service><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus infection><oral oncogenic HPV><oral papillomavirus infection><precancer><precancerous><predictive biological marker><predictive biomarkers><predictive marker><predictive molecular biomarker><premalignant><presence of HPV><presence of human papillomavirus><prognostic><progression risk><prospective><recruit><screening><screening cancer patients><screenings><sex><sex activity><sexual activities><social role><specific biomarkers><therapeutic target><transmission process><trend><tumor><wart virus><young adult><young adult age><young adulthood>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stefan David Baral

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$223,400
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S1

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory D Kirk

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$223,400
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S1

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ponsiano Ocama

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$223,400
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S1

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM L. BOXER

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$174,552
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S1

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley F Boeve

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$174,552
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S1

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HOWARD J ROSEN

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$174,552
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S1

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM L. BOXER

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$123,012
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S3

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley F Boeve

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$123,012
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S3

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HOWARD J ROSEN

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$123,012
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S3

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAM L. BOXER

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$89,338
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S4

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley F Boeve

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$89,338
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S4

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HOWARD J ROSEN

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$89,338
FY 2025

Project Title

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2)

Grant Number:

3U19AG063911-06S4

Activity Code:

U19

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/15/2019

End Date:

8/31/2030

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT – ALLFTD2: OVERALL SECTION Frontotemporal lobar degeneration (FTLD) is an overarching term for a group of neurodegenerative disorders associated with the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins—microtubule associated protein ...

Research Terms

<AD dementia><AD related dementia><ADRD><Abbreviations><Accuracy of Diagnosis><Achievement><Achievement Attainment><Address><Affect><Age><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Applications Grants><Autopsy><Behavioral><Biological><Biological Markers><Blood><Blood Reticuloendothelial System><Blood Sample><Blood specimen><Body Tissues><C9ORF72><Cerebrospinal Fluid><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Cognitive><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disease Progression><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Funding><Genes><Genetic><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Grant Proposals><Hereditary><History><Image><Individual><Industry><Infrastructure><Inherited><Knowledge><Laboratories><MAPT gene><MAPT protein><MRI Scans><MT-bound tau><MTBT1><Magnetic Resonance Imaging Scan><Manuscripts><Measurement><Measures><Methodology><Methods><Microtubule-Associated Proteins><Molecular Weight><Motor><Mutate><Mutation><NIH><National Institutes of Health><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><North America><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Persons><Phase><Preparation><Primary Senile Degenerative Dementia><Progranulin><Protocol><Protocols documentation><Publishing><Recommendation><Recording of previous events><Research><Sampling><Scanning><Symptoms><Technology Assessment><Testing><Time><Tissues><United States National Institutes of Health><ages><arm><bio-markers><biologic><biologic marker><biomarker><cerebral spinal fluid><chromosome 9 open reading frame 72><cohort><computer based prediction><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><depository><design><designing><developmental><diagnostic accuracy><effective therapy><effective treatment><enroll><familial disorder><front temporal dementia><frontal lobe dementia><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><gene product><genome mutation><granulin precursor><high risk><histories><imaging><improved><insoluble aggregate><kindred><meeting><meetings><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><necropsy><neural imaging><neuro-imaging><neurodegenerative illness><neuroimaging><neurological imaging><neuropathologic><neuropathological><neuropathology><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><patient advocacy group><phenotypic data><postmortem><predictive modeling><preparations><prevent><preventing><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><remote assessment><remote evaluation><repository><sample collection><senile dementia of the Alzheimer type><specific biomarkers><specimen collection><spinal fluid><tau><tau Proteins><tau factor><tool><treatment trial><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stefan David Baral

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$39,960
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S2

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory D Kirk

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$39,960
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S2

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ponsiano Ocama

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 44/100
Likely hiring
Active award
Team-scale grant
$39,960
FY 2025

Project Title

Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study

Grant Number:

3U01CA275117-02S2

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/3/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

Project Summary: For >18 years, Makerere and Johns Hopkins universities have partnered in Uganda to characterize the epidemiology of hepatitis B (HBV) and HIV co-infection, define the subsequent sequelae including hepatocellular carcinoma (HCC) and advance clinical management. Through an NCI-support...

Research Terms

<0-4 weeks old><21+ years old><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Adoption><Adult><Adult Human><Africa><Africa South of the Sahara><Aging><Anti-viral Therapy><Application Context><Area><Assess implementation><Attention><Birth><Cancer Control><Cancer Control Science><Cancer Intervention><Cancer Treatment><Cancers><Caring><Chronic Hepatitis B><Clinic><Clinical><Clinical Management><Communicable Diseases><Communities><Complex><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Data><Detection><Diagnosis><Diagnostic><Diagnostic Services><Diagnostic tests><Dose><Early identification><Economic Income><Economical Income><Effectiveness><Elements><Epidemiology><Funding><Goals><Government><Groups at risk><HBV><HBV Vaccination><HBV disease><HBV therapeutic><HBV therapy><HBV treatment><HCV infection><HIV><HIV and HBV><HIV and hepatitis B><HIV-HBV><HIV/HBV><HIV/hepatitis B><HIV/hepatitis B virus><Hep B vaccination><HepB><Hepatic Cancer><Hepatic Disorder><Hepatitis><Hepatitis B><Hepatitis B Therapeutic><Hepatitis B Therapy><Hepatitis B Treatment><Hepatitis B Vaccination><Hepatitis B Virus><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis C virus infection><Hepatocarcinoma><Hepatocellular Carcinoma><Hepatocellular cancer><Hepatoma><Human Immunodeficiency Viruses><Hybrids><Implementation assessment><Incidence><Income><Infectious Diseases><Infectious Disorder><Infrastructure><International><Intervention><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Leadership><Link><Liver Cells Carcinoma><Liver diseases><Lymphadenopathy-Associated Virus><Maintenance><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant neoplasm of liver><Measures><Mediating><Methods><Modeling><Modification><Monitor><Newborn Infant><Newborns><Parturition><Patients><People at risk><Persons><Persons at risk><Phase><Population><Populations at Risk><Predisposition><Pregnant Women><Prevention><Primary Malignant Neoplasm of Liver><Primary Prevention><Primary carcinoma of the liver cells><Primary liver cancer><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Rural><Services><Site><Stage at Diagnosis><Staging><Sub-Saharan Africa><Subsaharan Africa><Susceptibility><System><Uganda><Universities><Vaccination><Viral Hepatitis B><Virus-HIV><West Nile><Work><active followup><adulthood><antenatal care><anti-cancer research><anti-cancer therapy><antiretroviral therapy><antiretroviral treatment><assess effectiveness><barriers to implementation><cancer care><cancer research><cancer therapy><cancer-directed therapy><care delivery><chronic HBV infection><chronic hepatitis B infection><chronic hepatitis B virus infection><chronic infections with hepatitis B virus><chronically infected with HBV><chronically infected with hepatitis B><clinical infrastructure><co-infection><coinfection><contextual factors><cost effectiveness><determine effectiveness><diagnosis service><effectiveness and implementation trial><effectiveness assessment><effectiveness evaluation><effectiveness/implementation hybrid trial><effectiveness/implementation trial><epidemiologic><epidemiological><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine effectiveness><expectant mother><expectant women><expecting mother><expecting women><follow up><follow-up><followed up><followup><hep B><hepatic disease><hepatitis B virus and human immunodeficiency virus><hepatitis B virus disease><hepatitis B virus vaccination><hepatitis C infection><hepatopathy><immunization against hepatitis B><implementation barriers><implementation challenges><implementation evaluation><implementation science><implementation strategy><incomes><individuals who are pregnant><infected with HCV><infected with hepatitis C><infected with hepatitis C virus><infection by hepatitis c virus><infection with HCV><infection with hepatitis C><infection with hepatitis C virus><liver cancer><liver carcinoma><liver disorder><liver malignancy><malignancy><malignant liver tumor><mortality><neoplasm/cancer><newborn child><newborn children><people who are pregnant><pregnant females><pregnant mothers><pregnant people><pregnant populations><primary outcome><programs><reach, efficacy, adoption, implementation, and maintenance><recruit><research and methods><routine care><rural area><rural location><rural region><scale up><screening><screenings><secondary outcome><strategies for implementation><those who are pregnant><treatment services><vaccination against hepatitis B><viral infectious disease treatment><women who are pregnant>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kim Green

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$9,281,325
FY 2025

Project Title

UC Irvine MODEL-AD

Grant Number:

5U54AG054349-09

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2017

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT The goal of the University of California, Irvine MODEL-AD U54 Center is to develop novel mouse models of late- onset Alzheimer’s disease (LOAD), to deeply phenotype these and to make all data and mouse strains available to enable researchers to select the optimal mouse model and timepoints ...

Research Terms

<AD dementia><AD model><APOE><APOE e4><APOE-ε4><APOEε4><APP gene><ATAC sequencing><ATAC-seq><ATACseq><Academia><Affect><Aging><Alzheimer Disease 1 Protein><Alzheimer Disease Protease Nexin-II><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's Disease Amyloid Protein><Alzheimer's amyloid><Alzheimer's disease model><Alzheimer's disease risk><Alzheimer's disease therapy><Alzheimer's therapy><Alzheimers Dementia><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta A4 Precursor Protein><Amyloid Beta A4 Protein Precursor><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid of Aging and Alzheimer Disease Protein><Amyloid β><Amyloid β A4 Protein Precursor><Amyloid β-Peptide><Amyloid β-Protein><Animal Model><Animal Models and Related Studies><Animals><Apo-E><ApoE protein><Apolipoprotein E><Assay for Transposase-Accessible Chromatin using sequencing><Award><Aβ><Behavioral><Biochemical><Biochemistry><Bioinformatics><Biological Chemistry><Biological Markers><Blood Plasma><Body Tissues><Brain><Brain Nervous System><Brain imaging><CRISPR><CRISPR/Cas system><California><Cell Body><Cell Nucleus><Cells><Cerebralvascular Amyloid Peptide><Clustered Regularly Interspaced Short Palindromic Repeats><Communities><DNA mutation><Data><Data Bases><Data Set><Databases><Deposit><Deposition><Development><Diet><Disease><Disease Progression><Disorder><Electrophysiology><Electrophysiology (science)><Encephalon><Ensure><Evaluation><Expression Signature><Funding><GWA study><GWAS><Gene Expression><Gene Expression Profile><Generations><Genes><Genetic><Genetic Change><Genetic Risk><Genetic defect><Genetic mutation><Genome><Goals><Histology><Human><Image><Individual><Industry><Infrastructure><International><Intervention><Investigation><Investigators><Knowledge Portal><Knowledge base Portal><Knowledgebase Portal><Late Onset Alzheimer Disease><Liquid substance><MT-bound tau><Medical><Methods><Mice><Mice Mammals><Modeling><Modern Man><Mouse Strains><Murine><Mus><Mutation><NIH><Names><National Institutes of Health><Neurophysiology / Electrophysiology><Nomenclature><Nucleus><Outcome><Pathology><Pathway interactions><Persons><Phase><Phenocopy><Phenotype><Physiology><Plasma><Plasma Serum><Population><PreA4><Primary Senile Degenerative Dementia><Protease Nexin II><Proteomics><Protocol><Protocols documentation><RNA Seq><RNA sequencing><RNAseq><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk-associated variant><Rodent><Rodentia><Rodents Mammals><Sampling><Series><Societies><Synapses><Synaptic><Technology><Testing><The Jackson Laboratory><Therapeutic><Tissues><United States National Institutes of Health><Universities><Validation><Variant><Variation><Work><a beta peptide><abeta><alzheimer model><alzheimer risk><amyloid beta><amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) protein, human><amyloid-b protein><apo E-4><apo E4><apo epsilon4><apoE epsilon 4><apoE-4><apoE4><apolipoprotein E epsilon 4><apolipoprotein E-4><apolipoprotein E4><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><base><bases><beta amyloid fibril><bio-markers><biologic marker><biomarker><biomarker validation><brain visualization><cognitive assessment><cognitive testing><combat><data base><data management><data modeling><design><designing><developmental><diets><disease model><disease subgroups><disease subtype><disorder model><disorder subtype><economic impact><effective therapy><effective treatment><efficacious therapy><efficacious treatment><electrophysiological><environmental stresses><environmental stressor><fluid><forging><gene expression pattern><gene expression signature><gene replacement><genome mutation><genome wide association><genome wide association scan><genome wide association study><genomewide association scan><genomewide association study><human disease><human model><human protease nexin 2><image-based method><imaging><imaging method><imaging modality><improved><insight><late onset alzheimer><life span><lifespan><lipidomics><liquid><marker validation><member><metabolism measurement><metabolome><metabolomics><metabonome><metabonomics><microbiome><microtubule bound tau><microtubule-bound tau><model of animal><model of data><model of human><model organism><model the data><modeling of the data><mouse model><murine model><name><named><naming><neural imaging><neuro-imaging><neuro-vascular><neuroimaging><neurological imaging><neurovascular><novel><open source><pathway><primary degenerative dementia><programs><protease nexin 2><response><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><scRNA sequencing><scRNA-seq><screening><screenings><senile dementia of the Alzheimer type><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><socio-economic><socio-economically><socioeconomically><socioeconomics><soluble amyloid precursor protein><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><super high resolution><superresolution><synapse><tau><tau Proteins><tau factor><therapeutic evaluation><therapeutic testing><therapeutically effective><transcriptional profile><transcriptional signature><transcriptome sequencing><transcriptomic sequencing><ultra high resolution><validations><web site><website><whole genome association analysis><whole genome association study><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

FRANK M LAFERLA

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$9,281,325
FY 2025

Project Title

UC Irvine MODEL-AD

Grant Number:

5U54AG054349-09

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2017

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT The goal of the University of California, Irvine MODEL-AD U54 Center is to develop novel mouse models of late- onset Alzheimer’s disease (LOAD), to deeply phenotype these and to make all data and mouse strains available to enable researchers to select the optimal mouse model and timepoints ...

Research Terms

<AD dementia><AD model><APOE><APOE e4><APOE-ε4><APOEε4><APP gene><ATAC sequencing><ATAC-seq><ATACseq><Academia><Affect><Aging><Alzheimer Disease 1 Protein><Alzheimer Disease Protease Nexin-II><Alzheimer Type Dementia><Alzheimer beta-Protein><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Amyloid beta-Protein><Alzheimer's Disease><Alzheimer's Disease Amyloid Protein><Alzheimer's amyloid><Alzheimer's disease model><Alzheimer's disease risk><Alzheimer's disease therapy><Alzheimer's therapy><Alzheimers Dementia><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta A4 Precursor Protein><Amyloid Beta A4 Protein Precursor><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid of Aging and Alzheimer Disease Protein><Amyloid β><Amyloid β A4 Protein Precursor><Amyloid β-Peptide><Amyloid β-Protein><Animal Model><Animal Models and Related Studies><Animals><Apo-E><ApoE protein><Apolipoprotein E><Assay for Transposase-Accessible Chromatin using sequencing><Award><Aβ><Behavioral><Biochemical><Biochemistry><Bioinformatics><Biological Chemistry><Biological Markers><Blood Plasma><Body Tissues><Brain><Brain Nervous System><Brain imaging><CRISPR><CRISPR/Cas system><California><Cell Body><Cell Nucleus><Cells><Cerebralvascular Amyloid Peptide><Clustered Regularly Interspaced Short Palindromic Repeats><Communities><DNA mutation><Data><Data Bases><Data Set><Databases><Deposit><Deposition><Development><Diet><Disease><Disease Progression><Disorder><Electrophysiology><Electrophysiology (science)><Encephalon><Ensure><Evaluation><Expression Signature><Funding><GWA study><GWAS><Gene Expression><Gene Expression Profile><Generations><Genes><Genetic><Genetic Change><Genetic Risk><Genetic defect><Genetic mutation><Genome><Goals><Histology><Human><Image><Individual><Industry><Infrastructure><International><Intervention><Investigation><Investigators><Knowledge Portal><Knowledge base Portal><Knowledgebase Portal><Late Onset Alzheimer Disease><Liquid substance><MT-bound tau><Medical><Methods><Mice><Mice Mammals><Modeling><Modern Man><Mouse Strains><Murine><Mus><Mutation><NIH><Names><National Institutes of Health><Neurophysiology / Electrophysiology><Nomenclature><Nucleus><Outcome><Pathology><Pathway interactions><Persons><Phase><Phenocopy><Phenotype><Physiology><Plasma><Plasma Serum><Population><PreA4><Primary Senile Degenerative Dementia><Protease Nexin II><Proteomics><Protocol><Protocols documentation><RNA Seq><RNA sequencing><RNAseq><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Reticuloendothelial System, Serum, Plasma><Risk-associated variant><Rodent><Rodentia><Rodents Mammals><Sampling><Series><Societies><Synapses><Synaptic><Technology><Testing><The Jackson Laboratory><Therapeutic><Tissues><United States National Institutes of Health><Universities><Validation><Variant><Variation><Work><a beta peptide><abeta><alzheimer model><alzheimer risk><amyloid beta><amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) protein, human><amyloid-b protein><apo E-4><apo E4><apo epsilon4><apoE epsilon 4><apoE-4><apoE4><apolipoprotein E epsilon 4><apolipoprotein E-4><apolipoprotein E4><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><base><bases><beta amyloid fibril><bio-markers><biologic marker><biomarker><biomarker validation><brain visualization><cognitive assessment><cognitive testing><combat><data base><data management><data modeling><design><designing><developmental><diets><disease model><disease subgroups><disease subtype><disorder model><disorder subtype><economic impact><effective therapy><effective treatment><efficacious therapy><efficacious treatment><electrophysiological><environmental stresses><environmental stressor><fluid><forging><gene expression pattern><gene expression signature><gene replacement><genome mutation><genome wide association><genome wide association scan><genome wide association study><genomewide association scan><genomewide association study><human disease><human model><human protease nexin 2><image-based method><imaging><imaging method><imaging modality><improved><insight><late onset alzheimer><life span><lifespan><lipidomics><liquid><marker validation><member><metabolism measurement><metabolome><metabolomics><metabonome><metabonomics><microbiome><microtubule bound tau><microtubule-bound tau><model of animal><model of data><model of human><model organism><model the data><modeling of the data><mouse model><murine model><name><named><naming><neural imaging><neuro-imaging><neuro-vascular><neuroimaging><neurological imaging><neurovascular><novel><open source><pathway><primary degenerative dementia><programs><protease nexin 2><response><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><scRNA sequencing><scRNA-seq><screening><screenings><senile dementia of the Alzheimer type><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><socio-economic><socio-economically><socioeconomically><socioeconomics><soluble amyloid precursor protein><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><super high resolution><superresolution><synapse><tau><tau Proteins><tau factor><therapeutic evaluation><therapeutic testing><therapeutically effective><transcriptional profile><transcriptional signature><transcriptome sequencing><transcriptomic sequencing><ultra high resolution><validations><web site><website><whole genome association analysis><whole genome association study><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANGELA M. GRONENBORN

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$5,045,139
FY 2025

Project Title

Pittsburgh Center for HIV Protein Interactions (PCHPI)

Grant Number:

5U54AI170791-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2022

End Date:

4/30/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL Antiretroviral therapy has turned HIV/AIDS into a chronic disease, yet the emergence of drug-resistant variants and comorbidities after long-term ART remain a concern. Therefore, alternative approaches to inhibit infection and cure AIDS are needed. The proposed “Pittsburgh Center for HIV Pro...

Research Terms

<AIDS><AIDS Virus><AIDS/HIV><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Area><Award><Binding><Capsid><Capsid Proteins><Cell Body><Cell Nucleus><Cell membrane><Cells><Chromatin><Chronic Disease><Chronic Illness><Coat Proteins><Collaborations><Communication><Complex><Computing Methodologies><Cryo-electron Microscopy><Cryoelectron Microscopy><Cyclophilin A><Cytoplasmic Domain><Cytoplasmic Membrane><Cytoplasmic Tail><Data><Dependence><Development><Drug Targeting><Drug resistance><Electron Cryomicroscopy><Ensure><Fostering><GP-41><Generations><Genome><Goals><HIV><HIV-1><HIV-I><HIV/AIDS><HIV1><Host Factor><Host Factor Protein><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Immune Evasion><Immunologic Factors><Immunological Factors><In Situ><Individual><Infection><Institution><Integrase><Integrase Inhibitors><Integration Host Factors><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Length><Lymphadenopathy-Associated Virus><Mentors><Methodology><Methods><Microscopy><Mission><Modeling><Molecular><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><NIAID><NMR Spectrometer><NMR Spectroscopy><National Institute of Allergy and Infectious Disease><Non-Polyadenylated RNA><Nuclear><Nuclear Import><Nucleic Acids><Nucleus><Pathway interactions><Plasma Membrane><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Principal Investigator><Productivity><Program Development><Proteins><Proviruses><QOL><Quality of life><RNA><RNA Gene Products><Recombinants><Research><Research Associate><Research Personnel><Research Support><Researchers><Resistance development><Resistant development><Resolution><Ribonucleic Acid><Ribonucleoproteins><Role><Scientist><Structural Biologist><Structure><Technology><Time><Training><Variant><Variation><Viral><Viral Coat Proteins><Viral Genome><Viral Outer Coat Protein><Viral Reverse Transcription><Virion><Virus><Virus Particle><Virus-HIV><Work><antiretroviral therapy><antiretroviral treatment><career><career development><chromatin protein><chronic disorder><co-morbid><co-morbidity><comorbidity><computational methodology><computational methods><computer based method><computer methods><computing method><conformation><conformational><conformational state><conformationally><conformations><cryo-EM><cryoEM><cryogenic electron microscopy><design><designing><developing resistance><developmental><drug resistant><expectation><experience><fundamental research><glycoprotein 41><graduate student><immune evasive><immunologic substance><immunological substance><improved><inhibitor><insight><novel><nuclear magnetic resonance spectroscopy><pathway><plasmalemma><post-doc><post-doctoral><post-doctoral trainee><programs><protein complex><research associates><resistance to Drug><resistant to Drug><resolutions><single molecule><small molecular inhibitor><small molecule inhibitor><social role><structural biology><tool><trafficking><virology><virus genome><virus host interaction>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tatyana Polenova

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$5,045,139
FY 2025

Project Title

Pittsburgh Center for HIV Protein Interactions (PCHPI)

Grant Number:

5U54AI170791-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2022

End Date:

4/30/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL Antiretroviral therapy has turned HIV/AIDS into a chronic disease, yet the emergence of drug-resistant variants and comorbidities after long-term ART remain a concern. Therefore, alternative approaches to inhibit infection and cure AIDS are needed. The proposed “Pittsburgh Center for HIV Pro...

Research Terms

<AIDS><AIDS Virus><AIDS/HIV><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Area><Award><Binding><Capsid><Capsid Proteins><Cell Body><Cell Nucleus><Cell membrane><Cells><Chromatin><Chronic Disease><Chronic Illness><Coat Proteins><Collaborations><Communication><Complex><Computing Methodologies><Cryo-electron Microscopy><Cryoelectron Microscopy><Cyclophilin A><Cytoplasmic Domain><Cytoplasmic Membrane><Cytoplasmic Tail><Data><Dependence><Development><Drug Targeting><Drug resistance><Electron Cryomicroscopy><Ensure><Fostering><GP-41><Generations><Genome><Goals><HIV><HIV-1><HIV-I><HIV/AIDS><HIV1><Host Factor><Host Factor Protein><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Immune Evasion><Immunologic Factors><Immunological Factors><In Situ><Individual><Infection><Institution><Integrase><Integrase Inhibitors><Integration Host Factors><Investigators><Knowledge><LAV-HTLV-III><Laboratories><Length><Lymphadenopathy-Associated Virus><Mentors><Methodology><Methods><Microscopy><Mission><Modeling><Molecular><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><NIAID><NMR Spectrometer><NMR Spectroscopy><National Institute of Allergy and Infectious Disease><Non-Polyadenylated RNA><Nuclear><Nuclear Import><Nucleic Acids><Nucleus><Pathway interactions><Plasma Membrane><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Principal Investigator><Productivity><Program Development><Proteins><Proviruses><QOL><Quality of life><RNA><RNA Gene Products><Recombinants><Research><Research Associate><Research Personnel><Research Support><Researchers><Resistance development><Resistant development><Resolution><Ribonucleic Acid><Ribonucleoproteins><Role><Scientist><Structural Biologist><Structure><Technology><Time><Training><Variant><Variation><Viral><Viral Coat Proteins><Viral Genome><Viral Outer Coat Protein><Viral Reverse Transcription><Virion><Virus><Virus Particle><Virus-HIV><Work><antiretroviral therapy><antiretroviral treatment><career><career development><chromatin protein><chronic disorder><co-morbid><co-morbidity><comorbidity><computational methodology><computational methods><computer based method><computer methods><computing method><conformation><conformational><conformational state><conformationally><conformations><cryo-EM><cryoEM><cryogenic electron microscopy><design><designing><developing resistance><developmental><drug resistant><expectation><experience><fundamental research><glycoprotein 41><graduate student><immune evasive><immunologic substance><immunological substance><improved><inhibitor><insight><novel><nuclear magnetic resonance spectroscopy><pathway><plasmalemma><post-doc><post-doctoral><post-doctoral trainee><programs><protein complex><research associates><resistance to Drug><resistant to Drug><resolutions><single molecule><small molecular inhibitor><small molecule inhibitor><social role><structural biology><tool><trafficking><virology><virus genome><virus host interaction>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lee Ellen Buenconsejo-Lum

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,896,177
FY 2025

Project Title

Ola HAWAII

Grant Number:

5U54MD007601-39

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Area><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Inequality><Institution><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><access to health care><accessibility of health care><accessibility to health care><aspirate><base><bases><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jerris Robert Hedges

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,896,177
FY 2025

Project Title

Ola HAWAII

Grant Number:

5U54MD007601-39

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Area><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Inequality><Institution><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><access to health care><accessibility of health care><accessibility to health care><aspirate><base><bases><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kevin Sean Kimbro

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,833,611
FY 2025

Project Title

Center for Translational Research in Health Disparities

Grant Number:

5U54MD007602-38

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/7/1997

End Date:

3/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Morehouse School of Medicine (MSoM), since its inception, has been dedicated to addressing the health needs of urban and rural populations both in Georgia and across the nation. Embedded in the MSoM mission is the improvement of the overall health and well-being of individuals and communities; i...

Research Terms

<Address><Applications Grants><Area><Behavioral><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Center for Translational Science Activities><Clinical><Communities><Community Health><Community Networks><Consultations><Data Science><Dedications><Development><EXTMR><Education><Educational aspects><Educational workshop><Ensure><Extramural><Extramural Activities><Faculty><Faculty Recruitment><Floor><Fostering><Funding><Future Generations><Goals><Grant><Grant Proposals><Health><Health Care Professional><Health Care Providers><Health Disparities Research><Health Personnel><Health Professional><Health Services Evaluation><Health Services Research><Health disparities related research><High School Faculty><High School Teacher><Individual><Infectious Agent><Infrastructure><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><Investments><Knowledge><Laboratories><Leadership><Medical><Medical Care Research><Medical Education><Mentors><Minority><Mission><Modeling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Needles><Participant><Personal Satisfaction><Persons><Population><Population Research><Population-based research><Population-level research><Primary Health Care><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resources><Rural><Rural Population><Rural group><Rural people><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Schedule><Schools><Scientific Publication><Scientist><Secondary School Faculty><Secondary Teacher><Services><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Sight><Structure><Technology><Testing><Toxin><Training><Training Programs><Translational Research><Translational Science><United States><United States National Institutes of Health><Urban Population><Vaccines><Vision><Workshop><Writing><assess effectiveness><behavioral health><community based organizations><community engaged participatory research><community engaged research><community engagement><community marginalization><community organizations><community partnered research><community partners><community research><community-based health><community-based partners><community-engaged study><community-partnered study><consultation><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><determine effectiveness><developmental><disparity in health><effectiveness assessment><effectiveness evaluation><engagement with communities><evaluate effectiveness><examine effectiveness><experience><full professor><group of color><health care personnel><health care worker><health disparities science><health disparity><health disparity community><health disparity group><health disparity populations><health equity><health provider><health workforce><improved><individual of color><infectious organism><innovate><innovation><innovative><instructor><m-Health><mHealth><marginalized community><medical personnel><minority health><minority health disparity><mobile health><multidisciplinary><novel><outreach><pandemic><pandemic disease><people of color><person of color><population of color><programs><public health emergency><recruit teachers><research data dissemination><research dissemination><response><rural individual><rural under served><rural underserved><senior faculty><services research><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sq. ft><square foot><student engagement><student motivation><student participation><student research><student-led research><success><teacher recruitment><translation research><translational investigation><translational research center><translational sciences center><treatment provider><under served community><underserved community><urban group><urban individual><urban people><urban under served><urban underserved><visual function><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark Brian Reed

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,668,857
FY 2024

Project Title

SDSU FUERTE: Faculty United towards Excellence in Research and Transformational Engagement

Grant Number:

5U54CA267789-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

2/28/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – Project Summary San Diego State University (SDSU) is proposing a new program called SDSU FUERTE or Faculty Unified towards Excellence in Research and Transformational Engagement. The goal of SDSU FUERTE is to recruit a diverse, nine-person cohort of early career of health sciences faculty ...

Research Terms

<Academy><Acceleration><Address><Affect><Area><Biomedical Research><Climate><Cognitive Discrimination><Communities><Curriculum><Development><Development Plans><Discrimination><Disparities><Disparity><Diverse Workforce><Educational Curriculum><Eligibility><Eligibility Determination><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Sciences><Hispanic-serving Institution><Human><Individual><Individuals from minority><Individuals of minority><Institution><Institutionalization><Investigators><Knowledge><Latine><Latinx><Leadership><Mentors><Meteorological Climate><Minority><Minority Groups><Minority People><Minority Population><Minority individual><Modeling><Modern Man><NIH><National Institutes of Health><Obesity><Peer Review><Personal Satisfaction><Persons><Physical activity><Position><Positioning Attribute><Protocol Screening><Research><Research Personnel><Research Resources><Researchers><Resources><Scholarship><Schools><Science><Scientific Advances and Accomplishments><Secondary Schools><Secure><Students><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Tissue Growth><Training><Underrepresented Ethnic Minority><Underrepresented Minority><United States><United States National Institutes of Health><Universities><Work><Workplace Diversity><addiction><addictive disorder><adiposity><career><career development><climatic><cohort><community building><community engaged participatory research><community engaged research><community engagement><community partnered research><community-engaged study><community-partnered study><corpulence><design><designing><developmental><disparity in health><diversity, equity, and inclusiveness><early-career faculty><engagement with communities><equity, diversity, and inclusion><evidence base><experience><faculty development><faculty professional development><health disparity><health science research><implementation science><improved><innovate><innovation><innovative><instructor training><interest><lesson plans><model development><model developments><nutrition><ontogeny><programs><recruit><recruit teachers><scientific accomplishments><scientific advances><secondary education><skills><success><teacher development><teacher recruitment><tenure process><tenure track><under-representation of minorities><under-represented minority><underrepresentation of minorities><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maria Luisa Zuniga de Nuncio

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,668,857
FY 2024

Project Title

SDSU FUERTE: Faculty United towards Excellence in Research and Transformational Engagement

Grant Number:

5U54CA267789-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

2/28/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – Project Summary San Diego State University (SDSU) is proposing a new program called SDSU FUERTE or Faculty Unified towards Excellence in Research and Transformational Engagement. The goal of SDSU FUERTE is to recruit a diverse, nine-person cohort of early career of health sciences faculty ...

Research Terms

<Academy><Acceleration><Address><Affect><Area><Biomedical Research><Climate><Cognitive Discrimination><Communities><Curriculum><Development><Development Plans><Discrimination><Disparities><Disparity><Diverse Workforce><Educational Curriculum><Eligibility><Eligibility Determination><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Sciences><Hispanic-serving Institution><Human><Individual><Individuals from minority><Individuals of minority><Institution><Institutionalization><Investigators><Knowledge><Latine><Latinx><Leadership><Mentors><Meteorological Climate><Minority><Minority Groups><Minority People><Minority Population><Minority individual><Modeling><Modern Man><NIH><National Institutes of Health><Obesity><Peer Review><Personal Satisfaction><Persons><Physical activity><Position><Positioning Attribute><Protocol Screening><Research><Research Personnel><Research Resources><Researchers><Resources><Scholarship><Schools><Science><Scientific Advances and Accomplishments><Secondary Schools><Secure><Students><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Tissue Growth><Training><Underrepresented Ethnic Minority><Underrepresented Minority><United States><United States National Institutes of Health><Universities><Work><Workplace Diversity><addiction><addictive disorder><adiposity><career><career development><climatic><cohort><community building><community engaged participatory research><community engaged research><community engagement><community partnered research><community-engaged study><community-partnered study><corpulence><design><designing><developmental><disparity in health><diversity, equity, and inclusiveness><early-career faculty><engagement with communities><equity, diversity, and inclusion><evidence base><experience><faculty development><faculty professional development><health disparity><health science research><implementation science><improved><innovate><innovation><innovative><instructor training><interest><lesson plans><model development><model developments><nutrition><ontogeny><programs><recruit><recruit teachers><scientific accomplishments><scientific advances><secondary education><skills><success><teacher development><teacher recruitment><tenure process><tenure track><under-representation of minorities><under-represented minority><underrepresentation of minorities><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth O. Ofili

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,050,122
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

3U24MD015970-05S1

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Daniel F Sarpong

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,050,122
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

3U24MD015970-05S1

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul B. Tchounwou

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$4,050,122
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

3U24MD015970-05S1

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marissa Hall

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,755,600
FY 2025

Project Title

UNC Center of Tobacco Regulatory Science

Grant Number:

5U54DA060049-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2023

End Date:

12/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The US has made decades of progress in reducing cigarette smoking, but there are notable differences in menthol cigarette smoking and use of non-cigarette tobacco products including little cigars and e-cigarettes. We propose the U54 Program Project, “UNC Center of Tobacco Regulatory Science” to addr...

Research Terms

<21+ years old><Address><Adult><Adult Human><Attitude><Behavior><Belief><Cigar><Cigarette><Communication><Decision Making><Decrease health disparities><Development><Electronic cigarette><Epidemic><Funding><Goals><Health><Health disparity mitigation><Health disparity reduction><Investigators><Lower health disparities><Menthol><Mentorship><Mitigate health disparities><NIH><National Institutes of Health><Outcome><Population><Postdoc><Postdoctoral Fellow><Predisposition><Prevention><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Safety><Sales><Science><Seasons><Smoker><Susceptibility><Testing><Tobacco><Tobacco Consumption><Tobacco use><Training><United States><United States National Institutes of Health><Youth><Youth 10-21><adult youth><adulthood><alternative tobacco><career><cease smoking><cigarette smoking><cigarette use><cigarillos><design><designing><developmental><digital><e-cig><e-cig use><e-cigarette><e-cigarette use><ecig><ecig use><ecigarette><ecigarette use><electronic cigarette use><model-based simulation><models and simulation><mortality><multidisciplinary><non-cigarette products><non-cigarette tobacco product><novel><post-doc><post-doctoral><post-doctoral trainee><pre-doc><pre-doctoral><programs><quit smoking><reduce tobacco use><reduction in tobacco use><research associates><smoking cessation><stop smoking><success><tobacco control><tobacco flavor><tobacco product use><tobacco products><tobacco regulatory science><tobacco use reduction><vaping><young adult><young adult age><young adulthood><youth age>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KURT M. RIBISL

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,755,600
FY 2025

Project Title

UNC Center of Tobacco Regulatory Science

Grant Number:

5U54DA060049-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2023

End Date:

12/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The US has made decades of progress in reducing cigarette smoking, but there are notable differences in menthol cigarette smoking and use of non-cigarette tobacco products including little cigars and e-cigarettes. We propose the U54 Program Project, “UNC Center of Tobacco Regulatory Science” to addr...

Research Terms

<21+ years old><Address><Adult><Adult Human><Attitude><Behavior><Belief><Cigar><Cigarette><Communication><Decision Making><Decrease health disparities><Development><Electronic cigarette><Epidemic><Funding><Goals><Health><Health disparity mitigation><Health disparity reduction><Investigators><Lower health disparities><Menthol><Mentorship><Mitigate health disparities><NIH><National Institutes of Health><Outcome><Population><Postdoc><Postdoctoral Fellow><Predisposition><Prevention><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Safety><Sales><Science><Seasons><Smoker><Susceptibility><Testing><Tobacco><Tobacco Consumption><Tobacco use><Training><United States><United States National Institutes of Health><Youth><Youth 10-21><adult youth><adulthood><alternative tobacco><career><cease smoking><cigarette smoking><cigarette use><cigarillos><design><designing><developmental><digital><e-cig><e-cig use><e-cigarette><e-cigarette use><ecig><ecig use><ecigarette><ecigarette use><electronic cigarette use><model-based simulation><models and simulation><mortality><multidisciplinary><non-cigarette products><non-cigarette tobacco product><novel><post-doc><post-doctoral><post-doctoral trainee><pre-doc><pre-doctoral><programs><quit smoking><reduce tobacco use><reduction in tobacco use><research associates><smoking cessation><stop smoking><success><tobacco control><tobacco flavor><tobacco product use><tobacco products><tobacco regulatory science><tobacco use reduction><vaping><young adult><young adult age><young adulthood><youth age>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Noreen Mokuau

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,520,561
FY 2024

Project Title

Ola HAWAII

Grant Number:

5U54MD007601-38

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Area><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Inequality><Institution><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><access to health care><access to healthcare><accessibility of health care><accessibility to health care><accessibility to healthcare><aspirate><base><bases><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><healthcare access><healthcare accessibility><healthcare availability><healthcare policy><healthcare service access><healthcare service availability><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dong Liang

TEXAS SOUTHERN UNIVERSITY, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,494,598
FY 2025

Project Title

Center for Biomedical and Health Research at TSU

Grant Number:

2U54MD007605-32

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/1986

End Date:

5/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: Overall The Center for Biomedical and Health Research (CBMHR) at Texas Southern University (TSU) is requesting ~ $26.65 million to renew our U54 RCMI program for the cycle of 2025-2030. Currently, CBMHR has made significant strides in expanding research infrastructure, fostering community ...

Research Terms

<Address><Applications Grants><Area><Award><Basic Research><Basic Science><Behavioral><Behavioral Research><Bioinformatics><Biomedical Research><Black><Black race><Cancers><Certification><Cities><Clinical><Clinical Research><Clinical Study><Clinical Trials Design><Collaborations><Communities><Community Health><Community Health Aides><Community Outreach><Complex><Data Analyses><Data Analysis><Dedications><Development><Discipline><Disease><Disorder><EXTMR><Elderly><Ensure><Environment><Equipment><Evaluation><Event><Extramural><Extramural Activities><Fostering><Foundations><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><Goals><Grant><Grant Proposals><Health><Health Care Providers><Health Care Research><Health Instruction><Health Personnel><Health Tutoring><Health education><Hypertension><IRB><IRBs><Infrastructure><Institution><Institutional Review Boards><Investigators><Lead><Learning><Malignant Neoplasms><Malignant Tumor><Medical><Medical center><Mentors><Mentorship><Methodology><Mission><Monitor><NIH><National Institutes of Health><Outcome><Pb element><Pilot Projects><Population><Postpartum Hypertension><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Role><Rural Community><Scientific Publication><Secure><TNBC><Targeted Research><Technical Expertise><Texas><Trust><United States National Institutes of Health><Universities><Variant><Variation><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Work><Writing><advanced age><care outcomes><career development><college><collegiate><community based organizations><community engagement><community health worker><community organizations><community partnership><community-based health><computational resources><computing resources><conference><convention><data interpretation><developmental><engagement with communities><geographic site><geriatric><health care outcomes><health care personnel><health care worker><health provider><health workforce><heavy metal Pb><heavy metal lead><high blood pressure><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><improved><innovate><innovation><innovative><institutional capacity><instrument><malignancy><medical personnel><neoplasm/cancer><outreach program><pilot study><programs><public health relevance><senior citizen><social role><success><summit><symposia><symposium><technical skills><tool><treatment provider><triple-negative breast cancer><triple-negative invasive breast carcinoma>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Omonike Arike Olaleye

TEXAS SOUTHERN UNIVERSITY, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,494,598
FY 2025

Project Title

Center for Biomedical and Health Research at TSU

Grant Number:

2U54MD007605-32

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/1986

End Date:

5/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: Overall The Center for Biomedical and Health Research (CBMHR) at Texas Southern University (TSU) is requesting ~ $26.65 million to renew our U54 RCMI program for the cycle of 2025-2030. Currently, CBMHR has made significant strides in expanding research infrastructure, fostering community ...

Research Terms

<Address><Applications Grants><Area><Award><Basic Research><Basic Science><Behavioral><Behavioral Research><Bioinformatics><Biomedical Research><Black><Black race><Cancers><Certification><Cities><Clinical><Clinical Research><Clinical Study><Clinical Trials Design><Collaborations><Communities><Community Health><Community Health Aides><Community Outreach><Complex><Data Analyses><Data Analysis><Dedications><Development><Discipline><Disease><Disorder><EXTMR><Elderly><Ensure><Environment><Equipment><Evaluation><Event><Extramural><Extramural Activities><Fostering><Foundations><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><Goals><Grant><Grant Proposals><Health><Health Care Providers><Health Care Research><Health Instruction><Health Personnel><Health Tutoring><Health education><Hypertension><IRB><IRBs><Infrastructure><Institution><Institutional Review Boards><Investigators><Lead><Learning><Malignant Neoplasms><Malignant Tumor><Medical><Medical center><Mentors><Mentorship><Methodology><Mission><Monitor><NIH><National Institutes of Health><Outcome><Pb element><Pilot Projects><Population><Postpartum Hypertension><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Role><Rural Community><Scientific Publication><Secure><TNBC><Targeted Research><Technical Expertise><Texas><Trust><United States National Institutes of Health><Universities><Variant><Variation><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Work><Writing><advanced age><care outcomes><career development><college><collegiate><community based organizations><community engagement><community health worker><community organizations><community partnership><community-based health><computational resources><computing resources><conference><convention><data interpretation><developmental><engagement with communities><geographic site><geriatric><health care outcomes><health care personnel><health care worker><health provider><health workforce><heavy metal Pb><heavy metal lead><high blood pressure><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><improved><innovate><innovation><innovative><institutional capacity><instrument><malignancy><medical personnel><neoplasm/cancer><outreach program><pilot study><programs><public health relevance><senior citizen><social role><success><summit><symposia><symposium><technical skills><tool><treatment provider><triple-negative breast cancer><triple-negative invasive breast carcinoma>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Huan Xie

TEXAS SOUTHERN UNIVERSITY, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,494,598
FY 2025

Project Title

Center for Biomedical and Health Research at TSU

Grant Number:

2U54MD007605-32

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/1986

End Date:

5/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: Overall The Center for Biomedical and Health Research (CBMHR) at Texas Southern University (TSU) is requesting ~ $26.65 million to renew our U54 RCMI program for the cycle of 2025-2030. Currently, CBMHR has made significant strides in expanding research infrastructure, fostering community ...

Research Terms

<Address><Applications Grants><Area><Award><Basic Research><Basic Science><Behavioral><Behavioral Research><Bioinformatics><Biomedical Research><Black><Black race><Cancers><Certification><Cities><Clinical><Clinical Research><Clinical Study><Clinical Trials Design><Collaborations><Communities><Community Health><Community Health Aides><Community Outreach><Complex><Data Analyses><Data Analysis><Dedications><Development><Discipline><Disease><Disorder><EXTMR><Elderly><Ensure><Environment><Equipment><Evaluation><Event><Extramural><Extramural Activities><Fostering><Foundations><Funding><Geographic Area><Geographic Locations><Geographic Region><Geographical Location><Goals><Grant><Grant Proposals><Health><Health Care Providers><Health Care Research><Health Instruction><Health Personnel><Health Tutoring><Health education><Hypertension><IRB><IRBs><Infrastructure><Institution><Institutional Review Boards><Investigators><Lead><Learning><Malignant Neoplasms><Malignant Tumor><Medical><Medical center><Mentors><Mentorship><Methodology><Mission><Monitor><NIH><National Institutes of Health><Outcome><Pb element><Pilot Projects><Population><Postpartum Hypertension><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Role><Rural Community><Scientific Publication><Secure><TNBC><Targeted Research><Technical Expertise><Texas><Trust><United States National Institutes of Health><Universities><Variant><Variation><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Work><Writing><advanced age><care outcomes><career development><college><collegiate><community based organizations><community engagement><community health worker><community organizations><community partnership><community-based health><computational resources><computing resources><conference><convention><data interpretation><developmental><engagement with communities><geographic site><geriatric><health care outcomes><health care personnel><health care worker><health provider><health workforce><heavy metal Pb><heavy metal lead><high blood pressure><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><improved><innovate><innovation><innovative><institutional capacity><instrument><malignancy><medical personnel><neoplasm/cancer><outreach program><pilot study><programs><public health relevance><senior citizen><social role><success><summit><symposia><symposium><technical skills><tool><treatment provider><triple-negative breast cancer><triple-negative invasive breast carcinoma>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael J Kenney

UNIVERSITY OF TEXAS EL PASO, EL PASO, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,494,597
FY 2025

Project Title

UTEP Border Biomedical Research Center

Grant Number:

2U54MD007592-31A1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/15/1998

End Date:

3/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Border Biomedical Research Center (BBRC) at The University of Texas at El Paso (UTEP) is supported by the Research Centers at Minority Institutions (RCMI) Program and is a critical point for research initiatives focused on addressing health disparities that permeate the population in the far Wes...

Research Terms

<AI system><Address><Adult-Onset Diabetes Mellitus><Affect><Area><Artificial Intelligence><Basic Research><Basic Science><Behavioral><Behavioral Research><Bioinformatics><Biological Markers><Biomedical Research><COBRE><Cancer Biology><Caring><Center of Biomedical Research Excellence><Centers of Research Excellence><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Collection><Communities><Complex><Computer Reasoning><Core Facility><Data><Data Analyses><Data Analysis><Data Banks><Data Bases><Data Collection><Databanks><Databases><Decrease health disparities><Development><Disease><Disorder><Economic Income><Economical Income><Education><Education for Intervention><Educational Intervention><Educational aspects><Educational workshop><Ensure><Environment><Ethnic Origin><Ethnicity><Evaluation><Face><Faculty><Fostering><Funding><Generalized Growth><Goals><Growth><Health><Health Care><Health disparity mitigation><Health disparity reduction><Hospitals><Image><Immune system><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Income><Individual><Infrastructure><Instruction Intervention><Intervention><Investigators><Ketosis-Resistant Diabetes Mellitus><Lead><Lower health disparities><Machine Intelligence><Maturity-Onset Diabetes Mellitus><Medical><Mentors><Metabolic><Metabolic Diseases><Metabolic Disorder><Methods><Minority-Serving Institution><Mission><Mitigate health disparities><Modeling><Molecular><NCMHD><NIDDM><NIH><NIMHD><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><National Institutes of Health><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Outcome><Pathology><Patients><Pattern><Pb element><Persons><Physiologic><Physiological><Play><Population><Population Sciences><Position><Positioning Attribute><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Researchers><Role><Scientist><Sight><Slow-Onset Diabetes Mellitus><Social Behavior><Social Interaction><Stable Diabetes Mellitus><Strategic vision><Stress><Students><System><T2 DM><T2D><T2DM><Technology><Testing><Texas><Thesaurismosis><Tissue Growth><Training><Training Intervention><Type 2 Diabetes Mellitus><Type 2 diabetes><Type II Diabetes Mellitus><Type II diabetes><United States National Institutes of Health><Universities><Vision><Workshop><adult onset diabetes><advanced analytics><analytical tool><bio-markers><biologic marker><biomarker><cancer immunology><collaboration with communities><community based participatory research><community collaboration><community engagement><community led research><community participatory research><community partnered participatory research><community partners><community-based collaboration><community-based partners><computer based prediction><data base><data depository><data integration><data interpretation><data repository><data set repository><dataset repository><design><designing><developmental><diabetes education><diabetes self-care><diabetes self-management><digital><digital health><disparity in health><education research><engagement with communities><evidence base><faces><facial><health disparity><heavy metal Pb><heavy metal lead><imaging><improve minority health><improved><improvement of minority health><incomes><indicators of resilience><instructional intervention><ketosis resistant diabetes><marker of biological resilience><markers underlying resilience><maturity onset diabetes><metabolism disorder><minority institution><neoplasm immunology><next generation><ontogeny><participatory action research><predictive modeling><programs><recruit><resilience biomarker><resilience marker><signatures of resilience><social health determinants><social role><sociobehavior><sociobehavioral><success><synergism><tool><tumor immunology><type 2 DM><type II DM><type two diabetes><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory E Hicks

UNIVERSITY OF DELAWARE, Newark, DE

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$3,171,679
FY 2025

Project Title

Delaware Clinical and Translational Research ACCEL Program

Grant Number:

5U54GM104941-13

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/25/2013

End Date:

6/30/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This proposal is a competitive renewal of the Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013 to the University of Delaware. The ACCEL CTR Program has completed nine years of funding at the time...

Research Terms

<21+ years old><Acceleration><Adult><Adult Human><African American><Afro American><Afroamerican><Agreement><American><Area><Asian><Award><Biometrics><Biometry><Biostatistics><Black><Black race><Budgets><Cancers><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Cessation of life><Child Health><Childhood><Clinical><Clinical Research><Clinical Study><Communities><Community Outreach><Death><Delaware><Development><Drugs><Epidemiology><Equity><Ethnic Origin><Ethnicity><Evaluation><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Care><Health Care Systems><Health Promotion><Hispanic><Hospitals><Infrastructure><Institution><Intention><Investigators><Investments><Learning><Letters><Malignant Neoplasms><Malignant Tumor><Medication><Mission><Modeling><Modification><Native American><Obesity><Occidental><Outreach Research><Pharmaceutical Preparations><Pilot Projects><Population><Population Heterogeneity><Population Research><Population-based research><Population-level research><Recommendation><Research Design><Research Personnel><Researchers><Rural><Salutogenesis><Scientist><Societies><Structure><Study Type><System><Time><Tissue Growth><Training><Translational Research><Translational Research Enterprise><Translational Science><Universities><Work><Writing><adiposity><adulthood><clinical infrastructure><community engagement><corpulence><demographics><design><designing><developmental><diverse populations><drug/agent><engagement with communities><epidemiologic><epidemiological><health care quality><health equity><heterogeneous population><hospitalization rates><improved><innovate><innovation><innovative><malignancy><member><multimorbidity><multiple chronic conditions><neoplasm/cancer><ontogeny><pediatric><pilot study><population diversity><population health><programs><promoting health><racial diversity><racially diverse><recruit><study design><translation research><translation research enterprise><translational investigation><translational investigator><translational research program><translational researcher><translational scientist><white race>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christina S Leslie

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,654,999
FY 2025

Project Title

The Center for Tumor-Immune Systems Biology at MSKCC

Grant Number:

5U54CA274492-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Center for Tumor-Immune Systems Biology at MSKCC SUMMARY The advent of cancer immunotherapies based on immune checkpoint blockade (ICB) has revolutionized clinical care in multiple solid tumor types and demonstrated the power of the immune system to target and eliminate cancer cells. Despite the...

Research Terms

<Address><Algorithmic Analyses><Algorithmic Analysis><Analyses of Algorithms><Analysis of Algorithms><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Astrocytes><Astrocytus><Astroglia><Award><Blood Vessels><Brain><Brain Nervous System><Breast Cancer><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><Cancer Biology><Cancer Center><Cancers><Caspase><Caspase Gene><Cell Body><Cell Death><Cell-Death Protease><Cells><Chromatin><Clear cell renal cell carcinoma><Colon Cancer><Colon Carcinoma><Colorectal Cancer><Complex><Computational Biology><Computing Methodologies><Cysteine Endopeptidases><Cysteine Protease><Cysteine Proteinases><Data><Data Set><Dendritic Cells><Development><Disease associated microglia><Distal><Dysfunction><Ecologic Systems><Ecological Systems><Ecosystem><Education and Outreach><Educational workshop><Encephalon><Engineering><Functional disorder><Gene Transcription><Genes><Genetic Transcription><Grawitz Tumor><Human><Hypernephroid Carcinoma><Hypernephroma><ICE-like protease><Immune><Immune mediated therapy><Immune response><Immune system><Immunes><Immunochemical Immunologic><Immunofluorescence><Immunofluorescence Immunologic><Immunologic><Immunologic Model><Immunological><Immunological Models><Immunologically><Immunologically Directed Therapy><Immunologics><Immunology><Immunotherapeutic agent><Immunotherapy><In complete remission><Instruction and Outreach><Invaded><Investigation><Investigators><Leptomeningeal Metastasis><Ligands><Link><Liver><Lung Adenocarcinoma><MSKCC><Malignant Breast Neoplasm><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Mediating><Melanoma Cell><Memorial Sloan-Kettering Cancer Center><Meningeal Carcinomatosis><Metastasis to Lymph Nodes><Metastasis to the Leptomeninges><Metastatic Neoplasm to Lymph Nodes><Metastatic Neoplasm to the Leptomeninges><Metastatic Tumor to Lymph Nodes><Metastatic Tumor to the Leptomeninges><Methods><Mismatch Repair><Mitochondria><Modality><Modeling><Modern Man><Molecular Analysis><Multiomic Data><Nephroid Carcinoma><Organ><Patients><Physiopathology><Post-Replication Mismatch Repair><Process><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><Receptor Protein><Refractory><Renal Adenocarcinoma><Renal Cell Adenocarcinoma><Renal Cell Cancer><Renal Cell Carcinoma><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resistance><Resource Sharing><Role><Scientific Advances and Accomplishments><Scientist><Solid Neoplasm><Solid Tumor><System><Systems Biology><T cell response><T memory cell><T-Cells><T-Lymphocyte><T8 Cells><T8 Lymphocytes><Technology><Therapeutic><Training><Training Activity><Training Programs><Training and Outreach><Transcription><Tumor Immunity><Tutoring and Outreach><Veiled Cells><Workshop><anti-cancer><anti-cancer immunotherapy><anti-tumor immunity><anticancer immunotherapy><antitumor immunity><astrocytic glia><cancer care><cancer cell><cancer immune therapeutics><cancer immunity><cancer immunology><cancer immunotherapeutics><cancer immunotherapy><cancer in the colon><ccRCC><check point blockade><checkpoint blockade><clinical care><complete response><computational methodology><computational methods><computational studies><computer based method><computer biology><computer methods><computer studies><computing method><conference><convention><cystein protease><cystein proteinase><cysteine endopeptidase><design><designing><developmental><experiment><experimental research><experimental study><experiments><graduate student><hepatic body system><hepatic organ system><host response><immune check point blockade><immune checkpoint blockade><immune drugs><immune microenvironment><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapeutics><immune-based therapies><immune-based treatments><immuno therapy><immunogenic><immunogenic apoptosis><immunogenic cell death><immunologic therapeutics><immunoresponse><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapeutics><immunotherapy agent><immunotherapy for cancer><immunotherapy of cancer><improved><innovate><innovation><innovative><insight><kidney adenocarcinoma><learning activity><learning method><learning strategies><learning strategy><lectures><lymph node metastasis><machine learning based model><machine learning model><malignancy><malignant breast tumor><memory T lymphocyte><meningeal metastases><mitochondrial><mouse model><multidisciplinary><multiomics><multiple omic data><multiple omics><murine model><necrocytosis><neoplasm immunology><neoplasm/cancer><neoplastic meningitis><new approaches><novel><novel approaches><novel strategies><novel strategy><optic imaging><optical imaging><panomics><pathophysiology><programs><receptor><refractory cancer><regenerate new tissue><regenerate tissue><regenerating damaged tissue><regenerating tissue><resistant><resistant cancer><response><scientific accomplishments><scientific advances><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><standard of care><success><summit><symposia><symposium><thymus derived lymphocyte><tissue regeneration><tissue regrowth><tissue renewal><tissue specific regeneration><tool><training module><transcriptomics><tumor><tumor immune microenvironment><tumor immunology><tumor-immune system interactions><undergrad><undergraduate><undergraduate student><vascular>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexander Y Rudensky

SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,654,999
FY 2025

Project Title

The Center for Tumor-Immune Systems Biology at MSKCC

Grant Number:

5U54CA274492-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Center for Tumor-Immune Systems Biology at MSKCC SUMMARY The advent of cancer immunotherapies based on immune checkpoint blockade (ICB) has revolutionized clinical care in multiple solid tumor types and demonstrated the power of the immune system to target and eliminate cancer cells. Despite the...

Research Terms

<Address><Algorithmic Analyses><Algorithmic Analysis><Analyses of Algorithms><Analysis of Algorithms><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Astrocytes><Astrocytus><Astroglia><Award><Blood Vessels><Brain><Brain Nervous System><Breast Cancer><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><Cancer Biology><Cancer Center><Cancers><Caspase><Caspase Gene><Cell Body><Cell Death><Cell-Death Protease><Cells><Chromatin><Clear cell renal cell carcinoma><Colon Cancer><Colon Carcinoma><Colorectal Cancer><Complex><Computational Biology><Computing Methodologies><Cysteine Endopeptidases><Cysteine Protease><Cysteine Proteinases><Data><Data Set><Dendritic Cells><Development><Disease associated microglia><Distal><Dysfunction><Ecologic Systems><Ecological Systems><Ecosystem><Education and Outreach><Educational workshop><Encephalon><Engineering><Functional disorder><Gene Transcription><Genes><Genetic Transcription><Grawitz Tumor><Human><Hypernephroid Carcinoma><Hypernephroma><ICE-like protease><Immune><Immune mediated therapy><Immune response><Immune system><Immunes><Immunochemical Immunologic><Immunofluorescence><Immunofluorescence Immunologic><Immunologic><Immunologic Model><Immunological><Immunological Models><Immunologically><Immunologically Directed Therapy><Immunologics><Immunology><Immunotherapeutic agent><Immunotherapy><In complete remission><Instruction and Outreach><Invaded><Investigation><Investigators><Leptomeningeal Metastasis><Ligands><Link><Liver><Lung Adenocarcinoma><MSKCC><Malignant Breast Neoplasm><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Mediating><Melanoma Cell><Memorial Sloan-Kettering Cancer Center><Meningeal Carcinomatosis><Metastasis to Lymph Nodes><Metastasis to the Leptomeninges><Metastatic Neoplasm to Lymph Nodes><Metastatic Neoplasm to the Leptomeninges><Metastatic Tumor to Lymph Nodes><Metastatic Tumor to the Leptomeninges><Methods><Mismatch Repair><Mitochondria><Modality><Modeling><Modern Man><Molecular Analysis><Multiomic Data><Nephroid Carcinoma><Organ><Patients><Physiopathology><Post-Replication Mismatch Repair><Process><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><Receptor Protein><Refractory><Renal Adenocarcinoma><Renal Cell Adenocarcinoma><Renal Cell Cancer><Renal Cell Carcinoma><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Resistance><Resource Sharing><Role><Scientific Advances and Accomplishments><Scientist><Solid Neoplasm><Solid Tumor><System><Systems Biology><T cell response><T memory cell><T-Cells><T-Lymphocyte><T8 Cells><T8 Lymphocytes><Technology><Therapeutic><Training><Training Activity><Training Programs><Training and Outreach><Transcription><Tumor Immunity><Tutoring and Outreach><Veiled Cells><Workshop><anti-cancer><anti-cancer immunotherapy><anti-tumor immunity><anticancer immunotherapy><antitumor immunity><astrocytic glia><cancer care><cancer cell><cancer immune therapeutics><cancer immunity><cancer immunology><cancer immunotherapeutics><cancer immunotherapy><cancer in the colon><ccRCC><check point blockade><checkpoint blockade><clinical care><complete response><computational methodology><computational methods><computational studies><computer based method><computer biology><computer methods><computer studies><computing method><conference><convention><cystein protease><cystein proteinase><cysteine endopeptidase><design><designing><developmental><experiment><experimental research><experimental study><experiments><graduate student><hepatic body system><hepatic organ system><host response><immune check point blockade><immune checkpoint blockade><immune drugs><immune microenvironment><immune system response><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapeutics><immune-based therapies><immune-based treatments><immuno therapy><immunogenic><immunogenic apoptosis><immunogenic cell death><immunologic therapeutics><immunoresponse><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapeutics><immunotherapy agent><immunotherapy for cancer><immunotherapy of cancer><improved><innovate><innovation><innovative><insight><kidney adenocarcinoma><learning activity><learning method><learning strategies><learning strategy><lectures><lymph node metastasis><machine learning based model><machine learning model><malignancy><malignant breast tumor><memory T lymphocyte><meningeal metastases><mitochondrial><mouse model><multidisciplinary><multiomics><multiple omic data><multiple omics><murine model><necrocytosis><neoplasm immunology><neoplasm/cancer><neoplastic meningitis><new approaches><novel><novel approaches><novel strategies><novel strategy><optic imaging><optical imaging><panomics><pathophysiology><programs><receptor><refractory cancer><regenerate new tissue><regenerate tissue><regenerating damaged tissue><regenerating tissue><resistant><resistant cancer><response><scientific accomplishments><scientific advances><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><standard of care><success><summit><symposia><symposium><thymus derived lymphocyte><tissue regeneration><tissue regrowth><tissue renewal><tissue specific regeneration><tool><training module><transcriptomics><tumor><tumor immune microenvironment><tumor immunology><tumor-immune system interactions><undergrad><undergraduate><undergraduate student><vascular>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph Ramon Biggio

TULANE UNIVERSITY OF LOUISIANA, NEW ORLEANS, LA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,631,572
FY 2025

Project Title

Southern Center for Maternal Health

Grant Number:

5U54HD113159-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/17/2023

End Date:

7/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Overall ABSTRACT: Nowhere is poor maternal health in starker relief than in Louisiana and Mississippi, which consistently rank last in the country on several health indicators. Urgently needed are interventions, at multiple levels, coupled with sustained implementation of programs and policies th...

Research Terms

<Access to Care><Address><Aptitude><Area><Assess implementation><Award><Caring><Clinical Research><Clinical Study><Collaborations><Communities><Country><Coupled><Data><Development><Education><Education and Training><Educational aspects><Epidemiology><Female Health><Gestation><Goals><Health><Health Care><Health Care Systems><Health Policy><Health Services Accessibility><Health system><Implementation assessment><Improve Access><Infant Health><Infrastructure><Intervention><Legislation><Louisiana><Maternal Health><Maternal Mortality><Medicaid><Mississippi><Modeling><Outcomes Research><Policies><Population><Position><Positioning Attribute><Postpartum Period><Pregnancy><R-Series Research Projects><R01 Mechanism><R01 Program><Reproductive Health><Research><Research Grants><Research Project Grants><Research Projects><Risk><Sight><Social Policies><Statutes and Laws><Technical Expertise><Testing><Training><Training and Education><Translating><Translational Research><Translational Science><Translations><Universities><Vision><Woman><Women's Health><access to health care><access to health services><access to services><access to treatment><accessibility of health care><accessibility to health care><accessibility to health services><after pregnancy><availability of services><behavior change><care access><career><clinical care><community partners><community partnership><community-based partners><cost effectiveness><design><designing><developmental><effective intervention><epidemiologic><epidemiological><evaluate implementation><evaluation of implementation><evidence base><health care access><health care availability><health care policy><health care service access><health care service availability><health economics><health service access><health services availability><implementation evaluation><improved><innovate><innovation><innovative><low maternity care access area><maternal care desert><maternal death><maternal health desert><maternal healthcare desert><maternal morbidity><maternity care desert><maternity care underserved area><maternity desert><maternity healthcare desert><multidisciplinary><new approaches><novel approaches><novel strategies><novel strategy><obstetric care desert><outreach><post pregnancy><post-partum><pregnancy health><prevent><preventing><programs><public health relevance><remote monitoring><reproductive epidemiology><service availability><severe maternal morbidity><social><technical skills><training opportunity><translation><translation research><translational investigation><treatment access><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Emily Wheeler Harville

TULANE UNIVERSITY OF LOUISIANA, NEW ORLEANS, LA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,631,572
FY 2025

Project Title

Southern Center for Maternal Health

Grant Number:

5U54HD113159-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/17/2023

End Date:

7/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Overall ABSTRACT: Nowhere is poor maternal health in starker relief than in Louisiana and Mississippi, which consistently rank last in the country on several health indicators. Urgently needed are interventions, at multiple levels, coupled with sustained implementation of programs and policies th...

Research Terms

<Access to Care><Address><Aptitude><Area><Assess implementation><Award><Caring><Clinical Research><Clinical Study><Collaborations><Communities><Country><Coupled><Data><Development><Education><Education and Training><Educational aspects><Epidemiology><Female Health><Gestation><Goals><Health><Health Care><Health Care Systems><Health Policy><Health Services Accessibility><Health system><Implementation assessment><Improve Access><Infant Health><Infrastructure><Intervention><Legislation><Louisiana><Maternal Health><Maternal Mortality><Medicaid><Mississippi><Modeling><Outcomes Research><Policies><Population><Position><Positioning Attribute><Postpartum Period><Pregnancy><R-Series Research Projects><R01 Mechanism><R01 Program><Reproductive Health><Research><Research Grants><Research Project Grants><Research Projects><Risk><Sight><Social Policies><Statutes and Laws><Technical Expertise><Testing><Training><Training and Education><Translating><Translational Research><Translational Science><Translations><Universities><Vision><Woman><Women's Health><access to health care><access to health services><access to services><access to treatment><accessibility of health care><accessibility to health care><accessibility to health services><after pregnancy><availability of services><behavior change><care access><career><clinical care><community partners><community partnership><community-based partners><cost effectiveness><design><designing><developmental><effective intervention><epidemiologic><epidemiological><evaluate implementation><evaluation of implementation><evidence base><health care access><health care availability><health care policy><health care service access><health care service availability><health economics><health service access><health services availability><implementation evaluation><improved><innovate><innovation><innovative><low maternity care access area><maternal care desert><maternal death><maternal health desert><maternal healthcare desert><maternal morbidity><maternity care desert><maternity care underserved area><maternity desert><maternity healthcare desert><multidisciplinary><new approaches><novel approaches><novel strategies><novel strategy><obstetric care desert><outreach><post pregnancy><post-partum><pregnancy health><prevent><preventing><programs><public health relevance><remote monitoring><reproductive epidemiology><service availability><severe maternal morbidity><social><technical skills><training opportunity><translation><translation research><translational investigation><treatment access><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Susan Perez

TULANE UNIVERSITY OF LOUISIANA, NEW ORLEANS, LA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,631,572
FY 2025

Project Title

Southern Center for Maternal Health

Grant Number:

5U54HD113159-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/17/2023

End Date:

7/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Overall ABSTRACT: Nowhere is poor maternal health in starker relief than in Louisiana and Mississippi, which consistently rank last in the country on several health indicators. Urgently needed are interventions, at multiple levels, coupled with sustained implementation of programs and policies th...

Research Terms

<Access to Care><Address><Aptitude><Area><Assess implementation><Award><Caring><Clinical Research><Clinical Study><Collaborations><Communities><Country><Coupled><Data><Development><Education><Education and Training><Educational aspects><Epidemiology><Female Health><Gestation><Goals><Health><Health Care><Health Care Systems><Health Policy><Health Services Accessibility><Health system><Implementation assessment><Improve Access><Infant Health><Infrastructure><Intervention><Legislation><Louisiana><Maternal Health><Maternal Mortality><Medicaid><Mississippi><Modeling><Outcomes Research><Policies><Population><Position><Positioning Attribute><Postpartum Period><Pregnancy><R-Series Research Projects><R01 Mechanism><R01 Program><Reproductive Health><Research><Research Grants><Research Project Grants><Research Projects><Risk><Sight><Social Policies><Statutes and Laws><Technical Expertise><Testing><Training><Training and Education><Translating><Translational Research><Translational Science><Translations><Universities><Vision><Woman><Women's Health><access to health care><access to health services><access to services><access to treatment><accessibility of health care><accessibility to health care><accessibility to health services><after pregnancy><availability of services><behavior change><care access><career><clinical care><community partners><community partnership><community-based partners><cost effectiveness><design><designing><developmental><effective intervention><epidemiologic><epidemiological><evaluate implementation><evaluation of implementation><evidence base><health care access><health care availability><health care policy><health care service access><health care service availability><health economics><health service access><health services availability><implementation evaluation><improved><innovate><innovation><innovative><low maternity care access area><maternal care desert><maternal death><maternal health desert><maternal healthcare desert><maternal morbidity><maternity care desert><maternity care underserved area><maternity desert><maternity healthcare desert><multidisciplinary><new approaches><novel approaches><novel strategies><novel strategy><obstetric care desert><outreach><post pregnancy><post-partum><pregnancy health><prevent><preventing><programs><public health relevance><remote monitoring><reproductive epidemiology><service availability><severe maternal morbidity><social><technical skills><training opportunity><translation><translation research><translational investigation><treatment access><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY, SEATTLE, WA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,564,339
FY 2025

Project Title

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

Grant Number:

5U54CA274509-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The proposed U54 program Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor --Immunotherapy Combinations (ST-Analytics) is designed to develop the recent conceptual advance that targeted inhibitor + cancer immunotherapy (IT) combination treatments may yield significantly greate...

Research Terms

<Acceleration><Address><Adoptive Cell Transfers><Algorithms><American><Automobile Driving><Biological><Biopsy><Body Tissues><Brain Metastasis><Calibration><Cancers><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Physiology><Cellular Process><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Combination immunotherapy><Combined Modality Therapy><Communities><Coupled><Data><Data Bases><Databases><Development><Dimensions><Distal><Dose><Drugs><Education and Outreach><Educational Models><Environment><Environment Design><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Gene Transcription><Genetic Transcription><Immune><Immune mediated therapy><Immune system><Immunes><Immunologic Factors><Immunological Factors><Immunologically Directed Therapy><Immunooncology><Immunotherapy><Individual><Instruction and Outreach><Instructional Models><Internships><Investigators><K-12 Education><K-12 classroom><K-12 level><K12 classroom><K12 education><K12 level><Kinetics><Knowledge><Lead><Leadership><MAPK Inhibitors><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Measurement><Medication><Melanoma><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Neoplasm to the Brain><Metastatic Tumor><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Mitogen-Activated Protein Kinase Inhibitor><Modeling><Multimodal Therapy><Multimodal Treatment><Nature><Neoplasm Metastasis><Outcome><Patients><Pb element><Pharmaceutical Preparations><Pilot Projects><Play><Primary Neoplasm><Primary Tumor><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resistance><Resources><Role><STEM Education><STEM knowledge><Science><Science, Technology, Engineering and Math Education><Science, Technology, Engineering and Mathematics Education><Scientist><Secondary Neoplasm><Secondary Tumor><Self evaluation><Self-Examination><Self-Surveillance><Series><Structure><Subcellular Process><System><Systems Biology><Therapeutic><Time><Tissues><Training and Outreach><Transcription><Tutoring and Outreach><Visual><Work><adoptive cell therapy><adoptive cellular therapy><anti-cancer immunotherapy><anticancer immunotherapy><biobank><biologic><biorepository><brain micrometastasis><cancer immunotherapy><cancer metastasis><check point blockade><checkpoint blockade><combination therapy><combinatorial><combinatorial immunotherapy><combined modality treatment><combined treatment><computational resources><computing resources><data base><design><designing><developmental><disease model><disorder model><driving><drug/agent><dual immunotherapy><educational methods><educational practices><educational principles><epigenetically><heavy metal Pb><heavy metal lead><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immune-oncology><immuno oncology><immuno therapy><immunologic substance><immunological substance><immunology oncology><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><in silico><in vivo><inhibitor><inhibitor drug><inhibitor therapeutic><inhibitor therapy><intern><malignancy><medical college><medical schools><model design><mouse model><multi-modal therapy><multi-modal treatment><murine model><neoplasm/cancer><oncoimmunology><outreach><outreach program><pilot study><prevent><preventing><programs><recruit><resistant><school of medicine><science, technology, engineering and math knowledge><science, technology, engineering and mathematics knowledge><social role><spatial and temporal><spatial multiomics><spatial omics><spatial temporal><spatial tri-omics><spatiotemporal><tool><transcriptomics><tumor><tumor cell metastasis><tumor immune microenvironment><tumor-immune system interactions>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ASHOK BALASUBRAMANYAM

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,500,000
FY 2025

Project Title

RARE and Atypical Diabetes Network(RADIANT)

Grant Number:

5U54DK118638-07

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY P KRISCHER

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,500,000
FY 2025

Project Title

RARE and Atypical Diabetes Network(RADIANT)

Grant Number:

5U54DK118638-07

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Louis H. Philipson

UNIVERSITY OF CHICAGO, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,500,000
FY 2025

Project Title

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus

Grant Number:

5U54DK118612-07

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Miriam Sargon Udler

UNIVERSITY OF CHICAGO, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,500,000
FY 2025

Project Title

Center for Identification and Study of Individuals with Atypical Diabetes Mellitus

Grant Number:

5U54DK118612-07

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maria Monica Gramatges

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,494,110
FY 2025

Project Title

Reducing Disparities in Acute Leukemia (REDIAL) Consortium

Grant Number:

1U54CA302464-01

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2025

End Date:

8/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and, although cure rates have improved over the past 50 years, population-based disparities persist. In particular, Latinos have the highest incidence and among the lowest survival rates for leukemia in the U.S. The underlying ...

Research Terms

<0-11 years old><Acute Lymphoblastic Leukemia><Acute Lymphocytic Leukemia><Acute Lymphoid Leukemia><Acute leukemia><Address><Adolescent><Adolescent Youth><Advocate><Area><Bioinformatics><Biologic Factor><Biological><Biological Factors><Biology><Biometrics><Biometry><Biostatistics><Blood><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><Cancer Center><Care Givers><Caregivers><Causality><Cell Body><Cells><Cerebrospinal Fluid><Child><Child Youth><Childhood ALL><Childhood Acute Lymphoblastic Leukemia><Childhood Acute Lymphocytic Leukemia><Childhood Acute Lymphogenous Leukemia><Childhood Acute Lymphoid Leukemia><Childhood Cancers><Childhood Leukemia><Children (0-21)><Communication><Communities><Community Outreach><Data Management Core><Data Set><Development><Disease><Disorder><Disparities><Disparity><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Ethnic Group><Ethnic Origin><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity><Ethnicity People><Ethnicity Population><Etiology><Exposure to><Family Research><Fostering><Foundations><Future><Goals><Health><Hepatotoxic effect><Hepatotoxicity><Host Factor><Host Factor Protein><Human Resources><Incidence><Infrastructure><Integration Host Factors><Intervention Strategies><Investigation><Investigators><L1 Lymphocytic Leukemia><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Leadership><Liver Toxicity><Lymphoblastic Leukemia, Acute, L1><Maintenance><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant childhood cancer><Manpower><Mentorship><Methotrexate><Methotrexate Methylaminopterin><Methotrexatum><Metotrexato><Morbidity><Morbidity - disease rate><Outcome><Participant><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Pediatric ALL><Pediatric Acute Lymphoblastic Leukemia><Pediatric Acute Lymphocytic Leukemia><Pediatric Acute Lymphogenous Leukemia><Pediatric Acute Lymphoid Leukemia><Pediatric Leukemia><Pharmacogenomics><Physicians><Pilot Projects><Precursor Cell Lymphoblastic Leukemia><Precursor Lymphoblastic Leukemia><Predicting Risk><Predisposition><Preventative strategy><Prevention strategy><Preventive strategy><Procedures><Process><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Sampling><Scientist><Secure><Site><Specialized Program of Research Excellence><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Survival Rate><Susceptibility><Toxic effect><Toxic effect on liver cells><Toxicities><Training><Treatment-related toxicity><Work><acute lymphatic leukemia><acute lymphogenous leukemia><acute lymphomatic leukemia><adverse consequence><adverse outcome><biobank><biologic><biorepository><cancer in a child><cancer in children><career><causation><central database><cerebral spinal fluid><child with cancer><childhood malignancy><children with leukemia><community advisory board><community advisory committee><community advisory panel><community engagement><cooking><data management><data management and coordinating center><data management center><design><designing><developmental><disease causation><disparate effect><disparate impact><disparate result><disparity in ethnic><engagement with communities><epigenetically><epigenomics><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnic subgroup><ethnicity disparity><ethnicity group><forecasting risk><hepatic toxicity><hepatoxicity><improved><improved outcome><inequitable effect><inequitable impact><inequitable outcome><infant ALL><innovate><innovation><innovative><juvenile><juvenile human><kids><leukemia><leukemia in children><leukemia treatment><leukemic therapy><lipidomics><metabolism measurement><metabolomics><metabonomics><mortality><multidisciplinary><neuron toxicity><neuronal toxicity><neurotoxicity><outcome disparities><outcome inequality><outcome inequity><outreach><patient centered><patient oriented><pediatric cancer><pediatric malignancy><personnel><pilot study><predict risk><predict risks><predicted risk><predicted risks><predicting risks><predictive risk><predicts risk><programs><recruit><response to therapy><response to treatment><risk prediction><risk predictions><social health determinants><spinal fluid><statistical analysis><therapeutic response><therapeutic toxicity><therapy associated toxicity><therapy related toxicity><therapy response><therapy toxicity><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><treatment strategy><treatment toxicity><treatment-associated toxicity><unequal effect><unequal impact><unequal outcome><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Philip Lupo

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,494,110
FY 2025

Project Title

Reducing Disparities in Acute Leukemia (REDIAL) Consortium

Grant Number:

1U54CA302464-01

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2025

End Date:

8/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and, although cure rates have improved over the past 50 years, population-based disparities persist. In particular, Latinos have the highest incidence and among the lowest survival rates for leukemia in the U.S. The underlying ...

Research Terms

<0-11 years old><Acute Lymphoblastic Leukemia><Acute Lymphocytic Leukemia><Acute Lymphoid Leukemia><Acute leukemia><Address><Adolescent><Adolescent Youth><Advocate><Area><Bioinformatics><Biologic Factor><Biological><Biological Factors><Biology><Biometrics><Biometry><Biostatistics><Blood><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><Cancer Center><Care Givers><Caregivers><Causality><Cell Body><Cells><Cerebrospinal Fluid><Child><Child Youth><Childhood ALL><Childhood Acute Lymphoblastic Leukemia><Childhood Acute Lymphocytic Leukemia><Childhood Acute Lymphogenous Leukemia><Childhood Acute Lymphoid Leukemia><Childhood Cancers><Childhood Leukemia><Children (0-21)><Communication><Communities><Community Outreach><Data Management Core><Data Set><Development><Disease><Disorder><Disparities><Disparity><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Ethnic Group><Ethnic Origin><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity><Ethnicity People><Ethnicity Population><Etiology><Exposure to><Family Research><Fostering><Foundations><Future><Goals><Health><Hepatotoxic effect><Hepatotoxicity><Host Factor><Host Factor Protein><Human Resources><Incidence><Infrastructure><Integration Host Factors><Intervention Strategies><Investigation><Investigators><L1 Lymphocytic Leukemia><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Leadership><Liver Toxicity><Lymphoblastic Leukemia, Acute, L1><Maintenance><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant childhood cancer><Manpower><Mentorship><Methotrexate><Methotrexate Methylaminopterin><Methotrexatum><Metotrexato><Morbidity><Morbidity - disease rate><Outcome><Participant><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Pediatric ALL><Pediatric Acute Lymphoblastic Leukemia><Pediatric Acute Lymphocytic Leukemia><Pediatric Acute Lymphogenous Leukemia><Pediatric Acute Lymphoid Leukemia><Pediatric Leukemia><Pharmacogenomics><Physicians><Pilot Projects><Precursor Cell Lymphoblastic Leukemia><Precursor Lymphoblastic Leukemia><Predicting Risk><Predisposition><Preventative strategy><Prevention strategy><Preventive strategy><Procedures><Process><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Sampling><Scientist><Secure><Site><Specialized Program of Research Excellence><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Survival Rate><Susceptibility><Toxic effect><Toxic effect on liver cells><Toxicities><Training><Treatment-related toxicity><Work><acute lymphatic leukemia><acute lymphogenous leukemia><acute lymphomatic leukemia><adverse consequence><adverse outcome><biobank><biologic><biorepository><cancer in a child><cancer in children><career><causation><central database><cerebral spinal fluid><child with cancer><childhood malignancy><children with leukemia><community advisory board><community advisory committee><community advisory panel><community engagement><cooking><data management><data management and coordinating center><data management center><design><designing><developmental><disease causation><disparate effect><disparate impact><disparate result><disparity in ethnic><engagement with communities><epigenetically><epigenomics><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnic subgroup><ethnicity disparity><ethnicity group><forecasting risk><hepatic toxicity><hepatoxicity><improved><improved outcome><inequitable effect><inequitable impact><inequitable outcome><infant ALL><innovate><innovation><innovative><juvenile><juvenile human><kids><leukemia><leukemia in children><leukemia treatment><leukemic therapy><lipidomics><metabolism measurement><metabolomics><metabonomics><mortality><multidisciplinary><neuron toxicity><neuronal toxicity><neurotoxicity><outcome disparities><outcome inequality><outcome inequity><outreach><patient centered><patient oriented><pediatric cancer><pediatric malignancy><personnel><pilot study><predict risk><predict risks><predicted risk><predicted risks><predicting risks><predictive risk><predicts risk><programs><recruit><response to therapy><response to treatment><risk prediction><risk predictions><social health determinants><spinal fluid><statistical analysis><therapeutic response><therapeutic toxicity><therapy associated toxicity><therapy related toxicity><therapy response><therapy toxicity><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><treatment strategy><treatment toxicity><treatment-associated toxicity><unequal effect><unequal impact><unequal outcome><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karen R Rabin

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,494,110
FY 2025

Project Title

Reducing Disparities in Acute Leukemia (REDIAL) Consortium

Grant Number:

1U54CA302464-01

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2025

End Date:

8/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and, although cure rates have improved over the past 50 years, population-based disparities persist. In particular, Latinos have the highest incidence and among the lowest survival rates for leukemia in the U.S. The underlying ...

Research Terms

<0-11 years old><Acute Lymphoblastic Leukemia><Acute Lymphocytic Leukemia><Acute Lymphoid Leukemia><Acute leukemia><Address><Adolescent><Adolescent Youth><Advocate><Area><Bioinformatics><Biologic Factor><Biological><Biological Factors><Biology><Biometrics><Biometry><Biostatistics><Blood><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><Cancer Center><Care Givers><Caregivers><Causality><Cell Body><Cells><Cerebrospinal Fluid><Child><Child Youth><Childhood ALL><Childhood Acute Lymphoblastic Leukemia><Childhood Acute Lymphocytic Leukemia><Childhood Acute Lymphogenous Leukemia><Childhood Acute Lymphoid Leukemia><Childhood Cancers><Childhood Leukemia><Children (0-21)><Communication><Communities><Community Outreach><Data Management Core><Data Set><Development><Disease><Disorder><Disparities><Disparity><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Ethnic Group><Ethnic Origin><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity><Ethnicity People><Ethnicity Population><Etiology><Exposure to><Family Research><Fostering><Foundations><Future><Goals><Health><Hepatotoxic effect><Hepatotoxicity><Host Factor><Host Factor Protein><Human Resources><Incidence><Infrastructure><Integration Host Factors><Intervention Strategies><Investigation><Investigators><L1 Lymphocytic Leukemia><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Leadership><Liver Toxicity><Lymphoblastic Leukemia, Acute, L1><Maintenance><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant childhood cancer><Manpower><Mentorship><Methotrexate><Methotrexate Methylaminopterin><Methotrexatum><Metotrexato><Morbidity><Morbidity - disease rate><Outcome><Participant><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patients><Pediatric ALL><Pediatric Acute Lymphoblastic Leukemia><Pediatric Acute Lymphocytic Leukemia><Pediatric Acute Lymphogenous Leukemia><Pediatric Acute Lymphoid Leukemia><Pediatric Leukemia><Pharmacogenomics><Physicians><Pilot Projects><Precursor Cell Lymphoblastic Leukemia><Precursor Lymphoblastic Leukemia><Predicting Risk><Predisposition><Preventative strategy><Prevention strategy><Preventive strategy><Procedures><Process><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Sampling><Scientist><Secure><Site><Specialized Program of Research Excellence><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Survival Rate><Susceptibility><Toxic effect><Toxic effect on liver cells><Toxicities><Training><Treatment-related toxicity><Work><acute lymphatic leukemia><acute lymphogenous leukemia><acute lymphomatic leukemia><adverse consequence><adverse outcome><biobank><biologic><biorepository><cancer in a child><cancer in children><career><causation><central database><cerebral spinal fluid><child with cancer><childhood malignancy><children with leukemia><community advisory board><community advisory committee><community advisory panel><community engagement><cooking><data management><data management and coordinating center><data management center><design><designing><developmental><disease causation><disparate effect><disparate impact><disparate result><disparity in ethnic><engagement with communities><epigenetically><epigenomics><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnic subgroup><ethnicity disparity><ethnicity group><forecasting risk><hepatic toxicity><hepatoxicity><improved><improved outcome><inequitable effect><inequitable impact><inequitable outcome><infant ALL><innovate><innovation><innovative><juvenile><juvenile human><kids><leukemia><leukemia in children><leukemia treatment><leukemic therapy><lipidomics><metabolism measurement><metabolomics><metabonomics><mortality><multidisciplinary><neuron toxicity><neuronal toxicity><neurotoxicity><outcome disparities><outcome inequality><outcome inequity><outreach><patient centered><patient oriented><pediatric cancer><pediatric malignancy><personnel><pilot study><predict risk><predict risks><predicted risk><predicted risks><predicting risks><predictive risk><predicts risk><programs><recruit><response to therapy><response to treatment><risk prediction><risk predictions><social health determinants><spinal fluid><statistical analysis><therapeutic response><therapeutic toxicity><therapy associated toxicity><therapy related toxicity><therapy response><therapy toxicity><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><treatment strategy><treatment toxicity><treatment-associated toxicity><unequal effect><unequal impact><unequal outcome><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Monica Kraft

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,450,312
FY 2025

Project Title

The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center

Grant Number:

5U54AG075936-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT –SCENT– Overall Cellular senescence is a stress-response, as well as a critical component of cell fate during development, repair, resilience and normal aging. Deepening and broadening our investigations into cellular senescence in normal condition will advance our knowledge of healthy agin...

Research Terms

<Address><Age><Aging><Agreement><Area><Atlases><Biochemical><Bioinformatics><Biological><Blood><Blood Reticuloendothelial System><Body Tissues><Cardiac Transplantation><Cell Aging><Cell Body><Cell Components><Cell Senescence><Cell Structure><Cell model><Cells><Cellular Aging><Cellular Senescence><Cellular Structures><Cellular model><Clinical><Collaborations><Colon><Communication><Computer software><Consultations><Critical Care><Data><Data Collection><Development><Evaluation><Faculty><Future><Goals><Heart><Heart Grafting><Heart Transplantation><Heterogeneity><Human><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunologic Subtyping><Immunological><Immunologically><Immunologics><Immunophenotyping><Improve Access><Institution><Investigation><Knowledge><Leadership><Lung><Lung Grafting><Lung Respiratory System><Lung Transplantation><Methods><Mission><Modern Man><Molecular><Muscle><Muscle Tissue><NIH><National Institutes of Health><Normal Cell><Normal Tissue><Normal tissue morphology><Organ><Organoids><PBMC><Peripheral Blood Mononuclear Cell><Phase><Phenotype><Problem Solving><Process><Protocol><Protocols documentation><Pulmonary Graft><Pulmonary Transplant><Pulmonary Transplantation><Replicative Senescence><Research><Research Specimen><Resolution><Scientist><Skin><Software><Specimen><Testing><Tissues><Translational Research><Translational Science><Transplantation Surgery><United States National Institutes of Health><Universities><age associated><age correlated><age dependent><age linked><age related><age specific><ages><aging associated disease><aging associated disorders><aging related disease><aging related disorders><anti aging based therapeutic><anti aging therapeutic><anti-aging property therapeutic><biobank><biologic><biological adaptation to stress><biorepository><cardiac graft><cellular senescence mapping><cellular senescence tracing><consultation><data analysis core><data analysis research core><data analytics core><data analytics research core><data integration><data sharing><deep learning algorithm><demographics><design><designing><developmental><dimensional analysis><disability><disease associated with aging><disease of aging><disorder of aging><disorders associated with aging><disorders related to aging><geroprotectant><geroprotection><geroprotective><geroprotector><geroscience therapeutic><gerotherapeutic><healthy aging><healthy human aging><heart transplant><human tissue><interoperability><lung transplant><medical college><medical schools><multi-modality><multimodality><muscular><natural aging><normal aging><normative aging><preservation><prospective><pulmonary><reactioncrisis><repair><repaired><replicative aging><resilience><resilient><resolutions><school of medicine><senescence><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent><senescent cell><senescent cell mapping><senescent cell tracing><single cell technology><skills><stress response><stressreaction><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic against aging><therapeutic interventions against aging><therapeutic strategies for aging><therapeutic strategies targeting aging><therapeutic target for anti-aging><therapeutic targeting aging><therapeutic targets to reverse aging><therapeutic to prevent aging><therapeutics impacts on aging><therapeutics that slow aging><tissue map><tissue mapping><translation research><translational investigation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PATTY J LEE

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,450,312
FY 2025

Project Title

The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center

Grant Number:

5U54AG075936-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT –SCENT– Overall Cellular senescence is a stress-response, as well as a critical component of cell fate during development, repair, resilience and normal aging. Deepening and broadening our investigations into cellular senescence in normal condition will advance our knowledge of healthy agin...

Research Terms

<Address><Age><Aging><Agreement><Area><Atlases><Biochemical><Bioinformatics><Biological><Blood><Blood Reticuloendothelial System><Body Tissues><Cardiac Transplantation><Cell Aging><Cell Body><Cell Components><Cell Senescence><Cell Structure><Cell model><Cells><Cellular Aging><Cellular Senescence><Cellular Structures><Cellular model><Clinical><Collaborations><Colon><Communication><Computer software><Consultations><Critical Care><Data><Data Collection><Development><Evaluation><Faculty><Future><Goals><Heart><Heart Grafting><Heart Transplantation><Heterogeneity><Human><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunologic Subtyping><Immunological><Immunologically><Immunologics><Immunophenotyping><Improve Access><Institution><Investigation><Knowledge><Leadership><Lung><Lung Grafting><Lung Respiratory System><Lung Transplantation><Methods><Mission><Modern Man><Molecular><Muscle><Muscle Tissue><NIH><National Institutes of Health><Normal Cell><Normal Tissue><Normal tissue morphology><Organ><Organoids><PBMC><Peripheral Blood Mononuclear Cell><Phase><Phenotype><Problem Solving><Process><Protocol><Protocols documentation><Pulmonary Graft><Pulmonary Transplant><Pulmonary Transplantation><Replicative Senescence><Research><Research Specimen><Resolution><Scientist><Skin><Software><Specimen><Testing><Tissues><Translational Research><Translational Science><Transplantation Surgery><United States National Institutes of Health><Universities><age associated><age correlated><age dependent><age linked><age related><age specific><ages><aging associated disease><aging associated disorders><aging related disease><aging related disorders><anti aging based therapeutic><anti aging therapeutic><anti-aging property therapeutic><biobank><biologic><biological adaptation to stress><biorepository><cardiac graft><cellular senescence mapping><cellular senescence tracing><consultation><data analysis core><data analysis research core><data analytics core><data analytics research core><data integration><data sharing><deep learning algorithm><demographics><design><designing><developmental><dimensional analysis><disability><disease associated with aging><disease of aging><disorder of aging><disorders associated with aging><disorders related to aging><geroprotectant><geroprotection><geroprotective><geroprotector><geroscience therapeutic><gerotherapeutic><healthy aging><healthy human aging><heart transplant><human tissue><interoperability><lung transplant><medical college><medical schools><multi-modality><multimodality><muscular><natural aging><normal aging><normative aging><preservation><prospective><pulmonary><reactioncrisis><repair><repaired><replicative aging><resilience><resilient><resolutions><school of medicine><senescence><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent><senescent cell><senescent cell mapping><senescent cell tracing><single cell technology><skills><stress response><stressreaction><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic against aging><therapeutic interventions against aging><therapeutic strategies for aging><therapeutic strategies targeting aging><therapeutic target for anti-aging><therapeutic targeting aging><therapeutic targets to reverse aging><therapeutic to prevent aging><therapeutics impacts on aging><therapeutics that slow aging><tissue map><tissue mapping><translation research><translational investigation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDREW B. NIXON

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,450,312
FY 2025

Project Title

The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center

Grant Number:

5U54AG075936-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT –SCENT– Overall Cellular senescence is a stress-response, as well as a critical component of cell fate during development, repair, resilience and normal aging. Deepening and broadening our investigations into cellular senescence in normal condition will advance our knowledge of healthy agin...

Research Terms

<Address><Age><Aging><Agreement><Area><Atlases><Biochemical><Bioinformatics><Biological><Blood><Blood Reticuloendothelial System><Body Tissues><Cardiac Transplantation><Cell Aging><Cell Body><Cell Components><Cell Senescence><Cell Structure><Cell model><Cells><Cellular Aging><Cellular Senescence><Cellular Structures><Cellular model><Clinical><Collaborations><Colon><Communication><Computer software><Consultations><Critical Care><Data><Data Collection><Development><Evaluation><Faculty><Future><Goals><Heart><Heart Grafting><Heart Transplantation><Heterogeneity><Human><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunologic Subtyping><Immunological><Immunologically><Immunologics><Immunophenotyping><Improve Access><Institution><Investigation><Knowledge><Leadership><Lung><Lung Grafting><Lung Respiratory System><Lung Transplantation><Methods><Mission><Modern Man><Molecular><Muscle><Muscle Tissue><NIH><National Institutes of Health><Normal Cell><Normal Tissue><Normal tissue morphology><Organ><Organoids><PBMC><Peripheral Blood Mononuclear Cell><Phase><Phenotype><Problem Solving><Process><Protocol><Protocols documentation><Pulmonary Graft><Pulmonary Transplant><Pulmonary Transplantation><Replicative Senescence><Research><Research Specimen><Resolution><Scientist><Skin><Software><Specimen><Testing><Tissues><Translational Research><Translational Science><Transplantation Surgery><United States National Institutes of Health><Universities><age associated><age correlated><age dependent><age linked><age related><age specific><ages><aging associated disease><aging associated disorders><aging related disease><aging related disorders><anti aging based therapeutic><anti aging therapeutic><anti-aging property therapeutic><biobank><biologic><biological adaptation to stress><biorepository><cardiac graft><cellular senescence mapping><cellular senescence tracing><consultation><data analysis core><data analysis research core><data analytics core><data analytics research core><data integration><data sharing><deep learning algorithm><demographics><design><designing><developmental><dimensional analysis><disability><disease associated with aging><disease of aging><disorder of aging><disorders associated with aging><disorders related to aging><geroprotectant><geroprotection><geroprotective><geroprotector><geroscience therapeutic><gerotherapeutic><healthy aging><healthy human aging><heart transplant><human tissue><interoperability><lung transplant><medical college><medical schools><multi-modality><multimodality><muscular><natural aging><normal aging><normative aging><preservation><prospective><pulmonary><reactioncrisis><repair><repaired><replicative aging><resilience><resilient><resolutions><school of medicine><senescence><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent><senescent cell><senescent cell mapping><senescent cell tracing><single cell technology><skills><stress response><stressreaction><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic against aging><therapeutic interventions against aging><therapeutic strategies for aging><therapeutic strategies targeting aging><therapeutic target for anti-aging><therapeutic targeting aging><therapeutic targets to reverse aging><therapeutic to prevent aging><therapeutics impacts on aging><therapeutics that slow aging><tissue map><tissue mapping><translation research><translational investigation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Trey Ideker

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,378,309
FY 2025

Project Title

The Cancer Cell Map Initiative v2.0

Grant Number:

5U54CA274502-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/14/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

THE CANCER CELL MAP INITIATIVE v2.0 OVERALL SUMMARY The Cancer Genome Atlas and sister projects have now sequenced over 20,000 tumor genomes, providing a catalog of gene mutations, copy number variants and other genetic alterations associated with cancer. These data have made it clear that every can...

Research Terms

<Advanced Cancer><Advanced Malignant Neoplasm><Antioncogene Protein p53><Area><Assay><Atlas of Cancer Mortality in the United States><Attention><Binding><Bioassay><Bioinformatics><Biological Assay><Biology><Breast><CRISPR><CRISPR/Cas system><California><Cancer Center><Cancer Maps><Cancers><Cataloging><Catalogs><Cell Growth in Number><Cell Line><Cell Locomotion><Cell Migration><Cell Movement><Cell Multiplication><Cell Proliferation><CellLine><Cellular Migration><Cellular Motility><Cellular Proliferation><Cellular Tumor Antigen P53><Center for Cancer Research><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats><Collection><Complex><Computational toolkit><Copy Number Polymorphism><Cryo-electron Microscopy><Cryoelectron Microscopy><DNA Alteration><DNA Sequence Alteration><DNA mutation><Data><Dependence><Disease><Disorder><Electron Cryomicroscopy><Expert Systems><FDA approved><Faculty><Funding><Gene Alteration><Gene Mutation><Genes><Genetic Alteration><Genetic Change><Genetic Diseases><Genetic Screening><Genetic defect><Genetic mutation><Head and Neck Neoplasms><Heterogeneity><Image><Immunofluorescence Microscopy><Information Networks><Institution><Intelligent systems><Investigators><Laboratories><Logic><Lung><Lung Respiratory System><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Maps><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Mind><Mission><Modeling><Molecular><Molecular Interaction><Molecular Modeling Nucleic Acid Biochemistry><Molecular Modeling Protein/Amino Acid Biochemistry><Molecular Models><Mutation><NCI Center for Cancer Research><Neoplasm Metastasis><Oncoprotein p53><Other Genetics><P53><PI3K-Alpha><PIK3-Alpha><PIK3CA><PIK3CA gene><Pathogenesis><Pathway interactions><Patients><Pattern><Phenotype><Phosphatidylinositol 3-Kinase, Catalytic, 110-kD, Alpha><Phosphatidylinositol 3-Kinase, Catalytic, Alpha><Phosphoprotein P53><Phosphoprotein pp53><Physiologic><Physiological><Point Mutation><Principal Investigator><Proliferating><Protein TP53><Proteins><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Secondary Neoplasm><Secondary Tumor><Sequence Alteration><Sister><Squamous Cell><Strains Cell Lines><Structural Models><Structure><System><Systems Biology><TCGA><TP53><TP53 gene><TRP53><Techniques><The Cancer Genome Atlas><Time><Training><Translating><Tumor Cell><Tumor Protein p53><Tumor Protein p53 Gene><Universities><anti-cancer research><cancer cell><cancer cell genome><cancer genome><cancer metastasis><cancer research><cancers that are rare><catalog><cell motility><combinatorial><computational toolbox><computational tools><computational toolset><computerized tools><copy number variant><copy number variation><cryo-EM><cryoEM><cryogenic electron microscopy><cultured cell line><deep learning><deep learning method><deep learning strategy><driver lesion><driver mutation><drug response prediction><experiment><experimental research><experimental study><experiments><gene defect><gene panel><genetic condition><genetic disorder><genome mutation><genome scale><genome-wide><genomewide><genomic alteration><head and neck tumor><imaging><individualized cancer care><individualized oncology><interest><knockout gene><malignancy><molecular modeling><mouse model><multigene panel><murine model><mutant allele><neoplasm/cancer><neoplastic cell><next generation><p110-Alpha><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient response><patient specific response><personalization of treatment><personalized medicine><personalized oncology><personalized therapy><personalized treatment><precision cancer care><precision cancer medicine><precision medicine><precision oncology><precision-based medicine><pressure><protein complex><protein p53><rare cancer><rare malignancy><rare tumor><response to therapy><response to treatment><responsive patient><scale up><simulation><spatial and temporal><spatial temporal><spatiotemporal><therapeutic response><therapy response><training opportunity><transfer learning><treatment response><treatment responsiveness><tumor><tumor cell metastasis><tumor genome><tumor initiation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Nevan J Krogan

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$2,378,309
FY 2025

Project Title

The Cancer Cell Map Initiative v2.0

Grant Number:

5U54CA274502-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/14/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

THE CANCER CELL MAP INITIATIVE v2.0 OVERALL SUMMARY The Cancer Genome Atlas and sister projects have now sequenced over 20,000 tumor genomes, providing a catalog of gene mutations, copy number variants and other genetic alterations associated with cancer. These data have made it clear that every can...

Research Terms

<Advanced Cancer><Advanced Malignant Neoplasm><Antioncogene Protein p53><Area><Assay><Atlas of Cancer Mortality in the United States><Attention><Binding><Bioassay><Bioinformatics><Biological Assay><Biology><Breast><CRISPR><CRISPR/Cas system><California><Cancer Center><Cancer Maps><Cancers><Cataloging><Catalogs><Cell Growth in Number><Cell Line><Cell Locomotion><Cell Migration><Cell Movement><Cell Multiplication><Cell Proliferation><CellLine><Cellular Migration><Cellular Motility><Cellular Proliferation><Cellular Tumor Antigen P53><Center for Cancer Research><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats><Collection><Complex><Computational toolkit><Copy Number Polymorphism><Cryo-electron Microscopy><Cryoelectron Microscopy><DNA Alteration><DNA Sequence Alteration><DNA mutation><Data><Dependence><Disease><Disorder><Electron Cryomicroscopy><Expert Systems><FDA approved><Faculty><Funding><Gene Alteration><Gene Mutation><Genes><Genetic Alteration><Genetic Change><Genetic Diseases><Genetic Screening><Genetic defect><Genetic mutation><Head and Neck Neoplasms><Heterogeneity><Image><Immunofluorescence Microscopy><Information Networks><Institution><Intelligent systems><Investigators><Laboratories><Logic><Lung><Lung Respiratory System><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Maps><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Mind><Mission><Modeling><Molecular><Molecular Interaction><Molecular Modeling Nucleic Acid Biochemistry><Molecular Modeling Protein/Amino Acid Biochemistry><Molecular Models><Mutation><NCI Center for Cancer Research><Neoplasm Metastasis><Oncoprotein p53><Other Genetics><P53><PI3K-Alpha><PIK3-Alpha><PIK3CA><PIK3CA gene><Pathogenesis><Pathway interactions><Patients><Pattern><Phenotype><Phosphatidylinositol 3-Kinase, Catalytic, 110-kD, Alpha><Phosphatidylinositol 3-Kinase, Catalytic, Alpha><Phosphoprotein P53><Phosphoprotein pp53><Physiologic><Physiological><Point Mutation><Principal Investigator><Proliferating><Protein TP53><Proteins><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Secondary Neoplasm><Secondary Tumor><Sequence Alteration><Sister><Squamous Cell><Strains Cell Lines><Structural Models><Structure><System><Systems Biology><TCGA><TP53><TP53 gene><TRP53><Techniques><The Cancer Genome Atlas><Time><Training><Translating><Tumor Cell><Tumor Protein p53><Tumor Protein p53 Gene><Universities><anti-cancer research><cancer cell><cancer cell genome><cancer genome><cancer metastasis><cancer research><cancers that are rare><catalog><cell motility><combinatorial><computational toolbox><computational tools><computational toolset><computerized tools><copy number variant><copy number variation><cryo-EM><cryoEM><cryogenic electron microscopy><cultured cell line><deep learning><deep learning method><deep learning strategy><driver lesion><driver mutation><drug response prediction><experiment><experimental research><experimental study><experiments><gene defect><gene panel><genetic condition><genetic disorder><genome mutation><genome scale><genome-wide><genomewide><genomic alteration><head and neck tumor><imaging><individualized cancer care><individualized oncology><interest><knockout gene><malignancy><molecular modeling><mouse model><multigene panel><murine model><mutant allele><neoplasm/cancer><neoplastic cell><next generation><p110-Alpha><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient response><patient specific response><personalization of treatment><personalized medicine><personalized oncology><personalized therapy><personalized treatment><precision cancer care><precision cancer medicine><precision medicine><precision oncology><precision-based medicine><pressure><protein complex><protein p53><rare cancer><rare malignancy><rare tumor><response to therapy><response to treatment><responsive patient><scale up><simulation><spatial and temporal><spatial temporal><spatiotemporal><therapeutic response><therapy response><training opportunity><transfer learning><treatment response><treatment responsiveness><tumor><tumor cell metastasis><tumor genome><tumor initiation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDREA CALIFANO

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,826,689
FY 2025

Project Title

Center for Cancer Systems Therapeutics (CaST)

Grant Number:

5U54CA274506-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus deriving only modest improvement in disease-free survival from targeted therapy and immunotherapy. Tumor heterogeneity adds further complexity ...

Research Terms

<3-D structure><3-dimensional structure><3D structure><Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Binding><Biological><Biological Markers><Body Tissues><Brain Metastasis><Buffers><Cancer Center><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Clinical><Collaborations><Combined Modality Therapy><DNA mutation><Dependence><Development><Disease-Free Survival><Dissection><Drug Therapy><Drug resistance><Drugs><Education><Educational aspects><Endocrine><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Event><Event-Free Survival><Fostering><Gene Transcription><Genetic><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Goals><Immune mediated therapy><Immunologically Directed Therapy><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Individual><Intervention Trial><Interventional trial><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><Ligands><Maintenance><Malignant><Malignant - descriptor><Malignant Cell><Malignant Melanoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mediating><Medication><Melanoma><Metastatic Neoplasm to the Brain><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Methodology><Molecular><Molecular Interaction><Multimodal Therapy><Multimodal Treatment><Mutation><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Network-based><Non-Malignant><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Outcome><Patients><Pharmaceutical Preparations><Pharmacological Treatment><Pharmacology><Pharmacotherapy><Phenotype><Productivity><Prognosis><Proteome><Proteomics><RNA Expression><Receptor Protein><Research><Research Personnel><Researchers><Reverse engineering><Science><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Structure><System><Systems Biology><Systems Integration><Technology><Therapeutic><Therapy trial><Tissues><Transcription><Validation><actionable mutation><actionable variants><anti-cancer therapy><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><brain micrometastasis><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer-directed therapy><cell type><check point blockade><checkpoint blockade><clinical relevance><clinical translation><clinically relevant><clinically translatable><combination therapy><combined modality treatment><combined treatment><design><designing><developmental><drug intervention><drug mechanism><drug resistant><drug treatment><drug/agent><epigenetically><evidence base><forging><genome mutation><heterogeneity in tumors><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune suppression><immune suppressive activity><immune suppressive function><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive activity><immunosuppressive function><immunosuppressive microenvironment><immunosuppressive response><immunosuppressive tumor microenvironment><improved><innovate><innovation><innovative><integrated system><interest><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><multi-modal therapy><multi-modal treatment><multiomics><multiple data sources><multiple omics><neoplasm progression><neoplasm/cancer><neoplastic progression><next generation><nonmalignant><novel><outreach><panomics><paracrine><patient responsibilities><pharmaceutical intervention><pharmacologic><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><programs><receptor><receptor-mediated signaling><recruit><relapse patients><resistance to Drug><resistant to Drug><single cell technology><system integration><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><three dimensional structure><tumor><tumor heterogeneity><tumor immune microenvironment><tumor initiation><tumor microenvironment><tumor progression><tumor-immune system interactions><validations><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BARRY H HONIG

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,826,689
FY 2025

Project Title

Center for Cancer Systems Therapeutics (CaST)

Grant Number:

5U54CA274506-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus deriving only modest improvement in disease-free survival from targeted therapy and immunotherapy. Tumor heterogeneity adds further complexity ...

Research Terms

<3-D structure><3-dimensional structure><3D structure><Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Binding><Biological><Biological Markers><Body Tissues><Brain Metastasis><Buffers><Cancer Center><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Clinical><Collaborations><Combined Modality Therapy><DNA mutation><Dependence><Development><Disease-Free Survival><Dissection><Drug Therapy><Drug resistance><Drugs><Education><Educational aspects><Endocrine><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Event><Event-Free Survival><Fostering><Gene Transcription><Genetic><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Goals><Immune mediated therapy><Immunologically Directed Therapy><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunotherapy><Individual><Intervention Trial><Interventional trial><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><Ligands><Maintenance><Malignant><Malignant - descriptor><Malignant Cell><Malignant Melanoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mediating><Medication><Melanoma><Metastatic Neoplasm to the Brain><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Methodology><Molecular><Molecular Interaction><Multimodal Therapy><Multimodal Treatment><Mutation><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Network-based><Non-Malignant><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Outcome><Patients><Pharmaceutical Preparations><Pharmacological Treatment><Pharmacology><Pharmacotherapy><Phenotype><Productivity><Prognosis><Proteome><Proteomics><RNA Expression><Receptor Protein><Research><Research Personnel><Researchers><Reverse engineering><Science><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Structure><System><Systems Biology><Systems Integration><Technology><Therapeutic><Therapy trial><Tissues><Transcription><Validation><actionable mutation><actionable variants><anti-cancer therapy><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><brain micrometastasis><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer-directed therapy><cell type><check point blockade><checkpoint blockade><clinical relevance><clinical translation><clinically relevant><clinically translatable><combination therapy><combined modality treatment><combined treatment><design><designing><developmental><drug intervention><drug mechanism><drug resistant><drug treatment><drug/agent><epigenetically><evidence base><forging><genome mutation><heterogeneity in tumors><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune suppression><immune suppressive activity><immune suppressive function><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive activity><immunosuppressive function><immunosuppressive microenvironment><immunosuppressive response><immunosuppressive tumor microenvironment><improved><innovate><innovation><innovative><integrated system><interest><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><multi-modal therapy><multi-modal treatment><multiomics><multiple data sources><multiple omics><neoplasm progression><neoplasm/cancer><neoplastic progression><next generation><nonmalignant><novel><outreach><panomics><paracrine><patient responsibilities><pharmaceutical intervention><pharmacologic><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><programs><receptor><receptor-mediated signaling><recruit><relapse patients><resistance to Drug><resistant to Drug><single cell technology><system integration><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><three dimensional structure><tumor><tumor heterogeneity><tumor immune microenvironment><tumor initiation><tumor microenvironment><tumor progression><tumor-immune system interactions><validations><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory Alan Abel

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,768,394
FY 2025

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

5U54CA156732-15

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KASISOMAYAJULA VISWANATH

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,768,394
FY 2025

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

5U54CA156732-15

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joel Erblich

TEMPLE UNIV OF THE COMMONWEALTH, PHILADELPHIA, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,670,747
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221705-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer S Ford

TEMPLE UNIV OF THE COMMONWEALTH, PHILADELPHIA, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,670,747
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221705-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GRACE X. MA

TEMPLE UNIV OF THE COMMONWEALTH, PHILADELPHIA, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,670,747
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221705-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Camille C. Ragin

TEMPLE UNIV OF THE COMMONWEALTH, PHILADELPHIA, PA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,670,747
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221705-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAPHNE A. HAAS-KOGAN

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,606,288
FY 2025

Project Title

Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science

Grant Number:

5U54CA274516-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Basic scientists and clinical investigators from Dana-Farber/Harvard Cancer Center (DF/HCC) join forces with their counterparts at University of California, San Francisco’s (UCSF) Helen Diller Family Comprehensive Cancer Center to propose a Harvard/UCSF ROBIN Center. Our Objective is...

Research Terms

<0-11 years old><21+ years old><AI system><Accounting><Address><Adult><Adult Human><Adverse Late Effects><Advisory Committees><Advocate><Anatomic Sites><Anatomic structures><Anatomy><Artificial Intelligence><Award><Biological><Biological Markers><Biology><Boston><California><Cancer Biology><Cancer Center><Cancer Center Director><Cancers><Cell Body><Cells><Child><Child Youth><Childhood><Childhood Cancers><Childhood Glioma><Childhood Neoplasm><Childhood Solid Neoplasm><Childhood Solid Tumor><Childhood Tumor><Children (0-21)><Clinical><Clinical Investigator><Clinical Trials><Clinical Trials Network><Collection><Communities><Comprehensive Cancer Center><Computational Biology><Computer Reasoning><Core Facility><Credentialing><DNA mutation><Daphne><Daphne plant><Data><Data Science><Data Set><Definitive Radiation Therapy><Development><Discipline><Doctor of Medicine><Doctor of Philosophy><EBRT><EXTMR><Education><Educational aspects><Elements><Evolution><Experimental Therapies><External Beam RT><External Beam Radiation Therapy><External Radiation><Extramural><Extramural Activities><Face><Family><Funding><Future><General Population><General Public><Genetic><Genetic Change><Genetic defect><Genetic mutation><Heterogeneity><Image><Infrastructure><Infrequent Neoplasm><Infrequent Tumor><Institution><International><Intratumoral heterogeneity><Investigational Therapies><Investigational Treatments><Investigators><Iobenguane><Late Effects><M.D.><MIBG><Machine Intelligence><Machine Learning><Malignant Cell><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Neoplasms><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant Tumor><Malignant childhood cancer><Math Models><Medical><Methodology><Mission><Modality><Molecular><Mutation><NCI Organization><National Cancer Institute><National Clinical Trials Network><Neuroblastoma><Oncology><Oncology Cancer><Outcome><Patient advocacy><Patients><Pediatric Glioma><Pediatric Neoplasm><Pediatric Solid Tumor><Pediatric Tumor><Pediatric high-grade glioma><Persons><Ph.D.><PhD><Physics><Pilot Projects><Population><Position><Positioning Attribute><Process><Productivity><QOL><Quality of life><R-Series Research Projects><R01 Mechanism><R01 Program><Radiation><Radiation Biology><Radiation Oncologist><Radiation Oncology><Radiation therapy><Radiobiology><Radiogenomics><Radiopharmaceutical Compound><Radiopharmaceuticals><Radioresistance><Radiotherapeutics><Radiotherapy><Records><Regimen><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Researchers><Resistance><Resources><Robin><Robin bird><Sampling><San Francisco><Scientist><Solid Neoplasm><Solid Tumor><Specific qualifier value><Specified><Specimen><Students><Sum><Task Forces><Technology><Testing><Toxic effect><Toxicities><Training><Training Programs><Tumor Cell><Tumor Tissue><Universities><Variant><Variation><Work><adulthood><advisory team><bio-markers><biologic><biologic marker><biomarker><cancer cell><cancer genetics><cancer in a child><cancer in children><cancer research center director><child with cancer><childhood malignancy><childhood radiation><clinical material><cohort><computer biology><data integration><data modeling><design><designing><developmental><diffuse midline glioma><dosimetry><experience><experimental therapeutic agents><experimental therapeutics><external-beam radiation><faces><facial><genome mutation><genomic data><genomic dataset><heterogeneity in tumors><high risk><imaging><immune microenvironment><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><insight><intra-tumoral heterogeneity><intratumor heterogeneity><irradiation response><kids><m-Iodobenzylguanidine><machine based learning><malignancy><mathematic model><mathematical model><mathematical modeling><meta-Iodobenzylguanidine><metaiodobenzylguanidine><model of data><model the data><modeling of the data><multi-modality><multi-scale data><multimodality><multiscale data><neoplasm/cancer><neoplastic cell><novel><outreach program><pediatric><pediatric cancer><pediatric malignancy><pediatric radiation><physical science><pilot study><professor><programs><prospective><radiation during childhood><radiation in children><radiation resistance><radiation resistant><radiation response><radiation treatment><radio resistance><radioactive drugs><radioresistant><radiotherapeutic drugs><resistant><resistant to radiation><response><response to radiation><response to therapy><response to treatment><skills><spatial and temporal><spatial temporal><spatiotemporal><standard of care><therapeutic response><therapy response><treatment response><treatment responsiveness><treatment with radiation><tumor><tumor heterogeneity><tumor immune microenvironment><tumor-immune system interactions><tumors in children><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Franziska Michor

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,606,288
FY 2025

Project Title

Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science

Grant Number:

5U54CA274516-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Basic scientists and clinical investigators from Dana-Farber/Harvard Cancer Center (DF/HCC) join forces with their counterparts at University of California, San Francisco’s (UCSF) Helen Diller Family Comprehensive Cancer Center to propose a Harvard/UCSF ROBIN Center. Our Objective is...

Research Terms

<0-11 years old><21+ years old><AI system><Accounting><Address><Adult><Adult Human><Adverse Late Effects><Advisory Committees><Advocate><Anatomic Sites><Anatomic structures><Anatomy><Artificial Intelligence><Award><Biological><Biological Markers><Biology><Boston><California><Cancer Biology><Cancer Center><Cancer Center Director><Cancers><Cell Body><Cells><Child><Child Youth><Childhood><Childhood Cancers><Childhood Glioma><Childhood Neoplasm><Childhood Solid Neoplasm><Childhood Solid Tumor><Childhood Tumor><Children (0-21)><Clinical><Clinical Investigator><Clinical Trials><Clinical Trials Network><Collection><Communities><Comprehensive Cancer Center><Computational Biology><Computer Reasoning><Core Facility><Credentialing><DNA mutation><Daphne><Daphne plant><Data><Data Science><Data Set><Definitive Radiation Therapy><Development><Discipline><Doctor of Medicine><Doctor of Philosophy><EBRT><EXTMR><Education><Educational aspects><Elements><Evolution><Experimental Therapies><External Beam RT><External Beam Radiation Therapy><External Radiation><Extramural><Extramural Activities><Face><Family><Funding><Future><General Population><General Public><Genetic><Genetic Change><Genetic defect><Genetic mutation><Heterogeneity><Image><Infrastructure><Infrequent Neoplasm><Infrequent Tumor><Institution><International><Intratumoral heterogeneity><Investigational Therapies><Investigational Treatments><Investigators><Iobenguane><Late Effects><M.D.><MIBG><Machine Intelligence><Machine Learning><Malignant Cell><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Neoplasms><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant Tumor><Malignant childhood cancer><Math Models><Medical><Methodology><Mission><Modality><Molecular><Mutation><NCI Organization><National Cancer Institute><National Clinical Trials Network><Neuroblastoma><Oncology><Oncology Cancer><Outcome><Patient advocacy><Patients><Pediatric Glioma><Pediatric Neoplasm><Pediatric Solid Tumor><Pediatric Tumor><Pediatric high-grade glioma><Persons><Ph.D.><PhD><Physics><Pilot Projects><Population><Position><Positioning Attribute><Process><Productivity><QOL><Quality of life><R-Series Research Projects><R01 Mechanism><R01 Program><Radiation><Radiation Biology><Radiation Oncologist><Radiation Oncology><Radiation therapy><Radiobiology><Radiogenomics><Radiopharmaceutical Compound><Radiopharmaceuticals><Radioresistance><Radiotherapeutics><Radiotherapy><Records><Regimen><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Researchers><Resistance><Resources><Robin><Robin bird><Sampling><San Francisco><Scientist><Solid Neoplasm><Solid Tumor><Specific qualifier value><Specified><Specimen><Students><Sum><Task Forces><Technology><Testing><Toxic effect><Toxicities><Training><Training Programs><Tumor Cell><Tumor Tissue><Universities><Variant><Variation><Work><adulthood><advisory team><bio-markers><biologic><biologic marker><biomarker><cancer cell><cancer genetics><cancer in a child><cancer in children><cancer research center director><child with cancer><childhood malignancy><childhood radiation><clinical material><cohort><computer biology><data integration><data modeling><design><designing><developmental><diffuse midline glioma><dosimetry><experience><experimental therapeutic agents><experimental therapeutics><external-beam radiation><faces><facial><genome mutation><genomic data><genomic dataset><heterogeneity in tumors><high risk><imaging><immune microenvironment><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><insight><intra-tumoral heterogeneity><intratumor heterogeneity><irradiation response><kids><m-Iodobenzylguanidine><machine based learning><malignancy><mathematic model><mathematical model><mathematical modeling><meta-Iodobenzylguanidine><metaiodobenzylguanidine><model of data><model the data><modeling of the data><multi-modality><multi-scale data><multimodality><multiscale data><neoplasm/cancer><neoplastic cell><novel><outreach program><pediatric><pediatric cancer><pediatric malignancy><pediatric radiation><physical science><pilot study><professor><programs><prospective><radiation during childhood><radiation in children><radiation resistance><radiation resistant><radiation response><radiation treatment><radio resistance><radioactive drugs><radioresistant><radiotherapeutic drugs><resistant><resistant to radiation><response><response to radiation><response to therapy><response to treatment><skills><spatial and temporal><spatial temporal><spatiotemporal><standard of care><therapeutic response><therapy response><treatment response><treatment responsiveness><treatment with radiation><tumor><tumor heterogeneity><tumor immune microenvironment><tumor-immune system interactions><tumors in children><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANIRBAN MAITRA

NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,547,663
FY 2025

Project Title

Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer

Grant Number:

7U54CA274371-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is the 3rd most common cause of cancer-related mortality in the United States, with the overhwhelming majority of patients presenting advanced stage disease. Invasive neoplasia in the pancreas represents the culmination of a multistep progre...

Research Terms

<3-D><3-Dimensional><3D><Abscission><Accounting><Animal Model><Animal Models and Related Studies><Architecture><Basic Research><Basic Science><Biology><C-K-RAS><Cancer Biology><Cancer Cause><Cancer Center><Cancer Etiology><Cancers><Cell Communication and Signaling><Cell Signaling><Cessation of life><Collaborations><Communication><Computational Biology><Credentialing><Cues><DNA mutation><Data Analyses><Data Analysis><Data Science><Death><Dependence><Disease><Disease Progression><Disorder><Distant><E3 Ligase><E3 Ubiquitin Ligase><ER stress><Early Diagnosis><Engineering / Architecture><Epithelium><Event><Excision><Extirpation><Fibroblasts><Genetic><Genetic Change><Genetic Engineering><Genetic Engineering Biotechnology><Genetic Engineering Molecular Biology><Genetic defect><Genetic mutation><Genome><Goals><Heterogeneity><Histologic><Histologically><Histology><Human><Immune><Immunes><Individual><Institution><Interleukins><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS2><KRAS2 gene><Ki-RAS><Lesion><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Maps><Mediator><Metabolic><Mice><Mice Mammals><Michigan><Mitochondria><Modeling><Modern Man><Molecular><Mucinous Neoplasm><Mucinous Tumor><Murine><Mus><Mutation><Neoplasms><Oncogene K-Ras><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><PanIN><Pancreas><Pancreas Adenocarcinoma><Pancreas Cancer><Pancreas Ductal Adenocarcinoma><Pancreas Neoplasms><Pancreas Tumor><Pancreatic><Pancreatic Adenocarcinoma><Pancreatic Cancer><Pancreatic Duct Dysplasia><Pancreatic Ductal Adenocarcinoma><Pancreatic Ductal Dysplasia><Pancreatic Intraepithelial Neoplasia><Pancreatic Tumor><Pancreatic cystic neoplasia><Papillary><Pathogenesis><Pathway interactions><Patients><Play><Pre-Clinical Model><Preclinical Models><Process><Quality Control><RASK2><Recombinant DNA Technology><Removal><Research><Research Personnel><Researchers><Resolution><Resource Sharing><Role><Seminal><Signal Transduction><Signal Transduction Systems><Signaling><Site><Specificity><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Survival Rate><Testing><Translational Research><Translational Science><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><United States><Universities><Validation><biological signal transduction><cancer cell metabolism><cancer genomics><cancer metabolism><cancer microenvironment><cancer progression><computer biology><cytokine><data analysis pipeline><data harmonization><data interpretation><data processing pipeline><data sharing><dimensional analysis><early detection><endoplasmic reticulum stress><genetically engineered><genome mutation><harmonized data><heterogeneity in tumors><high dimensionality><improved><improved outcome><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><member><mitochondrial><model of animal><molecular pathology><mortality><neoplasia><neoplasm progression><neoplasm/cancer><neoplastic growth><neoplastic progression><oncogenomics><pancreas duct dysplasia><pancreas ductal dysplasia><pancreatic cystic lesions><pancreatic cystic neoplasms><pancreatic cystic tumors><pancreatic malignancy><pancreatic neoplasia><pancreatic neoplasm><paracrine><pathway><precancer><precancerous><premalignant><programs><prototype><reconstruction><resection><resolutions><response><social role><surgery><three dimensional><tool><translation research><translational investigation><translational study><tumor cell metabolism><tumor heterogeneity><tumor metabolism><tumor microenvironment><tumor progression><ubiquitin-protein ligase><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog><validations>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marina Pasca Di Magliano

NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NEW YORK, NY

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,547,663
FY 2025

Project Title

Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer

Grant Number:

7U54CA274371-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL - ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is the 3rd most common cause of cancer-related mortality in the United States, with the overhwhelming majority of patients presenting advanced stage disease. Invasive neoplasia in the pancreas represents the culmination of a multistep progre...

Research Terms

<3-D><3-Dimensional><3D><Abscission><Accounting><Animal Model><Animal Models and Related Studies><Architecture><Basic Research><Basic Science><Biology><C-K-RAS><Cancer Biology><Cancer Cause><Cancer Center><Cancer Etiology><Cancers><Cell Communication and Signaling><Cell Signaling><Cessation of life><Collaborations><Communication><Computational Biology><Credentialing><Cues><DNA mutation><Data Analyses><Data Analysis><Data Science><Death><Dependence><Disease><Disease Progression><Disorder><Distant><E3 Ligase><E3 Ubiquitin Ligase><ER stress><Early Diagnosis><Engineering / Architecture><Epithelium><Event><Excision><Extirpation><Fibroblasts><Genetic><Genetic Change><Genetic Engineering><Genetic Engineering Biotechnology><Genetic Engineering Molecular Biology><Genetic defect><Genetic mutation><Genome><Goals><Heterogeneity><Histologic><Histologically><Histology><Human><Immune><Immunes><Individual><Institution><Interleukins><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS2><KRAS2 gene><Ki-RAS><Lesion><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Maps><Mediator><Metabolic><Mice><Mice Mammals><Michigan><Mitochondria><Modeling><Modern Man><Molecular><Mucinous Neoplasm><Mucinous Tumor><Murine><Mus><Mutation><Neoplasms><Oncogene K-Ras><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><PanIN><Pancreas><Pancreas Adenocarcinoma><Pancreas Cancer><Pancreas Ductal Adenocarcinoma><Pancreas Neoplasms><Pancreas Tumor><Pancreatic><Pancreatic Adenocarcinoma><Pancreatic Cancer><Pancreatic Duct Dysplasia><Pancreatic Ductal Adenocarcinoma><Pancreatic Ductal Dysplasia><Pancreatic Intraepithelial Neoplasia><Pancreatic Tumor><Pancreatic cystic neoplasia><Papillary><Pathogenesis><Pathway interactions><Patients><Play><Pre-Clinical Model><Preclinical Models><Process><Quality Control><RASK2><Recombinant DNA Technology><Removal><Research><Research Personnel><Researchers><Resolution><Resource Sharing><Role><Seminal><Signal Transduction><Signal Transduction Systems><Signaling><Site><Specificity><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Survival Rate><Testing><Translational Research><Translational Science><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><United States><Universities><Validation><biological signal transduction><cancer cell metabolism><cancer genomics><cancer metabolism><cancer microenvironment><cancer progression><computer biology><cytokine><data analysis pipeline><data harmonization><data interpretation><data processing pipeline><data sharing><dimensional analysis><early detection><endoplasmic reticulum stress><genetically engineered><genome mutation><harmonized data><heterogeneity in tumors><high dimensionality><improved><improved outcome><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><member><mitochondrial><model of animal><molecular pathology><mortality><neoplasia><neoplasm progression><neoplasm/cancer><neoplastic growth><neoplastic progression><oncogenomics><pancreas duct dysplasia><pancreas ductal dysplasia><pancreatic cystic lesions><pancreatic cystic neoplasms><pancreatic cystic tumors><pancreatic malignancy><pancreatic neoplasia><pancreatic neoplasm><paracrine><pathway><precancer><precancerous><premalignant><programs><prototype><reconstruction><resection><resolutions><response><social role><surgery><three dimensional><tool><translation research><translational investigation><translational study><tumor cell metabolism><tumor heterogeneity><tumor metabolism><tumor microenvironment><tumor progression><ubiquitin-protein ligase><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog><validations>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAN COLON-CARMONA

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,525,000
FY 2025

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

5U54CA156734-15

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jill A. Macoska

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,525,000
FY 2025

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

5U54CA156734-15

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Amit Sawant

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,505,442
FY 2025

Project Title

Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center

Grant Number:

5U54CA273956-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/4/2022

End Date:

7/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Metastasis is a complex systems problem, with critical changes across cell, tissue, organ, and organism scales. The limited efficacy of current therapies in metastatic patients argues that we do not fully understand metastasis. The metastatic capacity of prostate cancer (PCa) behaves along a spectru...

Research Terms

<Affect><African American><Afro American><Afroamerican><Baltimore><Biologic Models><Biological Models><Biology><Blood Plasma><Body Tissues><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Cell Body><Cells><Clinical Data><Clinical Trials><Complex><Computing Methodologies><DNA><Data><Data Analyses><Data Analysis><Deoxyribonucleic Acid><Deposit><Deposition><Development><Disease><Disorder><Disparities><Disparity><Disseminated Malignant Neoplasm><Distant><Ensure><Evaluation><Faculty><Failure><Funding><Genomics><Grant><History><Human><Image Analyses><Image Analysis><Immune><Immune Evasion><Immune response><Immunes><Institution><Intermediary Metabolism><Intervention><Invaded><Joints><Leadership><Liquid substance><Location><Malignant Cell><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medicine><Metabolic><Metabolic Processes><Metabolism><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Mice><Mice Mammals><Microscopic><Model System><Modeling><Modern Man><Molecular><Murine><Mus><Neoplasm Circulating Cells><Neoplasm Metastasis><Network Analysis><Non-Polyadenylated RNA><Occidental><Organ><Organism><Pathway Analysis><Patients><Pattern><Phase><Physics><Plasma><Plasma Serum><Progression-Free Survivals><Prostate CA><Prostate Cancer><Prostate malignancy><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><Radiation><Radiation Biology><Radiation Oncology><Radiation therapy><Radiobiology><Radiotherapeutics><Radiotherapy><Randomization trial><Randomized><Recording of previous events><Recurrence><Recurrent><Research><Research Grants><Research Project Grants><Research Projects><Resource Sharing><Reticuloendothelial System, Serum, Plasma><Ribonucleic Acid><Sampling><Secondary Neoplasm><Secondary Tumor><System><Techniques><Testing><Time><Tissues><Training><Tumor Immunity><Universities><Validation><anti-tumor immunity><antitumor immunity><cancer cell><cancer cell metabolism><cancer immunity><cancer metabolism><cancer metastasis><cancer microenvironment><candidate identification><circulating neoplastic cell><circulating tumor cell><clinical relevance><clinically relevant><combat><computational methodology><computational methods><computer based method><computer methods><computing method><data interpretation><design><designing><developmental><experience><first in man><first-in-human><fluid><genome profiling><genomic profiling><histories><host response><image evaluation><image interpretation><immune evasive><immune system response><immunoresponse><in vivo><innovate><innovation><innovative><liquid><liquid biopsy><living system><metabolism measurement><metabolomics><metabonomics><metastatic process><mouse model><multidisciplinary><multiomics><multiple omics><murine model><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><panomics><quantitative imaging><radiation treatment><radiomics><randomisation><randomization><randomized trial><randomly assigned><treatment with radiation><tumor><tumor behavior><tumor cell metabolism><tumor cell metastasis><tumor metabolism><tumor microenvironment><validations><white race>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Nicole L Simone

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,505,442
FY 2025

Project Title

Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center

Grant Number:

5U54CA273956-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/4/2022

End Date:

7/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Metastasis is a complex systems problem, with critical changes across cell, tissue, organ, and organism scales. The limited efficacy of current therapies in metastatic patients argues that we do not fully understand metastasis. The metastatic capacity of prostate cancer (PCa) behaves along a spectru...

Research Terms

<Affect><African American><Afro American><Afroamerican><Baltimore><Biologic Models><Biological Models><Biology><Blood Plasma><Body Tissues><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Cell Body><Cells><Clinical Data><Clinical Trials><Complex><Computing Methodologies><DNA><Data><Data Analyses><Data Analysis><Deoxyribonucleic Acid><Deposit><Deposition><Development><Disease><Disorder><Disparities><Disparity><Disseminated Malignant Neoplasm><Distant><Ensure><Evaluation><Faculty><Failure><Funding><Genomics><Grant><History><Human><Image Analyses><Image Analysis><Immune><Immune Evasion><Immune response><Immunes><Institution><Intermediary Metabolism><Intervention><Invaded><Joints><Leadership><Liquid substance><Location><Malignant Cell><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medicine><Metabolic><Metabolic Processes><Metabolism><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Mice><Mice Mammals><Microscopic><Model System><Modeling><Modern Man><Molecular><Murine><Mus><Neoplasm Circulating Cells><Neoplasm Metastasis><Network Analysis><Non-Polyadenylated RNA><Occidental><Organ><Organism><Pathway Analysis><Patients><Pattern><Phase><Physics><Plasma><Plasma Serum><Progression-Free Survivals><Prostate CA><Prostate Cancer><Prostate malignancy><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><Radiation><Radiation Biology><Radiation Oncology><Radiation therapy><Radiobiology><Radiotherapeutics><Radiotherapy><Randomization trial><Randomized><Recording of previous events><Recurrence><Recurrent><Research><Research Grants><Research Project Grants><Research Projects><Resource Sharing><Reticuloendothelial System, Serum, Plasma><Ribonucleic Acid><Sampling><Secondary Neoplasm><Secondary Tumor><System><Techniques><Testing><Time><Tissues><Training><Tumor Immunity><Universities><Validation><anti-tumor immunity><antitumor immunity><cancer cell><cancer cell metabolism><cancer immunity><cancer metabolism><cancer metastasis><cancer microenvironment><candidate identification><circulating neoplastic cell><circulating tumor cell><clinical relevance><clinically relevant><combat><computational methodology><computational methods><computer based method><computer methods><computing method><data interpretation><design><designing><developmental><experience><first in man><first-in-human><fluid><genome profiling><genomic profiling><histories><host response><image evaluation><image interpretation><immune evasive><immune system response><immunoresponse><in vivo><innovate><innovation><innovative><liquid><liquid biopsy><living system><metabolism measurement><metabolomics><metabonomics><metastatic process><mouse model><multidisciplinary><multiomics><multiple omics><murine model><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><panomics><quantitative imaging><radiation treatment><radiomics><randomisation><randomization><randomized trial><randomly assigned><treatment with radiation><tumor><tumor behavior><tumor cell metabolism><tumor cell metastasis><tumor metabolism><tumor microenvironment><validations><white race>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Phuoc T. Tran

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,505,442
FY 2025

Project Title

Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center

Grant Number:

5U54CA273956-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/4/2022

End Date:

7/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Metastasis is a complex systems problem, with critical changes across cell, tissue, organ, and organism scales. The limited efficacy of current therapies in metastatic patients argues that we do not fully understand metastasis. The metastatic capacity of prostate cancer (PCa) behaves along a spectru...

Research Terms

<Affect><African American><Afro American><Afroamerican><Baltimore><Biologic Models><Biological Models><Biology><Blood Plasma><Body Tissues><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Cell Body><Cells><Clinical Data><Clinical Trials><Complex><Computing Methodologies><DNA><Data><Data Analyses><Data Analysis><Deoxyribonucleic Acid><Deposit><Deposition><Development><Disease><Disorder><Disparities><Disparity><Disseminated Malignant Neoplasm><Distant><Ensure><Evaluation><Faculty><Failure><Funding><Genomics><Grant><History><Human><Image Analyses><Image Analysis><Immune><Immune Evasion><Immune response><Immunes><Institution><Intermediary Metabolism><Intervention><Invaded><Joints><Leadership><Liquid substance><Location><Malignant Cell><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medicine><Metabolic><Metabolic Processes><Metabolism><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Mice><Mice Mammals><Microscopic><Model System><Modeling><Modern Man><Molecular><Murine><Mus><Neoplasm Circulating Cells><Neoplasm Metastasis><Network Analysis><Non-Polyadenylated RNA><Occidental><Organ><Organism><Pathway Analysis><Patients><Pattern><Phase><Physics><Plasma><Plasma Serum><Progression-Free Survivals><Prostate CA><Prostate Cancer><Prostate malignancy><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><Radiation><Radiation Biology><Radiation Oncology><Radiation therapy><Radiobiology><Radiotherapeutics><Radiotherapy><Randomization trial><Randomized><Recording of previous events><Recurrence><Recurrent><Research><Research Grants><Research Project Grants><Research Projects><Resource Sharing><Reticuloendothelial System, Serum, Plasma><Ribonucleic Acid><Sampling><Secondary Neoplasm><Secondary Tumor><System><Techniques><Testing><Time><Tissues><Training><Tumor Immunity><Universities><Validation><anti-tumor immunity><antitumor immunity><cancer cell><cancer cell metabolism><cancer immunity><cancer metabolism><cancer metastasis><cancer microenvironment><candidate identification><circulating neoplastic cell><circulating tumor cell><clinical relevance><clinically relevant><combat><computational methodology><computational methods><computer based method><computer methods><computing method><data interpretation><design><designing><developmental><experience><first in man><first-in-human><fluid><genome profiling><genomic profiling><histories><host response><image evaluation><image interpretation><immune evasive><immune system response><immunoresponse><in vivo><innovate><innovation><innovative><liquid><liquid biopsy><living system><metabolism measurement><metabolomics><metabonomics><metastatic process><mouse model><multidisciplinary><multiomics><multiple omics><murine model><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><panomics><quantitative imaging><radiation treatment><radiomics><randomisation><randomization><randomized trial><randomly assigned><treatment with radiation><tumor><tumor behavior><tumor cell metabolism><tumor cell metastasis><tumor metabolism><tumor microenvironment><validations><white race>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROGER D KAMM

MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,462,791
FY 2025

Project Title

Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth

Grant Number:

5U54CA261694-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/17/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Overall: PROJECT SUMMARY Metastatic disease is responsible for the vast majority of cancer mortality. Understanding of the fundamental mechanisms leading to metastatic cancer has been hampered by the need for models that replicate the step- wise metastatic process in vivo, yet are amenable to tight ...

Research Terms

<3-D><3-Dimensional><3D><Address><Adhesions><Adhesives><Affect><Assay><Basement membrane><Bioassay><Biological Assay><Blood Platelets><Body Tissues><Cancers><Cell Body><Cell Communication><Cell Death><Cell Interaction><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cell-to-Cell Interaction><Cells><Cellular Matrix><Cessation of life><Chromatin><Chromatin Structure><Circulation><Complex><Computer Analysis><Corium><Cutis><Cytoskeletal System><Cytoskeleton><Death><Dermis><Disease><Disorder><Disseminated Malignant Neoplasm><ECM><Endothelium><Environment><Extracellular Matrix><Extravasation><Fibrin><Gene Expression><Genomics><Goals><Image><In Vitro><Individual><Intervention><Leakage><Liver><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Marrow platelet><Measurement><Mechanics><Melanoma><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Microcirculation><Modeling><Molecular><Neoplasm Circulating Cells><Neoplasm Metastasis><Nuclear><Organ><Organ Specificity><Pathway interactions><Phenotype><Platelets><Primary Neoplasm><Primary Tumor><Probability><Process><Proliferating><Property><Resolution><Role><Secondary Neoplasm><Secondary Tumor><Sight><Site><Spillage><Stress><TNBC><Techniques><Technology><Therapeutic><Thrombocytes><Thrombus><Time><Tissues><Tumor Cell><Tumor Cell Invasion><Tumor Invasion><Vision><Work><cancer metastasis><cell behavior><cell type><cellular behavior><circulating neoplastic cell><circulating tumor cell><computational analyses><computational analysis><computational studies><computer analyses><computer studies><coping><experience><experiment><experimental research><experimental study><experiments><global gene expression><global transcription profile><hemodynamics><hepatic body system><hepatic organ system><imaging><in vitro Model><in vivo><insight><intra-vital imaging><intracellular skeleton><intravital imaging><malignancy><mechanic><mechanical><metastatic process><migration><monolayer><mortality><necrocytosis><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><prevent><preventing><programs><resolutions><response><shear stress><social role><stressor><three dimensional><transcriptome><transcriptomics><triple-negative breast cancer><triple-negative invasive breast carcinoma><tumor cell metastasis><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vivek Shenoy

MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE, MA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,462,791
FY 2025

Project Title

Mechanical determinants of organ-selective metastatic colonization, dormancy and outgrowth

Grant Number:

5U54CA261694-05

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/17/2021

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Overall: PROJECT SUMMARY Metastatic disease is responsible for the vast majority of cancer mortality. Understanding of the fundamental mechanisms leading to metastatic cancer has been hampered by the need for models that replicate the step- wise metastatic process in vivo, yet are amenable to tight ...

Research Terms

<3-D><3-Dimensional><3D><Address><Adhesions><Adhesives><Affect><Assay><Basement membrane><Bioassay><Biological Assay><Blood Platelets><Body Tissues><Cancers><Cell Body><Cell Communication><Cell Death><Cell Interaction><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cell-to-Cell Interaction><Cells><Cellular Matrix><Cessation of life><Chromatin><Chromatin Structure><Circulation><Complex><Computer Analysis><Corium><Cutis><Cytoskeletal System><Cytoskeleton><Death><Dermis><Disease><Disorder><Disseminated Malignant Neoplasm><ECM><Endothelium><Environment><Extracellular Matrix><Extravasation><Fibrin><Gene Expression><Genomics><Goals><Image><In Vitro><Individual><Intervention><Leakage><Liver><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Marrow platelet><Measurement><Mechanics><Melanoma><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Microcirculation><Modeling><Molecular><Neoplasm Circulating Cells><Neoplasm Metastasis><Nuclear><Organ><Organ Specificity><Pathway interactions><Phenotype><Platelets><Primary Neoplasm><Primary Tumor><Probability><Process><Proliferating><Property><Resolution><Role><Secondary Neoplasm><Secondary Tumor><Sight><Site><Spillage><Stress><TNBC><Techniques><Technology><Therapeutic><Thrombocytes><Thrombus><Time><Tissues><Tumor Cell><Tumor Cell Invasion><Tumor Invasion><Vision><Work><cancer metastasis><cell behavior><cell type><cellular behavior><circulating neoplastic cell><circulating tumor cell><computational analyses><computational analysis><computational studies><computer analyses><computer studies><coping><experience><experiment><experimental research><experimental study><experiments><global gene expression><global transcription profile><hemodynamics><hepatic body system><hepatic organ system><imaging><in vitro Model><in vivo><insight><intra-vital imaging><intracellular skeleton><intravital imaging><malignancy><mechanic><mechanical><metastatic process><migration><monolayer><mortality><necrocytosis><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><prevent><preventing><programs><resolutions><response><shear stress><social role><stressor><three dimensional><transcriptome><transcriptomics><triple-negative breast cancer><triple-negative invasive breast carcinoma><tumor cell metastasis><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Charles Boucher

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,425,304
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

1U54HL185005-01

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kenneth N. Olivier

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,425,304
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

1U54HL185005-01

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jaimee Heffner

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,422,885
FY 2025

Project Title

2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132381-19

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Merranda Marin

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,422,885
FY 2025

Project Title

2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132381-19

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Julian Simon

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,422,885
FY 2025

Project Title

2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132381-19

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Graciela Alexandra Unguez

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,422,885
FY 2025

Project Title

2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132381-19

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ERNEST MARTINEZ

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, DUARTE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,380,454
FY 2025

Project Title

1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership

Grant Number:

5U54CA285116-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The United States has led the world in drug discovery for over 50 years; however, the majority of scientific ideas that progress to clinical trials frequently come from Comprehensive Cancer Centers. Unfortunately, not all local universities and colleges have the resources to take their ideas forward...

Research Terms

<AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Area><Breast Cancer><California><Cancer Center Planning Grant><Cancers><Catchment Area><City of Hope Comprehensive Cancer Center><Clinical><Clinical Trials><Collaborations><Communities><Comprehensive Cancer Center><County><Drugs><Economics><Ensure><Faculty><Farm><Fellowship><Fostering><Funding><Generalized Growth><Goals><Grant><Growth><Health><Infrastructure><Institution><Investigators><Joints><Los Angeles><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Medication><Mentors><Mentorship><Obesity><P20 Grant><Pancreas Cancer><Pancreatic Cancer><Pharmaceutical Preparations><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Prognosis><Research Associate><Research Personnel><Research Resources><Researchers><Resources><Rural><Scientist><Students><Therapeutic><Therapeutic Agents><Therapeutic Trials><Tissue Growth><Training><Training Programs><United States><Universities><acute granulocytic leukemia><acute myeloid leukemia><adiposity><anti-cancer research><cancer research><college><collegiate><corpulence><drug development><drug discovery><drug/agent><economic><improved><malignancy><malignant breast tumor><medical college><medical schools><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><pancreatic malignancy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><research associates><school of medicine><small molecular inhibitor><small molecule inhibitor><success><therapeutic agent development><therapeutic development>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victoria L. Seewaldt

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, DUARTE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,380,454
FY 2025

Project Title

1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership

Grant Number:

5U54CA285116-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The United States has led the world in drug discovery for over 50 years; however, the majority of scientific ideas that progress to clinical trials frequently come from Comprehensive Cancer Centers. Unfortunately, not all local universities and colleges have the resources to take their ideas forward...

Research Terms

<AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Area><Breast Cancer><California><Cancer Center Planning Grant><Cancers><Catchment Area><City of Hope Comprehensive Cancer Center><Clinical><Clinical Trials><Collaborations><Communities><Comprehensive Cancer Center><County><Drugs><Economics><Ensure><Faculty><Farm><Fellowship><Fostering><Funding><Generalized Growth><Goals><Grant><Growth><Health><Infrastructure><Institution><Investigators><Joints><Los Angeles><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Medication><Mentors><Mentorship><Obesity><P20 Grant><Pancreas Cancer><Pancreatic Cancer><Pharmaceutical Preparations><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Prognosis><Research Associate><Research Personnel><Research Resources><Researchers><Resources><Rural><Scientist><Students><Therapeutic><Therapeutic Agents><Therapeutic Trials><Tissue Growth><Training><Training Programs><United States><Universities><acute granulocytic leukemia><acute myeloid leukemia><adiposity><anti-cancer research><cancer research><college><collegiate><corpulence><drug development><drug discovery><drug/agent><economic><improved><malignancy><malignant breast tumor><medical college><medical schools><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><pancreatic malignancy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><research associates><school of medicine><small molecular inhibitor><small molecule inhibitor><success><therapeutic agent development><therapeutic development>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ERNEST MARTINEZ

UNIVERSITY OF CALIFORNIA RIVERSIDE, RIVERSIDE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,356,807
FY 2025

Project Title

2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership

Grant Number:

5U54CA285114-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The United States has led the world in drug discovery for over 50 years; however, the majority of scientific ideas that progress to clinical trials frequently come from Comprehensive Cancer Centers. Unfortunately, not all local universities and colleges have the resources to take their ideas forward...

Research Terms

<AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Area><Breast Cancer><California><Cancer Center Planning Grant><Cancers><Catchment Area><City of Hope Comprehensive Cancer Center><Clinical><Clinical Trials><Collaborations><Communities><Comprehensive Cancer Center><County><Drugs><Economics><Ensure><Faculty><Farm><Fellowship><Fostering><Funding><Generalized Growth><Goals><Grant><Growth><Health><Infrastructure><Institution><Investigators><Joints><Los Angeles><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Medication><Mentors><Mentorship><Obesity><P20 Grant><Pancreas Cancer><Pancreatic Cancer><Pharmaceutical Preparations><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Prognosis><Research Associate><Research Personnel><Research Resources><Researchers><Resources><Rural><Scientist><Students><Therapeutic><Therapeutic Agents><Therapeutic Trials><Tissue Growth><Training><Training Programs><United States><Universities><acute granulocytic leukemia><acute myeloid leukemia><adiposity><anti-cancer research><cancer research><college><collegiate><corpulence><drug development><drug discovery><drug/agent><economic><improved><malignancy><malignant breast tumor><medical college><medical schools><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><pancreatic malignancy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><research associates><school of medicine><small molecular inhibitor><small molecule inhibitor><success><therapeutic agent development><therapeutic development>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victoria L. Seewaldt

UNIVERSITY OF CALIFORNIA RIVERSIDE, RIVERSIDE, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,356,807
FY 2025

Project Title

2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership

Grant Number:

5U54CA285114-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The United States has led the world in drug discovery for over 50 years; however, the majority of scientific ideas that progress to clinical trials frequently come from Comprehensive Cancer Centers. Unfortunately, not all local universities and colleges have the resources to take their ideas forward...

Research Terms

<AML - Acute Myeloid Leukemia><Acute Myeloblastic Leukemia><Acute Myelocytic Leukemia><Acute Myelogenous Leukemia><Area><Breast Cancer><California><Cancer Center Planning Grant><Cancers><Catchment Area><City of Hope Comprehensive Cancer Center><Clinical><Clinical Trials><Collaborations><Communities><Comprehensive Cancer Center><County><Drugs><Economics><Ensure><Faculty><Farm><Fellowship><Fostering><Funding><Generalized Growth><Goals><Grant><Growth><Health><Infrastructure><Institution><Investigators><Joints><Los Angeles><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Medication><Mentors><Mentorship><Obesity><P20 Grant><Pancreas Cancer><Pancreatic Cancer><Pharmaceutical Preparations><Pilot Projects><Population><Postdoc><Postdoctoral Fellow><Prognosis><Research Associate><Research Personnel><Research Resources><Researchers><Resources><Rural><Scientist><Students><Therapeutic><Therapeutic Agents><Therapeutic Trials><Tissue Growth><Training><Training Programs><United States><Universities><acute granulocytic leukemia><acute myeloid leukemia><adiposity><anti-cancer research><cancer research><college><collegiate><corpulence><drug development><drug discovery><drug/agent><economic><improved><malignancy><malignant breast tumor><medical college><medical schools><neoplasm/cancer><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><pancreatic malignancy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><research associates><school of medicine><small molecular inhibitor><small molecule inhibitor><success><therapeutic agent development><therapeutic development>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rao Khan

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,346,813
FY 2025

Project Title

2/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295336-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Heng Li

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,346,813
FY 2025

Project Title

2/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295336-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CARLA D WILLIAMS

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,346,813
FY 2025

Project Title

2/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295336-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clayton Yates

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,346,813
FY 2025

Project Title

2/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295336-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rao Khan

HOWARD UNIVERSITY, WASHINGTON, DC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,340,544
FY 2025

Project Title

1/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295337-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Heng Li

HOWARD UNIVERSITY, WASHINGTON, DC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,340,544
FY 2025

Project Title

1/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295337-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CARLA D WILLIAMS

HOWARD UNIVERSITY, WASHINGTON, DC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,340,544
FY 2025

Project Title

1/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295337-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clayton Yates

HOWARD UNIVERSITY, WASHINGTON, DC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,340,544
FY 2025

Project Title

1/2 Howard - Hopkins Comprehensive Partnerships to Advance Cancer Health

Grant Number:

5U54CA295337-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2024

End Date:

8/31/2029

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The H-H U54 Program aims to strengthen collaborative research, training, and community-focused initiatives between Howard University (HU) and the Johns Hopkins University (JHU) Sidney Kimmel Comprehensive Cancer Center (SKCCC). Based in the Washington, DC–Maryland–Virginia (DMV) region, the two inst...

Research Terms

<Accreditation><Address><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Appointment><Baltimore><Biometrics><Biometry><Biostatistics><Cancer Burden><Cancer Center><Cancers><Caring><Clinical><Clinical Trials><Collaborations><Communities><Community Education><Community Health Education><Community Integration><Community Outreach><Comprehensive Cancer Center><Data><Data Science><Dedications><Diagnosis><Disease><Disorder><Doctor of Philosophy><Education><Education and Outreach><Educational aspects><Elements><Ensure><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Faculty><Fostering><Foundations><Funding><Goals><Grant><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Image><Imaging Procedures><Imaging Technics><Imaging Techniques><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Neoplasms><Malignant Pancreatic Neoplasm><Malignant Tumor><Malignant neoplasm of pancreas><Malignant neoplasm of prostate><Malignant prostatic tumor><Maryland><Medical><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Mentors><Mentorship><Modeling><Molecular><NMR Imaging><NMR Tomography><National Cancer Burden><Nuclear Magnetic Resonance Imaging><Outcome><Pancreas Cancer><Pancreatic Cancer><Peer Review><Ph.D.><PhD><Physics><Pilot Projects><Position><Positioning Attribute><Prevention><Prostate CA><Prostate Cancer><Prostate malignancy><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Support><Research Training><Researchers><Resource Sharing><Scientific Publication><Screening for Prostate Cancer><Secure><Structure><Students><Time><Training><Training Support><Training and Infrastructure><Training and Outreach><Tutoring and Outreach><Universities><Urban Population><Virginia><Washington><Workforce Development><Zeugmatography><accredited><anti-cancer research><cancer care><cancer prevention><cancer research><cancer risk><care delivery><career><community engagement><data science infrastructure><design><designing><detect prostate cancer><disparate effect><disparate impact><disparate result><education research><engagement with communities><epigenetically><experience><graduate student><hands on research><high school><imaging><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><insight><malignancy><neoplasm/cancer><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapy approaches><new treatment approach><new treatment strategy><next generation><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapy approach><operation><operations><outcome disparities><outcome inequality><outcome inequity><outreach><pancreatic malignancy><peer><pilot study><programs><prostate cancer detection><prostate cancer early detection><proton therapy><skill acquisition><skill development><super high resolution><superresolution><synergism><training opportunity><translation strategy><translational approach><translational strategy><ultra high resolution><undergrad><undergraduate><undergraduate student><unequal effect><unequal impact><unequal outcome><urban group><urban individual><urban people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Julie Dutil

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,316,605
FY 2024

Project Title

2/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership

Grant Number:

5U54CA163068-12

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2012

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT | OVERALL The Hispanic/Latino (H/L) communities in the Ponce and Tampa Bay regions experience both shared and unique challenges associated with poverty, access to care, and language. The Ponce Health Sciences University (PHSU) in Puerto Rico (PR) and the Moffitt Cancer Center (MCC) in Flori...

Research Terms

<Access to Care><Accreditation><Achievement><Achievement Attainment><Address><Admixture><Advocate><Affect><Basic Cancer Research><Basic Research><Basic Science><Bay Region><Biological><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Cancer Center><Cancer Patient><Cancers><Care Givers><Caregivers><Clinical><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Community Developments><Community Education><Community Health><Community Health Education><Community Outreach><Complex><Comprehensive Cancer Center><Decrease health disparities><Development><Direct Costs><Doctor of Philosophy><Earthquakes><Education><Educational Materials><Educational aspects><Ensure><Environment><Evaluation><Evaluation Research><Evolution><Faculty><Florida><Fostering><Funding><Generalized Growth><Genetic><Genomics><Goals><Grant><Growth><Health><Health Disparities Research><Health Educators><Health Sciences><Health Services Accessibility><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hematology><Hispanic><Hurricane><Impoverished><Infrastructure><Institution><Intervention><Intervention Strategies><Investigators><Joints><Language><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><MD students><Malignant Neoplasms><Malignant Tumor><Medical><Medical Students><Minority Participation><Mitigate health disparities><NCI-Designated Cancer Center><Natural Disasters><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><Outcome><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D.><Ph.D. student><PhD><PhD student><PhD. student><Population><Postdoc><Postdoctoral Fellow><Poverty><Preparation><Process><Productivity><Psychological Factors><Publications><Puerto Rico><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Research Support><Researchers><Residencies><Resources><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Science><Scientific Publication><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Specimen><Surgical><Surgical Interventions><Surgical Procedure><Tissue Arrays><Tissue Chip><Tissue Growth><Tissue Microarray><Training><Universities><access to health services><access to services><access to treatment><accessibility to health services><accredited><anti-cancer research><availability of services><biobank><biologic><biorepository><cancer clinical trial><cancer disparity><cancer education><cancer health disparity><cancer research><cancer-related health disparity><care access><career><catalyst><community empowerment><community engagement><community-based health><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><developmental><disparity gap><disparity in cancer><disparity in health><doctoral student><engagement with communities><equity gap><experience><forging><gap in equity><gap in inequality><gap in inequity><genomic data><genomic data-set><genomic dataset><graduate medical education><health disparities science><health disparity><health service access><health services availability><improved><inequality gap><inequitable gap><inequity gap><innovate><innovation><innovative><inter-institutional><interventional strategy><malignancy><medical school students><neoplasm/cancer><novel><oncology clinical trial><ontogeny><outreach><outreach program><post-doc><post-doctoral><post-doctoral trainee><preparations><programs><recruit><research associates><resilience><resilient><service availability><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social factors><social media><surgery><translational cancer research><treatment access><tropical cyclone><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jaime L Matta

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,316,605
FY 2024

Project Title

2/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership

Grant Number:

5U54CA163068-12

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2012

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT | OVERALL The Hispanic/Latino (H/L) communities in the Ponce and Tampa Bay regions experience both shared and unique challenges associated with poverty, access to care, and language. The Ponce Health Sciences University (PHSU) in Puerto Rico (PR) and the Moffitt Cancer Center (MCC) in Flori...

Research Terms

<Access to Care><Accreditation><Achievement><Achievement Attainment><Address><Admixture><Advocate><Affect><Basic Cancer Research><Basic Research><Basic Science><Bay Region><Biological><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Cancer Center><Cancer Patient><Cancers><Care Givers><Caregivers><Clinical><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Community Developments><Community Education><Community Health><Community Health Education><Community Outreach><Complex><Comprehensive Cancer Center><Decrease health disparities><Development><Direct Costs><Doctor of Philosophy><Earthquakes><Education><Educational Materials><Educational aspects><Ensure><Environment><Evaluation><Evaluation Research><Evolution><Faculty><Florida><Fostering><Funding><Generalized Growth><Genetic><Genomics><Goals><Grant><Growth><Health><Health Disparities Research><Health Educators><Health Sciences><Health Services Accessibility><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hematology><Hispanic><Hurricane><Impoverished><Infrastructure><Institution><Intervention><Intervention Strategies><Investigators><Joints><Language><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><MD students><Malignant Neoplasms><Malignant Tumor><Medical><Medical Students><Minority Participation><Mitigate health disparities><NCI-Designated Cancer Center><Natural Disasters><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><Outcome><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D.><Ph.D. student><PhD><PhD student><PhD. student><Population><Postdoc><Postdoctoral Fellow><Poverty><Preparation><Process><Productivity><Psychological Factors><Publications><Puerto Rico><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Research Support><Researchers><Residencies><Resources><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Science><Scientific Publication><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Specimen><Surgical><Surgical Interventions><Surgical Procedure><Tissue Arrays><Tissue Chip><Tissue Growth><Tissue Microarray><Training><Universities><access to health services><access to services><access to treatment><accessibility to health services><accredited><anti-cancer research><availability of services><biobank><biologic><biorepository><cancer clinical trial><cancer disparity><cancer education><cancer health disparity><cancer research><cancer-related health disparity><care access><career><catalyst><community empowerment><community engagement><community-based health><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><developmental><disparity gap><disparity in cancer><disparity in health><doctoral student><engagement with communities><equity gap><experience><forging><gap in equity><gap in inequality><gap in inequity><genomic data><genomic data-set><genomic dataset><graduate medical education><health disparities science><health disparity><health service access><health services availability><improved><inequality gap><inequitable gap><inequity gap><innovate><innovation><innovative><inter-institutional><interventional strategy><malignancy><medical school students><neoplasm/cancer><novel><oncology clinical trial><ontogeny><outreach><outreach program><post-doc><post-doctoral><post-doctoral trainee><preparations><programs><recruit><research associates><resilience><resilient><service availability><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social factors><social media><surgery><translational cancer research><treatment access><tropical cyclone><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alvaro N Monteiro

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,316,605
FY 2024

Project Title

2/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership

Grant Number:

5U54CA163068-12

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2012

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT | OVERALL The Hispanic/Latino (H/L) communities in the Ponce and Tampa Bay regions experience both shared and unique challenges associated with poverty, access to care, and language. The Ponce Health Sciences University (PHSU) in Puerto Rico (PR) and the Moffitt Cancer Center (MCC) in Flori...

Research Terms

<Access to Care><Accreditation><Achievement><Achievement Attainment><Address><Admixture><Advocate><Affect><Basic Cancer Research><Basic Research><Basic Science><Bay Region><Biological><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Cancer Center><Cancer Patient><Cancers><Care Givers><Caregivers><Clinical><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Community Developments><Community Education><Community Health><Community Health Education><Community Outreach><Complex><Comprehensive Cancer Center><Decrease health disparities><Development><Direct Costs><Doctor of Philosophy><Earthquakes><Education><Educational Materials><Educational aspects><Ensure><Environment><Evaluation><Evaluation Research><Evolution><Faculty><Florida><Fostering><Funding><Generalized Growth><Genetic><Genomics><Goals><Grant><Growth><Health><Health Disparities Research><Health Educators><Health Sciences><Health Services Accessibility><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hematology><Hispanic><Hurricane><Impoverished><Infrastructure><Institution><Intervention><Intervention Strategies><Investigators><Joints><Language><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><MD students><Malignant Neoplasms><Malignant Tumor><Medical><Medical Students><Minority Participation><Mitigate health disparities><NCI-Designated Cancer Center><Natural Disasters><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><Outcome><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D.><Ph.D. student><PhD><PhD student><PhD. student><Population><Postdoc><Postdoctoral Fellow><Poverty><Preparation><Process><Productivity><Psychological Factors><Publications><Puerto Rico><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Research Support><Researchers><Residencies><Resources><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Science><Scientific Publication><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Specimen><Surgical><Surgical Interventions><Surgical Procedure><Tissue Arrays><Tissue Chip><Tissue Growth><Tissue Microarray><Training><Universities><access to health services><access to services><access to treatment><accessibility to health services><accredited><anti-cancer research><availability of services><biobank><biologic><biorepository><cancer clinical trial><cancer disparity><cancer education><cancer health disparity><cancer research><cancer-related health disparity><care access><career><catalyst><community empowerment><community engagement><community-based health><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><developmental><disparity gap><disparity in cancer><disparity in health><doctoral student><engagement with communities><equity gap><experience><forging><gap in equity><gap in inequality><gap in inequity><genomic data><genomic data-set><genomic dataset><graduate medical education><health disparities science><health disparity><health service access><health services availability><improved><inequality gap><inequitable gap><inequity gap><innovate><innovation><innovative><inter-institutional><interventional strategy><malignancy><medical school students><neoplasm/cancer><novel><oncology clinical trial><ontogeny><outreach><outreach program><post-doc><post-doctoral><post-doctoral trainee><preparations><programs><recruit><research associates><resilience><resilient><service availability><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social factors><social media><surgery><translational cancer research><treatment access><tropical cyclone><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KENNETH Lynn WRIGHT

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,316,605
FY 2024

Project Title

2/2 Ponce Health Sciences University-Moffitt Cancer Center Partnership

Grant Number:

5U54CA163068-12

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2012

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT | OVERALL The Hispanic/Latino (H/L) communities in the Ponce and Tampa Bay regions experience both shared and unique challenges associated with poverty, access to care, and language. The Ponce Health Sciences University (PHSU) in Puerto Rico (PR) and the Moffitt Cancer Center (MCC) in Flori...

Research Terms

<Access to Care><Accreditation><Achievement><Achievement Attainment><Address><Admixture><Advocate><Affect><Basic Cancer Research><Basic Research><Basic Science><Bay Region><Biological><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Cancer Center><Cancer Patient><Cancers><Care Givers><Caregivers><Clinical><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Community Developments><Community Education><Community Health><Community Health Education><Community Outreach><Complex><Comprehensive Cancer Center><Decrease health disparities><Development><Direct Costs><Doctor of Philosophy><Earthquakes><Education><Educational Materials><Educational aspects><Ensure><Environment><Evaluation><Evaluation Research><Evolution><Faculty><Florida><Fostering><Funding><Generalized Growth><Genetic><Genomics><Goals><Grant><Growth><Health><Health Disparities Research><Health Educators><Health Sciences><Health Services Accessibility><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hematology><Hispanic><Hurricane><Impoverished><Infrastructure><Institution><Intervention><Intervention Strategies><Investigators><Joints><Language><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><MD students><Malignant Neoplasms><Malignant Tumor><Medical><Medical Students><Minority Participation><Mitigate health disparities><NCI-Designated Cancer Center><Natural Disasters><Oncology><Oncology Cancer><Operative Procedures><Operative Surgical Procedures><Outcome><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D.><Ph.D. student><PhD><PhD student><PhD. student><Population><Postdoc><Postdoctoral Fellow><Poverty><Preparation><Process><Productivity><Psychological Factors><Publications><Puerto Rico><R-Series Research Projects><R01 Mechanism><R01 Program><Reduce health disparities><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Research Support><Researchers><Residencies><Resources><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Science><Scientific Publication><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Specimen><Surgical><Surgical Interventions><Surgical Procedure><Tissue Arrays><Tissue Chip><Tissue Growth><Tissue Microarray><Training><Universities><access to health services><access to services><access to treatment><accessibility to health services><accredited><anti-cancer research><availability of services><biobank><biologic><biorepository><cancer clinical trial><cancer disparity><cancer education><cancer health disparity><cancer research><cancer-related health disparity><care access><career><catalyst><community empowerment><community engagement><community-based health><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><developmental><disparity gap><disparity in cancer><disparity in health><doctoral student><engagement with communities><equity gap><experience><forging><gap in equity><gap in inequality><gap in inequity><genomic data><genomic data-set><genomic dataset><graduate medical education><health disparities science><health disparity><health service access><health services availability><improved><inequality gap><inequitable gap><inequity gap><innovate><innovation><innovative><inter-institutional><interventional strategy><malignancy><medical school students><neoplasm/cancer><novel><oncology clinical trial><ontogeny><outreach><outreach program><post-doc><post-doctoral><post-doctoral trainee><preparations><programs><recruit><research associates><resilience><resilient><service availability><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social factors><social media><surgery><translational cancer research><treatment access><tropical cyclone><undergrad><undergraduate><undergraduate student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Yong Li

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,308,925
FY 2025

Project Title

Cancer Prevention-Interception Against MGUS Progression

Grant Number:

5U54CA272691-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous condition in which a person has moderately elevated levels of an abnormal immunoglobulin (Ig) protein (called M protein) in the blood. MGUS patients have a cancer risk ~6.5 times as high as the control popula...

Research Terms

<19S Gamma Globulin><7S Gamma Globulin><Active Follow-up><Affect><Age Years><American><Amyloid><Amyloid Substance><Automobile Driving><B-Cell CLL><B-Cell Chronic Lymphocytic Leukemia><B-Cell Chronic Lymphogenous Leukemia><B-Cell Chronic Lymphoid Leukemia><B-Cell Lymphocytic Leukemia><B-Lymphocytic Leukemia><Blood><Blood Diseases><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Blood-Deriving Cell><Bone Marrow Blood-Forming Cell><Bone Marrow Cells><Bone Marrow Reticuloendothelial System><Cancer Center><Cancers><Chemicals><Chemoprevention><Chronic B-Lymphocytic Leukemia><Chronic Lymphatic Leukemia><Chronic Lymphoblastic Leukemia><Chronic Lymphocytic Leukemia><Chronic Lymphogenous Leukemia><Communication><Consensus><DNA Vaccines><Dedications><Development><Development and Research><Diagnosis><Diagnostic><Disease><Disorder><E3 Ligase><E3 Ubiquitin Ligase><Funding><Ganciclovir><Gancyclovir><Goals><Hematologic Diseases><Hematological Disease><Hematological Disorder><IgA><IgD><IgE><IgG><IgM><Immune Globulins><Immunochemical Immunologic><Immunoglobulin A><Immunoglobulin D><Immunoglobulin E><Immunoglobulin G><Immunoglobulin M><Immunoglobulins><Immunologic><Immunological><Immunologically><Immunologics><Immunoprevention><In Vitro><Infrastructure><Intercept><Intervention><Intervention Strategies><Investigation><Investigators><Life Expectancy><Light><Light-Chain Immunoglobulins><Lymphoid><Lymphoplasmacytic Lymphoma><Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia><Lymphoplasmacytic Type Immunocytoma><Lymphoplasmacytoid Lymphoma><M protein><MGUS><Macroglobulinemia><Malignant Neoplasms><Malignant Tumor><Molecular><Monoclonal Gammopathy of Undetermined Significance><Monoclonal Gammopathy of Unknown Significance><Monoclonal gammopathy of uncertain significance><Multiple Myeloma><Mutate><Naked DNA Vaccines><Network Infrastructure><Non-Hodgkin's Lymphoma><Nonhodgkins Lymphoma><Nordeoxyguanosine><Oncogene Products><Oncogene Proteins><Oncogenic><Oncoproteins><P50 Mechanism><P50 Program><Patients><Persons><Photoradiation><Plasma-Cell Myeloma><Plasmacytoma><Population><Population Control><Precancerous Conditions><Premalignant Condition><Premalignant State><Prevention><Preventive><Process><Protein Secretion><Proteins><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Recombinant DNA Vaccines><Recommendation><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Risk><Risk Factors><Role><Solitary Plasmacytoma><Specialized Center><Syndrome><Testing><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><Waldenstrom Macroglobulinemia><Waldenstrom's macroglobulinaemia><Waldenström's hyperglobulinaemia><Waldenström's hyperglobulinemia><Waldenström's macroglobulinaemia><Waldenström's macroglobulinemia><active followup><blood disorder><cancer diagnosis><cancer invasiveness><cancer prevention><cancer progression><cancer risk><chronic lymphoid leukemia><clinical practice><determine efficacy><developmental><driving><early clinical trial><early phase clinical trial><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><examine efficacy><follow up><follow-up><followed up><followup><high risk><in vivo><individualized cancer care><individualized oncology><innovate><innovation><innovative><light chain amyloidosis><malignancy><multiple myeloma M Protein><myeloma><myelomatosis><neoplasm progression><neoplasm/cancer><neoplastic progression><non-Hodgkins disease><novel><personalized oncology><precancerous state><precision cancer care><precision cancer medicine><precision cancer prevention><precision oncology><prevent><preventing><primary amyloidosis of light chain type><programs><progression risk><research and development><senescence><senescent><small molecule><social role><targeted agent><tumor initiation><tumor progression><ubiquitin-protein ligase>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

UPENDER MANNE

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,237,451
FY 2025

Project Title

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118948-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Brian M. Rivers

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,237,451
FY 2025

Project Title

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118948-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clayton Yates

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,237,451
FY 2025

Project Title

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118948-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christina Ciecierski

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph M Feinglass

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lidia Filus

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marian L. Fitzgibbon

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Masahito Jimbo

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELISSA A. SIMON

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,233,255
FY 2024

Project Title

3/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202997-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

UPENDER MANNE

TUSKEGEE UNIVERSITY, TUSKEGEE INSTITUTE, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,222,368
FY 2025

Project Title

2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118623-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Brian M. Rivers

TUSKEGEE UNIVERSITY, TUSKEGEE INSTITUTE, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,222,368
FY 2025

Project Title

2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118623-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TIMOTHY TURNER

TUSKEGEE UNIVERSITY, TUSKEGEE INSTITUTE, AL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,222,368
FY 2025

Project Title

2/3 Morehouse School of Medicine/Tuskegee University/ University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118623-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christina Ciecierski

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph M Feinglass

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lidia Filus

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marian L. Fitzgibbon

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELISSA A. SIMON

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John H Stewart

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,195,987
FY 2024

Project Title

1/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA203000-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Chicago Cancer Health Collaborative (ChicagoCHeC) is a comprehensive partnership to advance solution-oriented approaches to cancer health disparities. ChicagoCHeC brings together the synergistic strengths of two public institutions, the University of Illinois at Chicago (UIC) and Northeastern Il...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Julian Simon

NEW MEXICO STATE UNIVERSITY LAS CRUCES, LAS CRUCES, NM

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,178,138
FY 2025

Project Title

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132383-18

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Graciela Alexandra Unguez

NEW MEXICO STATE UNIVERSITY LAS CRUCES, LAS CRUCES, NM

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,178,138
FY 2025

Project Title

1/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch

Grant Number:

5U54CA132383-18

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2007

End Date:

8/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The Partnership between NMSU, a land-grant university, and Fred Hutch, a Comprehensive Cancer Center, has matured into a strong, mutually beneficial partnership. The Partnership has expanded and adapted opportunities for research, education, training, and community engagement for communities (in the...

Research Terms

<Address><Adopted><Advanced Cancer><Advanced Malignant Neoplasm><American><Area><Basic Research><Basic Science><Cancer Center><Cancer Research Programs><Cancer Research Project><Cancers><Clinical><Collaborations><Communities><Comprehensive Cancer Center><Dedications><Education><Educational aspects><Environment><Evaluation><Faculty><Funding><Future><Goals><Graduate Degree><Grant><Health><Health Instruction><Health Sciences><Health Tutoring><Health education><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Malignant Neoplasms><Malignant Tumor><Mentors><Mission><New Mexico><Pacific Northwest><Participant><Population Sciences><Process><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resource Sharing><Resources><Science><Scientific Publication><Scientist><Southwest U.S.><Southwest US><Southwestern United States><Students><Time><Training><Underserved Population><Universities><Voice><Washington><Work><anti-cancer research><cancer education><cancer prevention><cancer research><career><collaboration with communities><college><college student><collegiate><community based organizations><community collaboration><community engaged participatory research><community engaged research><community engagement><community organizations><community partnered research><community-based collaboration><community-engaged study><community-partnered study><design><designing><education research><engagement with communities><experience><improved><innovate><innovation><innovative><intern><malignancy><meeting><meetings><member><neoplasm/cancer><outreach><outreach program><population health><programs><recruit><success><survivorship><under served group><under served individual><under served people><under served population><undergrad><undergraduate><undergraduate student><underserved group><underserved individual><underserved people><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

UPENDER MANNE

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,173,804
FY 2025

Project Title

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118638-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Brian M. Rivers

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,173,804
FY 2025

Project Title

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118638-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Clayton Yates

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,173,804
FY 2025

Project Title

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

Grant Number:

5U54CA118638-20

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2005

End Date:

8/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This type-2 application seeks to strengthen and build upon the established U54 Partnership between Morehouse School of Medicine (MSM), Tuskegee University (TU), and the UAB O’Neal Comprehensive Cancer Center (UAB OCCC). The Partnership, located in the Southeast, a region with under-resourced and imp...

Research Terms

<12th grade><Acceleration><Address><Adherence><Alabama><Anti-Cancer Agents><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Applications Grants><Area><Award><Behavioral><Bioethics><Bioinformatics><Bioinformatics Shared Resource><Biological><Biomedical Ethics><Biometrics><Biometry><Biostatistics><Biotech><Biotechnology><Breast Cancer><CRC screening><Cancer Biology><Cancer Burden><Cancer Cause><Cancer Center Planning Grant><Cancer Control><Cancer Control Science><Cancer Drug><Cancer Etiology><Cancer Research Programs><Cancer Research Project><Cancers><Caring><Cell Density><Clinical><Clinical Research><Clinical Study><Clinical Trials><Communities><Comprehensive Cancer Center><Curriculum><DNA mutation><Data><Deep South><Development><Development and Research><EXTMR><Education><Educational Curriculum><Educational aspects><Endometrial Cancer><Endometrial Carcinoma><Endometrium Cancer><Endometrium Carcinoma><Ensure><Ethics><Evaluation><Expression Signature><Extramural><Extramural Activities><Faculty><Food Preferences><Foundations><Funding><Gene Expression Profile><Genetic Change><Genetic defect><Genetic mutation><Geography><Goals><Grant><Grant Proposals><Health><Health Informatics><Heart><Impoverished><Individual><Institution><Investigators><Link><MD students><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Students><Methods><Modeling><Molecular><Molecular Fingerprinting><Molecular Profiling><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><Mutation><NCI-Designated Cancer Center><National Cancer Burden><Neoplastic Disease Chemotherapeutic Agents><Outcome><Outcomes Research><P20 Grant><Patients><Peer Review><Physical activity><Pilot Projects><Policies><Population><Population Sciences><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Poverty><Productivity><Public Health Informatics><Publications><Publishing><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Regional Cancer><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Reduction><Scientific Publication><Scientist><Sight><Taxotere><Therapeutic Trials><Training><Training Programs><Treatment Efficacy><Tumor Cell><Tumor-Specific Treatment Agents><Universities><Vision><anti-cancer drug><anti-cancer research><bio-informatics shared resource><biologic><biological research><cancer care><cancer education><cancer genomics><cancer research><cancer risk><career><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><community engagement><community involvement><conference><consumer informatics><convention><detect colorectal cancer><developmental><diagnostic biomarker><diagnostic marker><diet choice><diet preference><dietary choice><dietary preferences><differences in health><docetaxel><docetaxol><education research><engagement with communities><ethical><evidence base><food choice><gene expression pattern><gene expression signature><genome mutation><graduate student><health difference><healthy lifestyle><high school senior><honokiol><improved><innovate><innovation><innovative><intervention efficacy><lab experience><lab training><laboratory experience><laboratory training><lesson plans><lung cancer early detection><lung cancer screening><malignancy><malignant breast tumor><medical school students><member><molecular profile><molecular signature><multidisciplinary><nano particle><nano-sized particle><nanoparticle><nanosized particle><neoplasm/cancer><neoplastic cell><new diagnostics><next generation><next generation diagnostics><novel diagnostics><oncogenomics><outreach><outreach program><participant enrollment><patient enrollment><pilot study><post-doc><post-doctoral><post-doctoral trainee><pre-clinical><preclinical><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and development><research associates><research faculty><risk-reducing><rural dwellers><rural resident><social><summer research><summit><symposia><symposium><theories><therapeutic biomarker><therapeutic efficacy><therapeutic marker><therapy efficacy><transcriptional profile><transcriptional signature><twelfth grade><undergrad><undergraduate><undergraduate student><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Simon Alexander Marshall

NORTH CAROLINA CENTRAL UNIVERSITY, DURHAM, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,085,760
FY 2025

Project Title

1/2 Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC)

Grant Number:

5U54AA030451-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This is an application for a cooperative agreement (U54), “Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC),” between faculties of North Carolina Central University (NCCU), and the Bowles Center for Alcohol Studies (BCAS) at the University of North Carolina (UNC) School of Medi...

Research Terms

<21+ years old><ARHGEF5><ARHGEF5 gene><Address><Adolescent><Adolescent Youth><Adult><Adult Human><Alcohol Chemical Class><Alcohol abuse><Alcohol toxicity><Alcohols><Area><Award><Behavioral><Body Tissues><Brain><Brain Nervous System><Breast Cancer><Cancer Induction><Cancers><Chronic><Chronic Disease><Chronic Illness><Collaborations><Cooperative Agreements><Core Facility><Course Content><Curriculum><Data><Development and Research><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Encephalon><Endowment><Environment><EtOH abuse><Ethanol toxicity><FASD><Faculty><Fetal Alcohol Spectrum Disorder><Funding><Future><GEF5><Goals><Grant><Health><Health Care Professional><Health Professional><Inflammation><Infrastructure><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Laboratory Research><Leadership><Learning><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Libraries><Mentors><Molecular><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Neuroimmune><North Carolina><Outcome><P60><Pathology><Preparation><Process><Productivity><Publications><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Technics><Research Techniques><Researchers><Resource Sharing><Resources><Scholarship><Scientific Publication><Series><Structure><Students><TIM1><Teaching><Techniques><Tissues><Toxic effect><Toxicities><Training><U-Series Cooperative Agreements><United States National Institutes of Health><Universities><Work><adulthood><alcohol co-abuse><alcohol exposed><alcohol exposure><alcohol problem><alcohol related research><alcohol research><alcohol use disorder><breast progenitor><breast progenitor cell><breast stem cell><carcinogenesis><career><cellular pathology><chronic disorder><co-morbid><co-morbidity><college student><comorbidity><course curriculum><ethanol abuse><ethanol exposed><ethanol exposure><ethanol research><ethanol use disorder><expectation><experience><experiment><experimental research><experimental study><experiments><exposed to alcohol><exposed to ethanol><exposure to alcohol><exposure to ethanol><faculty mentor><fetal><graduate student><hazardous alcohol use><improved><interest><intern><juvenile><juvenile human><lab development><lab experience><lab training><laboratory development><laboratory experience><laboratory training><lectures><lesson plans><malignancy><malignant breast tumor><mammary gland progenitor><mammary gland stem cells><mammary progenitor><mammary stem cells><medical college><medical schools><meeting><meetings><neoplasm/cancer><neuron toxicity><neuronal toxicity><neuropathologic><neuropathological><neuropathology><neurotoxicity><post-doctoral training><preparations><problem alcohol use><problem drinking><problematic alcohol consumption><problematic alcohol use><programs><recruit><research and development><response><school of medicine><skills><student research><student-led research><success><summer intern><summer internship><synergism><undergrad><undergraduate><undergraduate student><university student><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Trever G Bivona

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,079,739
FY 2025

Project Title

BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)

Grant Number:

5U54CA224081-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2017

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract: The goal of this BAATAAR-UP renewal program application within the NCI ARTNet is to characterize the mechanisms of, and therapeutically counteract, acquired resistance to molecular therapies in non-small cell lung cancer (NSCLC) by delineating the tumor-tumor microenvironme...

Research Terms

<Address><Area><C-K-RAS><CD47><CD47 Antigen><CD47 Glycoprotein><CD47 gene><Cancer Cause><Cancer Etiology><Cancer Patient><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cells><Chronic><Clinical><Communities><Cues><Data Science Core><Data Science Resource Core><Data Set><Development><Disease><Disorder><Drug resistance><Drugs><ECM><EGF Receptor><EGFR><ERBB Protein><Ecologic Systems><Ecological Systems><Ecosystem><Ensure><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Event><Extracellular Matrix><Fibroblasts><Foundations><Funding><Future><Geography><Goals><HER1><Human><Immune><Immunes><Immunoglobulin Enhancer-Binding Protein><Integrin-Associated Protein><Intracellular Communication and Signaling><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS2><KRAS2 gene><Ki-RAS><Link><Lung><Lung Adenocarcinoma><Lung Respiratory System><MER6><Macrophage><Macrophage Activation><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Lung><Malignant neoplasm of lung><Medication><Medicine><Methods><Modeling><Modern Man><Molecular><Mφ><NF-kB><NF-kappa B><NF-kappaB><NFKB><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Nature><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Nuclear Factor kappa B><Nuclear Transcription Factor NF-kB><Oncogene K-Ras><Oncogenic><Organoids><PD-1/PD-L1><PD-1/PDL1><PD1-PD-L1><PD1/PD-L1><PD1/PDL1><PDK1><PDPK1><PDPK1 gene><PDX model><PRO0461><Paracrine Communication><Paracrine Signaling><Pathway interactions><Patient derived xenograft><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pharmaceutical Preparations><Pre-Clinical Model><Preclinical Models><Process><Progress Reports><Proteomics><Public Health><Pulmonary Cancer><Pulmonary malignant Neoplasm><R-Series Research Projects><R01 Mechanism><R01 Program><RASK2><Refractory><Research><Research Grants><Research Project Grants><Research Projects><Research Specimen><Resistance><Signal Transduction><Signal Transduction Systems><Signaling><Specimen><Surface Antigen Identified by Monoclonal Antibody 1D8><System><TGF-alpha Receptor><Testing><Therapeutic><Transcription Factor NF-kB><Transforming Growth Factor alpha Receptor><Tumor Cell><Urogastrone Receptor><acquired drug resistance><anti-cancer therapy><biological signal transduction><c-erbB-1><c-erbB-1 Protein><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer type><cancer-directed therapy><clinical translation><clinically translatable><cytokine><data sharing><developmental><drug resistant><drug/agent><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><humanized mice><humanized mouse><immunosuppressive check point><immunosuppressive checkpoint><improved><improved outcome><individualized cancer care><individualized oncology><innovate><innovation><innovative><kappa B Enhancer Binding Protein><lung cancer><malignancy><molecular targeted therapeutics><molecular targeted therapies><molecular targeted treatment><mortality><mouse model><murine model><mutant><neoplasm progression><neoplasm/cancer><neoplastic cell><neoplastic progression><nuclear factor kappa beta><pathway><patient derived xenograft model><patient oriented outcomes><personalized oncology><precision cancer care><precision cancer medicine><precision oncology><prevent><preventing><programs><proto-oncogene protein c-erbB-1><resistance mechanism><resistance to Drug><resistance to therapy><resistant><resistant mechanism><resistant to Drug><resistant to therapy><response><success><synthetic lethal interaction><synthetic lethality><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic evaluation><therapeutic resistance><therapeutic testing><therapy resistant><treatment resistance><treatment strategy><tumor><tumor microenvironment><tumor progression><tumor xenograft><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jack Roth

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,079,739
FY 2025

Project Title

BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)

Grant Number:

5U54CA224081-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2017

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract: The goal of this BAATAAR-UP renewal program application within the NCI ARTNet is to characterize the mechanisms of, and therapeutically counteract, acquired resistance to molecular therapies in non-small cell lung cancer (NSCLC) by delineating the tumor-tumor microenvironme...

Research Terms

<Address><Area><C-K-RAS><CD47><CD47 Antigen><CD47 Glycoprotein><CD47 gene><Cancer Cause><Cancer Etiology><Cancer Patient><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cells><Chronic><Clinical><Communities><Cues><Data Science Core><Data Science Resource Core><Data Set><Development><Disease><Disorder><Drug resistance><Drugs><ECM><EGF Receptor><EGFR><ERBB Protein><Ecologic Systems><Ecological Systems><Ecosystem><Ensure><Epidermal Growth Factor Receptor><Epidermal Growth Factor Receptor Kinase><Epidermal Growth Factor Receptor Protein-Tyrosine Kinase><Epidermal Growth Factor-Urogastrone Receptors><Event><Extracellular Matrix><Fibroblasts><Foundations><Funding><Future><Geography><Goals><HER1><Human><Immune><Immunes><Immunoglobulin Enhancer-Binding Protein><Integrin-Associated Protein><Intracellular Communication and Signaling><K-RAS2A><K-RAS2B><K-Ras><K-Ras 2A><K-Ras-2 Oncogene><KRAS><KRAS2><KRAS2 gene><Ki-RAS><Link><Lung><Lung Adenocarcinoma><Lung Respiratory System><MER6><Macrophage><Macrophage Activation><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Lung><Malignant neoplasm of lung><Medication><Medicine><Methods><Modeling><Modern Man><Molecular><Mφ><NF-kB><NF-kappa B><NF-kappaB><NFKB><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Nature><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Nuclear Factor kappa B><Nuclear Transcription Factor NF-kB><Oncogene K-Ras><Oncogenic><Organoids><PD-1/PD-L1><PD-1/PDL1><PD1-PD-L1><PD1/PD-L1><PD1/PDL1><PDK1><PDPK1><PDPK1 gene><PDX model><PRO0461><Paracrine Communication><Paracrine Signaling><Pathway interactions><Patient derived xenograft><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pharmaceutical Preparations><Pre-Clinical Model><Preclinical Models><Process><Progress Reports><Proteomics><Public Health><Pulmonary Cancer><Pulmonary malignant Neoplasm><R-Series Research Projects><R01 Mechanism><R01 Program><RASK2><Refractory><Research><Research Grants><Research Project Grants><Research Projects><Research Specimen><Resistance><Signal Transduction><Signal Transduction Systems><Signaling><Specimen><Surface Antigen Identified by Monoclonal Antibody 1D8><System><TGF-alpha Receptor><Testing><Therapeutic><Transcription Factor NF-kB><Transforming Growth Factor alpha Receptor><Tumor Cell><Urogastrone Receptor><acquired drug resistance><anti-cancer therapy><biological signal transduction><c-erbB-1><c-erbB-1 Protein><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer type><cancer-directed therapy><clinical translation><clinically translatable><cytokine><data sharing><developmental><drug resistant><drug/agent><erbB-1><erbB-1 Proto-Oncogene Protein><erbBl><humanized mice><humanized mouse><immunosuppressive check point><immunosuppressive checkpoint><improved><improved outcome><individualized cancer care><individualized oncology><innovate><innovation><innovative><kappa B Enhancer Binding Protein><lung cancer><malignancy><molecular targeted therapeutics><molecular targeted therapies><molecular targeted treatment><mortality><mouse model><murine model><mutant><neoplasm progression><neoplasm/cancer><neoplastic cell><neoplastic progression><nuclear factor kappa beta><pathway><patient derived xenograft model><patient oriented outcomes><personalized oncology><precision cancer care><precision cancer medicine><precision oncology><prevent><preventing><programs><proto-oncogene protein c-erbB-1><resistance mechanism><resistance to Drug><resistance to therapy><resistant><resistant mechanism><resistant to Drug><resistant to therapy><response><success><synthetic lethal interaction><synthetic lethality><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic evaluation><therapeutic resistance><therapeutic testing><therapy resistant><treatment resistance><treatment strategy><tumor><tumor microenvironment><tumor progression><tumor xenograft><v-Ki-RAS2 Kirsten Rat Sarcoma 2 Viral Oncogene Homolog>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory Jay Cole

NORTH CAROLINA CENTRAL UNIVERSITY, DURHAM, NC

Exploratory lead · 42/100
Large award
Active award
Team-scale grant
$1,064,370
FY 2024

Project Title

1/2 Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC)

Grant Number:

5U54AA030451-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

This is an application for a cooperative agreement (U54), “Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC),” between faculties of North Carolina Central University (NCCU), a Historically Black College or University, and the Bowles Center for Alcohol Studies (BCAS) at the Unive...

Research Terms

<21+ years old><ARHGEF5><ARHGEF5 gene><Address><Adolescent><Adolescent Youth><Adult><Adult Human><African American><African American group><African American individual><African American people><African American population><African American student><African Americans><Afro American><Afroamerican><Alcohol Chemical Class><Alcohol abuse><Alcohol toxicity><Alcohols><Area><Award><Behavioral><Body Tissues><Brain><Brain Nervous System><Breast Cancer><Cancer Induction><Collaborations><Cooperative Agreements><Core Facility><Course Content><Curriculum><Data><Development and Research><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Encephalon><Endowment><Environment><EtOH abuse><Ethanol toxicity><FASD><Faculty><Fetal Alcohol Spectrum Disorder><Funding><Future><GEF5><Goals><Grant><HBCUs><Health Care Professional><Health Professional><Healthcare professional><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Inflammation><Infrastructure><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Laboratory Research><Leadership><Learning><Malignant Breast Neoplasm><Manuscripts><Medical><Medical Libraries><Mentors><Minority><Minority researcher><Molecular><Morbidity><Morbidity - disease rate><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Neuroimmune><North Carolina><P60><Pathology><Preparation><Process><Productivity><Progenitor Cells><Publications><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Technics><Research Techniques><Researchers><Resource Sharing><Resources><Scholarship><Scientific Publication><Series><Severities><Structure><Students><TIM1><Teaching><Techniques><Tissues><Toxic effect><Toxicities><Training><U-Series Cooperative Agreements><URM student><Underrepresented Ethnic Minority><Underrepresented Minority><United States National Institutes of Health><Universities><Work><adulthood><alcohol co-abuse><alcohol exposed><alcohol exposure><alcohol problem><alcohol related research><alcohol research><alcohol use disorder><black student><carcinogenesis><career><cellular pathology><college student><course curriculum><disparity in health><ethanol abuse><ethanol exposed><ethanol exposure><ethanol research><ethanol use disorder><expectation><experience><experiment><experimental research><experimental study><experiments><exposed to alcohol><exposed to ethanol><exposure to alcohol><exposure to ethanol><faculty mentor><fetal><graduate student><hazardous alcohol use><health disparity><improved><interest><intern><juvenile><juvenile human><lab development><lab experience><lab training><laboratory development><laboratory experience><laboratory training><lectures><lesson plans><malignant breast tumor><mammary><medical college><medical schools><meeting><meetings><minority investigator><neuron toxicity><neuronal toxicity><neuropathologic><neuropathological><neuropathology><neurotoxicity><post-doctoral training><postdoctoral training><preparations><problem alcohol use><problem drinking><problematic alcohol consumption><problematic alcohol use><programs><recruit><research and development><response><role model><school of medicine><skills><stem cells><success><summer intern><summer internship><synergism><under-representation of minorities><under-represented minority><undergrad><undergraduate><undergraduate student><underrepresentation of minorities><underrepresented minority student><university student><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sarah H Heil

UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, BURLINGTON, VT

Exploratory lead · 38/100
Training-friendly
Solid budget
Active award
$416,044
FY 2025

Project Title

Behavioral Pharmacology of Human Drug Use Disorders

Grant Number:

5T32DA007242-35

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/30/1990

End Date:

6/30/2027

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY The purpose of this application is to continue the University of Vermont’s highly successful 30-year T32 training program in the human behavioral pharmacology of drug use disorders. During the past 15 years, we trained 16 predoctoral and 22 postdoctoral fellows. Among those 38 fellow...

Research Terms

<Drug Use Disorder><Human><Modern Man><behavioral pharmacology><pharmacobehavioral>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephen T Higgins

UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, BURLINGTON, VT

Exploratory lead · 38/100
Training-friendly
Solid budget
Active award
$416,044
FY 2025

Project Title

Behavioral Pharmacology of Human Drug Use Disorders

Grant Number:

5T32DA007242-35

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/30/1990

End Date:

6/30/2027

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY The purpose of this application is to continue the University of Vermont’s highly successful 30-year T32 training program in the human behavioral pharmacology of drug use disorders. During the past 15 years, we trained 16 predoctoral and 22 postdoctoral fellows. Among those 38 fellow...

Research Terms

<Drug Use Disorder><Human><Modern Man><behavioral pharmacology><pharmacobehavioral>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ashley Leak Bryant

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 38/100
Training-friendly
Solid budget
Active award
$268,401
FY 2024

Project Title

Cancer Undergraduate Research Education Program

Grant Number:

1R25CA291602-01

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/3/2024

End Date:

6/30/2029

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT Cancer disproportionately affects Black Americans and other economically disadvantaged groups, yet these individuals are underrepresented in cancer research. The Cancer Undergraduate Research Education Program (CUREP) proposes to address this disparity by expanding and diversifying the pool...

Research Terms

<Address><Admission><Admission activity><Affect><Alum Adjuvant><Baccalaureate Degree><Bachelor's Degree><Basic Research><Basic Science><Biomedical Research><Black><Black American><Black Populations><Black group><Black individual><Black people><Black race><Blacks><Cancer Biology><Cancer Burden><Cancers><Career Choice><Career Path><Collaborations><Communication><Communities><Comprehensive Cancer Center><Degree Attainment><Degree Completion><Development><Disparities><Disparity><Economically Deprived><Economically Deprived Population><Education><Educational aspects><Elements><Ethics><Face><Family><First Generation College Students><First Generation College graduates><First Generation Students><Foundations><Funding><Future><Goals><Graduate Education><Grant><HBCUs><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Individual><Inequality><Intervention><Intervention Strategies><Investigators><Knowledge><Laboratories><Life><Low income><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><NIH><National Cancer Burden><National Institutes of Health><North Carolina><Outcome><Participant><Personal Satisfaction><Physicians><Population><Population Sciences><Postdoc><Postdoctoral Fellow><Principal Investigator><Public Health><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resources><STEM career><STEM workforce><Schools><Science, Technology, Engineering and Math><Science, Technology, Engineering and Mathematics><Scientist><Self Efficacy><Structure><Students><Study Skills><Supervision><Time Management><Training><Undergraduate Degree><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><United States National Institutes of Health><Universities><Work><Writing><alum><aluminum sulfate><anti-cancer research><cancer disparity><cancer health disparity><cancer prevention><cancer research><cancer-related health disparity><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><design><designing><developmental><disadvantaged background><disparity elimination><disparity in cancer><economic disparity><economically deprived group><economically deprived people><economically disadvantaged><economically disadvantaged group><economically disadvantaged individual><economically disadvantaged people><economically disadvantaged population><education research><eliminate disparities><eliminating disparities><ethical><ethnic diversity><ethnically diverse><experience><faces><facial><faculty mentor><falls><graduate student><holistic approach><improved><innovate><innovation><innovative><interest><interventional strategy><malignancy><marginalized background><neoplasm/cancer><next generation><post-doc><post-doctoral><post-doctoral trainee><programs><racial diversity><racially diverse><research associates><role model><science, technology, engineering and math career><science, technology, engineering and math workforce><science, technology, engineering and mathematics career><science, technology, engineering and mathematics workforce><skills><social><social disadvantage><social disparities><social inequality><success><summer intern><summer internship><summer program><summer research><summer session><translational cancer research><under representation of groups><under represented groups><under represented people><under represented populations><underclass><undergrad><undergraduate><undergraduate research><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><underrepresentation of groups><underrepresented people><university student><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Temitope O. Keku

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 38/100
Training-friendly
Solid budget
Active award
$268,401
FY 2024

Project Title

Cancer Undergraduate Research Education Program

Grant Number:

1R25CA291602-01

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/3/2024

End Date:

6/30/2029

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT Cancer disproportionately affects Black Americans and other economically disadvantaged groups, yet these individuals are underrepresented in cancer research. The Cancer Undergraduate Research Education Program (CUREP) proposes to address this disparity by expanding and diversifying the pool...

Research Terms

<Address><Admission><Admission activity><Affect><Alum Adjuvant><Baccalaureate Degree><Bachelor's Degree><Basic Research><Basic Science><Biomedical Research><Black><Black American><Black Populations><Black group><Black individual><Black people><Black race><Blacks><Cancer Biology><Cancer Burden><Cancers><Career Choice><Career Path><Collaborations><Communication><Communities><Comprehensive Cancer Center><Degree Attainment><Degree Completion><Development><Disparities><Disparity><Economically Deprived><Economically Deprived Population><Education><Educational aspects><Elements><Ethics><Face><Family><First Generation College Students><First Generation College graduates><First Generation Students><Foundations><Funding><Future><Goals><Graduate Education><Grant><HBCUs><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Individual><Inequality><Intervention><Intervention Strategies><Investigators><Knowledge><Laboratories><Life><Low income><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><NIH><National Cancer Burden><National Institutes of Health><North Carolina><Outcome><Participant><Personal Satisfaction><Physicians><Population><Population Sciences><Postdoc><Postdoctoral Fellow><Principal Investigator><Public Health><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resources><STEM career><STEM workforce><Schools><Science, Technology, Engineering and Math><Science, Technology, Engineering and Mathematics><Scientist><Self Efficacy><Structure><Students><Study Skills><Supervision><Time Management><Training><Undergraduate Degree><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><United States National Institutes of Health><Universities><Work><Writing><alum><aluminum sulfate><anti-cancer research><cancer disparity><cancer health disparity><cancer prevention><cancer research><cancer-related health disparity><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><design><designing><developmental><disadvantaged background><disparity elimination><disparity in cancer><economic disparity><economically deprived group><economically deprived people><economically disadvantaged><economically disadvantaged group><economically disadvantaged individual><economically disadvantaged people><economically disadvantaged population><education research><eliminate disparities><eliminating disparities><ethical><ethnic diversity><ethnically diverse><experience><faces><facial><faculty mentor><falls><graduate student><holistic approach><improved><innovate><innovation><innovative><interest><interventional strategy><malignancy><marginalized background><neoplasm/cancer><next generation><post-doc><post-doctoral><post-doctoral trainee><programs><racial diversity><racially diverse><research associates><role model><science, technology, engineering and math career><science, technology, engineering and math workforce><science, technology, engineering and mathematics career><science, technology, engineering and mathematics workforce><skills><social><social disadvantage><social disparities><social inequality><success><summer intern><summer internship><summer program><summer research><summer session><translational cancer research><under representation of groups><under represented groups><under represented people><under represented populations><underclass><undergrad><undergraduate><undergraduate research><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><underrepresentation of groups><underrepresented people><university student><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Checo James Rorie

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 38/100
Training-friendly
Solid budget
Active award
$268,401
FY 2024

Project Title

Cancer Undergraduate Research Education Program

Grant Number:

1R25CA291602-01

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/3/2024

End Date:

6/30/2029

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT Cancer disproportionately affects Black Americans and other economically disadvantaged groups, yet these individuals are underrepresented in cancer research. The Cancer Undergraduate Research Education Program (CUREP) proposes to address this disparity by expanding and diversifying the pool...

Research Terms

<Address><Admission><Admission activity><Affect><Alum Adjuvant><Baccalaureate Degree><Bachelor's Degree><Basic Research><Basic Science><Biomedical Research><Black><Black American><Black Populations><Black group><Black individual><Black people><Black race><Blacks><Cancer Biology><Cancer Burden><Cancers><Career Choice><Career Path><Collaborations><Communication><Communities><Comprehensive Cancer Center><Degree Attainment><Degree Completion><Development><Disparities><Disparity><Economically Deprived><Economically Deprived Population><Education><Educational aspects><Elements><Ethics><Face><Family><First Generation College Students><First Generation College graduates><First Generation Students><Foundations><Funding><Future><Goals><Graduate Education><Grant><HBCUs><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Individual><Inequality><Intervention><Intervention Strategies><Investigators><Knowledge><Laboratories><Life><Low income><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><NIH><National Cancer Burden><National Institutes of Health><North Carolina><Outcome><Participant><Personal Satisfaction><Physicians><Population><Population Sciences><Postdoc><Postdoctoral Fellow><Principal Investigator><Public Health><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resources><STEM career><STEM workforce><Schools><Science, Technology, Engineering and Math><Science, Technology, Engineering and Mathematics><Scientist><Self Efficacy><Structure><Students><Study Skills><Supervision><Time Management><Training><Undergraduate Degree><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><United States National Institutes of Health><Universities><Work><Writing><alum><aluminum sulfate><anti-cancer research><cancer disparity><cancer health disparity><cancer prevention><cancer research><cancer-related health disparity><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><design><designing><developmental><disadvantaged background><disparity elimination><disparity in cancer><economic disparity><economically deprived group><economically deprived people><economically disadvantaged><economically disadvantaged group><economically disadvantaged individual><economically disadvantaged people><economically disadvantaged population><education research><eliminate disparities><eliminating disparities><ethical><ethnic diversity><ethnically diverse><experience><faces><facial><faculty mentor><falls><graduate student><holistic approach><improved><innovate><innovation><innovative><interest><interventional strategy><malignancy><marginalized background><neoplasm/cancer><next generation><post-doc><post-doctoral><post-doctoral trainee><programs><racial diversity><racially diverse><research associates><role model><science, technology, engineering and math career><science, technology, engineering and math workforce><science, technology, engineering and mathematics career><science, technology, engineering and mathematics workforce><skills><social><social disadvantage><social disparities><social inequality><success><summer intern><summer internship><summer program><summer research><summer session><translational cancer research><under representation of groups><under represented groups><under represented people><under represented populations><underclass><undergrad><undergraduate><undergraduate research><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><underrepresentation of groups><underrepresented people><university student><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christina Ciecierski

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph M Feinglass

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lidia Filus

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marian L. Fitzgibbon

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Masahito Jimbo

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELISSA A. SIMON

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,357
FY 2024

Project Title

2/3: The Chicago Cancer Health Collaborative (ChicagoCHEC)

Grant Number:

5U54CA202995-10

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

OVERALL – ABSTRACT The Chicago Cancer Health Equity Collaborative (ChicagoCHEC) is a comprehensive partnership to advance cancer health equity bringing together the synergistic strengths of two federally designated Hispanic Serving Institutions, the University of Illinois at Chicago (UIC) and Northe...

Research Terms

<Acceleration><Advanced Cancer><Advanced Malignant Neoplasm><African American><Afro American><Afroamerican><Applications Grants><Award><Cancer Research Infrastructure><Cancer Research Programs><Cancer Research Project><Cancer health equity><Cancers><Chicago><Circadian Rhythms><Cities><Clinical><Collaborations><Communities><Community Outreach><Comprehensive Cancer Center><DNA Double Strand Break><Decision Making><Dedications><Double Strand Break Repair><EXTMR><Education><Education and Outreach><Educational aspects><Evaluation><Extramural><Extramural Activities><Faculty><Fortification><Funding><Funding Mechanisms><GI microbiome><Generations><Goals><Grant><Grant Proposals><HSC transplantation><Health Disparities Research><Health Inequity><Health disparities related research><Hematopoietic Stem Cell Transplant><Hematopoietic Stem Cell Transplantation><Hispanic-serving Institution><Illinois><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Instruction and Outreach><Investigators><Lead><Leadership><Long-Term Effects><Longterm Effects><Malignant Neoplasms><Malignant Tumor><Mentors><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Mouth microbiome><Nyctohemeral Rhythm><Pb element><Peer Review><Pilot Projects><Position><Positioning Attribute><Prevention><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Records><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Science><Scientific Publication><Scientist><Students><Survivors><Training><Training and Outreach><Translational Research><Translational Science><Transplant Recipients><Tutoring and Outreach><Twenty-Four Hour Rhythm><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><Underserved Population><Universities><Variant><Variation><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><circadian process><community engagement><community partners><community-based partners><daily biorhythm><digestive tract microbiome><disability><disparity in cancer><early-career faculty><education research><empowerment><engagement with communities><enteric microbiome><experience><forging><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><health disparities science><health disparity community><health disparity group><health disparity populations><health inequalities><heavy metal Pb><heavy metal lead><hematopoietic cell transplantation><hematopoietic cellular transplantation><hematopoietic progenitor cell transplantation><high risk><improved><innovate><innovation><innovative><intestinal biome><intestinal microbiome><lung cancer early detection><lung cancer screening><mHealth self-management><malignancy><men><minority student><mobile health self-management><neoplasm/cancer><next generation><oral microbiome><outreach><outreach program><pilot study><programs><rapid growth><recruit><social><survivorship><tool><translation research><translational investigation><transplant patient><under representation of groups><under represented groups><under represented people><under represented populations><under served community><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joel Erblich

HUNTER COLLEGE, NEW YORK, NY

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,026
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221704-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/18/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer S Ford

HUNTER COLLEGE, NEW YORK, NY

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,026
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221704-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/18/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GRACE X. MA

HUNTER COLLEGE, NEW YORK, NY

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,026
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221704-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/18/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Camille C. Ragin

HUNTER COLLEGE, NEW YORK, NY

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$959,026
FY 2025

Project Title

TUFCCC/HC Regional Comprehensive Cancer Health Partnership

Grant Number:

5U54CA221704-08

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/18/2018

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

The Synergistic Partnership for Enhancing Excellence in Cancer Health (SPEECH) is a highly collaborative and mutually beneficial Partnership between Temple University/Fox Chase Cancer Center (TUFCCC) and Hunter College (HC) and the only NCI-funded U54 CPACHE in PA and NJ and one of two in NYC. Our e...

Research Terms

<Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Cancer Intervention><Cancer Research Programs><Cancer Research Project><Cancers><Career Mobility><Clinical Sciences><Collaborations><Communities><Competence><Data><Diagnosis><Education><Educational aspects><Evaluation><Feedback><Fostering><Fox Chase Cancer Center><Funding><Grant><Health><High Prevalence><Infrastructure><Institution><Intervention><Investigators><Malignant Neoplasms><Malignant Tumor><Mentors><Mentorship><Methods><Monitor><Morbidity><Morbidity - disease rate><Neighborhoods><Outcome><Patients><Pilot Projects><Population><Population Sciences><Publications><Research><Research Activity><Research Infrastructure><Research Institute><Research Personnel><Researchers><Risk Factors><Scientific Publication><Scientist><Sight><Students><Training><United States><Universities><Vision><advanced disease><advanced illness><anti-cancer research><cancer disparity><cancer education><cancer health disparity><cancer prevention><cancer research><cancer risk><cancer-related health disparity><career advancement><career development><career transition><college><collegiate><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community partnered approach><community partnered strategy><disparity in cancer><education research><experience><improved><innovate><innovation><innovative><malignancy><member><mortality><multidisciplinary><neoplasm/cancer><next generation><outreach><outreach program><pilot study><prevention service><programs><recruit><research education experience><screening><screenings><success><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth O. Ofili

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$949,878
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

5U24MD015970-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Daniel F Sarpong

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$949,878
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

5U24MD015970-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul B. Tchounwou

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$949,878
FY 2024

Project Title

Research Centers in Minority Institutions (RCMI) Coordinating Center

Grant Number:

5U24MD015970-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/8/2020

End Date:

4/30/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY- 1U24MD015979-01 The overall objective of the proposed RCMI Coordinating Center (RCMI CC) is to serve as a national resource to advance the science of minority health and health disparities across the RCMI U54 Centers through coordination of intellectual exchange and collaborative in...

Research Terms

<Acceleration><Award><Basic Research><Basic Science><Behavioral Research><Behavioral Sciences><Biological><Biomedical Research><Clinical Research><Clinical Sciences><Clinical Study><Clinical and Translational Science Awards><Collaborations><Common Data Element><Communication><Consultations><Core Facility><Development><Educational workshop><Equipment><Evaluation><Fostering><Funding><Grant><Information Technology><Infrastructure><Institution><Investigators><Marketing><Measures><Mentors><Methodology><Minority-Serving Institution><Modeling><Monitor><NCATS><NCMHD><NIGMS><NIMHD><National Center for Advancing Translational Sciences><National Center on Minority Health and Health Disparities><National Institute of General Medical Sciences><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><On-Line Systems><Online Systems><Patient Recruitments><Performance><Pilot Projects><Principal Investigator><Productivity><Program Evaluation><Research><Research Activity><Research Design><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Study Type><Translational Research><Translational Science><Visit><Workshop><biologic><career development><central database><clinical infrastructure><community based organizations><community engaged approach><community engaged approaches><community engaged strategies><community engaged strategy><community engagement><community organizations><community partnered approach><community partnered strategy><community partners><community-based partners><conference><consultation><convention><culturally adapted intervention><culturally appropriate intervention><culturally centered intervention><culturally focused intervention><culturally informed intervention><culturally responsive intervention><culturally tailored intervention><developmental><disparity in ethnic><disparity in health><effective intervention><engagement with communities><ethnic based disparity><ethnic disadvantage><ethnic disparity><ethnic inequality><ethnic inequity><ethnicity disparity><expectation><experience><geographic disadvantage><geographic disparity><geographic inequality><geographic inequity><geographic location disparity><health disparity><implementation facilitation><improved><inter-institutional><meeting><meetings><minority health><minority health disparity><minority institution><online computer><outreach><participant recruitment><participant retention><pilot study><programs><research study><searchable data base><searchable database><social health determinants><study design><success><summit><symposia><symposium><translation research><translational investigation><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Subramaniam Pennathur

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$937,567
FY 2024

Project Title

University of Michigan O'Brien Kidney Translational Resource Center (MKTC)

Grant Number:

5U54DK137314-02

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

6/30/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT – CENTER OVERVIEW The main goal of the University of Michigan O'Brien Kidney Translational Resource Center (MKTC) is to provide an effective translational research pipeline to develop novel, mechanistic treatment strategies for patients with kidney diseases. The center will support all basi...

Research Terms

<Acute><Acute Renal Failure with Renal Papillary Necrosis><Area><Basic Research><Basic Science><Big Data><BigData><Bio-Informatics><Bioinformatics><Biologic Models><Biological><Biological Markers><Biological Models><Cessation of life><Chronic Kidney Failure><Chronic Renal Disease><Chronic Renal Failure><Clinical><Clinical Research><Clinical Study><Collaborations><Communities><Community Outreach><Complex><Data><Data Analyses><Data Analysis><Data Analytics><Data Bases><Data Coordinating Center><Data Coordination Center><Data Set><Databases><Death><Development><Diagnosis><Disease><Disorder><Dysfunction><ESRD><Education><Educational aspects><End stage renal failure><End-Stage Kidney Disease><End-Stage Renal Disease><Ensure><Faculty><Fostering><Functional disorder><Future><Genetic><Goals><Health><Hematology><Human><Human Resources><Individual><Infrastructure><Injury><Injury to Kidney><Intervention><Intervention Strategies><Investigators><Kidney><Kidney Diseases><Kidney Urinary System><Manpower><Medicine><Methodology><Michigan><Mission><Model System><Modern Man><Modernization><Molecular><Multiomic Data><Nephropathy><On-Line Systems><Online Systems><Pathway interactions><Patient Care><Patient Care Delivery><Patients><Physiology><Physiopathology><Prognostic Marker><Proteomics><Public Health><Renal Disease><Renal function><Research><Research Personnel><Research Resources><Research Training><Researchers><Resource Development><Resources><Risk><Scientific Advances and Accomplishments><Services><Structure><Students><Surrogate End Points><Surrogate Endpoint><System><Systems Biology><Technology><Therapeutic><Translational Research><Translational Science><Translations><Universities><Urology><Validation><Work><acute kidney injury><base><bases><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><bio-markers><biologic><biologic marker><biological systems><biomarker><care for patients><care of patients><career><caring for patients><chronic kidney disease><cohort><data base><data interpretation><data management and coordinating center><data management center><data mining><datamining><death risk><design><designing><developmental><disability><diversity and equity><diversity, equity, and inclusiveness><effective intervention><effective therapy><effective treatment><equity, diversity, and inclusion><experience><high dimensional data><high school><improved><individual patient><injuries><innovate><innovation><innovative><interdisciplinary collaboration><interventional strategy><kidney disorder><kidney function><kidney injury><lipidomics><metabolism measurement><metabolomics><metabonomics><mortality><mortality risk><multidimensional data><multidimensional datasets><multiple omic data><new diagnostics><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation diagnostics><next generation therapeutics><novel><novel diagnostics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><online computer><operation><operations><outreach><outreach program><pathophysiology><pathway><patient centered><patient oriented><personnel><premature><prematurity><prognostic><prognostic biomarker><programs><recruit><renal><renal disorder><renal injury><research study><scientific accomplishments><scientific advances><tool><transcriptomics><transdisciplinary collaboration><translation><translation research><translational investigation><treatment strategy><undergrad><undergraduate><undergraduate student><user-friendly><validations><web based>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Pierre C Dagher

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$878,240
FY 2025

Project Title

Indiana Center for Advanced Renal Microscopy and Molecular Imaging

Grant Number:

5U54DK137328-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

6/30/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract (Center Overview) From its inception as an NIDDK-funded P50 Center in 2002, the mission of the Indiana O’Brien Center for Advanced Renal Microscopy has been to provide renal researchers with effective access to advanced forms of microscopy. Over the past 20 years of continu...

Research Terms

<3-D><3-Dimensional><3D><Applications Grants><Biological><Body Tissues><Collaborations><Common Rat Strains><Communities><Cytometry><Data><Development><Diabetes Mellitus><Dysfunction><Educational workshop><Environment><Equipment><Functional disorder><Funding><Generations><Goals><Grant Proposals><Hematology><HuBMAP><Human BioMolecular Atlas Program><Image><Image Analyses><Image Analysis><Imaging technology><Indiana><Individual><Infrastructure><Institution><Investigators><Kidney><Kidney Urinary System><Left><Light><Methods><Mice><Mice Mammals><Microscopy><Mission><Molecular><Murine><Mus><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Nebraska><Nephrology><Photoradiation><Physiology><Physiopathology><Publications><Quantitative Microscopy><Rat><Rats Mammals><Rattus><Renal Tissue><Reporter><Research><Research Personnel><Research Resources><Researchers><Resolution><Resource Development><Resources><Scientific Publication><Services><Techniques><Technology><Tissues><Training><United States National Institutes of Health><Universities><Washington><Work><Workshop><biologic><biomedical resource><career><computer imaging><design><designing><developmental><diabetes><digital imaging><experience><image evaluation><image interpretation><imaging><innovative technologies><intra-vital microscopy><intravital microscopy><microscope imaging><microscopic imaging><microscopy imaging><molecular imaging><molecule imaging><multi-photon><new technology><novel><novel technologies><outreach><pathophysiology><precision medicine><precision-based medicine><programs><renal><resolutions><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><synergism><three dimensional><tool>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

OLIVER CHUKWUJEKWU EZECHI

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$717,894
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

5U54CA284110-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Juliet Iwelunmor

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$717,894
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

5U54CA284110-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph David Tucker

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$717,894
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

5U54CA284110-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VANDERLEI BAGNATO

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Y. Chiao

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CESALTINA FERREIRA LORENZONI

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca R. Richards-Kortum

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathleen Schmeler

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

regis kreitchmann

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$647,289
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

5U54CA277843-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Priyamvada Acharya

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$590,000
FY 2024

Project Title

Administrative Supplement for U54 AI170752

Grant Number:

3U54AI170752-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/14/2022

End Date:

3/31/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Administrative Supplement for U54 AI170752 In the absence of an effective preventive vaccine or a cure, HIV-1 continues to be a major global health crisis. Having claimed 40.4 million lives so far with ongoing transmission in all countries globally, according to the World Health Organization, with ...

Research Terms

<AIDS Virus><Acceleration><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Administrative Supplement><Affinity><Antibodies><Antigenic Determinants><Area><B cell receptor><B-Cell Antigen Receptor><Binding><Binding Determinants><Biology><Cell Body><Cells><Clinical Trials><Collaborations><Complex><Computer Analysis><Consumption><Country><Coupled><Cryo-electron Microscopy><Cryo-electron tomography><Cryoelectron Microscopy><Data><Data Collection><Disease Progression><Dissection><Drug Targeting><ELISA><Electron Cryomicroscopy><Ensure><Envelope Protein><Enzyme-Linked Immunosorbent Assay><Epitopes><Equilibrium><Equipment><Event><Funding><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G-Protein-Coupled Receptors><GPCR><Goals><HAART><HIV><HIV-1><HIV-I><HIV1><Hand><Highly Active Antiretroviral Therapy><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Immune Cell Activation><Infection><Knowledge><LAV-HTLV-III><Lymphadenopathy-Associated Virus><Measurement><Measures><Mediating><Medicine><Membrane><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methods><Microscope><Molecular><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><Morbidity><Morbidity - disease rate><Persons><Preventative vaccine><Preventive vaccine><Production><Prophylactic vaccine><Proteins><Publications><Receptor Protein><Reporting><Reproducibility><Research><Resolution><Rest><Role><Sampling><Scientific Publication><Scientist><Site><Structure><Surface Proteins><System><Technology><Time><Training><Transmission><Tropism><Vaccination><Vaccines><Viral><Viral Latency><Virus Latency><Virus-HIV><World Health Organization><balance><balance function><biological systems><career><computational analyses><computational analysis><computer analyses><conformation><conformational><conformational state><conformationally><conformations><cryo-EM><cryo-EM tomography><cryoEM><cryoEM tomography><cryoelectron tomography><cryogenic electron microscopy><data acquisition><data acquisitions><detector><electron cryo-tomography><env Antigens><env Gene Products><env Polyproteins><env Protein><enzyme linked immunoassay><expectation><experiment><experimental research><experimental study><experiments><global health><hands><immune activation><inhibitor><insight><membrane structure><memory CD4 T cell><memory CD4 T lymphocyte><mimetics><mortality><neutralizing antibody><new vaccines><news><next generation vaccines><novel><novel vaccines><particle><receptor><resolutions><social role><structural biology><tool><transmission process><trend><viral rebound><virus rebound>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Ddungu Kambugu

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$560,167
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

5U54CA254571-06

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY N MARTIN

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$560,167
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

5U54CA254571-06

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert Richard Freimuth

MAYO CLINIC JACKSONVILLE, JACKSONVILLE, FL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$554,405
FY 2025

Project Title

The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)

Grant Number:

5U24CA277825-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Despite the decline in overall mortality and incidence of cancer in the US population, the burden of cancer care is still high. One key barrier experienced by those that have high burden of cancer is the lack of dedicated efforts employing scientifically rigorous approaches and implementation strate...

Research Terms

<Administrative Efficiency><Adopted><Award><Benchmarking><Best Practice Analysis><Cancer Burden><Cancers><Caring><Center for Cancer Research><Clinical Data><Clinical Trials><Collaborations><Common Data Element><Communication><Communities><Consensus><Data><Data Analytics><Data Collection><Data Management Core><Data Pooling><Data Science><Dedications><Department of Defense><Development><Discipline><Education and Outreach><Education for Intervention><Educational Intervention><Enrollment><Ethics><Evaluation><Fostering><Generations><Goals><Grant><Health><Human><Incidence><Infrastructure><Institution><Instruction Intervention><Instruction and Outreach><Intervention><Investigators><Leadership><Learning><Logistics><Malignant Neoplasms><Malignant Tumor><Manuscripts><Measures><Methods><Mission><Modern Man><NCATS><NCI Center for Cancer Research><National Cancer Burden><National Center for Advancing Translational Sciences><Oncology><Oncology Cancer><Outcome><Participant><Patients><Policies><Population><Position><Positioning Attribute><Procedures><Process><Program Evaluation><Protocol><Protocols documentation><Publications><Recommendation><Reporting><Research><Research Activity><Research Design><Research Personnel><Research Resources><Research Support><Researchers><Resources><Science><Scientific Publication><Secure><Services><Site><Standardization><Structure><Study Type><Terminology><Training Intervention><Training and Outreach><Tutoring and Outreach><Underrepresented Groups><Underrepresented Populations><Work><benchmark><cancer care><clinical trial participant><data exchange><data harmonization><data management><data management and coordinating center><data management center><data sharing><data transfer><data transmission><developmental><enroll><ethical><evidence base><experience><harmonized data><implementation strategy><instructional intervention><internet portal><interoperability><malignancy><meeting><meetings><member><mortality><neoplasm/cancer><on-line portal><online portal><operation><operations><patient population><privacy preservation><programs><social media><statistics><strategies for implementation><study design><tool><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><web portal><web-based portal>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer G. Le-Rademacher

MAYO CLINIC JACKSONVILLE, JACKSONVILLE, FL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$554,405
FY 2025

Project Title

The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)

Grant Number:

5U24CA277825-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Despite the decline in overall mortality and incidence of cancer in the US population, the burden of cancer care is still high. One key barrier experienced by those that have high burden of cancer is the lack of dedicated efforts employing scientifically rigorous approaches and implementation strate...

Research Terms

<Administrative Efficiency><Adopted><Award><Benchmarking><Best Practice Analysis><Cancer Burden><Cancers><Caring><Center for Cancer Research><Clinical Data><Clinical Trials><Collaborations><Common Data Element><Communication><Communities><Consensus><Data><Data Analytics><Data Collection><Data Management Core><Data Pooling><Data Science><Dedications><Department of Defense><Development><Discipline><Education and Outreach><Education for Intervention><Educational Intervention><Enrollment><Ethics><Evaluation><Fostering><Generations><Goals><Grant><Health><Human><Incidence><Infrastructure><Institution><Instruction Intervention><Instruction and Outreach><Intervention><Investigators><Leadership><Learning><Logistics><Malignant Neoplasms><Malignant Tumor><Manuscripts><Measures><Methods><Mission><Modern Man><NCATS><NCI Center for Cancer Research><National Cancer Burden><National Center for Advancing Translational Sciences><Oncology><Oncology Cancer><Outcome><Participant><Patients><Policies><Population><Position><Positioning Attribute><Procedures><Process><Program Evaluation><Protocol><Protocols documentation><Publications><Recommendation><Reporting><Research><Research Activity><Research Design><Research Personnel><Research Resources><Research Support><Researchers><Resources><Science><Scientific Publication><Secure><Services><Site><Standardization><Structure><Study Type><Terminology><Training Intervention><Training and Outreach><Tutoring and Outreach><Underrepresented Groups><Underrepresented Populations><Work><benchmark><cancer care><clinical trial participant><data exchange><data harmonization><data management><data management and coordinating center><data management center><data sharing><data transfer><data transmission><developmental><enroll><ethical><evidence base><experience><harmonized data><implementation strategy><instructional intervention><internet portal><interoperability><malignancy><meeting><meetings><member><mortality><neoplasm/cancer><on-line portal><online portal><operation><operations><patient population><privacy preservation><programs><social media><statistics><strategies for implementation><study design><tool><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><web portal><web-based portal>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

FOLAKEMI T ODEDINA

MAYO CLINIC JACKSONVILLE, JACKSONVILLE, FL

Exploratory lead · 36/100
Above-average budget
Active award
Team-scale grant
$554,405
FY 2025

Project Title

The Data, Evaluation, and Coordination Center (DECC) for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)

Grant Number:

5U24CA277825-05

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/16/2022

End Date:

8/31/2027

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Despite the decline in overall mortality and incidence of cancer in the US population, the burden of cancer care is still high. One key barrier experienced by those that have high burden of cancer is the lack of dedicated efforts employing scientifically rigorous approaches and implementation strate...

Research Terms

<Administrative Efficiency><Adopted><Award><Benchmarking><Best Practice Analysis><Cancer Burden><Cancers><Caring><Center for Cancer Research><Clinical Data><Clinical Trials><Collaborations><Common Data Element><Communication><Communities><Consensus><Data><Data Analytics><Data Collection><Data Management Core><Data Pooling><Data Science><Dedications><Department of Defense><Development><Discipline><Education and Outreach><Education for Intervention><Educational Intervention><Enrollment><Ethics><Evaluation><Fostering><Generations><Goals><Grant><Health><Human><Incidence><Infrastructure><Institution><Instruction Intervention><Instruction and Outreach><Intervention><Investigators><Leadership><Learning><Logistics><Malignant Neoplasms><Malignant Tumor><Manuscripts><Measures><Methods><Mission><Modern Man><NCATS><NCI Center for Cancer Research><National Cancer Burden><National Center for Advancing Translational Sciences><Oncology><Oncology Cancer><Outcome><Participant><Patients><Policies><Population><Position><Positioning Attribute><Procedures><Process><Program Evaluation><Protocol><Protocols documentation><Publications><Recommendation><Reporting><Research><Research Activity><Research Design><Research Personnel><Research Resources><Research Support><Researchers><Resources><Science><Scientific Publication><Secure><Services><Site><Standardization><Structure><Study Type><Terminology><Training Intervention><Training and Outreach><Tutoring and Outreach><Underrepresented Groups><Underrepresented Populations><Work><benchmark><cancer care><clinical trial participant><data exchange><data harmonization><data management><data management and coordinating center><data management center><data sharing><data transfer><data transmission><developmental><enroll><ethical><evidence base><experience><harmonized data><implementation strategy><instructional intervention><internet portal><interoperability><malignancy><meeting><meetings><member><mortality><neoplasm/cancer><on-line portal><online portal><operation><operations><patient population><privacy preservation><programs><social media><statistics><strategies for implementation><study design><tool><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><web portal><web-based portal>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anna R. Giuliano

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 36/100
Likely hiring
Active award
$146,655
FY 2025

Project Title

Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study)

Grant Number:

3R01CA274950-04S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/12/2022

End Date:

8/31/2028

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT Oropharyngeal cancer (OPC) is predominantly caused by HPV 16 and other oncogenic HPV types and disproportionately impacts men and people living with HIV (PLWH). There is no reliable method to detect OPC pre-cancerous lesions for secondary prevention. Trials assessing efficacy of the 9vHPV v...

Research Terms

<AIDS Virus><Aberrant DNA Methylation><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Age><Aging><Alcohol Chemical Class><Alcohols><Americas><Anal Cancer><Anatomic Sites><Anatomic structures><Anatomy><Anti-Oncogenes><Antioncogenes><Anus Cancer><Area><Behavioral><Biological Aging><Biological Markers><Burkitt Herpesvirus><Burkitt Lymphoma Virus><CD4 Lymphocyte Count><CD4+ Cell Counts><CD4+ Counts><Cancer Induction><Cancer Suppressor Genes><Cancers><Cervical Cancer><Cervix Cancer><Chronic><Clinical><Clinical Data><Collaborations><Country><Data><Dental Care><Dental Hygiene><Dental Procedure><Development><Disproportionate number of men><Disproportionately impacts males><Disproportionately in men><EB virus><EBV><Early Diagnosis><Emerogenes><Epstein Barr Virus><Exclusion><Funding><Future><Goals><Grant><Gum Disease><HHV-4><HHV4><HIV><HIV infected men><HIV positive men><HIV therapy><HIV+ men><HPV><HPV + oropharyngeal carcinoma><HPV 16><HPV Vaccination><HPV Vaccine><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV detection><HPV driven cancers><HPV induced Oral Cancer><HPV induced cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV prevention><HPV related cancer of the mouth><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-16><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HPV16><History><Host Factor><Host Factor Protein><Human Herpesvirus 4><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus detection><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papilloma virus infection><Human papilloma virus type 16><Human papillomavirus 16><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus type 16><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immunes><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Incidence><Infection><Infectious Human Wart Virus><Infectious Mononucleosis Virus><Inflammation><Infrastructure><Integration Host Factors><Knowledge><LAV-HTLV-III><Latin America><Latin American><Literature><Location><Lymphadenopathy-Associated Virus><Males living with HIV><Malignant Anal Neoplasm><Malignant Anal Tumor><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Malignant Tumor of the Anus><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of anus><Malignant neoplasm of cervix uteri><Measures><Men with HIV><Methods><Methylation><Mouth Cancer><Natural History><Nested Case-Control Study><Onco-Suppressor Genes><Oncogenes-Tumor Suppressors><Oncogenic><Oral><Oral Cancer><Oral Hygiene><Oral health><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Parodontosis><Patients><Periodontal Diseases><Persons><Policies><Population><Predictive Factor><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Prospective Studies><Recessive Oncogenes><Recording of previous events><Reproducibility><Research><Research Specimen><Risk><Risk Factors><Secondary Lesion><Secondary Prevention><Services><Sex Behavior><Sexual Activity><Sexual Behavior><Specimen><T4 Lymphocyte Count><Testing><Tobacco Consumption><Tobacco use><Tooth Loss><Tumor Suppressing Genes><Tumor Suppressor Genes><Uterine Cervix Cancer><Vaccination><Vaccines><Viral><Virus-HIV><Visit><Woman><accelerated aging><accelerated biological age><accelerated biological aging><active followup><age acceleration><ages><anal squamous cell carcinoma><bio-markers><biologic marker><biological age><biological process of age><biomarker><biomarker identification><cancer risk><carcinogenesis><care utilization><co-infection><coinfection><dental health><dental service><determine efficacy><developmental><disease risk><disorder risk><disproportionately affects males><disproportionately affects men><disproportionately concentrated among men><disproportionately distributed among men><disproportionately higher among men><disproportionately impacts men><disproportionately occurs in men><early detection><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><epigenetic biomarker><epigenetic marker><evaluate efficacy><examine efficacy><follow up><follow-up><followed up><followup><high risk><histories><human papilloma virus 16><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><identification of biomarkers><identification of new biomarkers><infection mouth><male><male bias><male predominance><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><malleable risk><man living with HIV><marker identification><men><men diagnosed with HIV><men disproportionately diagnosed><men disproportionately experience><men experience disproportionate rates><men infected with HIV><men living with HIV><modifiable risk><multidisciplinary><neoplasm/cancer><novel><old age><oncosuppressor gene><oral HPV><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus><oral human papillomavirus infection><oral infection><oral infectious><oral oncogenic HPV><oral papillomavirus infection><periodontal disorder><periodontium disease><periodontium disorder><precancer><precancerous><predominantly affecting men><premalignant><prevent><prevent HPV><prevent human papillomavirus><preventing><programs><screening><screenings><sex activity><sexual activities><social factors><tobacco product use><type 16 Human papilloma virus><type 16 Human papillomavirus><wart virus><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anna R. Giuliano

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 36/100
Likely hiring
Active award
$141,464
FY 2025

Project Title

Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study)

Grant Number:

3R01CA274950-04S2

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/12/2022

End Date:

8/31/2028

Why this may be worth a closer look

  • • Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT Oropharyngeal cancer (OPC) is predominantly caused by HPV 16 and other oncogenic HPV types and disproportionately impacts men and people living with HIV (PLWH). There is no reliable method to detect OPC pre-cancerous lesions for secondary prevention. Trials assessing efficacy of the 9vHPV v...

Research Terms

<AIDS Virus><Aberrant DNA Methylation><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Active Follow-up><Age><Aging><Alcohol Chemical Class><Alcohols><Americas><Anal Cancer><Anatomic Sites><Anatomic structures><Anatomy><Anti-Oncogenes><Antioncogenes><Anus Cancer><Area><Behavioral><Biological Aging><Biological Markers><Burkitt Herpesvirus><Burkitt Lymphoma Virus><CD4 Lymphocyte Count><CD4+ Cell Counts><CD4+ Counts><Cancer Induction><Cancer Suppressor Genes><Cancers><Cervical Cancer><Cervix Cancer><Chronic><Clinical><Clinical Data><Collaborations><Country><Data><Dental Care><Dental Hygiene><Dental Procedure><Development><Disproportionate number of men><Disproportionately impacts males><Disproportionately in men><EB virus><EBV><Early Diagnosis><Emerogenes><Epstein Barr Virus><Exclusion><Funding><Future><Goals><Grant><Gum Disease><HHV-4><HHV4><HIV><HIV infected men><HIV positive men><HIV therapy><HIV+ men><HPV><HPV + oropharyngeal carcinoma><HPV 16><HPV Vaccination><HPV Vaccine><HPV associated mouth cancer><HPV associated oral cancer><HPV associated oral malignancies><HPV caused cancer><HPV detection><HPV driven cancers><HPV induced Oral Cancer><HPV induced cancer><HPV infection><HPV infection-associated oral cancer><HPV malignancy><HPV mediated oropharynx cancer><HPV oropharyngeal cancer><HPV positive oropharyngeal cancer><HPV positive oropharynx cancer><HPV prevention><HPV related cancer of the mouth><HPV related oral cancer><HPV related oral malignancies><HPV related oropharyngeal cancer><HPV related oropharyngeal carcinoma><HPV+ OPC><HPV+ cancer><HPV+ oral cancer><HPV+ oropharyngeal cancer><HPV-16><HPV-OPC><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-associated oropharyngeal cancer><HPV-driven oropharyngeal cancer><HPV-related OPC><HPV-related cancer><HPV-related oropharyngeal cancer><HPV16><History><Host Factor><Host Factor Protein><Human Herpesvirus 4><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus detection><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papilloma virus infection><Human papilloma virus type 16><Human papillomavirus 16><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus driven oropharyngeal cancer><Human papillomavirus induced cancer><Human papillomavirus infection><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus related oropharyngeal carcinoma><Human papillomavirus type 16><Human papillomavirus- related oropharyngeal cancer><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Human papillomavirus-associated oropharyngeal cancer><Immune><Immune Diseases><Immune Disorders><Immune Dysfunction><Immune System Diseases><Immune System Disorder><Immune System Dysfunction><Immune System and Related Disorders><Immunes><Immunologic Diseases><Immunological Diseases><Immunological Dysfunction><Immunological System Dysfunction><Incidence><Infection><Infectious Human Wart Virus><Infectious Mononucleosis Virus><Inflammation><Infrastructure><Integration Host Factors><Knowledge><LAV-HTLV-III><Latin America><Latin American><Literature><Location><Lymphadenopathy-Associated Virus><Males living with HIV><Malignant Anal Neoplasm><Malignant Anal Tumor><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Oropharyngeal Neoplasm><Malignant Oropharyngeal Tumor><Malignant Tumor><Malignant Tumor of the Anus><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of anus><Malignant neoplasm of cervix uteri><Measures><Men with HIV><Methods><Methylation><Mouth Cancer><Natural History><Nested Case-Control Study><Onco-Suppressor Genes><Oncogenes-Tumor Suppressors><Oncogenic><Oral><Oral Cancer><Oral Hygiene><Oral health><Oropharnyx Cancers><Oropharyngeal Cancer><Oropharyngeal Carcinoma><Oropharynx Cancer><Oropharynx Carcinoma><Parodontosis><Patients><Periodontal Diseases><Persons><Policies><Population><Predictive Factor><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Prospective Studies><Recessive Oncogenes><Recording of previous events><Reproducibility><Research><Research Specimen><Risk><Risk Factors><Secondary Lesion><Secondary Prevention><Services><Sex Behavior><Sexual Activity><Sexual Behavior><Specimen><T4 Lymphocyte Count><Testing><Tobacco Consumption><Tobacco use><Tooth Loss><Tumor Suppressing Genes><Tumor Suppressor Genes><Uterine Cervix Cancer><Vaccination><Vaccines><Viral><Virus-HIV><Visit><Woman><accelerated aging><accelerated biological age><accelerated biological aging><active followup><age acceleration><ages><anal squamous cell carcinoma><bio-markers><biologic marker><biological age><biological process of age><biomarker><biomarker identification><cancer risk><carcinogenesis><care utilization><co-infection><coinfection><dental health><dental service><determine efficacy><developmental><disease risk><disorder risk><disproportionately affects males><disproportionately affects men><disproportionately concentrated among men><disproportionately distributed among men><disproportionately higher among men><disproportionately impacts men><disproportionately occurs in men><early detection><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><epigenetic biomarker><epigenetic marker><evaluate efficacy><examine efficacy><follow up><follow-up><followed up><followup><high risk><histories><human papilloma virus 16><human papillomavirus associated malignancy><human papillomavirus associated oral cancer><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus mediated oropharynx cancer><human papillomavirus positive oropharyngeal cancer><human papillomavirus positive oropharyngeal carcinoma><human papillomavirus positive oropharynx carcinoma><human papillomavirus+ oropharyngeal cancer><human papillomavirus-associated cancer><human papillomavirus-related cancer><identification of biomarkers><identification of new biomarkers><infection mouth><male><male bias><male predominance><malignancy><malignant mouth neoplasm><malignant mouth tumor><malignant oropharynx neoplasm><malignant oropharynx tumor><malleable risk><man living with HIV><marker identification><men><men diagnosed with HIV><men disproportionately diagnosed><men disproportionately experience><men experience disproportionate rates><men infected with HIV><men living with HIV><modifiable risk><multidisciplinary><neoplasm/cancer><novel><old age><oncosuppressor gene><oral HPV><oral HPV infection><oral cancer associated with HPV><oral cancer caused by human papillomavirus><oral cavity cancer><oral human papilloma virus infection><oral human papillomavirus><oral human papillomavirus infection><oral infection><oral infectious><oral oncogenic HPV><oral papillomavirus infection><periodontal disorder><periodontium disease><periodontium disorder><precancer><precancerous><predominantly affecting men><premalignant><prevent><prevent HPV><prevent human papillomavirus><preventing><programs><screening><screenings><sex activity><sexual activities><social factors><tobacco product use><type 16 Human papilloma virus><type 16 Human papillomavirus><wart virus><♂>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Selina Faith Darling-Reed

FLORIDA AGRICULTURAL AND MECHANICAL UNIV, TALLAHASSEE, FL

Exploratory lead · 34/100
Large award
Active award
$7,991,046
FY 2024

Project Title

Expanding Infrastructure for Translational and Health Disparities Research at Florida A&M University

Grant Number:

1C06OD037803-01

Activity Code:

C06

Mechanism:

Construction Grants

Agency:

NIH

Start Date:

9/15/2024

End Date:

7/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT: The overarching goal of the Florida A&M University (FAMU) C06 application is to buildout a multi-disciplinary 16,000 square foot integrated shared service core facility ; "Expanding Infrastructure for Translational and Health Disparities Research at Florida A&M University" ...

Research Terms

<African American><African American group><African American individual><African American people><African American population><African Americans><Afro American><Afroamerican><Architecture><Behavioral><Behavioral Research><Biomedical Research><California><Classification><Collaborations><Communities><Community Outreach><Core Facility><Cost Analyses><Cost Analysis><County><Decrease health disparities><Engineering / Architecture><Floor><Florida><Fostering><Funding><Funding Agency><Funding Source><Future><Geography><Goals><HBCUs><Health Disparities Research><Health disparities related research><Health disparity mitigation><Health disparity reduction><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Infrastructure><Institution><Instruction><Investigators><Leadership><Life Cycle><Life Cycle Stages><Lower health disparities><Minority-Serving Institution><Mission><Mitigate health disparities><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Pharmaceutical Agent><Pharmaceuticals><Pharmacies><Pharmacologic Substance><Pharmacological Substance><Pharmacy facility><Phase><Public Health><Reduce health disparities><Research><Research Activity><Research Personnel><Researchers><Science><Services><Systematics><Technology><United States National Institutes of Health><Universities><assess cost><college><collegiate><community center><community centers><community engagement><cost assessment><cost evaluation><design><designing><engagement with communities><evaluate cost><examine cost><health disparities science><health equity><innovate><innovation><innovative><life course><minority health><minority health disparity><minority institution><minority student><multidisciplinary><outreach><pharmaceutical><sound><sq. ft><square foot><stem>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mario R De La Rosa

FLORIDA INTERNATIONAL UNIVERSITY, MIAMI, FL

Exploratory lead · 34/100
Large award
Active award
$2,000,000
FY 2025

Project Title

Florida International University-Health Disparities Initiative (FIU-HDI)

Grant Number:

5S21MD010683-08

Activity Code:

S21

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2016

End Date:

5/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY The long-term objective of the proposed Florida International University-Health Disparities Initiative (FIU-HDI) is to enhance and expand FIU’s capacity for health disparities research and training. These efforts will have a direct impact on reducing health disparities in communicabl...

Research Terms

<AIDS Virus><AIDS/HIV><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Affect><Area><Award><Behavioral><Biometrics><Biometry><Biostatistics><Cancers><Cardiovascular Diseases><Caribbean><Caribbean Sea Region><Caribbean region><Clinical><Communities><Data><Decrease health disparities><Dedications><Development><Diagnosis><Dietetics><Discipline><Doctor's Degree><Doctorate Degree><Education><Educational aspects><Engineering><Enrollment><Environmental Health><Environmental Health Science><Epidemiology><Faculty><Florida><Funding><Goals><HIV><HIV/AIDS><Health><Health Disparities Research><Health Inequity><Health Promotion><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hispanic-serving Institution><Human Immunodeficiency Viruses><Inequalities in Health><Inequities in Health><Institution><International><Intervention><Investigators><Investments><LAV-HTLV-III><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><Lymphadenopathy-Associated Virus><MD students><Malignant Neoplasms><Malignant Tumor><Measurable><Medical><Medical Students><Medicine><Mental Health><Mental Hygiene><Mentors><Mitigate health disparities><NIH><National Academy of Sciences><National Institutes of Health><Nutrition><Obesity><Outcome><Patient Care><Patient Care Delivery><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D. student><PhD student><PhD. student><Physicians><Population><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Psychological Health><Public Health><Publications><Records><Reduce health disparities><Research><Research Associate><Research Infrastructure><Research Personnel><Research Training><Researchers><Role><Salutogenesis><Scholarship><Schools><Science><Scientific Publication><Social Service><Social Work><Students><Substance abuse problem><Training><Training Programs><Training and Infrastructure><Translating><Underrepresented Students><Underserved Population><United States><United States National Academy of Sciences><United States National Institutes of Health><Universities><Virus-HIV><West Indies Region><abuse of substances><adiposity><cardiovascular disorder><care for patients><care of patients><career development><caring for patients><cohort><collaboration with communities><college><college student><collegiate><community collaboration><community-based collaboration><corpulence><cultural competence><culturally competent><developmental><disease prevention><disorder prevention><disparity in health><doctoral degree><doctoral student><enroll><epidemiologic><epidemiological><experience><global health><health determinants><health disparities science><health disparity><health equity><health inequalities><improved><interdisciplinary approach><malignancy><medical school students><member><multidisciplinary approach><neoplasm/cancer><next generation><population health><post-doc><post-doctoral><post-doctoral trainee><post-doctoral training><programs><promoting health><research associates><research study><science education><social><social role><substance abuse><substance use><substance using><success><tenure process><tenure track><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people><university student><vulnerable community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDRES G GIL

FLORIDA INTERNATIONAL UNIVERSITY, MIAMI, FL

Exploratory lead · 34/100
Large award
Active award
$2,000,000
FY 2025

Project Title

Florida International University-Health Disparities Initiative (FIU-HDI)

Grant Number:

5S21MD010683-08

Activity Code:

S21

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2016

End Date:

5/31/2028

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY The long-term objective of the proposed Florida International University-Health Disparities Initiative (FIU-HDI) is to enhance and expand FIU’s capacity for health disparities research and training. These efforts will have a direct impact on reducing health disparities in communicabl...

Research Terms

<AIDS Virus><AIDS/HIV><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Affect><Area><Award><Behavioral><Biometrics><Biometry><Biostatistics><Cancers><Cardiovascular Diseases><Caribbean><Caribbean Sea Region><Caribbean region><Clinical><Communities><Data><Decrease health disparities><Dedications><Development><Diagnosis><Dietetics><Discipline><Doctor's Degree><Doctorate Degree><Education><Educational aspects><Engineering><Enrollment><Environmental Health><Environmental Health Science><Epidemiology><Faculty><Florida><Funding><Goals><HIV><HIV/AIDS><Health><Health Disparities Research><Health Inequity><Health Promotion><Health disparities related research><Health disparity mitigation><Health disparity reduction><Hispanic-serving Institution><Human Immunodeficiency Viruses><Inequalities in Health><Inequities in Health><Institution><International><Intervention><Investigators><Investments><LAV-HTLV-III><Latino><Latino Population><Latino group><Latino individual><Latino people><Latinos><Lower health disparities><Lymphadenopathy-Associated Virus><MD students><Malignant Neoplasms><Malignant Tumor><Measurable><Medical><Medical Students><Medicine><Mental Health><Mental Hygiene><Mentors><Mitigate health disparities><NIH><National Academy of Sciences><National Institutes of Health><Nutrition><Obesity><Outcome><Patient Care><Patient Care Delivery><Peer Review><Ph D student><Ph D. student><Ph. D. student><Ph.D student><Ph.D. student><PhD student><PhD. student><Physicians><Population><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Psychological Health><Public Health><Publications><Records><Reduce health disparities><Research><Research Associate><Research Infrastructure><Research Personnel><Research Training><Researchers><Role><Salutogenesis><Scholarship><Schools><Science><Scientific Publication><Social Service><Social Work><Students><Substance abuse problem><Training><Training Programs><Training and Infrastructure><Translating><Underrepresented Students><Underserved Population><United States><United States National Academy of Sciences><United States National Institutes of Health><Universities><Virus-HIV><West Indies Region><abuse of substances><adiposity><cardiovascular disorder><care for patients><care of patients><career development><caring for patients><cohort><collaboration with communities><college><college student><collegiate><community collaboration><community-based collaboration><corpulence><cultural competence><culturally competent><developmental><disease prevention><disorder prevention><disparity in health><doctoral degree><doctoral student><enroll><epidemiologic><epidemiological><experience><global health><health determinants><health disparities science><health disparity><health equity><health inequalities><improved><interdisciplinary approach><malignancy><medical school students><member><multidisciplinary approach><neoplasm/cancer><next generation><population health><post-doc><post-doctoral><post-doctoral trainee><post-doctoral training><programs><promoting health><research associates><research study><science education><social><social role><substance abuse><substance use><substance using><success><tenure process><tenure track><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people><university student><vulnerable community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Raegan Winston Durant

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 32/100
Large award
Team-scale grant
$3,481,168
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)

Grant Number:

5U54CA267746-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

4/8/2025

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of the University of Alabama at Birmingham (UAB)/Tuskegee University (TU) Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Partnership is to create systemic and sustainable culture change to further support inclusive excellence in research at both institu...

Research Terms

<Acceleration><Address><Advocate><Affect><Alabama><Area><Cancers><Cardiovascular Diseases><Collaborations><Communities><Development><Development Plans><Diabetes Mellitus><Ensure><Environment><Evaluation><Faculty><Fostering><Foundations><Goals><Grant><Health Status><Individual><Infrastructure><Institution><Institutional Policy><Investigators><Level of Health><Location><Logistics><Malignant Neoplasms><Malignant Tumor><Mentors><Modeling><NIH><National Institutes of Health><Neurosciences><Obesity><Outcome><Policies><Position><Positioning Attribute><Research><Research Personnel><Research Resources><Research Support><Research Training><Researchers><Resources><Rural><Scientist><Series><Surgeon><Testing><United States National Institutes of Health><Universities><Washington><Work><adiposity><cardiovascular disorder><career><career development><cohort><collaboratory><community building><corpulence><developmental><diabetes><disparity in health><diversity and equity><diversity and inclusion><diversity and inclusivity><diversity, equity, and inclusiveness><early-career faculty><equity, diversity, and inclusion><experience><health disparity><health level><improved><interest><malignancy><model design><neoplasm/cancer><peer networks><peer support><programs><recruit><social><success>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MONA N. FOUAD

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 32/100
Large award
Team-scale grant
$3,481,168
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)

Grant Number:

5U54CA267746-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

4/8/2025

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of the University of Alabama at Birmingham (UAB)/Tuskegee University (TU) Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Partnership is to create systemic and sustainable culture change to further support inclusive excellence in research at both institu...

Research Terms

<Acceleration><Address><Advocate><Affect><Alabama><Area><Cancers><Cardiovascular Diseases><Collaborations><Communities><Development><Development Plans><Diabetes Mellitus><Ensure><Environment><Evaluation><Faculty><Fostering><Foundations><Goals><Grant><Health Status><Individual><Infrastructure><Institution><Institutional Policy><Investigators><Level of Health><Location><Logistics><Malignant Neoplasms><Malignant Tumor><Mentors><Modeling><NIH><National Institutes of Health><Neurosciences><Obesity><Outcome><Policies><Position><Positioning Attribute><Research><Research Personnel><Research Resources><Research Support><Research Training><Researchers><Resources><Rural><Scientist><Series><Surgeon><Testing><United States National Institutes of Health><Universities><Washington><Work><adiposity><cardiovascular disorder><career><career development><cohort><collaboratory><community building><corpulence><developmental><diabetes><disparity in health><diversity and equity><diversity and inclusion><diversity and inclusivity><diversity, equity, and inclusiveness><early-career faculty><equity, diversity, and inclusion><experience><health disparity><health level><improved><interest><malignancy><model design><neoplasm/cancer><peer networks><peer support><programs><recruit><social><success>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TIMOTHY TURNER

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 32/100
Large award
Team-scale grant
$3,481,168
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54)

Grant Number:

5U54CA267746-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

4/8/2025

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of the University of Alabama at Birmingham (UAB)/Tuskegee University (TU) Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Partnership is to create systemic and sustainable culture change to further support inclusive excellence in research at both institu...

Research Terms

<Acceleration><Address><Advocate><Affect><Alabama><Area><Cancers><Cardiovascular Diseases><Collaborations><Communities><Development><Development Plans><Diabetes Mellitus><Ensure><Environment><Evaluation><Faculty><Fostering><Foundations><Goals><Grant><Health Status><Individual><Infrastructure><Institution><Institutional Policy><Investigators><Level of Health><Location><Logistics><Malignant Neoplasms><Malignant Tumor><Mentors><Modeling><NIH><National Institutes of Health><Neurosciences><Obesity><Outcome><Policies><Position><Positioning Attribute><Research><Research Personnel><Research Resources><Research Support><Research Training><Researchers><Resources><Rural><Scientist><Series><Surgeon><Testing><United States National Institutes of Health><Universities><Washington><Work><adiposity><cardiovascular disorder><career><career development><cohort><collaboratory><community building><corpulence><developmental><diabetes><disparity in health><diversity and equity><diversity and inclusion><diversity and inclusivity><diversity, equity, and inclusiveness><early-career faculty><equity, diversity, and inclusion><experience><health disparity><health level><improved><interest><malignancy><model design><neoplasm/cancer><peer networks><peer support><programs><recruit><social><success>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert Adam Schnoll

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Exploratory lead · 30/100
Recent
Active award
Career award
$194,086
FY 2026

Project Title

A Mentoring Program in Patient-Oriented Tobacco Dependence and Implementation Science Research

Grant Number:

5K24DA045244-09

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

3/1/2018

End Date:

3/31/2028

Project Abstract

Despite progress over the past 50 years in lowering the rate of smoking, tobacco use remains the leading cause of premature death in the US. To ensure the sustained and impactful research dedicated to addressing tobacco use, rigorous inter-disciplinary mentoring programs are needed to prepare the ne...

Research Terms

<AIDS Virus><AIDS care><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Appointment><Area><Award><Biological Markers><Cancer Center><Cancer Patient><Cancers><Cardiology><Cessation of life><Clinical><Communicable Diseases><Death><Dedications><Dissemination and Implementation><Drugs><EXTMR><Educational process of instructing><Educational workshop><Effectiveness><Electronic Health Record><Ensure><Evidence based treatment><Extramural><Extramural Activities><Faculty><Funding><Goals><Grant><HIV><HIV Care><HIV in patients><HIV medical care><HIV patient><HIV patient care><HIV positive patient><HIV related care><HIV related patient care><HIV-1 care><Health><Hospital Admission><Hospitalization><Human Immunodeficiency Viruses><Human immunodeficiency virus infected patients><Human immunodeficiency virus positive patients><Individual><Infectious Diseases><Infectious Disorder><Inpatients><Intention><Intermediary Metabolism><Investigators><LAV-HTLV-III><Lymphadenopathy-Associated Virus><Malignant Neoplasms><Malignant Tumor><Medication><Mentors><Mentorship><Metabolic Processes><Metabolism><Methods><N-octanoyl-beta-D-glucosylamine><N-octanoylglucosylamine><NIH><NOGA><National Institutes of Health><Neurology><Nicotine><Nicotine Dependence><Oncology><Oncology Cancer><Paper><Patients><Patients living with HIV><Patients suffering from HIV><Pennsylvania><Personalized medical approach><Pharmaceutical Preparations><Pilot Projects><Pragmatic clinical trial><Primary Care><Productivity><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Salaries><Science><Scientific Publication><Scientist><Smoker><Smoking><Structure><Students><Teaching><Testing><Time><Tobacco><Tobacco Consumption><Tobacco Dependence><Tobacco smoking><Tobacco smoking behavior><Tobacco use><Training><Training Programs><Treatment Effectiveness><Underrepresented Ethnic Minority><Underrepresented Minority><United States National Institutes of Health><Universities><Virus-HIV><Wages><Washington><Work><Workshop><behavior test><behavioral economics><behavioral test><bio-markers><biologic marker><biomarker><cancer care><care delivery><care of HIV-1><career><career development><clinical care><clinical practice><conference><convention><design><designing><drug/agent><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><gene testing><gene-based testing><genetic testing><human immunodeficiency virus care><human immunodeficiency virus patient><implementation research><implementation science><implementation strategy><improved><individualized approach><malignancy><neoplasm/cancer><next generation><nicotine addiction><nicotine consumption><nicotine dependent><nicotine treatment><nicotine use><patient centered><patient infected with HIV><patient oriented><patient oriented research><patient oriented study><patient with HIV><personalization of treatment><personalized approach><personalized medicine><personalized therapy><personalized treatment><pilot study><pilot test><precision approach><premature><prematurity><programs><recruit><reduce tobacco use><reduction in tobacco use><strategies for implementation><student mentoring><student research><student-led learning><student-led research><summit><symposia><symposium><tailored approach><tobacco addiction><tobacco control><tobacco dependent><tobacco product use><tobacco use reduction><under-representation of minorities><under-represented minority><underrepresentation of minorities><varenicline><work group><working group>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John C Carlson

LSU PENNINGTON BIOMEDICAL RESEARCH CTR, BATON ROUGE, LA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$454,747
FY 2025

Project Title

Louisiana Pediatric Clinical Trials Network

Grant Number:

2UG1OD024959-08

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/23/2016

End Date:

5/31/2030

Project Abstract

Louisiana's children experience significant health risks compared to their peers across the country and bear a high burden of several diseases. Enhancing the ability to implement high quality clinical trials directed toward the five focus areas of the Environmental influences on Child Health Outcome...

Research Terms

<0-11 years old><6th grade><ASD><Address><Affect><Area><Asthma><Autism><Autistic Disorder><Biomedical Research><Birth><Bronchial Asthma><Center for Translational Science Activities><Cessation of life><Child><Child Development Disorders><Child Health><Child Mental Health><Child Welfare><Child Youth><Childhood><Children (0-21)><Children's Hospital><Clinic><Clinical><Clinical Research><Clinical Sciences><Clinical Study><Clinical Trials><Clinical Trials Network><Clinics and Hospitals><Clinics or Hospitals><Collaborations><Communities><Complex><Conduct Clinical Trials><Country><Data><Death><Death Rate><Developmental Delay><Developmental Delay Disorders><Developmental Disabilities><Diagnosis><Disease><Disorder><Early Infantile Autism><Fetal health><Fostering><Future><Goals><Health><Health Sciences><Health system><High Prevalence><Hospitals><Infant><Infant Mortality><Infant Mortality Total><Infantile Autism><Infrastructure><Institution><Intellectual disability><Intellectual functioning disability><Intellectual limitation><Investigators><Kanner's Syndrome><Live Birth><Louisiana><Low Birth Weight Infant><Medical><Modeling><Multi-Institutional Clinical Trial><Multi-center clinical trial><Multi-site clinical trial><Multicenter clinical trial><Multisite clinical trial><NIH><National Institutes of Health><Neural Development><Non-Profit Organizations><Nonprofit Organizations><Obesity><Outcome><Parturition><Pediatric Hospitals><Pediatric Research><Pediatrics><Perinatal><Peripartum><Physicians><Position><Positioning Attribute><Prevalence><Process><Professional Organizations><Protocol><Protocols documentation><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Risk><Risk Reduction><Rural><Scientist><Site><Specific Child Development Disorders><System><Training><United States><United States National Institutes of Health><Universities><Work><Writing><academic program><adiposity><adolescent welfare><aged><autism spectral disorder><autism spectrum disorder><autistic spectrum disorder><burden of disease><burden of illness><child well being><child wellbeing><clinical infrastructure><clinical research site><clinical site><corpulence><death among infants><death in first year of life><death in infancy><death in infants><disease burden><disease risk><disorder risk><experience><improved><infant death><infant demise><infantile death><innovate><innovation><innovative><intellectual and developmental disability><inter-institutional><interest><kids><limited intellectual functioning><low birth weight><low birthweight><member><mortality in infants><mortality rate><mortality ratio><neurodevelopment><pediatric><peer><postnatal><prenatal><professional association><professional membership><professional society><programs><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><risk-reducing><rural area><rural location><rural region><sixth grade><success><translational research center><translational sciences center><unborn><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Amanda E. Staiano

LSU PENNINGTON BIOMEDICAL RESEARCH CTR, BATON ROUGE, LA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$454,747
FY 2025

Project Title

Louisiana Pediatric Clinical Trials Network

Grant Number:

2UG1OD024959-08

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/23/2016

End Date:

5/31/2030

Project Abstract

Louisiana's children experience significant health risks compared to their peers across the country and bear a high burden of several diseases. Enhancing the ability to implement high quality clinical trials directed toward the five focus areas of the Environmental influences on Child Health Outcome...

Research Terms

<0-11 years old><6th grade><ASD><Address><Affect><Area><Asthma><Autism><Autistic Disorder><Biomedical Research><Birth><Bronchial Asthma><Center for Translational Science Activities><Cessation of life><Child><Child Development Disorders><Child Health><Child Mental Health><Child Welfare><Child Youth><Childhood><Children (0-21)><Children's Hospital><Clinic><Clinical><Clinical Research><Clinical Sciences><Clinical Study><Clinical Trials><Clinical Trials Network><Clinics and Hospitals><Clinics or Hospitals><Collaborations><Communities><Complex><Conduct Clinical Trials><Country><Data><Death><Death Rate><Developmental Delay><Developmental Delay Disorders><Developmental Disabilities><Diagnosis><Disease><Disorder><Early Infantile Autism><Fetal health><Fostering><Future><Goals><Health><Health Sciences><Health system><High Prevalence><Hospitals><Infant><Infant Mortality><Infant Mortality Total><Infantile Autism><Infrastructure><Institution><Intellectual disability><Intellectual functioning disability><Intellectual limitation><Investigators><Kanner's Syndrome><Live Birth><Louisiana><Low Birth Weight Infant><Medical><Modeling><Multi-Institutional Clinical Trial><Multi-center clinical trial><Multi-site clinical trial><Multicenter clinical trial><Multisite clinical trial><NIH><National Institutes of Health><Neural Development><Non-Profit Organizations><Nonprofit Organizations><Obesity><Outcome><Parturition><Pediatric Hospitals><Pediatric Research><Pediatrics><Perinatal><Peripartum><Physicians><Position><Positioning Attribute><Prevalence><Process><Professional Organizations><Protocol><Protocols documentation><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Risk><Risk Reduction><Rural><Scientist><Site><Specific Child Development Disorders><System><Training><United States><United States National Institutes of Health><Universities><Work><Writing><academic program><adiposity><adolescent welfare><aged><autism spectral disorder><autism spectrum disorder><autistic spectrum disorder><burden of disease><burden of illness><child well being><child wellbeing><clinical infrastructure><clinical research site><clinical site><corpulence><death among infants><death in first year of life><death in infancy><death in infants><disease burden><disease risk><disorder risk><experience><improved><infant death><infant demise><infantile death><innovate><innovation><innovative><intellectual and developmental disability><inter-institutional><interest><kids><limited intellectual functioning><low birth weight><low birthweight><member><mortality in infants><mortality rate><mortality ratio><neurodevelopment><pediatric><peer><postnatal><prenatal><professional association><professional membership><professional society><programs><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><risk-reducing><rural area><rural location><rural region><sixth grade><success><translational research center><translational sciences center><unborn><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rachelle Hope Crosbie

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 28/100
Training-friendly
Solid budget
$442,297
FY 2025

Project Title

Muscle Cell Biology, Pathophysiology, and Therapeutics

Grant Number:

5T32AR065972-10

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2016

End Date:

4/30/2026

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Abstract This proposal is a competitive renewal application for a multidisciplinary training program in basic and translational research in muscle cell biology at UCLA from a group of highly engaged faculty mentors. The program in Muscle Cell Biology, Pathophysiology, and Therapeutics is focused on ...

Research Terms

<Cellular biology><Dysfunction><Functional disorder><Muscle Cells><Myocytes><Physiopathology><Therapeutic><cell biology><pathophysiology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES D. BROOKS

STANFORD UNIVERSITY, STANFORD, CA

Exploratory lead · 28/100
Solid budget
Active award
Career award
$434,161
FY 2025

Project Title

Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program

Grant Number:

5K12DK137162-03

Activity Code:

K12

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2027

Project Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. The overall objective of the Multidisciplinary K12 Urology Research at Stanford (KUReS) Career Development Program is to develop the next generation of highly qualifie...

Research Terms

<Address><Advisory Committees><Area><Basic Research><Basic Science><Benign><Clinical Research><Clinical Study><Collaborations><Committee Members><Communities><Competence><Curriculum><Disease><Disorder><Doctor of Philosophy><Dysfunction><Educational Curriculum><Engineering><Faculty><Functional disorder><Funding><Goals><Image><Immersion><Infection><Infrastructure><Interstitial Cystitis><Investigators><Junior Physician><K12><K12 Award><K12 Mechanism><K12 Program><Leadership><Mentored Clinical Scientist Development Program><Mentors><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Outcome><Ph.D.><PhD><Physicians><Physiopathology><Productivity><Program Development><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Regenerative Medicine><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Schools><Scientist><Solid><Structure><System><Task Forces><Text><Time><Training><Translational Research><Translational Science><United States National Institutes of Health><Urinary Calculi><Urinary Stones><Urinary Tract Stones><Urolith><Urology><advisory team><bladder pain syndrome><bridge program><career><career development><clinical care><didactic curriculum><didactic education><experience><hands on research><imaging><lesson plans><lower urinary tract symptoms><multidisciplinary><next generation><painful bladder syndrome><pathophysiology><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><programs><recruit><skill acquisition><skill development><skills><success><translation research><translational investigation><urologic><urological>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JOSEPH C LIAO

STANFORD UNIVERSITY, STANFORD, CA

Exploratory lead · 28/100
Solid budget
Active award
Career award
$434,161
FY 2025

Project Title

Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program

Grant Number:

5K12DK137162-03

Activity Code:

K12

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2027

Project Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. The overall objective of the Multidisciplinary K12 Urology Research at Stanford (KUReS) Career Development Program is to develop the next generation of highly qualifie...

Research Terms

<Address><Advisory Committees><Area><Basic Research><Basic Science><Benign><Clinical Research><Clinical Study><Collaborations><Committee Members><Communities><Competence><Curriculum><Disease><Disorder><Doctor of Philosophy><Dysfunction><Educational Curriculum><Engineering><Faculty><Functional disorder><Funding><Goals><Image><Immersion><Infection><Infrastructure><Interstitial Cystitis><Investigators><Junior Physician><K12><K12 Award><K12 Mechanism><K12 Program><Leadership><Mentored Clinical Scientist Development Program><Mentors><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Outcome><Ph.D.><PhD><Physicians><Physiopathology><Productivity><Program Development><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Regenerative Medicine><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Schools><Scientist><Solid><Structure><System><Task Forces><Text><Time><Training><Translational Research><Translational Science><United States National Institutes of Health><Urinary Calculi><Urinary Stones><Urinary Tract Stones><Urolith><Urology><advisory team><bladder pain syndrome><bridge program><career><career development><clinical care><didactic curriculum><didactic education><experience><hands on research><imaging><lesson plans><lower urinary tract symptoms><multidisciplinary><next generation><painful bladder syndrome><pathophysiology><peer coaching><peer instruction><peer led team learning><peer mentoring><peer teaching><programs><recruit><skill acquisition><skill development><skills><success><translation research><translational investigation><urologic><urological>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory E Hicks

UNIVERSITY OF DELAWARE, Newark, DE

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$395,556
FY 2024

Project Title

Delaware Clinical and Translational Research ACCEL Program

Grant Number:

3U54GM104941-12S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/25/2013

End Date:

6/30/2028

Project Abstract

ABSTRACT- OVERALL This proposal is a competitive renewal of the Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54) grant originally awarded in September 2013 to the University of Delaware. The ACCEL CTR Program, has completed nine years of ...

Research Terms

<21+ years old><Acceleration><Adult><Adult Human><African American><Afro American><Afroamerican><Agreement><American><Area><Asian><Award><Biometrics><Biometry><Biostatistics><Black><Black race><Budgets><Cancers><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Cessation of life><Child Health><Childhood><Clinical><Clinical Research><Clinical Study><Communities><Community Outreach><Death><Delaware><Development><Drugs><Epidemiology><Equity><Ethnic Origin><Ethnicity><Evaluation><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Care Systems><Health Inequity><Health Promotion><Healthcare><Healthcare Systems><Hispanic><Hospitals><Inequalities in Health><Inequities in Health><Infrastructure><Institution><Intention><Investigators><Investments><Learning><Letters><Malignant Neoplasms><Malignant Tumor><Medication><Mission><Modeling><Modification><Native Americans><Obesity><Occidental><Outreach Research><Pharmaceutical Preparations><Pilot Projects><Population><Population Heterogeneity><Population Research><Population-based research><Population-level research><Recommendation><Research Design><Research Personnel><Researchers><Rural><Salutogenesis><Scientist><Societies><Structure><Study Type><System><Time><Tissue Growth><Training><Translational Research><Translational Research Enterprise><Translational Science><Universities><Work><Writing><adiposity><adulthood><clinical infrastructure><community engagement><corpulence><design><designing><developmental><diverse populations><drug/agent><engagement with communities><epidemiologic><epidemiological><health care><health care quality><health equity><health inequalities><healthcare quality><heterogeneous population><hospitalization rates><improved><innovate><innovation><innovative><malignancy><member><multimorbidity><multiple chronic conditions><neoplasm/cancer><ontogeny><pediatric><pilot study><population diversity><population health><programs><promoting health><racial diversity><racially diverse><recruit><study design><translation research><translation research enterprise><translational investigation><translational investigator><translational research program><translational researcher><translational scientist><white race>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CHRISTINE K PAYNE

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$389,380
FY 2024

Project Title

Enhancing Laser Lithotripsy via Nanoparticle Fine-Tuned NIR absorption

Grant Number:

5P20DK135107-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2022

End Date:

5/31/2026

Project Abstract

ABSTRACT Ureteroscopy (URS) via laser lithotripsy (LL) is the treatment of choice for urinary stone disease (USD), which is the second most costly urologic condition in the US with an annual healthcare expenditure over $2 billion. The recent clinical introduction of high power/high frequency Holmium...

Research Terms

<Ablation><American><Applications Grants><Benign><Biomechanics><Biophotonics><Cellular injury><Circulatory Collapse><Clinical><Collaborations><Comment><Commentary><Communities><Computer Models><Computerized Models><Data><Data Collection><Data Scientist><Development Plans><Disease><Disorder><Doctor of Philosophy><Dust><Editorial Comment><Engineering><Enhancement Technology><Faculty><Fiber><Fostering><Foundations><Frequencies><Future><Genitourinary Diseases><Goals><Grant Proposals><Health Expenditures><Holmium><Hydrogels><In Situ><In Vitro><Injury to Kidney><Interdisciplinary Research><Interdisciplinary Study><Investigators><Irrigation><Journals><K12><K12 Award><K12 Mechanism><K12 Program><Kidney><Kidney Calculi><Kidney Stones><Kidney Urinary System><Knowledge><Laser Electromagnetic><Laser Lithotripsy><Laser Radiation><Lasers><Litholapaxy><Lithotripsy><Magazine><Mentored Clinical Scientist Development Program><Modeling><Multidisciplinary Collaboration><Multidisciplinary Research><NIDDK><Names><Nanotechnology><National Institute of Diabetes and Digestive and Kidney Diseases><Operative Procedures><Operative Surgical Procedures><Optics><Pain><Painful><Paper><Patients><Ph.D.><PhD><Play><Procedures><Productivity><Published Comment><R-Series Research Projects><R01 Mechanism><R01 Program><Renal Calculi><Renal Stone><Renal Tissue><Research><Research Activity><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Risk><Risk Reduction><Role><Safety><Saline><Saline Solution><Shock><Societies><Solid><Surgical><Surgical Interventions><Surgical Procedure><Technology><Temperature><Thulium><Time><Toxic effect><Toxicities><Universities><Ureteroscopy><Urinary Calculi><Urinary Stones><Urinary Tract Stones><Urogenital Diseases><Urolith><Urology><Viewpoint><absorption><biomechanical><career development><cell damage><cell injury><cellular damage><circulatory shock><computational modeling><computational models><computer based models><computerized modeling><cost><damage to cells><experience><health care expenditure><healthcare expenditure><improved><in vivo><injury to cells><injury to tissue><innovate><innovation><innovative><irrigation therapy><kidney injury><medical expenditure><multidisciplinary><name><named><naming><nano particle><nano tech><nano technology><nano-sized particle><nano-technological><nanomaterials><nanoparticle><nanosized particle><nanotech><nanotechnological><new approaches><novel approaches><novel strategies><novel strategy><operation><operations><optical><optimal therapies><optimal treatments><pig model><piglet model><porcine model><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><renal><renal injury><risk-reducing><shocks><social role><success><surgery><swine model><synergism><theories><tissue injury><treatment choice><urologic><urological>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PEI ZHONG

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$389,380
FY 2024

Project Title

Enhancing Laser Lithotripsy via Nanoparticle Fine-Tuned NIR absorption

Grant Number:

5P20DK135107-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2022

End Date:

5/31/2026

Project Abstract

ABSTRACT Ureteroscopy (URS) via laser lithotripsy (LL) is the treatment of choice for urinary stone disease (USD), which is the second most costly urologic condition in the US with an annual healthcare expenditure over $2 billion. The recent clinical introduction of high power/high frequency Holmium...

Research Terms

<Ablation><American><Applications Grants><Benign><Biomechanics><Biophotonics><Cellular injury><Circulatory Collapse><Clinical><Collaborations><Comment><Commentary><Communities><Computer Models><Computerized Models><Data><Data Collection><Data Scientist><Development Plans><Disease><Disorder><Doctor of Philosophy><Dust><Editorial Comment><Engineering><Enhancement Technology><Faculty><Fiber><Fostering><Foundations><Frequencies><Future><Genitourinary Diseases><Goals><Grant Proposals><Health Expenditures><Holmium><Hydrogels><In Situ><In Vitro><Injury to Kidney><Interdisciplinary Research><Interdisciplinary Study><Investigators><Irrigation><Journals><K12><K12 Award><K12 Mechanism><K12 Program><Kidney><Kidney Calculi><Kidney Stones><Kidney Urinary System><Knowledge><Laser Electromagnetic><Laser Lithotripsy><Laser Radiation><Lasers><Litholapaxy><Lithotripsy><Magazine><Mentored Clinical Scientist Development Program><Modeling><Multidisciplinary Collaboration><Multidisciplinary Research><NIDDK><Names><Nanotechnology><National Institute of Diabetes and Digestive and Kidney Diseases><Operative Procedures><Operative Surgical Procedures><Optics><Pain><Painful><Paper><Patients><Ph.D.><PhD><Play><Procedures><Productivity><Published Comment><R-Series Research Projects><R01 Mechanism><R01 Program><Renal Calculi><Renal Stone><Renal Tissue><Research><Research Activity><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Risk><Risk Reduction><Role><Safety><Saline><Saline Solution><Shock><Societies><Solid><Surgical><Surgical Interventions><Surgical Procedure><Technology><Temperature><Thulium><Time><Toxic effect><Toxicities><Universities><Ureteroscopy><Urinary Calculi><Urinary Stones><Urinary Tract Stones><Urogenital Diseases><Urolith><Urology><Viewpoint><absorption><biomechanical><career development><cell damage><cell injury><cellular damage><circulatory shock><computational modeling><computational models><computer based models><computerized modeling><cost><damage to cells><experience><health care expenditure><healthcare expenditure><improved><in vivo><injury to cells><injury to tissue><innovate><innovation><innovative><irrigation therapy><kidney injury><medical expenditure><multidisciplinary><name><named><naming><nano particle><nano tech><nano technology><nano-sized particle><nano-technological><nanomaterials><nanoparticle><nanosized particle><nanotech><nanotechnological><new approaches><novel approaches><novel strategies><novel strategy><operation><operations><optical><optimal therapies><optimal treatments><pig model><piglet model><porcine model><programs><recruit><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><renal><renal injury><risk-reducing><shocks><social role><success><surgery><swine model><synergism><theories><tissue injury><treatment choice><urologic><urological>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark Brian Reed

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$371,315
FY 2024

Project Title

SDSU FUERTE: Recognition of Excellence in DEIA and Mentorship in support of Faculty Success

Grant Number:

3U54CA267789-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Project Abstract

OVERALL – Project Summary San Diego State University (SDSU) is proposing a new program called SDSU FUERTE or Faculty Unified towards Excellence in Research and Transformational Engagement. The goal of SDSU FUERTE is to recruit a diverse, nine-person cohort of early career of health sciences faculty ...

Research Terms

<Academy><Acceleration><Address><Affect><Area><Biomedical Research><Climate><Cognitive Discrimination><Communities><Curriculum><Development><Development Plans><Discrimination><Disparities><Disparity><Diverse Workforce><Educational Curriculum><Eligibility><Eligibility Determination><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Sciences><Hispanic-serving Institution><Human><Individual><Individuals from minority><Individuals of minority><Institution><Institutionalization><Investigators><Knowledge><Latine><Latinx><Leadership><Mentors><Mentorship><Meteorological Climate><Minority><Minority Groups><Minority People><Minority Population><Minority individual><Modeling><Modern Man><NIH><National Institutes of Health><Obesity><Peer Review><Personal Satisfaction><Persons><Physical activity><Position><Positioning Attribute><Protocol Screening><Research><Research Personnel><Research Resources><Researchers><Resources><Scholarship><Schools><Science><Scientific Advances and Accomplishments><Secondary Schools><Secure><Students><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Tissue Growth><Training><Underrepresented Ethnic Minority><Underrepresented Minority><United States><United States National Institutes of Health><Universities><Work><Workplace Diversity><addiction><addictive disorder><adiposity><career><career development><climatic><cohort><community building><community engaged participatory research><community engaged research><community engagement><community partnered research><community-engaged study><community-partnered study><corpulence><design><designing><developmental><disparity in health><diversity, equity, and inclusiveness><early-career faculty><engagement with communities><equity, diversity, and inclusion><evidence base><experience><faculty development><faculty professional development><faculty support><health disparity><health science research><implementation science><improved><innovate><innovation><innovative><instructor training><interest><lesson plans><model development><model developments><nutrition><ontogeny><programs><recruit><recruit teachers><scientific accomplishments><scientific advances><secondary education><skills><success><teacher development><teacher recruitment><tenure process><tenure track><under-representation of minorities><under-represented minority><underrepresentation of minorities><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maria Luisa Zuniga de Nuncio

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$371,315
FY 2024

Project Title

SDSU FUERTE: Recognition of Excellence in DEIA and Mentorship in support of Faculty Success

Grant Number:

3U54CA267789-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Project Abstract

OVERALL – Project Summary San Diego State University (SDSU) is proposing a new program called SDSU FUERTE or Faculty Unified towards Excellence in Research and Transformational Engagement. The goal of SDSU FUERTE is to recruit a diverse, nine-person cohort of early career of health sciences faculty ...

Research Terms

<Academy><Acceleration><Address><Affect><Area><Biomedical Research><Climate><Cognitive Discrimination><Communities><Curriculum><Development><Development Plans><Discrimination><Disparities><Disparity><Diverse Workforce><Educational Curriculum><Eligibility><Eligibility Determination><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Faculty Education><Faculty Recruitment><Faculty Training><Funding><Generalized Growth><Goals><Grant><Growth><Health><Health Sciences><Hispanic-serving Institution><Human><Individual><Individuals from minority><Individuals of minority><Institution><Institutionalization><Investigators><Knowledge><Latine><Latinx><Leadership><Mentors><Mentorship><Meteorological Climate><Minority><Minority Groups><Minority People><Minority Population><Minority individual><Modeling><Modern Man><NIH><National Institutes of Health><Obesity><Peer Review><Personal Satisfaction><Persons><Physical activity><Position><Positioning Attribute><Protocol Screening><Research><Research Personnel><Research Resources><Researchers><Resources><Scholarship><Schools><Science><Scientific Advances and Accomplishments><Secondary Schools><Secure><Students><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Tissue Growth><Training><Underrepresented Ethnic Minority><Underrepresented Minority><United States><United States National Institutes of Health><Universities><Work><Workplace Diversity><addiction><addictive disorder><adiposity><career><career development><climatic><cohort><community building><community engaged participatory research><community engaged research><community engagement><community partnered research><community-engaged study><community-partnered study><corpulence><design><designing><developmental><disparity in health><diversity, equity, and inclusiveness><early-career faculty><engagement with communities><equity, diversity, and inclusion><evidence base><experience><faculty development><faculty professional development><faculty support><health disparity><health science research><implementation science><improved><innovate><innovation><innovative><instructor training><interest><lesson plans><model development><model developments><nutrition><ontogeny><programs><recruit><recruit teachers><scientific accomplishments><scientific advances><secondary education><skills><success><teacher development><teacher recruitment><tenure process><tenure track><under-representation of minorities><under-represented minority><underrepresentation of minorities><well-being><wellbeing>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAN COLON-CARMONA

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$369,198
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jill A. Macoska

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$369,198
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KASISOMAYAJULA VISWANATH

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$369,198
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kevin Sean Kimbro

MOREHOUSE SCHOOL OF MEDICINE, ATLANTA, GA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$368,812
FY 2024

Project Title

Training the Trainers: Building Institutional Data Science Capacity to Support Health Disparities Research

Grant Number:

3U54MD007602-37S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/7/1997

End Date:

3/31/2028

Project Abstract

Project Summary Advances in biomedical and behavioral data science and machine learning have the potential to promote health equity by aiding in our understanding of the etiology of health disparities. In recognition of the need to foster diversity, improve the quality of biomedical research, and en...

Research Terms

<AI system><Address><Administrative Supplement><Area><Artificial Intelligence><Basic Research><Basic Science><Behavioral><Bio-Informatics><Bioinformatics><Biomedical Research><Black><Black race><Cancers><Causality><Center for Translational Science Activities><Collaborations><Communities><Computer Literacy><Computer Reasoning><Computer software><Curriculum><Data><Data Analyses><Data Analysis><Data Science><Data Scientist><Data Security><Data awareness><Disparities><Disparity><Education><Education and Training><Educational Curriculum><Educational aspects><Educational process of instructing><Educational workshop><Ethics><Etiology><Exclusion><Faculty Education><Faculty Training><Female><Florida><Fostering><Funding><Genomics><Goals><Health><Health Disparities Research><Health disparities related research><Healthcare><Hispanic><History><Informatics><Infrastructure><Institution><Instruction><International><Investigators><Investments><Knowledge><Latine><Latinx><Machine Intelligence><Machine Learning><Malignant Neoplasms><Malignant Tumor><Marketing><Mentors><Minority-Serving Institution><Morehouse Sch of Medicine><Morehouse School of Med><Morehouse School of Medicine><NCMHD><NIH><NIMHD><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><National Institutes of Health><Pathway interactions><Population><Position><Positioning Attribute><R programming language><Recording of previous events><Reporting><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Science><Scientist><Self Efficacy><Series><Software><Solid><Teacher Education><Teacher Educator><Teacher Preparation><Teacher Professional Development><Teacher Training><Teaching><Techniques><Technology><Trainers Training><Training><Training Programs><Training and Education><Underrepresented Groups><Underrepresented Populations><Underrepresented Students><United States National Institutes of Health><Universities><Workshop><aging associated disease><aging related disease><applied learning><biomedical data science><causation><cloud based><cohort><collaboratory><data infrastructure><data interpretation><data science education><disease causation><disease of aging><disorder of aging><disparity in health><ethical><experience><faculty development><faculty professional development><hands-on learning><health care><health data><health disparities science><health disparity><health equity promotion><histories><improved><information security><institutional capacity><instructor><instructor training><interactive engagement><interactive learning><lesson plans><machine based learning><malignancy><minority health><minority health disparity><minority institution><multidisciplinary><multiomics><multiple omics><neoplasm/cancer><next generation><panomics><parent award><parent project><pathway><personalized health care><personalized healthcare><precision health care><precision healthcare><precision medicine><precision-based medicine><programs><promote health equity><recruit><skills><success><teacher development><technological innovation><tool><training opportunity><translational research center><translational sciences center><under representation of groups><under represented groups><under represented people><under represented populations><underrepresentation of groups><underrepresented people><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAN COLON-CARMONA

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$325,963
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jill A. Macoska

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$325,963
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KASISOMAYAJULA VISWANATH

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$325,963
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Leon Garland Coleman

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$311,000
FY 2025

Project Title

2/2 Partnerships to Enhance Alcohol Research Across NCCU and UNC (PEAR-NC)

Grant Number:

5U54AA030463-04

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2022

End Date:

8/31/2027

Project Abstract

This is an application for a cooperative agreement (U54), “Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC),” between faculties of North Carolina Central University (NCCU), and the Bowles Center for Alcohol Studies (BCAS) at the University of North Carolina (UNC) School of Medi...

Research Terms

<21+ years old><ARHGEF5><ARHGEF5 gene><Address><Adolescent><Adolescent Youth><Adult><Adult Human><Alcohol Chemical Class><Alcohol abuse><Alcohol toxicity><Alcohols><Area><Award><Behavioral><Body Tissues><Brain><Brain Nervous System><Breast Cancer><Cancer Induction><Cancers><Chronic><Chronic Disease><Chronic Illness><Collaborations><Cooperative Agreements><Core Facility><Course Content><Curriculum><Data><Development and Research><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Encephalon><Endowment><Environment><EtOH abuse><Ethanol toxicity><FASD><Faculty><Fetal Alcohol Spectrum Disorder><Funding><Future><GEF5><Goals><Grant><Health><Health Care Professional><Health Professional><Inflammation><Infrastructure><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Laboratory Research><Leadership><Learning><Malignant Breast Neoplasm><Malignant Neoplasms><Malignant Tumor><Manuscripts><Medical><Medical Libraries><Mentors><Molecular><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Neuroimmune><North Carolina><Outcome><P60><Pathology><Preparation><Process><Productivity><Publications><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Technics><Research Techniques><Researchers><Resource Sharing><Resources><Scholarship><Scientific Publication><Series><Structure><Students><TIM1><Teaching><Techniques><Tissues><Toxic effect><Toxicities><Training><U-Series Cooperative Agreements><United States National Institutes of Health><Universities><Work><adulthood><alcohol co-abuse><alcohol exposed><alcohol exposure><alcohol problem><alcohol related research><alcohol research><alcohol use disorder><breast progenitor><breast progenitor cell><breast stem cell><carcinogenesis><career><cellular pathology><chronic disorder><co-morbid><co-morbidity><college student><comorbidity><course curriculum><ethanol abuse><ethanol exposed><ethanol exposure><ethanol research><ethanol use disorder><expectation><experience><experiment><experimental research><experimental study><experiments><exposed to alcohol><exposed to ethanol><exposure to alcohol><exposure to ethanol><faculty mentor><fetal><graduate student><hazardous alcohol use><improved><interest><intern><juvenile><juvenile human><lab development><lab experience><lab training><laboratory development><laboratory experience><laboratory training><lectures><lesson plans><malignancy><malignant breast tumor><mammary gland progenitor><mammary gland stem cells><mammary progenitor><mammary stem cells><medical college><medical schools><meeting><meetings><neoplasm/cancer><neuron toxicity><neuronal toxicity><neuropathologic><neuropathological><neuropathology><neurotoxicity><post-doctoral training><preparations><problem alcohol use><problem drinking><problematic alcohol consumption><problematic alcohol use><programs><recruit><research and development><response><school of medicine><skills><student research><student-led research><success><summer intern><summer internship><synergism><undergrad><undergraduate><undergraduate student><university student><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

FULTON T CREWS

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$311,000
FY 2024

Project Title

2/2 Partnerships to Enhance Alcohol Research Across NCCU and UNC (PEAR-NC)

Grant Number:

5U54AA030463-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2022

End Date:

8/31/2027

Project Abstract

This is an application for a cooperative agreement (U54), “Partnerships to Enhance Alcohol Research across NCCU and UNC (PEAR-NC),” between faculties of North Carolina Central University (NCCU), a Historically Black College or University, and the Bowles Center for Alcohol Studies (BCAS) at the Unive...

Research Terms

<21+ years old><ARHGEF5><ARHGEF5 gene><Address><Adolescent><Adolescent Youth><Adult><Adult Human><African American><African American group><African American individual><African American people><African American population><African American student><African Americans><Afro American><Afroamerican><Alcohol Chemical Class><Alcohol abuse><Alcohol toxicity><Alcohols><Area><Award><Behavioral><Body Tissues><Brain><Brain Nervous System><Breast Cancer><Cancer Induction><Collaborations><Cooperative Agreements><Core Facility><Course Content><Curriculum><Data><Development and Research><Education><Educational Curriculum><Educational aspects><Educational process of instructing><Encephalon><Endowment><Environment><EtOH abuse><Ethanol toxicity><FASD><Faculty><Fetal Alcohol Spectrum Disorder><Funding><Future><GEF5><Goals><Grant><HBCUs><Health Care Professional><Health Professional><Healthcare professional><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Inflammation><Infrastructure><Institution><Internships><Investigators><Joints><Knowledge><Laboratories><Laboratory Research><Leadership><Learning><Malignant Breast Neoplasm><Manuscripts><Medical><Medical Libraries><Mentors><Minority><Minority researcher><Molecular><Morbidity><Morbidity - disease rate><NIAAA><NIH><National Institute on Alcohol Abuse and Alcoholism><National Institutes of Health><Neuroimmune><North Carolina><P60><Pathology><Preparation><Process><Productivity><Progenitor Cells><Publications><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Technics><Research Techniques><Researchers><Resource Sharing><Resources><Scholarship><Scientific Publication><Series><Severities><Structure><Students><TIM1><Teaching><Techniques><Tissues><Toxic effect><Toxicities><Training><U-Series Cooperative Agreements><URM student><Underrepresented Ethnic Minority><Underrepresented Minority><United States National Institutes of Health><Universities><Work><adulthood><alcohol co-abuse><alcohol exposed><alcohol exposure><alcohol problem><alcohol related research><alcohol research><alcohol use disorder><black student><carcinogenesis><career><cellular pathology><college student><course curriculum><disparity in health><ethanol abuse><ethanol exposed><ethanol exposure><ethanol research><ethanol use disorder><expectation><experience><experiment><experimental research><experimental study><experiments><exposed to alcohol><exposed to ethanol><exposure to alcohol><exposure to ethanol><faculty mentor><fetal><graduate student><hazardous alcohol use><health disparity><improved><interest><intern><juvenile><juvenile human><lab development><lab experience><lab training><laboratory development><laboratory experience><laboratory training><lectures><lesson plans><malignant breast tumor><mammary><medical college><medical schools><meeting><meetings><minority investigator><neuron toxicity><neuronal toxicity><neuropathologic><neuropathological><neuropathology><neurotoxicity><post-doctoral training><postdoctoral training><preparations><problem alcohol use><problem drinking><problematic alcohol consumption><problematic alcohol use><programs><recruit><research and development><response><role model><school of medicine><skills><stem cells><success><summer intern><summer internship><synergism><under-representation of minorities><under-represented minority><undergrad><undergraduate><undergraduate student><underrepresentation of minorities><underrepresented minority student><university student><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christina Ciecierski

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph M Feinglass

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lidia Filus

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Marian L. Fitzgibbon

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Masahito Jimbo

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MELISSA A. SIMON

NORTHEASTERN ILLINOIS UNIVERSITY, CHICAGO, IL

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$306,150
FY 2024

Project Title

The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

Grant Number:

3U54CA202995-10S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/24/2015

End Date:

8/31/2026

Project Abstract

Title: Enhancing Data Science Capacity at Northeastern Illinois University Summary of the data science supplement for Northeastern Illinois University (NEIU), MSI partner of the U54 ChicagoCHEC Chicago's systemically underserved communities have disproportionately high cancer rates. The Chicago Can...

Research Terms

<Adopted><Advanced Cancer><Advanced Malignant Neoplasm><Area><Cancer Patient><Cancer health equity><Cancers><Chicago><Community Outreach><Complement><Complement Proteins><Comprehensive Cancer Center><Culturally Appropriate Education><Culturally Responsive Education><Culture-Based Education><Curriculum><Data Science><Dedications><Development><Education><Education and Outreach><Educational Activities><Educational Curriculum><Educational aspects><Educational workshop><Evaluation><Faculty><Funding><Goals><Health><Hispanic-serving Institution><Illinois><Institution><Instruction and Outreach><Knowledge><Learning><Life><Malignant Neoplasms><Malignant Tumor><Minority-Serving Institution><Multicultural Education><Multicultural Multilingual Education><Multicultural literacy><Parents><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Activity><Research Grants><Research Project Grants><Research Projects><Schools><Science><Training><Training and Outreach><Tutoring and Outreach><Universities><Workshop><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><complementation><data science resource><developmental><disability><disparity in cancer><education research><forging><graduate student><innovate><innovation><innovative><lesson plans><malignancy><metropolitan><minority institution><neoplasm/cancer><outreach><parent><programs><tool><under served community><undergrad><undergraduate><undergraduate student><underserved community>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Veronica B. Ajewole

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$300,123
FY 2025

Project Title

Collaborative Union for Cancer Research, and Educational Development (CURED)

Grant Number:

5P20CA284971-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2023

End Date:

8/31/2027

Project Abstract

Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated ...

Research Terms

<Advisory Committees><Area><Cancer Center><Cancers><Career Choice><Career Path><Collaborations><Communities><Community Education><Community Health Education><Community Outreach><Comprehensive Cancer Center><Cost Allocation><Cost Apportionment><Curriculum><Data><Degree program><Development><Development and Research><Education><Education and Outreach><Educational Curriculum><Educational aspects><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Environment><Evaluation><Exposure to><Facilities and Administrative Costs><Faculty><Fostering><Funding><Funding Agency><Funding Source><Goals><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Indirect Costs><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><Lead><Leadership><Malignant Neoplasms><Malignant Tumor><Medical center><Medicine><Mentors><Minority Health Research><Minority research><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Outcome><Pb element><Pilot Projects><Prevention><Process><Program Development><R & D><R&D><Research><Research Peer Review><Research Personnel><Research Resources><Researchers><Resources><Schools><Students><Task Forces><Texas><Training><Training Support><Training and Outreach><Tutoring and Outreach><United States National Institutes of Health><Universities><advisory team><anti-cancer research><cancer education><cancer research><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><cost><design><designing><developmental><education research><empowerment><experience><graduate student><heavy metal Pb><heavy metal lead><higher education><improved><innovate><innovation><innovative><lesson plans><malignancy><member><neoplasm/cancer><outreach><outreach program><pilot study><programs><research and development><research in minorities><research on minorities><research related to minorities><research with minorities><summer student><undergrad><undergraduate><undergraduate student><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rayne Helen Rouce

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 28/100
Solid budget
Active award
Team-scale grant
$300,123
FY 2025

Project Title

Collaborative Union for Cancer Research, and Educational Development (CURED)

Grant Number:

5P20CA284971-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2023

End Date:

8/31/2027

Project Abstract

Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated ...

Research Terms

<Advisory Committees><Area><Cancer Center><Cancers><Career Choice><Career Path><Collaborations><Communities><Community Education><Community Health Education><Community Outreach><Comprehensive Cancer Center><Cost Allocation><Cost Apportionment><Curriculum><Data><Degree program><Development><Development and Research><Education><Education and Outreach><Educational Curriculum><Educational aspects><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Environment><Evaluation><Exposure to><Facilities and Administrative Costs><Faculty><Fostering><Funding><Funding Agency><Funding Source><Goals><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Indirect Costs><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><Lead><Leadership><Malignant Neoplasms><Malignant Tumor><Medical center><Medicine><Mentors><Minority Health Research><Minority research><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Outcome><Pb element><Pilot Projects><Prevention><Process><Program Development><R & D><R&D><Research><Research Peer Review><Research Personnel><Research Resources><Researchers><Resources><Schools><Students><Task Forces><Texas><Training><Training Support><Training and Outreach><Tutoring and Outreach><United States National Institutes of Health><Universities><advisory team><anti-cancer research><cancer education><cancer research><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><cost><design><designing><developmental><education research><empowerment><experience><graduate student><heavy metal Pb><heavy metal lead><higher education><improved><innovate><innovation><innovative><lesson plans><malignancy><member><neoplasm/cancer><outreach><outreach program><pilot study><programs><research and development><research in minorities><research on minorities><research related to minorities><research with minorities><summer student><undergrad><undergraduate><undergraduate student><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Scott Dexter Boyd

STANFORD UNIVERSITY, STANFORD, CA

Exploratory lead · 26/100
Above-average budget
Team-scale grant
$939,222
FY 2024

Project Title

Mechanisms and Duration of Immunity to SARS-CoV-2 - Supplement Application for Sept 2024-Aug 2025

Grant Number:

3U54CA260517-02S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/2020

End Date:

8/31/2025

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

SUMMARY The Stanford U54 SARS-CoV-2 Serological Sciences Center of Excellence (SUSS-COE) has remained true to its original goals as a member of the SeroNet consortium organized to address the urgent need for better understanding of human immune responses to the SARS-CoV-2 coronavirus in the Covid-19...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><Achievement><Achievement Attainment><Address><Affect><Alleles><Allelomorphs><Antibodies><Antigenic Determinants><Antigens><Assay><Award><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><B-cell receptor repertoire sequencing><B-cell receptor sequencing><BCR repertoire sequencing><BCR seq><BCR sequencing><BCRseq><Binding><Binding Determinants><Bioassay><Biological Assay><Blood Plasma Cell><Body Tissues><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 immunity><COVID-19 infected patient><COVID-19 pandemic><COVID-19 pathogenesis><COVID-19 patient><COVID-19 period><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 vaccine><COVID-19 virus><COVID-19 years><COVID19 pathogenesis><COVID19 patient><COVID19 positive patient><COVID19 virus><Cell Body><Cell Isolation><Cell Lineage><Cell Segregation><Cell Separation><Cell Separation Technology><Cells><Clinical><Clinical Research><Clinical Study><CoV-2><CoV2><Collaborations><Communication><Coronaviridae><Coronavirus><Data><Data Bases><Databases><Development><Disease><Disorder><Epitopes><Evolution><Funding><Gender Bias><Genomics><Gestation><Goals><Guidelines><History><Human><Human Resources><Immune response><Immunity><Immunological response><Individual><Infection><Investigation><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><Lyonization><Manpower><Memory B Cell><Memory B-Lymphocyte><Modern Man><Molecular><Molecular Analysis><Molecular Interaction><Mucosa><Mucosal Tissue><Mucous Membrane><Organization Charts><Patient Recruitments><Patients><Performance><Plasma Cells><Plasmacytes><Population><Population Heterogeneity><Pregnancy><Procedures><RNA vaccine><RNA-based vaccine><Reaction><Recording of previous events><Reporting><Research><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 immunity><SARS-CoV-2 infected patient><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 vaccine><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Science><Serology><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 immunity><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Sex Bias><Site><T cell response><T-Cells><T-Lymphocyte><Tissues><Translations><Vaccination><Vaccines><Variant><Variation><Viral><Work><Wuhan coronavirus><X Inactivation><X-Chromosome Inactivation><acute COVID-19><acute SARS-CoV-2 infection><acute phase of COVID-19><acute phase of SARS-CoV-2 infection><adaptive immune response><cell sorting><chronic COVID><chronic COVID-19><chronic novel coronavirus disease 2019><clinical implementation><corona virus><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 immunity><coronavirus disease 2019 infected patient><coronavirus disease 2019 pandemic><coronavirus disease 2019 pathogenesis><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 pathogenesis><coronavirus disease-19 patient><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus patient><data base><developmental><diverse populations><experiment><experimental research><experimental study><experiments><global gene expression><global transcription profile><hCoV19><heterogeneous population><histories><host response><immune system response><immunity against COVID-19><immunity against SARS-CoV-2><immunity against Severe acute respiratory syndrome coronavirus 2><immunity against coronavirus disease 2019><immunity to COVID-19><immunity to SARS-CoV-2><immunity to Severe acute respiratory syndrome coronavirus 2><immunity to coronavirus disease 2019><immunogen><immunoresponse><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><mRNA vaccine><mRNA-based vaccine><member><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><organizational structure><pandemic><pandemic disease><participant recruitment><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><persistent COVID-19><personnel><plasmocyte><population diversity><post COVID syndrome><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><pregnant><prolonged COVID-19 symptoms><response><sample collection><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><social role><specimen collection><thymus derived lymphocyte><transcriptome><translation><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidates against SARS-CoV-2><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Adolfo Garcia-Sastre

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Exploratory lead · 26/100
Above-average budget
Team-scale grant
$599,601
FY 2024

Project Title

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses

Grant Number:

3U54CA260560-02S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2020

End Date:

8/31/2025

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract The Mount Sinai U54 continues to accrue new lung cancer (LC) patients to its large, highly annotated longitudinal cohort with routine specimen collection. Updated research focus areas include: 1) the ability of patients with lung cancer to maintain robust immune responses to...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Antibodies><Antibody Response><Area><Assay><Bioassay><Biologic Factor><Biological Assay><Biological Factors><Blood Plasma><Blood Sample><Blood specimen><COVID-19 infection><COVID-19 predisposition><COVID-19 susceptibility><COVID-19 virus><COVID-19 virus infection><COVID-19 vulnerability><COVID19 infection><COVID19 virus><Cancer Patient><Cancer Treatment><Clinical><CoV-2><CoV2><Consent><Control Groups><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Coupled><Data Bases><Databases><Demographic Factors><ELISA><Enzyme-Linked Immunosorbent Assay><Flu vaccination><Immune response><Immunological response><Infection><Influenza Virus><Influenza immunization><Influenza vaccination><Long-term cohort><Longitudinal cohort><Longterm cohort><Lung immune response><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Tumor of the Lung><Malignant neoplasm of lung><Molecular><Mucosal Immune Responses><Patient Selection><Patients><Plasma><Plasma Serum><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Prophylactic vaccination against influenza><Pulmonary Cancer><Pulmonary malignant Neoplasm><Research><Research Specimen><Residual><Residual state><Reticuloendothelial System, Serum, Plasma><Risk><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV-2 predisposition><SARS-CoV-2 susceptibility><SARS-CoV-2 vulnerability><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Serology><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severe acute respiratory syndrome related corona virus 2><Specimen><Symptoms><Update><Vaccination><Vaccines><Variant><Variation><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral Proteins><Viral reservoir><Virus Diseases><Virus reservoir><Wuhan coronavirus><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><anti-cancer therapy><cancer therapy><cancer-directed therapy><chronic effect of COVID-19><coronavirus disease 2019 infection><coronavirus disease 2019 virus><coronavirus disease-19 virus><data base><enzyme linked immunoassay><experience><flu immunisation><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><hCoV19><host response><immune system response><immunoresponse><in vitro Model><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><influenza virus vaccination><influenzavirus><long term consequences of COVID-19><long term consequences of SARS-CoV-2 infection><long term consequences of coronavirus disease-19><long term effects of COVID-19><long term health consequences of COVID-19><long term health consequences of SARS-CoV2 infection><long term impact of COVID-19><long term impact of SARS-CoV-2 infection><long-term consequence of severe acute respiratory distress syndrome-cov-2 infection><long-term effects of coronavirus disease-19><longterm consequences of COVID-19><longterm consequences of SARS-CoV-2 infection><longterm effects of COVID-19><longterm health consequences of COVID-19><longterm health consequences of SARS-CoV2 infection><longterm impact of COVID-19><longterm impact of SARS-CoV-2 infection><lung cancer><nCoV2><novel><patient population><post SARS-CoV-2 infection><predisposed to Coronavirus disease 2019><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><pulmonary immune response><sample collection><socio-economic><socio-economically><socioeconomically><socioeconomics><specimen collection><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><vaccination against influenza><vaccine platform><viral RNA><viral infection><virus RNA><virus infection><virus protein><virus-induced disease><vulnerable to COVID-19><vulnerable to Coronavirus disease 2019><vulnerable to SARS-CoV-2><vulnerable to Severe acute respiratory syndrome coronavirus 2>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

FRED R HIRSCH

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Exploratory lead · 26/100
Above-average budget
Team-scale grant
$599,601
FY 2024

Project Title

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses

Grant Number:

3U54CA260560-02S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2020

End Date:

8/31/2025

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract The Mount Sinai U54 continues to accrue new lung cancer (LC) patients to its large, highly annotated longitudinal cohort with routine specimen collection. Updated research focus areas include: 1) the ability of patients with lung cancer to maintain robust immune responses to...

Research Terms

<2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Antibodies><Antibody Response><Area><Assay><Bioassay><Biologic Factor><Biological Assay><Biological Factors><Blood Plasma><Blood Sample><Blood specimen><COVID-19 infection><COVID-19 predisposition><COVID-19 susceptibility><COVID-19 virus><COVID-19 virus infection><COVID-19 vulnerability><COVID19 infection><COVID19 virus><Cancer Patient><Cancer Treatment><Clinical><CoV-2><CoV2><Consent><Control Groups><Coronavirus disease 2019 predisposition><Coronavirus disease 2019 susceptibility><Coronavirus disease 2019 vulnerability><Coupled><Data Bases><Databases><Demographic Factors><ELISA><Enzyme-Linked Immunosorbent Assay><Flu vaccination><Immune response><Immunological response><Infection><Influenza Virus><Influenza immunization><Influenza vaccination><Long-term cohort><Longitudinal cohort><Longterm cohort><Lung immune response><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Tumor of the Lung><Malignant neoplasm of lung><Molecular><Mucosal Immune Responses><Patient Selection><Patients><Plasma><Plasma Serum><Predisposed to COVID-19><Predisposed to SARS-CoV-2><Predisposed to Severe acute respiratory syndrome coronavirus 2><Prophylactic vaccination against influenza><Pulmonary Cancer><Pulmonary malignant Neoplasm><Research><Research Specimen><Residual><Residual state><Reticuloendothelial System, Serum, Plasma><Risk><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 infection><SARS-CoV-2 predisposition><SARS-CoV-2 susceptibility><SARS-CoV-2 vulnerability><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Serology><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 predisposition><Severe acute respiratory syndrome coronavirus 2 susceptibility><Severe acute respiratory syndrome coronavirus 2 vulnerability><Severe acute respiratory syndrome related corona virus 2><Specimen><Symptoms><Update><Vaccination><Vaccines><Variant><Variation><Viral Diseases><Viral Gene Products><Viral Gene Proteins><Viral Proteins><Viral reservoir><Virus Diseases><Virus reservoir><Wuhan coronavirus><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><anti-cancer therapy><cancer therapy><cancer-directed therapy><chronic effect of COVID-19><coronavirus disease 2019 infection><coronavirus disease 2019 virus><coronavirus disease-19 virus><data base><enzyme linked immunoassay><experience><flu immunisation><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><hCoV19><host response><immune system response><immunoresponse><in vitro Model><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><influenza virus vaccination><influenzavirus><long term consequences of COVID-19><long term consequences of SARS-CoV-2 infection><long term consequences of coronavirus disease-19><long term effects of COVID-19><long term health consequences of COVID-19><long term health consequences of SARS-CoV2 infection><long term impact of COVID-19><long term impact of SARS-CoV-2 infection><long-term consequence of severe acute respiratory distress syndrome-cov-2 infection><long-term effects of coronavirus disease-19><longterm consequences of COVID-19><longterm consequences of SARS-CoV-2 infection><longterm effects of COVID-19><longterm health consequences of COVID-19><longterm health consequences of SARS-CoV2 infection><longterm impact of COVID-19><longterm impact of SARS-CoV-2 infection><lung cancer><nCoV2><novel><patient population><post SARS-CoV-2 infection><predisposed to Coronavirus disease 2019><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><pulmonary immune response><sample collection><socio-economic><socio-economically><socioeconomically><socioeconomics><specimen collection><susceptible to COVID-19><susceptible to Coronavirus disease 2019><susceptible to SARS-CoV-2><susceptible to Severe acute respiratory syndrome coronavirus 2><vaccination against influenza><vaccine platform><viral RNA><viral infection><virus RNA><virus infection><virus protein><virus-induced disease><vulnerable to COVID-19><vulnerable to Coronavirus disease 2019><vulnerable to SARS-CoV-2><vulnerable to Severe acute respiratory syndrome coronavirus 2>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Saria Hassan

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 26/100
Training-friendly
Career award
$171,745
FY 2024

Project Title

A Plan to Reduce Non-Communicable Disease-Related Morbidity and Mortality After Natural Disasters

Grant Number:

5K23HL152368-06

Activity Code:

K23

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/1/2020

End Date:

4/30/2026

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

There were over 1000 deaths during the 2017 hurricane season in the United States, with the majority occurring in the territories of Puerto Rico and the U.S. Virgin Islands (USVI). Over a third of post-disaster mortality and morbidity was due to complications of non-communicable diseases such as hyp...

Research Terms

<Acute><Address><Administrator><Adoption><Affect><Assess implementation><Cardiac Diseases><Cardiac Disorders><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Centers for Health Planning><Centers for Medicare and Medicaid Services><Cessation of life><Chronic Disease><Chronic Illness><Clinic><Clinical><Collaborations><Communication><Communities><Complex><Data><Data Analyses><Data Analysis><Death><Decrease disparity><Diabetes Mellitus><Diabetes prevention><Disaster Planning><Disasters><Disease><Disease Management><Disorder><Disorder Management><Disparities><Disparity><Emergencies><Emergency Situation><Evaluation><Evidence based intervention><Federally Qualified Health Center><Foundations><Frequencies><Funding><Future><Goals><Health Care Financing Administration><Health Care Systems><Health Planning Organizations><Healthcare Systems><Heart Diseases><Heart Vascular><Heart failure><Hurricane><Hypertension><Implementation assessment><Individual><Individuals from minority><Individuals of minority><Intervention><Intervention Strategies><Interview><Investigators><K12><K12 Award><K12 Mechanism><K12 Program><Knowledge><Lead><Location><Lower disparity><Medicine><Mentored Clinical Scientist Development Program><Mentors><Methods><Minority><Minority Groups><Minority People><Minority Population><Minority individual><Modeling><Morbidity><Morbidity - disease rate><NCMHD><NIH><NIMHD><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><National Institutes of Health><Natural Disasters><Patients><Pb element><Pediatrics><Persons><Physicians><Pilot Projects><Policies><Population><Position><Positioning Attribute><Preparedness><Preventative intervention><Procedures><Provider><Puerto Rico><R-Series Research Projects><R01 Mechanism><R01 Program><Readiness><Research><Research Grants><Research Methodology><Research Methods><Research Personnel><Research Project Grants><Research Projects><Researchers><Risk Assessment><Role><Science><Seasons><Self Management><Services><Site><Survey Instrument><Surveys><System><Testing><Texas><Time><Training><Underinsured><Underserved Population><Uninsured><United States><United States Centers for Medicare and Medicaid Services><United States Health Care Financing Administration><United States National Institutes of Health><United States Virgin Islands><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Virgin Islands><Vulnerable Populations><Work><acceptability and feasibility><burden of chronic disease><burden of chronic illness><cardiac failure><cardiovascular disorder><cardiovascular risk><cardiovascular risk factor><chronic disorder><circulatory system><data interpretation><design><designing><diabetes><disparity reduction><dynamic system><dynamical system><emergency preparedness><evaluate implementation><evaluation of implementation><experience><facilitators to implementation><heart disorder><heavy metal Pb><heavy metal lead><high blood pressure><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><implementation evaluation><implementation facilitators><implementation science><improved><informant><interest><intervention for prevention><interventional strategy><member><mitigate disparity><model-based simulation><models and simulation><mortality><patient centered><patient oriented><patient population><pilot study><post implementation><prevention intervention><preventional intervention strategy><preventive intervention><primary care health center><primary health center><reduce disparity><reduction in disparity><research and methods><service providers><simulation><skills><social role><socio-economic><socio-economically><socioeconomically><socioeconomics><tool><tropical cyclone><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><vulnerable group><vulnerable individual><vulnerable people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lauren Schmitt

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Exploratory lead · 26/100
Training-friendly
Career award
$92,313
FY 2024

Project Title

Electrophysiological Biomarkers of Neurocognitive Deficits in Fragile X Syndrome

Grant Number:

5K23HD101416-05

Activity Code:

K23

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2020

End Date:

12/2/2024

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY/ABSTRACT The primary objective of this K23 application is to provide the candidate with the necessary research training and mentorship to ensure her development as an independent clinical researcher. Her career goal is to investigate neurodevelopmental disorders, like Fragile X Synd...

Research Terms

<0-11 years old><21+ years old><Acceleration><Adult><Adult Human><Age><Allergy><Animal Model><Animal Models and Related Studies><Anterior><Area><Attenuated><Behavioral><Biological><Biological Markers><Brain><Brain Nervous System><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Child><Child Youth><Children (0-21)><Clinical><Clinical Psychology><Cognition><Cognitive><Coupling><Data><Development><Developmental Delay><Developmental Delay Disorders><Disabling><Disease><Disorder><EEG><Electroencephalogram><Electroencephalography><Electrophysiology><Electrophysiology (science)><Encephalon><Ensure><Escalante syndrome><Event-Related Potentials><Executive Dysfunction><Executive Function Deficit><Executive Impairment><Faculty><Family><Fragile X><Fragile X Syndrome><Functional impairment><Goals><Hereditary><Housing><Hypersensitivity><IQ Deficit><Individual><Inherited><Intellectual disability><Intellectual functioning disability><Intellectual limitation><Investigators><K-Awards><K-Series Research Career Programs><Knowledge><Language><Learning><Learning Disabilities><Learning disability><Link><Martin-Bell Syndrome><Martin-Bell-Renpenning syndrome><Measures><Mentors><Mentorship><Mice><Mice Mammals><Murine><Mus><NIH><National Institutes of Health><Neurocognitive><Neurocognitive Deficit><Neurodevelopmental Disorder><Neurological Development Disorder><Neurophysiology / Electrophysiology><Neuropsychologies><Neuropsychology><Neurosciences><Outcome><Parents><Parietal Lobe><Participant><Patients><Performance><Phase><Production><Renpenning syndrome 2><Reporting><Research><Research Career Program><Research Personnel><Research Resources><Research Support><Research Training><Researchers><Resources><Rest><Reversal Learning><Sampling><Seminal><Sensory><Severities><Specific Child Development Disorders><Speech><Speed><Standardization><System><Testing><Training><Training Programs><Translational Research><Translational Science><Treatment Effectiveness><United States National Institutes of Health><Validation><Work><X-linked mental deficiency-megalotestes syndrome><X-linked mental retardation with fragile X syndrome><X-linked mental retardation-fragile site 1 syndrome><adulthood><ages><alleviate symptom><ameliorating symptom><attenuate><attenuates><autism-fragile X (AFRAX) syndrome><behavior observation><behavior phenotype><behavior response><behavioral observation><behavioral phenotyping><behavioral response><bio-markers><biologic><biologic marker><biomarker><biomarker discovery><biomarker identification><career><clinical phenotype><cognitive task><decrease symptom><density><develop therapy><developmental><drug discovery><effective therapy><effective treatment><effectiveness measure><electrophysiological><event related potential><fewer symptoms><flexibility><flexible><fra(X) syndrome><fra(X)(28) syndrome><fra(X)(q27) syndrome><fra(X)(q27-28) syndrome><fragile X-mental retardation syndrome><fragile Xq syndrome><fragile site mental retardation 1><frontal cortex><frontal lobe><identification of biomarkers><identification of new biomarkers><improved><insight><intellectual and developmental disability><intelligence quotient deficit><intervention development><kids><language impairment><limited intellectual functioning><macro-orchidism-marker X (MOMX) syndrome><macro-orchidism-marker X syndrome><mar(X) syndrome><marker X syndrome><marker identification><mental retardation-macroorchidism syndrome><model of animal><neural><neurocognitive decline><neurocognitive impairment><neurodevelopmental disease><neurophysiological><neurophysiology><neuropsychologic><parent><parietal cortex><preservation><programs><recruit><reduce symptoms><relieves symptoms><repetitive behavior><research study><response><sex><skills><social anxiety><social communication><socially anxious><symptom alleviation><symptom reduction><symptom relief><therapy development><translation research><translational investigation><treatment development><validations><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Birgit Schilling

BUCK INSTITUTE FOR RESEARCH ON AGING, NOVATO, CA

Exploratory lead · 24/100
Large award
$1,759,412
FY 2025

Project Title

timsTOF fleX MALDI-2 for Spatial Molecular Imaging

Grant Number:

1S10OD038264-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2025

End Date:

3/31/2026

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT This shared instrumentation proposal seeks funding for the purchase of a Bruker ‘timsTOF fleX MALDI-2 for Spatial Molecular Imaging’ including a bundled HTX M3+ sprayer. This new mass spectrometry (MS) platform will facilitate ongoing and future scientific research to spatia...

Research Terms

<AD dementia><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Architecture><Biology of Aging><Body Tissues><Code><Coding System><Data Bases><Databases><Decline in mobility><Decrease in mobility><Decreased mobility><Degenerative Arthritis><Degenerative polyarthritis><Diminished mobility><Engineering / Architecture><Funding><Future><Glycans><Grant><Health><Human><Huntington Chorea><Huntington Disease><Huntington's><Huntington's Disease><Huntingtons Disease><Imaging technology><Institution><Investigators><Kidney Diseases><Laser Electromagnetic><Laser Radiation><Lasers><Libraries><Lipids><MALD-MS><MALDI><MALDI-MS><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Measurement><Metabolic Diseases><Metabolic Disorder><Mobility decline><Mobility impairment><Modern Man><Molecular Fingerprinting><Molecular Profiling><Monitor><NIH><National Institutes of Health><Nephropathy><Noise><Organ><Organoids><Osteoarthritis><Osteoarthrosis><Parkinsonian><Parkinsonian Condition><Parkinsonian Diseases><Parkinsonian Disorders><Parkinsonian Syndrome><Parkinsonism><Polysaccharides><Preparation><Primary Senile Degenerative Dementia><Principal Investigator><Proteins><Proteomics><Reduced mobility><Reduction in mobility><Renal Disease><Research><Research Institute><Research Personnel><Researchers><Resolution><Sampling><Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization><Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization><System><Thesaurismosis><Tissues><United States National Institutes of Health><Universities><age associated disease><age associated disorder><age associated impairment><age dependent disease><age dependent disorder><age dependent impairment><age related human disease><age-related disease><age-related disorder><age-related impairment><animal tissue><cost><data base><degenerative joint disease><equipment acquirement><equipment acquisition><equipment investment><equipment procurement><equipment purchase><equipment purchasing><healthspan><healthy life span><human tissue><hypertrophic arthritis><imaging mass spectrometry><improved><innovate><innovation><innovative><instrument acquisition><instrument investment><instrument procurement><instrument purchase><instrumentation><ion mobility><ionization><kidney disorder><lipidomics><mass spectrometric imaging><matrix assisted laser desorption ionization><metabolism disorder><metabolism measurement><metabolomics><metabonomics><meter><molecular imaging><molecular mass><molecular profile><molecular signature><molecule imaging><multiomics><multiple omics><novel><panomics><preparations><primary degenerative dementia><renal disorder><resolutions><senile dementia of the Alzheimer type><spatial molecular analysis><spatial molecular imaging><spatial molecular mapping><spatial molecular profiling>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Peter G Smith

UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS

Exploratory lead · 24/100
Large award
$1,078,438
FY 2024

Project Title

NovaSeq X Plus Sequencing System

Grant Number:

1S10OD036343-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/15/2024

End Date:

5/15/2025

Why this may be worth a closer look

  • • Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary / Abstract The University of Kansas Medical Center (KUMC) Genomics Core (GC) is requesting funds to upgrade high-throughput genomic sequencing capabilities with the purchase of an Illumina NovaSeq X Plus Sequencing System (NSXP). The GC has provided genomics services since 2002, ini...

Research Terms

<AD dementia><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Award><Bio-Informatics><Bioinformatics><COBRE><Cancer Center><Cell Body><Cells><Center of Biomedical Research Excellence><Centers of Research Excellence><Chromium><Clinical Research><Clinical Study><Coupled><Cr element><DNA><DNA Sequencing Facility><Data Analyses><Data Analysis><Deoxyribonucleic Acid><Development><Disadvantaged><Ensure><Funding><Future><Gene Chips><Gene Expression Chip><GeneChip><Genomics><Grant><Health><Infrastructure><Institution><Investigators><Kansas><Library Automation><Medical center><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minor><Mission><NCATS><NGS Method><NGS system><NIDDK><NIH><National Center for Advancing Translational Sciences><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Polycystic Kidney><Polycystic Kidney Diseases><Primary Senile Degenerative Dementia><Research><Research Personnel><Researchers><Savings><Sequencing Core><Services><Synthesis Chemistry><Synthetic Chemistry><System><Technology><Translational Research><Translational Science><United States National Institutes of Health><Universities><base><bases><cost><data interpretation><data management><data quality><developmental><expression array><frontier><gene expression microarray><improved><instrument><next gen sequencing><next generation sequencing><nextgen sequencing><operation><operations><primary degenerative dementia><programs><quality assurance><robotic system><senile dementia of the Alzheimer type><translation research><translational investigation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Chad J Achenbach

JOS UNIVERSITY TEACHING HOSPITAL, NIGERIA

Exploratory lead · 20/100
Solid budget
Active award
$289,297
FY 2025

Project Title

Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)

Grant Number:

5D43TW009575-12

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/9/2014

End Date:

3/31/2029

Project Abstract

PROJECT SUMMARY The Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM) addresses a high priority NIH research area and significant problem in sub-Saharan Africa because of the widespread HIV epidemic made worse by the high burden of oncogenic viral co-infections. Antiret...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Aging><Area><Assay><Bioassay><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><Cancer Diagnostics><Cancers><Clinical Data><Clinical Investigator><Collaborations><Collection><Country><Diagnosis><Diagnostics Research><Distance Learning><Doctor of Philosophy><Educational workshop><Epidemic><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiologist><Epidemiology><Epidemiology Research><Funding><Goals><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Immunodeficiency Viruses><Incidence><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><LAV-HTLV-III><LMIC><Laboratories><Leadership><Lymphadenopathy-Associated Virus><Malignant Neoplasms><Malignant Tumor><Master of Science><Master's Degree><Medical><Mentorship><Molecular><Molecular Epidemiology><Molecular Epidemiology of Cancer><Morbidity><Morbidity - disease rate><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Nigeria><Nigerian><Oncogenic><Ph.D.><PhD><Population><Prevention><Preventive><Protocol><Protocols documentation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Scientist><Sub-Saharan Africa><Subsaharan Africa><Therapeutic><Training><Training Programs><Translating><United States National Institutes of Health><Universities><Viral><Virus-HIV><Workshop><antiretroviral therapy><antiretroviral treatment><bio-markers><biologic marker><biomarker><cancer epidemiology><clinical epidemiology><clinical investigation><clinical validation><co-infection><coinfection><design><designing><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><epigenomics><improved><innovate><innovation><innovative><low and middle-income countries><malignancy><mortality><neoplasm/cancer><novel><point of care testing><population based><programs><remote learning><screening><screenings>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jonah Musa

JOS UNIVERSITY TEACHING HOSPITAL, NIGERIA

Exploratory lead · 20/100
Solid budget
Active award
$289,297
FY 2025

Project Title

Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)

Grant Number:

5D43TW009575-12

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/9/2014

End Date:

3/31/2029

Project Abstract

PROJECT SUMMARY The Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM) addresses a high priority NIH research area and significant problem in sub-Saharan Africa because of the widespread HIV epidemic made worse by the high burden of oncogenic viral co-infections. Antiret...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Aging><Area><Assay><Bioassay><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><Cancer Diagnostics><Cancers><Clinical Data><Clinical Investigator><Collaborations><Collection><Country><Diagnosis><Diagnostics Research><Distance Learning><Doctor of Philosophy><Educational workshop><Epidemic><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiologist><Epidemiology><Epidemiology Research><Funding><Goals><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Immunodeficiency Viruses><Incidence><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><LAV-HTLV-III><LMIC><Laboratories><Leadership><Lymphadenopathy-Associated Virus><Malignant Neoplasms><Malignant Tumor><Master of Science><Master's Degree><Medical><Mentorship><Molecular><Molecular Epidemiology><Molecular Epidemiology of Cancer><Morbidity><Morbidity - disease rate><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Nigeria><Nigerian><Oncogenic><Ph.D.><PhD><Population><Prevention><Preventive><Protocol><Protocols documentation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Scientist><Sub-Saharan Africa><Subsaharan Africa><Therapeutic><Training><Training Programs><Translating><United States National Institutes of Health><Universities><Viral><Virus-HIV><Workshop><antiretroviral therapy><antiretroviral treatment><bio-markers><biologic marker><biomarker><cancer epidemiology><clinical epidemiology><clinical investigation><clinical validation><co-infection><coinfection><design><designing><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><epigenomics><improved><innovate><innovation><innovative><low and middle-income countries><malignancy><mortality><neoplasm/cancer><novel><point of care testing><population based><programs><remote learning><screening><screenings>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

OLUWAKEMI ODUKOYA

JOS UNIVERSITY TEACHING HOSPITAL, NIGERIA

Exploratory lead · 20/100
Solid budget
Active award
$289,297
FY 2025

Project Title

Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)

Grant Number:

5D43TW009575-12

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/9/2014

End Date:

3/31/2029

Project Abstract

PROJECT SUMMARY The Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM) addresses a high priority NIH research area and significant problem in sub-Saharan Africa because of the widespread HIV epidemic made worse by the high burden of oncogenic viral co-infections. Antiret...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Aging><Area><Assay><Bioassay><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><Cancer Diagnostics><Cancers><Clinical Data><Clinical Investigator><Collaborations><Collection><Country><Diagnosis><Diagnostics Research><Distance Learning><Doctor of Philosophy><Educational workshop><Epidemic><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiologist><Epidemiology><Epidemiology Research><Funding><Goals><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Immunodeficiency Viruses><Incidence><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><LAV-HTLV-III><LMIC><Laboratories><Leadership><Lymphadenopathy-Associated Virus><Malignant Neoplasms><Malignant Tumor><Master of Science><Master's Degree><Medical><Mentorship><Molecular><Molecular Epidemiology><Molecular Epidemiology of Cancer><Morbidity><Morbidity - disease rate><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Nigeria><Nigerian><Oncogenic><Ph.D.><PhD><Population><Prevention><Preventive><Protocol><Protocols documentation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Scientist><Sub-Saharan Africa><Subsaharan Africa><Therapeutic><Training><Training Programs><Translating><United States National Institutes of Health><Universities><Viral><Virus-HIV><Workshop><antiretroviral therapy><antiretroviral treatment><bio-markers><biologic marker><biomarker><cancer epidemiology><clinical epidemiology><clinical investigation><clinical validation><co-infection><coinfection><design><designing><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><epigenomics><improved><innovate><innovation><innovative><low and middle-income countries><malignancy><mortality><neoplasm/cancer><novel><point of care testing><population based><programs><remote learning><screening><screenings>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Olugbenga Akindele Silas

JOS UNIVERSITY TEACHING HOSPITAL, NIGERIA

Exploratory lead · 20/100
Solid budget
Active award
$289,297
FY 2025

Project Title

Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)

Grant Number:

5D43TW009575-12

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/9/2014

End Date:

3/31/2029

Project Abstract

PROJECT SUMMARY The Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM) addresses a high priority NIH research area and significant problem in sub-Saharan Africa because of the widespread HIV epidemic made worse by the high burden of oncogenic viral co-infections. Antiret...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Aging><Area><Assay><Bioassay><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><Cancer Diagnostics><Cancers><Clinical Data><Clinical Investigator><Collaborations><Collection><Country><Diagnosis><Diagnostics Research><Distance Learning><Doctor of Philosophy><Educational workshop><Epidemic><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiologist><Epidemiology><Epidemiology Research><Funding><Goals><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Immunodeficiency Viruses><Incidence><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><LAV-HTLV-III><LMIC><Laboratories><Leadership><Lymphadenopathy-Associated Virus><Malignant Neoplasms><Malignant Tumor><Master of Science><Master's Degree><Medical><Mentorship><Molecular><Molecular Epidemiology><Molecular Epidemiology of Cancer><Morbidity><Morbidity - disease rate><Multidisciplinary Collaboration><Multidisciplinary Research><NIH><National Institutes of Health><Nigeria><Nigerian><Oncogenic><Ph.D.><PhD><Population><Prevention><Preventive><Protocol><Protocols documentation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Scientist><Sub-Saharan Africa><Subsaharan Africa><Therapeutic><Training><Training Programs><Translating><United States National Institutes of Health><Universities><Viral><Virus-HIV><Workshop><antiretroviral therapy><antiretroviral treatment><bio-markers><biologic marker><biomarker><cancer epidemiology><clinical epidemiology><clinical investigation><clinical validation><co-infection><coinfection><design><designing><epidemiologic><epidemiologic investigation><epidemiological><epidemiology study><epigenomics><improved><innovate><innovation><innovative><low and middle-income countries><malignancy><mortality><neoplasm/cancer><novel><point of care testing><population based><programs><remote learning><screening><screenings>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lameck Chinula

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 20/100
Solid budget
Active award
$268,228
FY 2025

Project Title

Malawi Cancer Outcomes Research Program (M-CORP)

Grant Number:

5D43CA260641-05

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/1/2021

End Date:

5/31/2027

Project Abstract

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there were more than 18 million new cancer cases and 9.5 million cancer deaths worldwide, and, by 2030, these numbers will increase by at least 50%. Countries with low or medium Hu...

Research Terms

<AIDS><AIDS Malignancy Consortium><AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Breast Cancer><Cancer Burden><Cancer Control><Cancer Control Science><Cancers><Cervical Cancer><Cervical Cancer Screening><Cervix Cancer><Cessation of life><Clinical Trials><Collaborations><Country><Curriculum><Data Bases><Databases><Death><Educational Curriculum><Ensure><Environment><Epidemiology><Esophageal Cancer><Esophagus Cancer><Foundations><Funding><Generations><Germinoblastic Sarcoma><Germinoblastoma><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Development><Human Immunodeficiency Viruses><Institution><International><Investigators><LAV-HTLV-III><Leadership><Lymphadenopathy-Associated Virus><Lymphoma><M tuberculosis infection><M. tb infection><M. tuberculosis infection><M.tb infection><M.tuberculosis infection><MTB infection><Malaria><Malawi><Malignant Breast Neoplasm><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Esophageal Neoplasm><Malignant Esophageal Tumor><Malignant Lymphoma><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Tumor of the Esophagus><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of esophagus><Medicine><Mentors><Mycobacterium tuberculosis (MTB) infection><Mycobacterium tuberculosis infection><NCI Organization><National Cancer Burden><National Cancer Institute><North Carolina><Nyasaland><Outcome><Outcomes Research><Paludism><Plasmodium Infections><Postdoc><Postdoctoral Fellow><Program Evaluation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Grants><Research Personnel><Research Priority><Research Project Grants><Research Projects><Researchers><Reticulolymphosarcoma><Sub-Saharan Africa><Subsaharan Africa><TB infection><Testing><Time><Training Programs><Tuberculosis><USAID><Universities><Uterine Cervix Cancer><Virus-HIV><anti-cancer research><cancer clinical trial><cancer research><career><cervical cancer early detection><cervical screening><clinical translation><clinically translatable><college><collegiate><data base><disseminated TB><disseminated tuberculosis><epidemiologic><epidemiological><experience><improved><indexing><infection due to Mycobacterium tuberculosis><investigator training><lesson plans><malignancy><malignant breast tumor><multidisciplinary><neoplasm/cancer><oesophageal cancer><oncology clinical trial><post-doc><post-doctoral><post-doctoral trainee><precancer cervical detection><programs><research associates><skills><success><training opportunity><tuberculosis infection><tuberculous spondyloarthropathy>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Yuri Fedoriw

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 20/100
Solid budget
Active award
$268,228
FY 2025

Project Title

Malawi Cancer Outcomes Research Program (M-CORP)

Grant Number:

5D43CA260641-05

Activity Code:

D43

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/1/2021

End Date:

5/31/2027

Project Abstract

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there were more than 18 million new cancer cases and 9.5 million cancer deaths worldwide, and, by 2030, these numbers will increase by at least 50%. Countries with low or medium Hu...

Research Terms

<AIDS><AIDS Malignancy Consortium><AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Africa South of the Sahara><African><Breast Cancer><Cancer Burden><Cancer Control><Cancer Control Science><Cancers><Cervical Cancer><Cervical Cancer Screening><Cervix Cancer><Cessation of life><Clinical Trials><Collaborations><Country><Curriculum><Data Bases><Databases><Death><Educational Curriculum><Ensure><Environment><Epidemiology><Esophageal Cancer><Esophagus Cancer><Foundations><Funding><Generations><Germinoblastic Sarcoma><Germinoblastoma><Grant><HIV><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><Human Development><Human Immunodeficiency Viruses><Institution><International><Investigators><LAV-HTLV-III><Leadership><Lymphadenopathy-Associated Virus><Lymphoma><M tuberculosis infection><M. tb infection><M. tuberculosis infection><M.tb infection><M.tuberculosis infection><MTB infection><Malaria><Malawi><Malignant Breast Neoplasm><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Esophageal Neoplasm><Malignant Esophageal Tumor><Malignant Lymphoma><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Tumor of the Esophagus><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of esophagus><Medicine><Mentors><Mycobacterium tuberculosis (MTB) infection><Mycobacterium tuberculosis infection><NCI Organization><National Cancer Burden><National Cancer Institute><North Carolina><Nyasaland><Outcome><Outcomes Research><Paludism><Plasmodium Infections><Postdoc><Postdoctoral Fellow><Program Evaluation><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Grants><Research Personnel><Research Priority><Research Project Grants><Research Projects><Researchers><Reticulolymphosarcoma><Sub-Saharan Africa><Subsaharan Africa><TB infection><Testing><Time><Training Programs><Tuberculosis><USAID><Universities><Uterine Cervix Cancer><Virus-HIV><anti-cancer research><cancer clinical trial><cancer research><career><cervical cancer early detection><cervical screening><clinical translation><clinically translatable><college><collegiate><data base><disseminated TB><disseminated tuberculosis><epidemiologic><epidemiological><experience><improved><indexing><infection due to Mycobacterium tuberculosis><investigator training><lesson plans><malignancy><malignant breast tumor><multidisciplinary><neoplasm/cancer><oesophageal cancer><oncology clinical trial><post-doc><post-doctoral><post-doctoral trainee><precancer cervical detection><programs><research associates><skills><success><training opportunity><tuberculosis infection><tuberculous spondyloarthropathy>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Shern

DIVISION OF BASIC SCIENCES - NCI

Exploratory lead · 18/100
Above-average budget
$927,446
FY 2025

Project Title

Genomic characterization and development of therapies for pediatric sarcoma

Grant Number:

1ZIABC011722-10

Activity Code:

ZIA

Mechanism:

Intramural Research

Agency:

NIH

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

The goal of this project is to enable precision oncology for patients with deadly subtypes of rhabdomyosarcoma (RMS), which is the most common soft tissue sarcoma of childhood. The prognosis for those with RMS remains poor in particular, for children with intermediate- or high-risk RMS where patient...

Research Terms

<0-11 years old><1-Phosphatidylinositol 3-Kinase><Adolescent><Adolescent Youth><Antifolates><Assay><Basal Transcription Factor><Basal transcription factor genes><Bioassay><Bioinformatics><Biologic Models><Biological Assay><Biological Models><Cancer Genes><Cancer-Promoting Gene><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Chemotherapy and Radiation><Chemotherapy and/or radiation><Child><Child Youth><Childhood><Childhood Soft Tissue Sarcoma><Children (0-21)><Children's Oncology Group><Chromatin><Chromatin Structure><Clinical Cooperative Groups><Clinical Trial Groups><Clinical Trials><Clinical Trials Cooperative Group><Collaborations><Combined Modality Therapy><Complex><Correlative Study><Cyclin Gene><Cyclin-Dependent Kinases><Cyclin-Dependent Protein Kinases><Cyclins><DNA Binding><DNA Binding Interaction><DNA bound><DNA mutation><DNA-Dependent RNA Polymerases><DNA-Directed RNA Polymerase><Data><Diagnosis><Disease><Disorder><Drug Combinations><Drug Screening><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><FKHR><FOXO1><FOXO1A><FOXO1A gene><Folate Analog><Folate Inhibitors><Folic Acid Analog><Folic Acid Antagonists><Folic Acid Inhibitors><Forkhead Box O1A><Forkhead in Rhabdomyosarcoma><Funding><Gene Action Regulation><Gene Down-Regulation><Gene Expression Regulation><Gene Regulation><Gene Regulation Process><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Genomics><Goals><HUP2><Histologic><Histologically><Intracellular Communication and Signaling><Kinases><Knowledge><Laboratories><Malignant Neoplasms><Malignant Peripheral Nerve Sheath Tumor><Malignant Schwannoma><Malignant Soft Tissue Neoplasm><Malignant Tumor><Measures><Mediator><Metabolic stress><Methods><Methylation><Model System><Molecular><Morbidity><Morbidity - disease rate><Multimodal Therapy><Multimodal Treatment><Mutation><NCATS><National Center for Advancing Translational Sciences><Neurofibrosarcoma><Neurogenic Sarcoma><Oncogenes><Operative Procedures><Operative Surgical Procedures><PAX3><PAX3 gene><PI-3 Kinase><PI3-Kinase><PI3CG><PI3K-Alpha><PI3KGamma><PI3k><PIK3><PIK3-Alpha><PIK3CA><PIK3CA gene><PIK3CG><PIK3CG gene><Paired Box Gene 3><Paired Domain Gene HuP2><Patients><Pediatric Oncology Group><Pediatric Soft Tissue Sarcoma><Phosphatidylinositol 3-Kinase><Phosphatidylinositol 3-Kinase, Catalytic, 110-kD, Alpha><Phosphatidylinositol 3-Kinase, Catalytic, Alpha><Phosphatidylinositol-3-OH Kinase><Phosphoinositide 3-Hydroxykinase><Phosphorylation><Phosphotransferase Gene><Phosphotransferases><Point Mutation><Pre-Clinical Model><Preclinical Models><Preclinical Testing><Prognosis><Protein Phosphorylation><Proteomics><PtdIns 3-Kinase><RNA Expression><RNA Polymerases><Radiation><Regimen><Relapse><Rhabdomyosarcoma><Sampling><Sarcoma><Signal Transduction><Signal Transduction Systems><Signaling><Soft tissue sarcoma><Surgical><Surgical Interventions><Surgical Procedure><Techniques><Testing><Time><Topoisomerase><Transcription><Transcription Activation><Transcription Factor Proto-Oncogene><Transcription Repression><Transcription factor genes><Transcriptional Activation><Transforming Genes><Translating><Transphosphorylases><Treatment Protocols><Treatment Regimen><Treatment Schedule><Tumor Cell><Type I Phosphatidylinositol Kinase><Type III Phosphoinositide 3-Kinase><United States><Upregulation><WS1><Work><Xenograft Model><aggressive therapy><aggressive treatment><biological signal transduction><cdk Proteins><cell free DNA profiling><cell free DNA screening><cell free DNA-based assay><cell-free DNA assay><cell-free DNA test><cfDNA assay><cfDNA profiling><cfDNA screening><cfDNA test><cfDNA-based assay><chemo/radiation therapy><chemotherapy><chemotherapy and radiotherapy><childhood sarcoma><clinical translation><clinically translatable><combination therapy><combined modality treatment><combined treatment><cyclin C><develop therapy><disease subgroups><disease subtype><disorder subtype><entire genome><epigenetically><expression subtypes><folate antagonist><full genome><functional genomics><gene repression><genome mutation><genome sequencing><high risk><high risk group><high risk individual><high risk people><high risk population><high-throughput drug screening><individualized cancer care><individualized oncology><inhibitor><insight><intervention development><juvenile><juvenile human><kids><malignancy><malignant soft tissue tumor><molecular sub-types><molecular subsets><molecular subtypes><mortality><multi-modal therapy><multi-modal treatment><mutant><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><p110-Alpha><patient stratification><pediatric><pediatric sarcoma><peripheral blood><permissiveness><personalized oncology><pre-clinical study><pre-clinical testing><precision cancer care><precision cancer medicine><precision oncology><preclinical study><prognostic tool><prognostication><programs><radiation or chemotherapy><relapse risk><response><risk stratification><small molecular inhibitor><small molecule inhibitor><stratified patient><stratify risk><surgery><synergism><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><test using cell free DNA><tests using cfDNA><therapy development><tool><transcription factor><treatment development><trial planning><tumor><whole genome><xenograft transplant model><xenotransplant model><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KENNETH W DUNN

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Exploratory lead · 18/100
Above-average budget
$562,000
FY 2024

Project Title

Lightsheet microscope system for the Indiana Center for Biological Microscopy

Grant Number:

1S10OD036391-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2024

End Date:

3/31/2025

Why this may be worth a closer look

  • • Award size is strong enough to merit immediate review.

Project Abstract

Lightsheet microscopy is a technology that provides the ability to rapidly acquire millimeter-scale fluorescence image volumes at subcellular resolution, providing a practical solution to the challenge of fluorescence microscopy of large optically-cleared tissue samples. This is a proposal for fundi...

Research Terms

<Address><Biological><Core Facility><Diabetes Mellitus><Equipment><Fluorescence Light Microscopy><Fluorescence Microscopy><Funding><Future><Goals><Health><Hematology><Human><Hybrids><Image><Indiana><Investigators><Kidney><Kidney Urinary System><Light><Medicine><Microscope><Microscopy><Modern Man><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Nephrology><Optics><Photoradiation><Productivity><Research><Research Personnel><Researchers><Resolution><Sampling><Slide><Speed><System><Technology><Tissue Sample><United States National Institutes of Health><Universities><biologic><design><designing><diabetes><fluorescence imaging><fluorescent imaging><high resolution imaging><imaging><medical college><medical schools><microscope imaging><microscopic imaging><microscopy imaging><millimeter><molecular imaging><molecule imaging><novel><optical><renal><resolutions><school of medicine>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANGELA M. GRONENBORN

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 18/100
Solid budget
Team-scale grant
$465,407
FY 2024

Project Title

Pittsburgh Center for HIV Protein Interactions (PCHPI)

Grant Number:

3U54AI170791-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/10/2024

End Date:

4/30/2025

Project Abstract

OVERALL Antiretroviral therapy has turned HIV/AIDS into a chronic disease, yet the emergence of drug-resistant variants and comorbidities after long-term ART remain a concern. Therefore, alternative approaches to inhibit infection and cure AIDS are needed. The proposed “Pittsburgh Center for HIV Pro...

Research Terms

<AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Area><Capsid><Chromatin><Chronic Disease><Chronic Illness><Collaborations><Communication><Complex><Cryo-electron Microscopy><Cryoelectron Microscopy><Development><Drug resistance><Electron Cryomicroscopy><Ensure><HIV><HIV-1><HIV-I><HIV/AIDS><HIV1><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><In Situ><Infection><Integrase Inhibitors><Investigators><Knowledge><LAV-HTLV-III><Lymphadenopathy-Associated Virus><Mentors><Mission><NMR Spectrometer><NMR Spectroscopy><Non-Polyadenylated RNA><Nuclear><Nucleic Acids><Position><Positioning Attribute><Productivity><Program Development><Proteins><RNA><RNA Gene Products><Research><Research Personnel><Researchers><Resistance development><Resistant development><Resolution><Ribonucleic Acid><Structure><Variant><Variation><Virus-HIV><Work><antiretroviral therapy><antiretroviral treatment><career development><chronic disorder><co-morbid><co-morbidity><comorbidity><cryo-EM><cryoEM><cryogenic electron microscopy><design><designing><developing resistance><developmental><drug resistant><expectation><fundamental research><improved><inhibitor><nuclear magnetic resonance spectroscopy><programs><protein complex><resistance to Drug><resistant to Drug><resolutions><single molecule><tool><trafficking><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tatyana Polenova

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 18/100
Solid budget
Team-scale grant
$465,407
FY 2024

Project Title

Pittsburgh Center for HIV Protein Interactions (PCHPI)

Grant Number:

3U54AI170791-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/10/2024

End Date:

4/30/2025

Project Abstract

OVERALL Antiretroviral therapy has turned HIV/AIDS into a chronic disease, yet the emergence of drug-resistant variants and comorbidities after long-term ART remain a concern. Therefore, alternative approaches to inhibit infection and cure AIDS are needed. The proposed “Pittsburgh Center for HIV Pro...

Research Terms

<AIDS><AIDS Virus><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Area><Capsid><Chromatin><Chronic Disease><Chronic Illness><Collaborations><Communication><Complex><Cryo-electron Microscopy><Cryoelectron Microscopy><Development><Drug resistance><Electron Cryomicroscopy><Ensure><HIV><HIV-1><HIV-I><HIV/AIDS><HIV1><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><In Situ><Infection><Integrase Inhibitors><Investigators><Knowledge><LAV-HTLV-III><Lymphadenopathy-Associated Virus><Mentors><Mission><NMR Spectrometer><NMR Spectroscopy><Non-Polyadenylated RNA><Nuclear><Nucleic Acids><Position><Positioning Attribute><Productivity><Program Development><Proteins><RNA><RNA Gene Products><Research><Research Personnel><Researchers><Resistance development><Resistant development><Resolution><Ribonucleic Acid><Structure><Variant><Variation><Virus-HIV><Work><antiretroviral therapy><antiretroviral treatment><career development><chronic disorder><co-morbid><co-morbidity><comorbidity><cryo-EM><cryoEM><cryogenic electron microscopy><design><designing><developing resistance><developmental><drug resistant><expectation><fundamental research><improved><inhibitor><nuclear magnetic resonance spectroscopy><programs><protein complex><resistance to Drug><resistant to Drug><resolutions><single molecule><tool><trafficking><virology>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Franziska Michor

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$249,999
FY 2024

Project Title

A digital twin to track and predict the evolution of pediatric neuroblastoma tumors

Grant Number:

3U54CA274516-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

SUMMARY/ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-24-015. The proposed project aims to pioneer the development of a tumor digital twin, specifically focusing on enhancing dosimetry and radiation biology within radiopharmace...

Research Terms

<0-11 years old><Abscission><Address><Affect><Apoptosis><Apoptosis Pathway><Architecture><Area><Behavior><Blood Vessels><Calibration><Cancer Treatment><Cancers><Cell Body><Cell Death><Cell Density><Cell model><Cells><Cellular model><Characteristics><Child><Child Youth><Childhood><Children (0-21)><Clinical><Clinical Data><Clinical Trials><Complement><Complement Proteins><Complex><Computer Models><Computerized Models><Data><Definitive Radiation Therapy><Deposit><Deposition><Development><Disease><Disorder><Dose><Drugs><EBRT><Engineering / Architecture><Environment><Event><Evolution><Excision><External Beam RT><External Beam Radiation Therapy><External Radiation><Extirpation><Foundations><Generalized Growth><Generations><Goals><Growth><Growth Agents><Growth Factor><Growth Substances><Health><Heterogeneity><History><Hybrids><Image><Immune><Immunes><Individual><Intervention><Intervention Strategies><Intratumoral heterogeneity><Iobenguane><Label><Ligands><MIBG><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Math><Math Models><Mathematics><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Medication><Methods><Modeling><Molecular><Movement><NMR Imaging><NMR Tomography><Nature><Necrosis><Necrotic><Neuroblastoma><Nuclear Magnetic Resonance Imaging><Nutrient><Oncology><Oncology Cancer><Parameter Estimation><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pediatric Oncology><Pharmaceutical Preparations><Phenotype><Position><Positioning Attribute><Precision care><Prediction of Response to Therapy><Programmed Cell Death><Proteins Growth Factors><Radiation><Radiation Biology><Radiation Oncology><Radiation Sensitivity><Radiation Tolerance><Radiation therapy><Radioactive Elements><Radiobiology><Radiopharmaceutical Compound><Radiopharmaceuticals><Radiosensitivity><Radiotherapeutics><Radiotherapy><Random Allocation><Random Selection><Reading><Receptor Protein><Recording of previous events><Removal><Research><SPECT><SPECT imaging><Shapes><Single-Photon Emission-Computed Radionuclide Tomography><Specificity><Surgical Removal><System><Techniques><Testing><Therapeutic><Time><Tissue Growth><Treatment Efficacy><Treatment outcome><Tumor Cell><Validation><Work><Zeugmatography><absorption><anti-cancer research><anti-cancer therapy><biological systems><body movement><cancer care><cancer cell><cancer research><cancer therapy><cancer-directed therapy><clinical applicability><clinical application><clinical relevance><clinically relevant><combinatorial><complementation><computational modeling><computational models><computer based models><computer based prediction><computerized modeling><developmental><differential expression><differentially expressed><digital twin><dosage><dosimetry><drug/agent><external-beam radiation><extracellular><flexibility><flexible><heterogeneity in tumors><high risk><histories><imaging><improved><improved outcome><individual patient><individualized care><individualized patient care><innovate><innovation><innovative><insight><interest><intervention efficacy><interventional strategy><intra-tumoral heterogeneity><intratumor heterogeneity><kids><m-Iodobenzylguanidine><malignancy><mathematic model><mathematical model><mathematical modeling><meta-Iodobenzylguanidine><metaiodobenzylguanidine><migration><necrocytosis><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><ontogeny><parent award><parent grant><parent project><patient oriented outcomes><patient response><patient specific response><pediatric><personalized care><personalized patient care><pharmacokinetic model><predict responsiveness><predict therapeutic response><predict therapy response><predicting response><predictive modeling><pressure><primary end point><primary endpoint><prototype><radiation effect><radiation treatment><radio-sensitivity><radioactive drugs><radiomics><radiosensitive><radiotherapeutic drugs><receptor><resection><response><response to therapy><response to treatment><responsive patient><simulation><single photon emission computed tomography><therapeutic efficacy><therapeutic response><therapy efficacy><therapy prediction><therapy response><tool><transcriptional differences><treatment prediction><treatment response><treatment response prediction><treatment responsiveness><treatment strategy><treatment with radiation><tumor><tumor heterogeneity><validations><vascular><youngster>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VANDERLEI BAGNATO

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Y. Chiao

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CESALTINA FERREIRA LORENZONI

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca R. Richards-Kortum

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathleen Schmeler

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

regis kreitchmann

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$246,592
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Veronica B. Ajewole

TEXAS SOUTHERN UNIVERSITY, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$203,015
FY 2025

Project Title

2/2 Collaborative Union for Cancer Research and Educational Development (CURED)

Grant Number:

5P20CA284967-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2023

End Date:

8/31/2027

Project Abstract

Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated ...

Research Terms

<Advisory Committees><Area><Cancer Center><Cancers><Career Choice><Career Path><Collaborations><Communities><Community Education><Community Health Education><Community Outreach><Comprehensive Cancer Center><Cost Allocation><Cost Apportionment><Curriculum><Data><Degree program><Development><Development and Research><Education><Education and Outreach><Educational Curriculum><Educational aspects><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Environment><Evaluation><Exposure to><Facilities and Administrative Costs><Faculty><Fostering><Funding><Funding Agency><Funding Source><Goals><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Indirect Costs><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><Lead><Leadership><Malignant Neoplasms><Malignant Tumor><Medical center><Medicine><Mentors><Minority Health Research><Minority research><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Outcome><Pb element><Pilot Projects><Prevention><Process><Program Development><R & D><R&D><Research><Research Peer Review><Research Personnel><Research Resources><Researchers><Resources><Schools><Students><Task Forces><Texas><Training><Training Support><Training and Outreach><Tutoring and Outreach><United States National Institutes of Health><Universities><advisory team><anti-cancer research><cancer education><cancer research><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><cost><design><designing><developmental><education research><empowerment><experience><graduate student><heavy metal Pb><heavy metal lead><higher education><improved><innovate><innovation><innovative><lesson plans><malignancy><member><neoplasm/cancer><outreach><outreach program><pilot study><programs><research and development><research in minorities><research on minorities><research related to minorities><research with minorities><summer student><undergrad><undergraduate><undergraduate student><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rayne Helen Rouce

TEXAS SOUTHERN UNIVERSITY, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$203,015
FY 2025

Project Title

2/2 Collaborative Union for Cancer Research and Educational Development (CURED)

Grant Number:

5P20CA284967-03

Activity Code:

P20

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2023

End Date:

8/31/2027

Project Abstract

Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated ...

Research Terms

<Advisory Committees><Area><Cancer Center><Cancers><Career Choice><Career Path><Collaborations><Communities><Community Education><Community Health Education><Community Outreach><Comprehensive Cancer Center><Cost Allocation><Cost Apportionment><Curriculum><Data><Degree program><Development><Development and Research><Education><Education and Outreach><Educational Curriculum><Educational aspects><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Environment><Evaluation><Exposure to><Facilities and Administrative Costs><Faculty><Fostering><Funding><Funding Agency><Funding Source><Goals><HBCUs><Health><Historically Black Colleges><Historically Black Colleges and Universities><Historically Black Institution><Historically Black University><Indirect Costs><Infrastructure><Institution><Instruction and Outreach><Investigators><Joints><Lead><Leadership><Malignant Neoplasms><Malignant Tumor><Medical center><Medicine><Mentors><Minority Health Research><Minority research><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Outcome><Pb element><Pilot Projects><Prevention><Process><Program Development><R & D><R&D><Research><Research Peer Review><Research Personnel><Research Resources><Researchers><Resources><Schools><Students><Task Forces><Texas><Training><Training Support><Training and Outreach><Tutoring and Outreach><United States National Institutes of Health><Universities><advisory team><anti-cancer research><cancer education><cancer research><career><career aspiration><career development><career interest><career pathway><career track><college><college student><collegiate><cost><design><designing><developmental><education research><empowerment><experience><graduate student><heavy metal Pb><heavy metal lead><higher education><improved><innovate><innovation><innovative><lesson plans><malignancy><member><neoplasm/cancer><outreach><outreach program><pilot study><programs><research and development><research in minorities><research on minorities><research related to minorities><research with minorities><summer student><undergrad><undergraduate><undergraduate student><university student>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

OLIVER CHUKWUJEKWU EZECHI

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 18/100
Active award
Team-scale grant
$202,500
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

3U54CA284110-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Juliet Iwelunmor

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 18/100
Active award
Team-scale grant
$202,500
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

3U54CA284110-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph David Tucker

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 18/100
Active award
Team-scale grant
$202,500
FY 2025

Project Title

US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)

Grant Number:

3U54CA284110-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

Nigeria has a substantial number of preventable cancer deaths each year. The human papillomavirus (HPV) vaccine and hepatitis B (HBV) vaccine are both evidence-based strategies to prevent cancer, but they have not been widely scaled up in Nigeria. This suggests the need for innovative strategies tha...

Research Terms

<0-4 weeks old><Acceleration><Address><Adoption><Advanced Cancer><Advanced Malignant Neoplasm><Affect><Africa><Antineoplastic Vaccine><Apical><Applications Grants><Assess implementation><Attention><Award><Birth><Cancer Burden><Cancer Control><Cancer Control Science><Cancer Vaccines><Cancers><Cervical Cancer><Cervix Cancer><Cessation of life><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Coupled><Death><Decentralization><Development and Research><Dose><Educational Activities><Environment><Evaluation><Evidence based intervention><Faculty><Goals><Grant><Grant Proposals><Guidelines><HBV Vaccination><HBV Vaccine><HBV disease><HPV><HPV Vaccination><HPV Vaccine><HPV caused cancer><HPV driven cancers><HPV induced cancer><HPV malignancy><HPV prevention><HPV vaccination acceptability><HPV vaccination acceptance><HPV vaccination confidence><HPV vaccination uptake><HPV vaccine acceptability><HPV vaccine acceptance><HPV vaccine confidence><HPV vaccine uptake><HPV+ cancer><HPV-Related Malignancy><HPV-associated cancer><HPV-associated malignancy><HPV-related cancer><Health><Hep B vaccination><HepB><Hepatic Cancer><Hepatitis B><Hepatitis B Vaccination><Hepatitis B Vaccines><Hepatitis B immunization><Hepatitis B series immunization><Hepatitis B virus vaccine><Human Papilloma Virus><Human Papilloma Virus Vaccination><Human Papilloma Virus Vaccine><Human Papilloma Virus-Related Malignancy><Human Papilloma Virus-Related Malignant Neoplasm><Human Papilloma Virus-associated cancer><Human Papilloma Virus-associated malignancy><Human Papilloma Virus-related cancer><Human Papillomavirus><Human Papillomavirus Vaccination><Human papillomavirus Vaccine><Human papillomavirus cancer><Human papillomavirus induced cancer><Human papillomavirus malignancy><Human papillomavirus prevention><Human papillomavirus-Related Malignancy><Human papillomavirus-Related Malignant Neoplasm><Implementation assessment><Incidence><Infectious Human Wart Virus><Infrastructure><Institution><Intervention><Investigators><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Oral Cavity Neoplasm><Malignant Oral Cavity Tumor><Malignant Oral Neoplasm><Malignant Penile Tumor><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant Vagina Neoplasm><Malignant Vagina Tumor><Malignant Vaginal Neoplasm><Malignant Vaginal Tumor><Malignant Vulva Tumor><Malignant Vulvar Neoplasm><Malignant Vulvar Tumor><Malignant neoplasm of cervix uteri><Malignant neoplasm of liver><Malignant neoplasm of penis><Malignant neoplasm of vulva><Medical Research><Mentors><Mentorship><Mission><Modeling><Monitor><Mouth Cancer><NIH><NIMH><National Cancer Burden><National Institute of Mental Health><National Institutes of Health><Neoplasm Vaccines><Newborn Infant><Newborns><Nigeria><Nigerian><North Carolina><Oral Cancer><Parturition><Penile Cancer><Phase><Policies><Principal Investigator><Process><Productivity><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Science><Services><Sight><Students><System><Testing><Training><Training Programs><Translations><Travel><Tumor Vaccines><United States National Institutes of Health><Universities><Uterine Cervix Cancer><Vaccination><Vaccines><Vagina Cancer><Vaginal Cancers><Viral Hepatitis B><Vision><Vulva Cancer><Vulvar Cancer><Washington><accept HPV vaccination><accept HPV vaccine><accept human papilloma virus vaccination><accept human papilloma virus vaccine><aged><anti-cancer research><anti-tumor vaccine><apprentice><apprenticeship><cancer prevention><cancer research><career><community based participatory research><community engagement><community led research><community participatory research><community partnered participatory research><community setting><conference><convention><crowd source><crowd-sourcing><crowdsource><crowdsourcing><design><designing><direct application><engagement with communities><evaluate implementation><evaluation of implementation><evidence base><facilitators to implementation><girls><hep B><hepatitis B virus disease><hepatitis B virus vaccination><human papilloma virus vaccination acceptability><human papilloma virus vaccination acceptance><human papilloma virus vaccination confidence><human papilloma virus vaccination uptake><human papilloma virus vaccine acceptability><human papilloma virus vaccine acceptance><human papilloma virus vaccine confidence><human papilloma virus vaccine uptake><human papillomavirus associated malignancy><human papillomavirus caused cancer><human papillomavirus driven cancers><human papillomavirus-associated cancer><human papillomavirus-related cancer><immunization against hepatitis B><implementation evaluation><implementation facilitators><implementation outcomes><implementation science><implementation strategy><improved><innovate><innovation><innovative><liver cancer><liver malignancy><malignancy><malignant liver tumor><malignant mouth neoplasm><malignant mouth tumor><mortality><multidisciplinary><neoplasm/cancer><newborn child><newborn children><novel><oral cavity cancer><outreach><participatory action research><prevent><prevent HPV><prevent human papillomavirus><preventing><research and development><research study><scale up><skills><strategies for implementation><success><summit><symposia><symposium><tool><translation><uptake><vaccination against hepatitis B><vaccine against hepatitis B><vaccine for cancer><visual function><vulval cancer><wart virus>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GR Scott Budinger

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 18/100
Active award
Team-scale grant
$200,000
FY 2025

Project Title

Administrative Supplement to U54 AG079754: Midwest Murine-Tissue Mapping Center (MM-TMC)

Grant Number:

3U54AG079754-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/2/2022

End Date:

7/31/2026

Project Abstract

ADMINISTRATIVE SUPPLEMENT GRANT SUMMARY The Midwest Murine Tissue Mapping Center (MM-TMC) is focused on identifying, characterizing and spatially mapping senescent cells (SnCs) in 5 different murine tissues – adipose, brain, liver, lung and muscle– from two different mouse strains (C57BL/6J and FVB;...

Research Terms

<Adipose tissue><Administrative Supplement><Age><Aging><Antibodies><Body Tissues><Brain><Brain Nervous System><Cell Body><Cells><Detection><Disease><Disorder><Encephalon><Expression Profiling><Fatty Tissue><Gene Expression><Gene Expression Monitoring><Gene Expression Pattern Analysis><Gene Expression Profiling><Gene Transcription><Genetic Transcription><Grant><Inflammatory><Ligands><Liver><Lung><Lung Respiratory System><Maps><Mice><Mice Mammals><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Molecular><Mouse Strains><Murine><Mus><Muscle><Muscle Tissue><Neurosciences><Non-Polyadenylated RNA><Paracrine Communication><Paracrine Signaling><Parents><Play><Population><Proteins><Proteome><RNA><RNA Expression><RNA Gene Products><Receptor Protein><Resolution><Ribonucleic Acid><Role><Single-Nucleus Sequencing><Time><Tissues><Transcript><Transcript Expression Analyses><Transcript Expression Analysis><Transcription><adipose><age associated disease><age associated disorder><age associated impairment><age dependent disease><age dependent disorder><age dependent impairment><age related human disease><age-related disease><age-related disorder><age-related impairment><ages><analyze gene expression><cellular senescence mapping><cellular senescence tracing><cost><digital><falls><gene expression analysis><gene expression assay><global gene expression><global transcription profile><hepatic body system><hepatic organ system><imager><improved><muscular><nanostring><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><paracrine><parent><receptor><resolutions><sNuc-Seq><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent cell><senescent cell mapping><senescent cell tracing><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><tissue map><tissue mapping><transcriptional profiling><transcriptome><white adipose tissue><yellow adipose tissue>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sundeep Khosla

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 18/100
Active award
Team-scale grant
$200,000
FY 2025

Project Title

Administrative Supplement to U54 AG079754: Midwest Murine-Tissue Mapping Center (MM-TMC)

Grant Number:

3U54AG079754-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/2/2022

End Date:

7/31/2026

Project Abstract

ADMINISTRATIVE SUPPLEMENT GRANT SUMMARY The Midwest Murine Tissue Mapping Center (MM-TMC) is focused on identifying, characterizing and spatially mapping senescent cells (SnCs) in 5 different murine tissues – adipose, brain, liver, lung and muscle– from two different mouse strains (C57BL/6J and FVB;...

Research Terms

<Adipose tissue><Administrative Supplement><Age><Aging><Antibodies><Body Tissues><Brain><Brain Nervous System><Cell Body><Cells><Detection><Disease><Disorder><Encephalon><Expression Profiling><Fatty Tissue><Gene Expression><Gene Expression Monitoring><Gene Expression Pattern Analysis><Gene Expression Profiling><Gene Transcription><Genetic Transcription><Grant><Inflammatory><Ligands><Liver><Lung><Lung Respiratory System><Maps><Mice><Mice Mammals><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Molecular><Mouse Strains><Murine><Mus><Muscle><Muscle Tissue><Neurosciences><Non-Polyadenylated RNA><Paracrine Communication><Paracrine Signaling><Parents><Play><Population><Proteins><Proteome><RNA><RNA Expression><RNA Gene Products><Receptor Protein><Resolution><Ribonucleic Acid><Role><Single-Nucleus Sequencing><Time><Tissues><Transcript><Transcript Expression Analyses><Transcript Expression Analysis><Transcription><adipose><age associated disease><age associated disorder><age associated impairment><age dependent disease><age dependent disorder><age dependent impairment><age related human disease><age-related disease><age-related disorder><age-related impairment><ages><analyze gene expression><cellular senescence mapping><cellular senescence tracing><cost><digital><falls><gene expression analysis><gene expression assay><global gene expression><global transcription profile><hepatic body system><hepatic organ system><imager><improved><muscular><nanostring><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><paracrine><parent><receptor><resolutions><sNuc-Seq><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent cell><senescent cell mapping><senescent cell tracing><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><tissue map><tissue mapping><transcriptional profiling><transcriptome><white adipose tissue><yellow adipose tissue>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul D. Robbins

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 18/100
Active award
Team-scale grant
$200,000
FY 2025

Project Title

Administrative Supplement to U54 AG079754: Midwest Murine-Tissue Mapping Center (MM-TMC)

Grant Number:

3U54AG079754-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/2/2022

End Date:

7/31/2026

Project Abstract

ADMINISTRATIVE SUPPLEMENT GRANT SUMMARY The Midwest Murine Tissue Mapping Center (MM-TMC) is focused on identifying, characterizing and spatially mapping senescent cells (SnCs) in 5 different murine tissues – adipose, brain, liver, lung and muscle– from two different mouse strains (C57BL/6J and FVB;...

Research Terms

<Adipose tissue><Administrative Supplement><Age><Aging><Antibodies><Body Tissues><Brain><Brain Nervous System><Cell Body><Cells><Detection><Disease><Disorder><Encephalon><Expression Profiling><Fatty Tissue><Gene Expression><Gene Expression Monitoring><Gene Expression Pattern Analysis><Gene Expression Profiling><Gene Transcription><Genetic Transcription><Grant><Inflammatory><Ligands><Liver><Lung><Lung Respiratory System><Maps><Mice><Mice Mammals><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Molecular><Mouse Strains><Murine><Mus><Muscle><Muscle Tissue><Neurosciences><Non-Polyadenylated RNA><Paracrine Communication><Paracrine Signaling><Parents><Play><Population><Proteins><Proteome><RNA><RNA Expression><RNA Gene Products><Receptor Protein><Resolution><Ribonucleic Acid><Role><Single-Nucleus Sequencing><Time><Tissues><Transcript><Transcript Expression Analyses><Transcript Expression Analysis><Transcription><adipose><age associated disease><age associated disorder><age associated impairment><age dependent disease><age dependent disorder><age dependent impairment><age related human disease><age-related disease><age-related disorder><age-related impairment><ages><analyze gene expression><cellular senescence mapping><cellular senescence tracing><cost><digital><falls><gene expression analysis><gene expression assay><global gene expression><global transcription profile><hepatic body system><hepatic organ system><imager><improved><muscular><nanostring><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><paracrine><parent><receptor><resolutions><sNuc-Seq><senescence cell mapping><senescence cells tracing><senescence mapping><senescence tracing><senescent cell><senescent cell mapping><senescent cell tracing><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><tissue map><tissue mapping><transcriptional profiling><transcriptome><white adipose tissue><yellow adipose tissue>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ADAN COLON-CARMONA

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$200,000
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jill A. Macoska

UNIVERSITY OF MASSACHUSETTS BOSTON, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$200,000
FY 2024

Project Title

1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156734-14S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/28/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Ddungu Kambugu

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$190,517
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S4

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY N MARTIN

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$190,517
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S4

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Yong Li

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$186,712
FY 2024

Project Title

DELINEATE THE TUMOR IMMUNE MICROENVIRONMENT FOR BETTER UNDERSTANDING IMMUNOTHERAPY RESPONSE

Grant Number:

3U54CA272691-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

8/31/2027

Project Abstract

Project Summary Monoclonal gammopathy of undetermined significance (MGUS) is a precancerous condition in which a person has moderately elevated levels of an abnormal immunoglobulin (Ig) protein (called M protein) in the blood. MGUS patients have a cancer risk ~6.5 times as high as the control popula...

Research Terms

<19S Gamma Globulin><7S Gamma Globulin><Active Follow-up><Affect><Age Years><American><Amyloid><Amyloid Substance><Automobile Driving><B-Cell CLL><B-Cell Chronic Lymphocytic Leukemia><B-Cell Chronic Lymphogenous Leukemia><B-Cell Chronic Lymphoid Leukemia><B-Cell Lymphocytic Leukemia><B-Lymphocytic Leukemia><Blood><Blood Diseases><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Blood-Deriving Cell><Bone Marrow Blood-Forming Cell><Bone Marrow Cells><Bone Marrow Reticuloendothelial System><Cancer Center><Cancers><Chemicals><Chemoprevention><Chronic B-Lymphocytic Leukemia><Chronic Lymphatic Leukemia><Chronic Lymphoblastic Leukemia><Chronic Lymphocytic Leukemia><Chronic Lymphogenous Leukemia><Communication><Consensus><DNA Vaccines><Dedications><Development><Development and Research><Diagnosis><Diagnostic><Disease><Disorder><E3 Ligase><E3 Ubiquitin Ligase><Funding><Ganciclovir><Gancyclovir><Goals><Hematologic Diseases><Hematological Disease><Hematological Disorder><IgA><IgD><IgE><IgG><IgM><Immune Globulins><Immune mediated therapy><Immunochemical Immunologic><Immunoglobulin A><Immunoglobulin D><Immunoglobulin E><Immunoglobulin G><Immunoglobulin M><Immunoglobulins><Immunologic><Immunological><Immunologically><Immunologically Directed Therapy><Immunologics><Immunoprevention><Immunotherapy><In Vitro><Infrastructure><Intercept><Intervention><Intervention Strategies><Investigation><Investigators><Life Expectancy><Light><Light-Chain Immunoglobulins><Lymphoid><Lymphoplasmacytic Lymphoma><Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia><Lymphoplasmacytic Type Immunocytoma><Lymphoplasmacytoid Lymphoma><M protein><MGUS><Macroglobulinemia><Malignant Neoplasms><Malignant Tumor><Molecular><Monoclonal Gammopathy of Undetermined Significance><Monoclonal Gammopathy of Unknown Significance><Monoclonal gammopathy of uncertain significance><Multiple Myeloma><Mutate><Naked DNA Vaccines><Network Infrastructure><Non-Hodgkin's Lymphoma><Nonhodgkins Lymphoma><Nordeoxyguanosine><Oncogene Products><Oncogene Proteins><Oncogenic><Oncoproteins><P50 Mechanism><P50 Program><Patients><Persons><Photoradiation><Plasma-Cell Myeloma><Plasmacytoma><Population><Population Control><Precancerous Conditions><Premalignant Condition><Premalignant State><Prevention><Preventive><Process><Protein Secretion><Proteins><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Recombinant DNA Vaccines><Recommendation><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Risk><Risk Factors><Role><Solitary Plasmacytoma><Specialized Center><Syndrome><Testing><Ubiquitin Protein Ligase><Ubiquitin-Protein Ligase Complexes><Ubiquitin-Protein Ligase E3><Waldenstrom Macroglobulinemia><Waldenstrom's macroglobulinaemia><Waldenström's hyperglobulinaemia><Waldenström's hyperglobulinemia><Waldenström's macroglobulinaemia><Waldenström's macroglobulinemia><active followup><blood disorder><cancer diagnosis><cancer invasiveness><cancer prevention><cancer progression><cancer risk><chronic lymphoid leukemia><clinical practice><determine efficacy><developmental><driving><early clinical trial><early phase clinical trial><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><evaluate efficacy><examine efficacy><follow up><follow-up><followed up><followup><high risk><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><in vivo><individualized cancer care><individualized oncology><innovate><innovation><innovative><interventional strategy><light chain amyloidosis><malignancy><multiple myeloma M Protein><myeloma><myelomatosis><neoplasm progression><neoplasm/cancer><neoplastic progression><non-Hodgkins disease><novel><personalized oncology><precancerous state><precision cancer care><precision cancer medicine><precision cancer prevention><precision oncology><prevent><preventing><primary amyloidosis of light chain type><programs><progression risk><research and development><response><senescence><senescent><small molecule><social role><targeted agent><tumor immune microenvironment><tumor initiation><tumor progression><tumor-immune system interactions><ubiquitin-protein ligase>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDREA CALIFANO

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 18/100
Active award
Team-scale grant
$164,500
FY 2024

Project Title

Studying the evolution of drug resistance in prostate cancer at the single cell level

Grant Number:

3U54CA274506-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

PROJECT SUMMARY Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus deriving only modest improvement in disease-free survival from targeted therapy and immunotherapy. Tumor heterogeneity adds fur...

Research Terms

<3-D structure><3-dimensional structure><3D structure><Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Binding><Biological><Biological Markers><Body Tissues><Brain Metastasis><Buffers><Cancer Center><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Clinical><Collaborations><Combined Modality Therapy><Dependence><Development><Disease-Free Survival><Dissection><Drug resistance><Drugs><Education><Educational aspects><Endocrine><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Event><Event-Free Survival><Evolution><Fostering><Gene Transcription><Genetic><Genetic Alteration><Genetic Change><Genetic Transcription><Genetic defect><Goals><Immune mediated therapy><Immunologically Directed Therapy><Immunotherapy><Individual><Intervention><Intervention Strategies><Intervention Trial><Interventional trial><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><Ligands><Maintenance><Malignant><Malignant - descriptor><Malignant Cell><Malignant Melanoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Prostate><Malignant neoplasm of prostate><Malignant prostatic tumor><Mediating><Medication><Melanoma><Metastatic Neoplasm to the Brain><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Methodology><Molecular><Molecular Interaction><Multimodal Therapy><Multimodal Treatment><Mutation><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Network-based><Non-Malignant><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Outcome><Patients><Pharmaceutical Preparations><Pharmacology><Phenotype><Printing><Productivity><Prognosis><Prostate CA><Prostate Cancer><Prostate malignancy><Prostatic Cancer><Proteome><Proteomics><Publications><RNA Expression><Receptor Protein><Research><Research Personnel><Researchers><Reverse engineering><Science><Scientific Publication><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Structure><System><Systems Biology><Systems Integration><Technology><Therapeutic><Therapy trial><Tissues><Transcription><Validation><actionable mutation><actionable variants><anti-cancer therapy><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><brain micrometastasis><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer-directed therapy><cell type><check point blockade><checkpoint blockade><clinical relevance><clinical translation><clinically relevant><clinically translatable><combination therapy><combined modality treatment><combined treatment><design><designing><developmental><drug mechanism><drug resistant><drug/agent><epigenetically><evidence base><forging><genome mutation><heterogeneity in tumors><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><innovate><innovation><innovative><integrated system><interest><interventional strategy><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><multi-modal therapy><multi-modal treatment><multiomics><multiple data sources><multiple omics><neoplasm progression><neoplasm/cancer><neoplastic progression><next generation><nonmalignant><novel><outreach><panomics><paracrine><patient responsibilities><pharmacologic><programs><receptor><receptor-mediated signaling><recruit><relapse patients><resistance to Drug><resistant to Drug><single cell technology><system integration><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><three dimensional structure><tumor><tumor heterogeneity><tumor immune microenvironment><tumor initiation><tumor microenvironment><tumor progression><tumor-immune system interactions><validations><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BARRY H HONIG

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 18/100
Active award
Team-scale grant
$164,500
FY 2024

Project Title

Studying the evolution of drug resistance in prostate cancer at the single cell level

Grant Number:

3U54CA274506-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

PROJECT SUMMARY Patients with aggressive cancers often present with no pharmacologically actionable mutations and poor or no sensitivity to immune checkpoint blockade, thus deriving only modest improvement in disease-free survival from targeted therapy and immunotherapy. Tumor heterogeneity adds fur...

Research Terms

<3-D structure><3-dimensional structure><3D structure><Acceleration><Address><Advanced Cancer><Advanced Malignant Neoplasm><Behavior><Binding><Biological><Biological Markers><Body Tissues><Brain Metastasis><Buffers><Cancer Center><Cancer Treatment><Cancers><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Clinical><Collaborations><Combined Modality Therapy><Dependence><Development><Disease-Free Survival><Dissection><Drug resistance><Drugs><Education><Educational aspects><Endocrine><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Event><Event-Free Survival><Evolution><Fostering><Gene Transcription><Genetic><Genetic Alteration><Genetic Change><Genetic Transcription><Genetic defect><Goals><Immune mediated therapy><Immunologically Directed Therapy><Immunotherapy><Individual><Intervention><Intervention Strategies><Intervention Trial><Interventional trial><Intracellular Communication and Signaling><Intratumoral heterogeneity><Investigators><Ligands><Maintenance><Malignant><Malignant - descriptor><Malignant Cell><Malignant Melanoma><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Prostate><Malignant neoplasm of prostate><Malignant prostatic tumor><Mediating><Medication><Melanoma><Metastatic Neoplasm to the Brain><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Methodology><Molecular><Molecular Interaction><Multimodal Therapy><Multimodal Treatment><Mutation><NSCLC><NSCLC - Non-Small Cell Lung Cancer><Network-based><Non-Malignant><Non-Small Cell Lung Cancer><Non-Small-Cell Lung Carcinoma><Outcome><Patients><Pharmaceutical Preparations><Pharmacology><Phenotype><Printing><Productivity><Prognosis><Prostate CA><Prostate Cancer><Prostate malignancy><Prostatic Cancer><Proteome><Proteomics><Publications><RNA Expression><Receptor Protein><Research><Research Personnel><Researchers><Reverse engineering><Science><Scientific Publication><Scientist><Signal Transduction><Signal Transduction Systems><Signaling><Structure><System><Systems Biology><Systems Integration><Technology><Therapeutic><Therapy trial><Tissues><Transcription><Validation><actionable mutation><actionable variants><anti-cancer therapy><bio-markers><biologic><biologic marker><biological signal transduction><biomarker><brain micrometastasis><cancer cell><cancer microenvironment><cancer progression><cancer therapy><cancer-directed therapy><cell type><check point blockade><checkpoint blockade><clinical relevance><clinical translation><clinically relevant><clinically translatable><combination therapy><combined modality treatment><combined treatment><design><designing><developmental><drug mechanism><drug resistant><drug/agent><epigenetically><evidence base><forging><genome mutation><heterogeneity in tumors><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><innovate><innovation><innovative><integrated system><interest><interventional strategy><intra-tumoral heterogeneity><intratumor heterogeneity><malignancy><multi-modal therapy><multi-modal treatment><multiomics><multiple data sources><multiple omics><neoplasm progression><neoplasm/cancer><neoplastic progression><next generation><nonmalignant><novel><outreach><panomics><paracrine><patient responsibilities><pharmacologic><programs><receptor><receptor-mediated signaling><recruit><relapse patients><resistance to Drug><resistant to Drug><single cell technology><system integration><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><three dimensional structure><tumor><tumor heterogeneity><tumor immune microenvironment><tumor initiation><tumor microenvironment><tumor progression><tumor-immune system interactions><validations><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY, SEATTLE, WA

Exploratory lead · 18/100
Active award
Team-scale grant
$144,537
FY 2025

Project Title

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

Grant Number:

3U54CA274509-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2022

End Date:

8/31/2027

Project Abstract

The proposed U54 program Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor --Immunotherapy Combinations (ST-Analytics) is designed to develop the recent conceptual advance that targeted inhibitor + cancer immunotherapy (IT) combination treatments may yield significantly greate...

Research Terms

<Acceleration><Address><Adoptive Cell Transfers><Algorithms><American><Automobile Driving><Biological><Biopsy><Body Tissues><Brain Metastasis><Calibration><Cancers><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Physiology><Cellular Process><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Combination immunotherapy><Combined Modality Therapy><Communities><Coupled><Data><Data Bases><Databases><Development><Dimensions><Distal><Dose><Drugs><Education and Outreach><Educational Models><Environment><Environment Design><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Gene Transcription><Genetic Transcription><Immune><Immune mediated therapy><Immune system><Immunes><Immunologic Factors><Immunological Factors><Immunologically Directed Therapy><Immunooncology><Immunotherapy><Individual><Instruction and Outreach><Instructional Models><Internships><Investigators><K-12 Education><K-12 classroom><K-12 level><K12 classroom><K12 education><K12 level><Kinetics><Knowledge><Lead><Leadership><MAPK Inhibitors><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Measurement><Medication><Melanoma><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Neoplasm to the Brain><Metastatic Tumor><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Mitogen-Activated Protein Kinase Inhibitor><Modeling><Multimodal Therapy><Multimodal Treatment><Nature><Neoplasm Metastasis><Outcome><Patients><Pb element><Pharmaceutical Preparations><Pilot Projects><Play><Primary Neoplasm><Primary Tumor><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resistance><Resources><Role><STEM Education><STEM knowledge><Science><Science, Technology, Engineering and Math Education><Science, Technology, Engineering and Mathematics Education><Scientist><Secondary Neoplasm><Secondary Tumor><Self evaluation><Self-Examination><Self-Surveillance><Series><Structure><Subcellular Process><System><Systems Biology><Therapeutic><Time><Tissues><Training and Outreach><Transcription><Tutoring and Outreach><Visual><Work><adoptive cell therapy><adoptive cellular therapy><anti-cancer immunotherapy><anticancer immunotherapy><biobank><biologic><biorepository><brain micrometastasis><cancer immunotherapy><cancer metastasis><check point blockade><checkpoint blockade><combination therapy><combinatorial><combinatorial immunotherapy><combined modality treatment><combined treatment><computational resources><computing resources><data base><design><designing><developmental><disease model><disorder model><driving><drug/agent><dual immunotherapy><educational methods><educational practices><educational principles><epigenetically><heavy metal Pb><heavy metal lead><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immune-oncology><immuno oncology><immuno therapy><immunologic substance><immunological substance><immunology oncology><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><in silico><in vivo><inhibitor><inhibitor drug><inhibitor therapeutic><inhibitor therapy><intern><malignancy><medical college><medical schools><model design><mouse model><multi-modal therapy><multi-modal treatment><murine model><neoplasm/cancer><oncoimmunology><outreach><outreach program><pilot study><prevent><preventing><programs><recruit><resistant><school of medicine><science, technology, engineering and math knowledge><science, technology, engineering and mathematics knowledge><social role><spatial and temporal><spatial multiomics><spatial omics><spatial temporal><spatial tri-omics><spatiotemporal><tool><transcriptomics><tumor><tumor cell metastasis><tumor immune microenvironment><tumor-immune system interactions>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TATIANA M. FOROUD

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Exploratory lead · 18/100
Active award
Team-scale grant
$136,792
FY 2025

Project Title

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)

Grant Number:

3U24AG021886-24S1

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/15/2002

End Date:

5/31/2027

Project Abstract

Project Summary/Abstract This administrative supplement outlines the critical role of the National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) in establishing a centralized, high-quality resource of induced pluripotent stem cells (iPSCs) developed as part of the U54 ...

Research Terms

<AD dementia><AD related dementia><ADRD><Acceleration><Address><Administrative Supplement><Affect><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><Animal Model><Animal Models and Related Studies><CNS Nervous System><Cell model><Cellular model><Central Nervous System><Clinical><Clinical Data><Collection><Complex><DNA><Data><Data Linkages><Deoxyribonucleic Acid><Dysfunction><Fostering><Functional disorder><Funding><Genetic><Infrastructure><Knowledge Portal><Knowledge base Portal><Knowledgebase Portal><Link><Manuals><Neuraxis><Peripheral Nervous System><Physiopathology><Position><Positioning Attribute><Prevalence><Primary Senile Degenerative Dementia><Procedures><Process><Protocol><Protocols documentation><Record Linkage Study><Reproducibility><Research><Research Resources><Resources><Risk-associated variant><Role><Sampling><Standardization><cell repository><cell type><cellular repository><depository><functional genomics><iPS><iPSC><iPSCs><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><innovate><innovation><innovative><interest><model of animal><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><pathophysiology><primary degenerative dementia><repository><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><senile dementia of the Alzheimer type><social role>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY, SEATTLE, WA

Exploratory lead · 18/100
Active award
Team-scale grant
$133,520
FY 2024

Project Title

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

Grant Number:

3U54CA274509-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2022

End Date:

8/31/2027

Project Abstract

Overall Project Summary The proposed U54 program Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor -- Immunotherapy Combinations (ST-Analytics) is designed to develop the recent conceptual advance that targeted inhibitor + cancer immunotherapy (IT) combination treatments may y...

Research Terms

<Acceleration><Address><Adoptive Cell Transfers><Algorithms><Automobile Driving><Biological><Biopsy><Body Tissues><Brain Metastasis><Calibration><Cancers><Cell Body><Cell Function><Cell Physiology><Cell Process><Cells><Cellular Function><Cellular Physiology><Cellular Process><Clinical><Clinical Data><Clinical Trials><Clinical Trials Design><Combination immunotherapy><Combined Modality Therapy><Communities><Coupled><Data><Data Bases><Databases><Development><Dimensions><Disadvantaged><Distal><Dose><Drugs><Education and Outreach><Educational Models><Environment><Environment Design><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Gene Transcription><Genetic Transcription><Immune><Immune mediated therapy><Immune system><Immunes><Immunologic Factors><Immunological Factors><Immunologically Directed Therapy><Immunooncology><Immunotherapy><Individual><Instruction and Outreach><Instructional Models><Internships><Investigators><K-12 Education><K-12 classroom><K-12 level><K12 classroom><K12 education><K12 level><Kinetics><Knowledge><Lead><Leadership><MAPK Inhibitors><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Measurement><Medication><Melanoma><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Neoplasm to the Brain><Metastatic Tumor><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Mitogen-Activated Protein Kinase Inhibitor><Modeling><Multimodal Therapy><Multimodal Treatment><Nature><Neoplasm Metastasis><Outcome><Patients><Pb element><Pharmaceutical Preparations><Pilot Projects><Play><Primary Neoplasm><Primary Tumor><Proteomics><R-Series Research Projects><R01 Mechanism><R01 Program><RNA Expression><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resistance><Resources><Role><STEM Education><STEM knowledge><Science><Science, Technology, Engineering and Math Education><Science, Technology, Engineering and Mathematics Education><Scientist><Secondary Neoplasm><Secondary Tumor><Self evaluation><Self-Examination><Self-Surveillance><Series><Structure><Subcellular Process><System><Systems Biology><Therapeutic><Time><Tissues><Training and Outreach><Transcription><Tutoring and Outreach><Visual><Work><adoptive cell therapy><adoptive cellular therapy><anti-cancer immunotherapy><anticancer immunotherapy><biobank><biologic><biorepository><brain micrometastasis><cancer immunotherapy><cancer metastasis><check point blockade><checkpoint blockade><combination therapy><combinatorial><combinatorial immunotherapy><combined modality treatment><combined treatment><computational resources><computing resources><data base><demographics><design><designing><developmental><disease model><disorder model><driving><drug/agent><dual immunotherapy><educational methods><educational practices><educational principles><epigenetically><heavy metal Pb><heavy metal lead><immune check point blockade><immune checkpoint blockade><immune microenvironment><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immune-oncology><immuno oncology><immuno therapy><immunologic substance><immunological substance><immunology oncology><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><immunotherapy for cancer><immunotherapy of cancer><in silico><in vivo><inhibitor><inhibitor drug><inhibitor therapeutic><inhibitor therapy><intern><malignancy><medical college><medical schools><model design><mouse model><multi-modal therapy><multi-modal treatment><multiomics><multiple omics><murine model><neoplasm/cancer><oncoimmunology><outreach><outreach program><panomics><pilot study><prevent><preventing><programs><recruit><resistant><school of medicine><science, technology, engineering and math knowledge><science, technology, engineering and mathematics knowledge><social role><spatiotemporal><tool><transcriptomics><tumor><tumor cell metastasis><tumor immune microenvironment><tumor-immune system interactions>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maria Eulalia Fernandez

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$127,173
FY 2024

Project Title

Implementation Evaluation of a Workplace Self-Sampling HPV Detection Program within the Mexican Social Security Institute

Grant Number:

3U54CA284109-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2023

End Date:

8/31/2028

Project Abstract

Cervical cancer (CC) is the second leading cause of cancer death among women in Mexico, yet screening participation is alarmingly low, with less than 30% of women aged 20 or older having ever been screened in 2022. Human papillomavirus (HPV) self-sampling is an effective method that increases access...

Research Terms

<Active Follow-up><Address><Administrative Supplement><Adopted><Adoption><Appointment><Assess implementation><Cancer Cause><Cancer Control><Cancer Control Science><Cancer Etiology><Cancers><Caring><Cervical Cancer><Cervix Cancer><Characteristics><Clinic><Clinical><Colposcopy><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Cytology><Diagnostic><E-Mail><Effectiveness><Electronic Mail><Email><Equity><Fear><Female><Floor><Fright><Funding><Goals><HPV><HPV detection><HPV positive><HPV screening><HPV(+)><HPV+><Health><Health Care Providers><Health Care Systems><Health Facilities><Health Personnel><Health care facility><Healthcare><Healthcare Facility><Healthcare Providers><Healthcare Systems><Healthcare worker><Human Papilloma Virus><Human Papilloma Virus detection><Human Papilloma Virus screening><Human Papillomavirus><Human Resources><Implementation assessment><Infectious Human Wart Virus><Institution><Integrated Health Care Systems><Interview><Job Location><Job Place><Job Setting><Job Site><LMIC><Latin America><Logic><Maintenance><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Manpower><Maps><Methods><Mexican><Mexico><Modeling><Morbidity><Morbidity - disease rate><NCI Organization><National Cancer Institute><Needs Assessment><Outcome><Pain><Painful><Parents><Patients><Population><Process><Program Effectiveness><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Sampling><Screening for cancer><Social Insurance><Social Security><Structure><Test Result><Testing><Texas><Time><Training><Underserved Population><Uterine Cervix Cancer><Variant><Variation><Woman><Women's mortality><Work><Work Location><Work Place><Work-Site><Working Women><Workplace><Worksite><active followup><aged><barriers to implementation><care facilities><cost effectiveness><death among females><death among women><death in females><death in women><death rate among women><death rate in women><design><designing><digital platform><early cancer detection><effectiveness outcome><effectiveness-related outcomes><electronic communication><evaluate implementation><evaluation of implementation><experience><facilitators to implementation><female death><female mortality><follow up><follow-up><followed up><followup><health care><health care personnel><health care service><health care worker><health provider><health workforce><healthcare personnel><healthcare service><human papillomavirus +><human papillomavirus positive><implementation barriers><implementation challenges><implementation design><implementation determinants><implementation efforts><implementation evaluation><implementation facilitators><implementation factors><implementation fidelity><implementation outcomes><implementation research><implementation research design><implementation science><implementation strategy><improved><integrated health system><integrated healthcare systems><integrated system of care><low and middle-income countries><malignancy><manufacturing facility><manufacturing plants><medical personnel><mortality><mortality among females><mortality among women><mortality in females><mortality in women><neoplasm/cancer><parent><personnel><presence of HPV><presence of human papillomavirus><primary care clinic><production plants><programs><reach, efficacy, adoption, implementation, and maintenance><screening><screening cancer patients><screening participation><screening program><screenings><strategies for implementation><success><training opportunity><treatment provider><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><uptake><wart virus><women's death><women's death rate><work setting><working females>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Martin Lajous

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$127,173
FY 2024

Project Title

Implementation Evaluation of a Workplace Self-Sampling HPV Detection Program within the Mexican Social Security Institute

Grant Number:

3U54CA284109-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2023

End Date:

8/31/2028

Project Abstract

Cervical cancer (CC) is the second leading cause of cancer death among women in Mexico, yet screening participation is alarmingly low, with less than 30% of women aged 20 or older having ever been screened in 2022. Human papillomavirus (HPV) self-sampling is an effective method that increases access...

Research Terms

<Active Follow-up><Address><Administrative Supplement><Adopted><Adoption><Appointment><Assess implementation><Cancer Cause><Cancer Control><Cancer Control Science><Cancer Etiology><Cancers><Caring><Cervical Cancer><Cervix Cancer><Characteristics><Clinic><Clinical><Colposcopy><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Cytology><Diagnostic><E-Mail><Effectiveness><Electronic Mail><Email><Equity><Fear><Female><Floor><Fright><Funding><Goals><HPV><HPV detection><HPV positive><HPV screening><HPV(+)><HPV+><Health><Health Care Providers><Health Care Systems><Health Facilities><Health Personnel><Health care facility><Healthcare><Healthcare Facility><Healthcare Providers><Healthcare Systems><Healthcare worker><Human Papilloma Virus><Human Papilloma Virus detection><Human Papilloma Virus screening><Human Papillomavirus><Human Resources><Implementation assessment><Infectious Human Wart Virus><Institution><Integrated Health Care Systems><Interview><Job Location><Job Place><Job Setting><Job Site><LMIC><Latin America><Logic><Maintenance><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Manpower><Maps><Methods><Mexican><Mexico><Modeling><Morbidity><Morbidity - disease rate><NCI Organization><National Cancer Institute><Needs Assessment><Outcome><Pain><Painful><Parents><Patients><Population><Process><Program Effectiveness><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Sampling><Screening for cancer><Social Insurance><Social Security><Structure><Test Result><Testing><Texas><Time><Training><Underserved Population><Uterine Cervix Cancer><Variant><Variation><Woman><Women's mortality><Work><Work Location><Work Place><Work-Site><Working Women><Workplace><Worksite><active followup><aged><barriers to implementation><care facilities><cost effectiveness><death among females><death among women><death in females><death in women><death rate among women><death rate in women><design><designing><digital platform><early cancer detection><effectiveness outcome><effectiveness-related outcomes><electronic communication><evaluate implementation><evaluation of implementation><experience><facilitators to implementation><female death><female mortality><follow up><follow-up><followed up><followup><health care><health care personnel><health care service><health care worker><health provider><health workforce><healthcare personnel><healthcare service><human papillomavirus +><human papillomavirus positive><implementation barriers><implementation challenges><implementation design><implementation determinants><implementation efforts><implementation evaluation><implementation facilitators><implementation factors><implementation fidelity><implementation outcomes><implementation research><implementation research design><implementation science><implementation strategy><improved><integrated health system><integrated healthcare systems><integrated system of care><low and middle-income countries><malignancy><manufacturing facility><manufacturing plants><medical personnel><mortality><mortality among females><mortality among women><mortality in females><mortality in women><neoplasm/cancer><parent><personnel><presence of HPV><presence of human papillomavirus><primary care clinic><production plants><programs><reach, efficacy, adoption, implementation, and maintenance><screening><screening cancer patients><screening participation><screening program><screenings><strategies for implementation><success><training opportunity><treatment provider><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><uptake><wart virus><women's death><women's death rate><work setting><working females>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karla Unger-Saldaña

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$127,173
FY 2024

Project Title

Implementation Evaluation of a Workplace Self-Sampling HPV Detection Program within the Mexican Social Security Institute

Grant Number:

3U54CA284109-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/20/2023

End Date:

8/31/2028

Project Abstract

Cervical cancer (CC) is the second leading cause of cancer death among women in Mexico, yet screening participation is alarmingly low, with less than 30% of women aged 20 or older having ever been screened in 2022. Human papillomavirus (HPV) self-sampling is an effective method that increases access...

Research Terms

<Active Follow-up><Address><Administrative Supplement><Adopted><Adoption><Appointment><Assess implementation><Cancer Cause><Cancer Control><Cancer Control Science><Cancer Etiology><Cancers><Caring><Cervical Cancer><Cervix Cancer><Characteristics><Clinic><Clinical><Colposcopy><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><Cytology><Diagnostic><E-Mail><Effectiveness><Electronic Mail><Email><Equity><Fear><Female><Floor><Fright><Funding><Goals><HPV><HPV detection><HPV positive><HPV screening><HPV(+)><HPV+><Health><Health Care Providers><Health Care Systems><Health Facilities><Health Personnel><Health care facility><Healthcare><Healthcare Facility><Healthcare Providers><Healthcare Systems><Healthcare worker><Human Papilloma Virus><Human Papilloma Virus detection><Human Papilloma Virus screening><Human Papillomavirus><Human Resources><Implementation assessment><Infectious Human Wart Virus><Institution><Integrated Health Care Systems><Interview><Job Location><Job Place><Job Setting><Job Site><LMIC><Latin America><Logic><Maintenance><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Manpower><Maps><Methods><Mexican><Mexico><Modeling><Morbidity><Morbidity - disease rate><NCI Organization><National Cancer Institute><Needs Assessment><Outcome><Pain><Painful><Parents><Patients><Population><Process><Program Effectiveness><Provider><Public Health><RE-AIM><Reach, Effectiveness, Adoption, Implementation, and Maintenance><Reporting><Research><Sampling><Screening for cancer><Social Insurance><Social Security><Structure><Test Result><Testing><Texas><Time><Training><Underserved Population><Uterine Cervix Cancer><Variant><Variation><Woman><Women's mortality><Work><Work Location><Work Place><Work-Site><Working Women><Workplace><Worksite><active followup><aged><barriers to implementation><care facilities><cost effectiveness><death among females><death among women><death in females><death in women><death rate among women><death rate in women><design><designing><digital platform><early cancer detection><effectiveness outcome><effectiveness-related outcomes><electronic communication><evaluate implementation><evaluation of implementation><experience><facilitators to implementation><female death><female mortality><follow up><follow-up><followed up><followup><health care><health care personnel><health care service><health care worker><health provider><health workforce><healthcare personnel><healthcare service><human papillomavirus +><human papillomavirus positive><implementation barriers><implementation challenges><implementation design><implementation determinants><implementation efforts><implementation evaluation><implementation facilitators><implementation factors><implementation fidelity><implementation outcomes><implementation research><implementation research design><implementation science><implementation strategy><improved><integrated health system><integrated healthcare systems><integrated system of care><low and middle-income countries><malignancy><manufacturing facility><manufacturing plants><medical personnel><mortality><mortality among females><mortality among women><mortality in females><mortality in women><neoplasm/cancer><parent><personnel><presence of HPV><presence of human papillomavirus><primary care clinic><production plants><programs><reach, efficacy, adoption, implementation, and maintenance><screening><screening cancer patients><screening participation><screening program><screenings><strategies for implementation><success><training opportunity><treatment provider><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><uptake><wart virus><women's death><women's death rate><work setting><working females>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michael Hoonbae Chung

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 18/100
Active award
Team-scale grant
$125,000
FY 2024

Project Title

Integrating cervical cancer screening within the outpatient emergency departments in Kenya

Grant Number:

3U54CA284036-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

Integrating cervical cancer screening within the outpatient emergency departments in Kenya This application is in response to Notice of Special Interest (NOSI): Administrative Supplements for NCI Global Oncology Mentored Research Notice Number: NOT-CA-24-028. Our U54 grant “Enhanced BReast and cErv...

Research Terms

<AIDS Virus><Accident and Emergency department><Acetic Acids><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Administrative Supplement><Africa South of the Sahara><Ambulatory Care Facilities><Award><Breast Cancer><Breast Feeding><Breast fed><Breastfed><Breastfeeding><Cancer Cause><Cancer Etiology><Cancers><Caring><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervix Cancer><Cessation of life><Charge><Clinic><Communities><Complement><Complement Proteins><Comprehensive Health Care><Comprehensive Healthcare><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><County><Data><Death><Early Diagnosis><Economic Income><Economical Income><Educational workshop><Emergency Department><Emergency room><Epithelial Cells><Family Planning><Family Planning Services><Formulation><Grant><Grips><Guidelines><Gynecologist><HIV><HPV><Health Care Providers><Health Care Systems><Health Facilities><Health Personnel><Health Planning><Health care facility><Healthcare Facility><Healthcare Providers><Healthcare Systems><Healthcare worker><High Prevalence><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papillomavirus><Income><Infectious Human Wart Virus><Interview><Iodine><Kenya><LAV-HTLV-III><Lesion><Lymphadenopathy-Associated Virus><Malignant Breast Neoplasm><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Maternal and Child Health><Mentors><Mentorship><National Cancer Program><Oncology><Oncology Cancer><Out-patients><Outpatient Clinics><Outpatients><Pap Test><Pap screening><Pap smear><Papanicolaou Smear><Papanicolaou Test><Primary Care><Primary Health Care><Primary Healthcare><R-Series Research Projects><R01 Mechanism><R01 Program><Recommendation><Research><Research Grants><Research Project Grants><Research Projects><Research Training><Screening for cancer><Services><Site><Sub-Saharan Africa><Subsaharan Africa><Survey Instrument><Surveys><Testing><Training><Universities><Uterine Cervix Cancer><Virus-HIV><Visual><Woman><Women's mortality><Workshop><care facilities><cervical cancer early detection><cervical cancer prevention><cervical screening><complementation><comprehensive care><death among females><death among women><death in females><death in women><death rate among women><death rate in women><death risk><demographics><design><designing><diagnosis among females><diagnosis among women><diagnosis in females><diagnosis in women><diagnosis within females><diagnosis within women><early cancer detection><early detection><effective therapy><effective treatment><falls><female death><female diagnosis><female mortality><grasp><health care personnel><health care worker><health provider><health workforce><healthcare personnel><implementation science><implementation strategy><incomes><insight><interest><lecturer><malignancy><malignant breast tumor><medical personnel><mortality among females><mortality among women><mortality in females><mortality in women><mortality risk><neoplasm/cancer><out-patient facility><outpatient center><outpatient facility><plan health><precancer><precancer cervical detection><precancerous><premalignant><preventable death><preventable mortality><prevention service><recommended screening><response><screening><screening cancer patients><screening guidelines><screening recommendations><screening services><screenings><skills><strategies for implementation><treatment provider><uptake><wart virus><women's death><women's death rate><women's diagnosis>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Kinuthia

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 18/100
Active award
Team-scale grant
$125,000
FY 2024

Project Title

Integrating cervical cancer screening within the outpatient emergency departments in Kenya

Grant Number:

3U54CA284036-02S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Project Abstract

Integrating cervical cancer screening within the outpatient emergency departments in Kenya This application is in response to Notice of Special Interest (NOSI): Administrative Supplements for NCI Global Oncology Mentored Research Notice Number: NOT-CA-24-028. Our U54 grant “Enhanced BReast and cErv...

Research Terms

<AIDS Virus><Accident and Emergency department><Acetic Acids><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Administrative Supplement><Africa South of the Sahara><Ambulatory Care Facilities><Award><Breast Cancer><Breast Feeding><Breast fed><Breastfed><Breastfeeding><Cancer Cause><Cancer Etiology><Cancers><Caring><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervix Cancer><Cessation of life><Charge><Clinic><Communities><Complement><Complement Proteins><Comprehensive Health Care><Comprehensive Healthcare><Consolidated Framework for Implementation Research><Consolidated Framework for Implementation Science><Consolidated Framework for Implementing Change><Country><County><Data><Death><Early Diagnosis><Economic Income><Economical Income><Educational workshop><Emergency Department><Emergency room><Epithelial Cells><Family Planning><Family Planning Services><Formulation><Grant><Grips><Guidelines><Gynecologist><HIV><HPV><Health Care Providers><Health Care Systems><Health Facilities><Health Personnel><Health Planning><Health care facility><Healthcare Facility><Healthcare Providers><Healthcare Systems><Healthcare worker><High Prevalence><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus><Human Papillomavirus><Income><Infectious Human Wart Virus><Interview><Iodine><Kenya><LAV-HTLV-III><Lesion><Lymphadenopathy-Associated Virus><Malignant Breast Neoplasm><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Maternal and Child Health><Mentors><Mentorship><National Cancer Program><Oncology><Oncology Cancer><Out-patients><Outpatient Clinics><Outpatients><Pap Test><Pap screening><Pap smear><Papanicolaou Smear><Papanicolaou Test><Primary Care><Primary Health Care><Primary Healthcare><R-Series Research Projects><R01 Mechanism><R01 Program><Recommendation><Research><Research Grants><Research Project Grants><Research Projects><Research Training><Screening for cancer><Services><Site><Sub-Saharan Africa><Subsaharan Africa><Survey Instrument><Surveys><Testing><Training><Universities><Uterine Cervix Cancer><Virus-HIV><Visual><Woman><Women's mortality><Workshop><care facilities><cervical cancer early detection><cervical cancer prevention><cervical screening><complementation><comprehensive care><death among females><death among women><death in females><death in women><death rate among women><death rate in women><death risk><demographics><design><designing><diagnosis among females><diagnosis among women><diagnosis in females><diagnosis in women><diagnosis within females><diagnosis within women><early cancer detection><early detection><effective therapy><effective treatment><falls><female death><female diagnosis><female mortality><grasp><health care personnel><health care worker><health provider><health workforce><healthcare personnel><implementation science><implementation strategy><incomes><insight><interest><lecturer><malignancy><malignant breast tumor><medical personnel><mortality among females><mortality among women><mortality in females><mortality in women><mortality risk><neoplasm/cancer><out-patient facility><outpatient center><outpatient facility><plan health><precancer><precancer cervical detection><precancerous><premalignant><preventable death><preventable mortality><prevention service><recommended screening><response><screening><screening cancer patients><screening guidelines><screening recommendations><screening services><screenings><skills><strategies for implementation><treatment provider><uptake><wart virus><women's death><women's death rate><women's diagnosis>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jerris Robert Hedges

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 18/100
Active award
Team-scale grant
$123,715
FY 2025

Project Title

Ola HAWAII

Grant Number:

3U54MD007601-39S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2027

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Area><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Inequality><Institution><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><access to health care><accessibility of health care><accessibility to health care><aspirate><base><bases><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Noreen Mokuau

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 18/100
Active award
Team-scale grant
$123,715
FY 2025

Project Title

Ola HAWAII

Grant Number:

3U54MD007601-39S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2027

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Area><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Inequality><Institution><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><access to health care><accessibility of health care><accessibility to health care><aspirate><base><bases><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VANDERLEI BAGNATO

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Y. Chiao

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CESALTINA FERREIRA LORENZONI

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca R. Richards-Kortum

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathleen Schmeler

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

regis kreitchmann

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$120,096
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ASHOK BALASUBRAMANYAM

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$110,505
FY 2025

Project Title

RARE and Atypical Diabetes Network(RADIANT)

Grant Number:

3U54DK118638-07S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY P KRISCHER

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$110,505
FY 2025

Project Title

RARE and Atypical Diabetes Network(RADIANT)

Grant Number:

3U54DK118638-07S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2018

End Date:

5/31/2029

Project Abstract

Diabetes is traditionally classified in two broad categories: autoimmune Type 1 and obesity-related Type 2. Numerous phenotypically and etiologically distinct forms exist and are emerging, collectively termed “atypical diabetes”, that do not fit into either category. We hypothesize that atypical dia...

Research Terms

<Adult-Onset Diabetes Mellitus><Age><Autoantibodies><Autoimmune><Blood Plasma><Brittle Diabetes Mellitus><Categories><Causality><Cell model><Cellular model><Characteristics><Classification><Clinical><Confusion><Confusional State><D-Glucose><DNA mutation><Data><Data Bases><Databases><Descriptor><Dextrose><Diabetes Mellitus><Diabetes mellitus syndrome in newborn infant><Diagnosis><Diagnostic><Disease><Disorder><Drug Targeting><Dysfunction><Elements><Enrollment><Etiology><Family><Family member><Functional disorder><Funding><Gene variant><Genes><Genetic Change><Genetic defect><Genetic mutation><Genome><Genomics><Genotype><Glucose><Goals><Human><Humulin R><Hyperglycemia><IDDM><Individual><Infrastructure><Insulin><Insulin Resistance><Insulin deficiency><Insulin-Dependent Diabetes Mellitus><Investigators><Juvenile-Onset Diabetes Mellitus><Ketosis-Prone Diabetes Mellitus><Ketosis-Resistant Diabetes Mellitus><Maturity-Onset Diabetes Mellitus><Mediating><Mental Confusion><Modeling><Modern Man><Molecular><Mutation><NIDDM><Non-Insulin Dependent Diabetes><Non-Insulin-Dependent Diabetes Mellitus><Noninsulin Dependent Diabetes><Noninsulin Dependent Diabetes Mellitus><Novolin R><Obesity><Pancreatic beta Cell><Pancreatic β-Cell><Participant><Pathogenicity><Pathologic><Pathway interactions><Patients><Persons><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Plasma><Plasma Serum><Process><RNA Seq><RNA sequencing><RNAseq><Regular Insulin><Research Personnel><Researchers><Reticuloendothelial System, Serum, Plasma><Slow-Onset Diabetes Mellitus><Source><Stable Diabetes Mellitus><Structure of beta Cell of islet><Subgroup><Sudden-Onset Diabetes Mellitus><Syndrome><Systematics><T-Cells><T-Lymphocyte><T1 DM><T1 diabetes><T1D><T1DM><T2 DM><T2D><T2DM><Therapeutic><Type 1 Diabetes Mellitus><Type 1 diabetes><Type 2 Diabetes Mellitus><Type 2 diabetes><Type I Diabetes Mellitus><Type II Diabetes Mellitus><Type II diabetes><Variant><Variation><Work><adiposity><adjudication><adjudicative process and procedure><adult onset diabetes><ages><allelic variant><autoimmune antibody><autoreactive antibody><causation><corpulence><data base><depository><diabetes><diagnostic criteria><disease causation><eligible participant><enroll><entire genome><falls><family genetics><full genome><genetic variant><genome mutation><genome sequencing><genomic variant><global gene expression><global transcription profile><hyperglycemic><iPS><iPSC><iPSCs><improved><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><insulin dependent diabetes><insulin dependent type 1><insulin resistant><insulin tolerance><juvenile diabetes><juvenile diabetes mellitus><ketosis prone diabetes><ketosis resistant diabetes><lean body mass><loss of function mutation><maturity onset diabetes><metabolism measurement><metabolomics><metabonomics><multidisciplinary><neonatal diabetes><neonatal diabetes mellitus><pancreas beta cell><pancreas β cell><pancreatic b-cell><participant enrollment><pathophysiology><pathway><patient enrollment><personalized diagnosis><personalized diagnostics><precise diagnostics><precision diagnostics><public health relevance><recruit><repository><response><screening><screenings><self reactive antibody><thymus derived lymphocyte><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><type 2 DM><type I diabetes><type II DM><type one diabetes><type two diabetes><whole genome>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROGER D KAMM

MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$95,400
FY 2024

Project Title

Delineating the role of SPP1+ macrophages in colorectal cancer metastasis

Grant Number:

3U54CA261694-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/17/2021

End Date:

8/31/2026

Project Abstract

Overall: PROJECT SUMMARY Metastatic disease is responsible for the vast majority of cancer mortality. Understanding of the fundamental mechanisms leading to metastatic cancer has been hampered by the need for models that replicate the step- wise metastatic process in vivo, yet are amenable to tight ...

Research Terms

<3-D><3-Dimensional><3D><Address><Adhesions><Adhesives><Affect><Assay><Basement membrane><Bioassay><Biological Assay><Blood Platelets><Body Tissues><Breast Melanoma><Cancers><Cell Body><Cell Communication><Cell Death><Cell Interaction><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cell-to-Cell Interaction><Cells><Cellular Matrix><Cessation of life><Chromatin><Chromatin Structure><Circulation><Complex><Computer Analysis><Corium><Cutis><Cytoskeletal System><Cytoskeleton><Death><Dermis><Disease><Disorder><Disseminated Malignant Neoplasm><ECM><Endothelium><Environment><Extracellular Matrix><Extravasation><Fibrin><Gene Expression><Genomics><Goals><Image><In Vitro><Individual><Intervention><Intervention Strategies><Leakage><Liver><Macrophage><Malignant Neoplasms><Malignant Tumor><Marrow platelet><Measurement><Mechanics><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Microcirculation><Modeling><Molecular><Mφ><Neoplasm Circulating Cells><Neoplasm Metastasis><Nuclear><Organ><Organ Specificity><Pathway interactions><Phenotype><Platelets><Primary Neoplasm><Primary Tumor><Probability><Process><Proliferating><Property><Resolution><Role><Secondary Neoplasm><Secondary Tumor><Sight><Site><Spillage><Stress><TNBC><Techniques><Technology><Therapeutic><Thrombocytes><Thrombus><Time><Tissues><Tumor Cell><Tumor Cell Invasion><Tumor Invasion><Vision><Work><cancer metastasis><cell behavior><cell type><cellular behavior><circulating neoplastic cell><circulating tumor cell><colorectal cancer metastasis><computational analyses><computational analysis><computational studies><computer analyses><computer studies><coping><experience><experiment><experimental research><experimental study><experiments><global gene expression><global transcription profile><hemodynamics><hepatic body system><hepatic organ system><imaging><in vitro Model><in vivo><insight><interventional strategy><intra-vital imaging><intracellular skeleton><intravital imaging><malignancy><mechanic><mechanical><metastatic process><migration><monolayer><mortality><necrocytosis><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><prevent><preventing><programs><resolutions><response><shear stress><social role><stressor><three dimensional><transcriptome><transcriptomics><triple-negative breast cancer><triple-negative invasive breast carcinoma><tumor cell metastasis><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vivek Shenoy

MASSACHUSETTS INSTITUTE OF TECHNOLOGY, CAMBRIDGE, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$95,400
FY 2024

Project Title

Delineating the role of SPP1+ macrophages in colorectal cancer metastasis

Grant Number:

3U54CA261694-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/17/2021

End Date:

8/31/2026

Project Abstract

Overall: PROJECT SUMMARY Metastatic disease is responsible for the vast majority of cancer mortality. Understanding of the fundamental mechanisms leading to metastatic cancer has been hampered by the need for models that replicate the step- wise metastatic process in vivo, yet are amenable to tight ...

Research Terms

<3-D><3-Dimensional><3D><Address><Adhesions><Adhesives><Affect><Assay><Basement membrane><Bioassay><Biological Assay><Blood Platelets><Body Tissues><Breast Melanoma><Cancers><Cell Body><Cell Communication><Cell Death><Cell Interaction><Cell Survival><Cell Viability><Cell-Extracellular Matrix><Cell-to-Cell Interaction><Cells><Cellular Matrix><Cessation of life><Chromatin><Chromatin Structure><Circulation><Complex><Computer Analysis><Corium><Cutis><Cytoskeletal System><Cytoskeleton><Death><Dermis><Disease><Disorder><Disseminated Malignant Neoplasm><ECM><Endothelium><Environment><Extracellular Matrix><Extravasation><Fibrin><Gene Expression><Genomics><Goals><Image><In Vitro><Individual><Intervention><Intervention Strategies><Leakage><Liver><Macrophage><Malignant Neoplasms><Malignant Tumor><Marrow platelet><Measurement><Mechanics><Metastasis><Metastasize><Metastatic Cancer><Metastatic Lesion><Metastatic Malignant Neoplasm><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Methods><Microcirculation><Modeling><Molecular><Mφ><Neoplasm Circulating Cells><Neoplasm Metastasis><Nuclear><Organ><Organ Specificity><Pathway interactions><Phenotype><Platelets><Primary Neoplasm><Primary Tumor><Probability><Process><Proliferating><Property><Resolution><Role><Secondary Neoplasm><Secondary Tumor><Sight><Site><Spillage><Stress><TNBC><Techniques><Technology><Therapeutic><Thrombocytes><Thrombus><Time><Tissues><Tumor Cell><Tumor Cell Invasion><Tumor Invasion><Vision><Work><cancer metastasis><cell behavior><cell type><cellular behavior><circulating neoplastic cell><circulating tumor cell><colorectal cancer metastasis><computational analyses><computational analysis><computational studies><computer analyses><computer studies><coping><experience><experiment><experimental research><experimental study><experiments><global gene expression><global transcription profile><hemodynamics><hepatic body system><hepatic organ system><imaging><in vitro Model><in vivo><insight><interventional strategy><intra-vital imaging><intracellular skeleton><intravital imaging><malignancy><mechanic><mechanical><metastatic process><migration><monolayer><mortality><necrocytosis><neoplasm/cancer><neoplastic cell><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><prevent><preventing><programs><resolutions><response><shear stress><social role><stressor><three dimensional><transcriptome><transcriptomics><triple-negative breast cancer><triple-negative invasive breast carcinoma><tumor cell metastasis><visual function>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alain Mefire Chichom

UNIVERSITY OF BUEA, CAMEROON

Exploratory lead · 18/100
Active award
Team-scale grant
$88,723
FY 2024

Project Title

Harnessing Data Science to Promote Equity in Injury and Surgery for Africa

Grant Number:

3U54TW012087-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2021

End Date:

6/30/2026

Project Abstract

PROJECT SUMMARY The Data Science Center for the Study of Surgery, Injury, and Equity in Africa (DSINE) is an NIH U54- funded research hub located at the University of Buea (Buea) in Cameroon through the current Data Science in Africa (DS-I Africa) initiative (U54TW012087). DSINE Africa is a strategi...

Research Terms

<Active Follow-up><Address><Africa><African><Air><Android App><Android Application><Area><California><Cameroon><Caring><Cell Phone><Cell Phone Application><Cell phone App><Cellular Phone><Cellular Phone App><Cellular Phone Application><Cellular Telephone><Cessation of life><Cognitive Discrimination><Collaborations><Communities><Community Health><Country><Data><Data Analyses><Data Analysis><Data Banks><Data Collection><Data Science><Databanks><Death><Development><Discrimination><Disease><Disorder><Disparities><Disparity><Emergencies><Emergency Situation><Equity><Event><Funding><Future><Goals><Heart><High School Student><Hospital Planning><Hospitals><Image><Improve Access><Inequity><Infrastructure><Injury><Intervention><Intervention Strategies><Interview><LMIC><Location><Los Angeles><Maps><Mission><Mobile Phones><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Operative Procedures><Operative Surgical Procedures><Outcome><Participant><Patients><Performance><Policy Maker><Population><Pre-hospital care><Pre-hospitalization care><Prehospital care><Prehospitalization care><Preventative strategy><Prevention strategy><Preventive strategy><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Registries><Reporting><Research><Research Grants><Research Project Grants><Research Projects><Research Resources><Resource Allocation><Resources><Secondary School Student><Secondary Student><Smart Phone App><Smart Phone Application><Smartphone App><South Africa><Structure><Surgical><Surgical Interventions><Surgical Procedure><Survey Instrument><Surveys><System><Technology><Testing><Trauma><Trauma patient><Triage><United States National Institutes of Health><Universities><Validation><Work><acceptability and feasibility><active followup><acute care><burden of disease><burden of illness><care services><care systems><cell phone based app><clinical care><community-based health><crowd source><crowd-sourcing><crowdsource><crowdsourcing><data depository><data interpretation><data management><data repository><data set repository><dataset repository><demographics><design><designing><developmental><disease burden><facilitators to implementation><follow up><follow-up><followed up><followup><high schoolers><iOS app><iOS application><iPhone><iPhone App><iPhone Application><imaging><implementation facilitators><implementation science><improved><injured><injuries><injury burden><injury prevention><injury-related death><interventional strategy><low and middle-income countries><math sciences><mathematic sciences><mathematical sciences><member><mobile phone app><mortality><prevent><preventable death><preventable mortality><preventing><prototype><recruit><smart phone><smartphone><smartphone application><smartphone based app><smartphone based application><surgery><trauma care><usability><validations>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sabrinah Ariane Christie

UNIVERSITY OF BUEA, CAMEROON

Exploratory lead · 18/100
Active award
Team-scale grant
$88,723
FY 2024

Project Title

Harnessing Data Science to Promote Equity in Injury and Surgery for Africa

Grant Number:

3U54TW012087-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2021

End Date:

6/30/2026

Project Abstract

PROJECT SUMMARY The Data Science Center for the Study of Surgery, Injury, and Equity in Africa (DSINE) is an NIH U54- funded research hub located at the University of Buea (Buea) in Cameroon through the current Data Science in Africa (DS-I Africa) initiative (U54TW012087). DSINE Africa is a strategi...

Research Terms

<Active Follow-up><Address><Africa><African><Air><Android App><Android Application><Area><California><Cameroon><Caring><Cell Phone><Cell Phone Application><Cell phone App><Cellular Phone><Cellular Phone App><Cellular Phone Application><Cellular Telephone><Cessation of life><Cognitive Discrimination><Collaborations><Communities><Community Health><Country><Data><Data Analyses><Data Analysis><Data Banks><Data Collection><Data Science><Databanks><Death><Development><Discrimination><Disease><Disorder><Disparities><Disparity><Emergencies><Emergency Situation><Equity><Event><Funding><Future><Goals><Heart><High School Student><Hospital Planning><Hospitals><Image><Improve Access><Inequity><Infrastructure><Injury><Intervention><Intervention Strategies><Interview><LMIC><Location><Los Angeles><Maps><Mission><Mobile Phones><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Operative Procedures><Operative Surgical Procedures><Outcome><Participant><Patients><Performance><Policy Maker><Population><Pre-hospital care><Pre-hospitalization care><Prehospital care><Prehospitalization care><Preventative strategy><Prevention strategy><Preventive strategy><Public Health><R-Series Research Projects><R01 Mechanism><R01 Program><Registries><Reporting><Research><Research Grants><Research Project Grants><Research Projects><Research Resources><Resource Allocation><Resources><Secondary School Student><Secondary Student><Smart Phone App><Smart Phone Application><Smartphone App><South Africa><Structure><Surgical><Surgical Interventions><Surgical Procedure><Survey Instrument><Surveys><System><Technology><Testing><Trauma><Trauma patient><Triage><United States National Institutes of Health><Universities><Validation><Work><acceptability and feasibility><active followup><acute care><burden of disease><burden of illness><care services><care systems><cell phone based app><clinical care><community-based health><crowd source><crowd-sourcing><crowdsource><crowdsourcing><data depository><data interpretation><data management><data repository><data set repository><dataset repository><demographics><design><designing><developmental><disease burden><facilitators to implementation><follow up><follow-up><followed up><followup><high schoolers><iOS app><iOS application><iPhone><iPhone App><iPhone Application><imaging><implementation facilitators><implementation science><improved><injured><injuries><injury burden><injury prevention><injury-related death><interventional strategy><low and middle-income countries><math sciences><mathematic sciences><mathematical sciences><member><mobile phone app><mortality><prevent><preventable death><preventable mortality><preventing><prototype><recruit><smart phone><smartphone><smartphone application><smartphone based app><smartphone based application><surgery><trauma care><usability><validations>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory Alan Abel

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$83,107
FY 2024

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156732-14S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KASISOMAYAJULA VISWANATH

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$83,107
FY 2024

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156732-14S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Project Abstract

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activit...

Research Terms

<Absenteeism><Address><Advanced Cancer><Advanced Malignant Neoplasm><Area><Biology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Science><Cancer health equity><Cancers><Charge><Color><Communities><Community Networks><Community Outreach><Creativeness><Data><Data Set><Dedications><Development and Research><Discipline><Disparities><Disparity><Education><Educational aspects><Ethnic Origin><Ethnicity><Experimental Designs><Faculty><Foundations><Funding><Genomics><Goals><Government><Grant><Health Disparities Research><Health disparities related research><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Phase><Population><Population Group><Population Heterogeneity><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Race><Races><Research><Research Associate><Research Design><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><SES disparity><Science><Solid><Source><Students><Study Type><Training><Underrepresented Groups><Underrepresented Populations><Underserved Population><United States National Institutes of Health><Universities><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><creativity><disparity in cancer><dissemination science><diverse populations><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><health disparities science><heterogeneous population><implementation science><innovate><innovation><innovative><malignancy><member><mortality><neoplasm/cancer><outreach><outreach program><population diversity><post-doc><post-doctoral><post-doctoral trainee><programs><racial><racial background><racial origin><research and development><research associates><research study><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><study design><translational model><translational opportunities><translational potential><under representation of groups><under represented groups><under represented people><under represented populations><under served group><under served individual><under served people><under served population><underrepresentation of groups><underrepresented people><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Amina Abubakar Ali

AGA KHAN UNIVERSITY (KENYA), KENYA

Exploratory lead · 18/100
Active award
Team-scale grant
$80,992
FY 2024

Project Title

Sustainable Cloud Operations for Research and Environmental Impact (SCORE - EI)

Grant Number:

3U54TW012089-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2021

End Date:

6/30/2026

Project Abstract

PROJECT SUMMARY/ABSTRACT The parent project, UZIMA-DS (UtiliZing Health Information for Meaningful Impact in East Africa through Data Science), aims to create a scalable and sustainable platform that leverages novel data assimilation approaches and advanced Artificial Intelligence (AI) and Machine L...

Research Terms

<AI system><Address><Administrative Supplement><Adopted><Africa><Artificial Intelligence><Benchmarking><Best Practice Analysis><Budgets><Carbon><Child Health><Cloud Computing><Cloud Infrastructure><Cloud Service><Collaborations><Computer Reasoning><Cost Savings><Cost efficiency><Coupled><Data><Data Science><Data Storage and Retrieval><Ecological impact><Ensure><Environment><Environmental Impact><Expenditure><Foundations><Frequencies><Funding><Future><Goals><Health><Health Care Providers><Health Personnel><Health Sciences><Healthcare Providers><Healthcare worker><High Performance Computing><Infrastructure><LMIC><Machine Intelligence><Maternal Health><Measures><Mental Health><Mental Hygiene><Methodology><Michigan><Movement><NIH><National Institutes of Health><Operations Research><Outcome><Position><Positioning Attribute><Process><Psychological Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Project Grants><Research Projects><Research Resources><Resources><Savings><Techniques><Testing><Time><United States National Institutes of Health><Universities><Work><benchmark><body movement><carbon emissions><climate research><climate science><cloud based><cloud based computing><cloud computer><computational resources><computerized data processing><computing resources><cost><cost effective><cost efficient><data exchange><data management><data pipeline><data processing><data retrieval><data sharing><data storage><data transfer><data transmission><empowerment><energy efficiency><fitbit><health care personnel><health care worker><health provider><health workforce><healthcare personnel><high-end computing><improved><innovate><innovation><innovative><large data sets><large datasets><low and middle-income countries><machine learning based method><machine learning method><machine learning methodologies><medical personnel><mindfulness><neonatal health><newborn health><novel><parent award><parent project><research in practice><skills><tool><treatment provider>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Akbar K Waljee

AGA KHAN UNIVERSITY (KENYA), KENYA

Exploratory lead · 18/100
Active award
Team-scale grant
$80,992
FY 2024

Project Title

Sustainable Cloud Operations for Research and Environmental Impact (SCORE - EI)

Grant Number:

3U54TW012089-04S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2021

End Date:

6/30/2026

Project Abstract

PROJECT SUMMARY/ABSTRACT The parent project, UZIMA-DS (UtiliZing Health Information for Meaningful Impact in East Africa through Data Science), aims to create a scalable and sustainable platform that leverages novel data assimilation approaches and advanced Artificial Intelligence (AI) and Machine L...

Research Terms

<AI system><Address><Administrative Supplement><Adopted><Africa><Artificial Intelligence><Benchmarking><Best Practice Analysis><Budgets><Carbon><Child Health><Cloud Computing><Cloud Infrastructure><Cloud Service><Collaborations><Computer Reasoning><Cost Savings><Cost efficiency><Coupled><Data><Data Science><Data Storage and Retrieval><Ecological impact><Ensure><Environment><Environmental Impact><Expenditure><Foundations><Frequencies><Funding><Future><Goals><Health><Health Care Providers><Health Personnel><Health Sciences><Healthcare Providers><Healthcare worker><High Performance Computing><Infrastructure><LMIC><Machine Intelligence><Maternal Health><Measures><Mental Health><Mental Hygiene><Methodology><Michigan><Movement><NIH><National Institutes of Health><Operations Research><Outcome><Position><Positioning Attribute><Process><Psychological Health><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Project Grants><Research Projects><Research Resources><Resources><Savings><Techniques><Testing><Time><United States National Institutes of Health><Universities><Work><benchmark><body movement><carbon emissions><climate research><climate science><cloud based><cloud based computing><cloud computer><computational resources><computerized data processing><computing resources><cost><cost effective><cost efficient><data exchange><data management><data pipeline><data processing><data retrieval><data sharing><data storage><data transfer><data transmission><empowerment><energy efficiency><fitbit><health care personnel><health care worker><health provider><health workforce><healthcare personnel><high-end computing><improved><innovate><innovation><innovative><large data sets><large datasets><low and middle-income countries><machine learning based method><machine learning method><machine learning methodologies><medical personnel><mindfulness><neonatal health><newborn health><novel><parent award><parent project><research in practice><skills><tool><treatment provider>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathleen Marie Fisch

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$79,877
FY 2024

Project Title

Administrative Supplement to U54 DA049115: Exploring Immune Transcriptome Signatures in the Development of Chronic Pain

Grant Number:

3U54DA049115-06S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2019

End Date:

7/31/2026

Project Abstract

Summary This Administrative Supplement request aims to perform single nucleus gene expression studies (snGEX) on white blood cells from buffy coat samples collected as part of the Acute to Chronic Pain Signatures (A2CPS) program. snGEX will be assessed at two timepoints per individual: baseline and ...

Research Terms

<Acute><Acute Pain><Administrative Supplement><Blood leukocyte><Cell Body><Cell Nucleus><Cells><Characteristics><Complement><Complement Proteins><Data><Development><Event><Expression Signature><Gene Expression><Gene Expression Profile><Generations><Goals><Immune><Immunes><Individual><Knee arthroplasty><Knee joint replacement operation><Knee replacement><Leukocytes><Leukocytes Reticuloendothelial System><Marrow leukocyte><Nucleus><Operative Procedures><Operative Surgical Procedures><Population><Post-operative Pain><Postoperative Pain><Predisposition><Public Health><Role><Sampling><Surgical><Surgical Interventions><Surgical Procedure><Susceptibility><Total Knee Replacement><White Blood Cells><White Cell><biomarker identification><biosignature><chronic pain><complementation><developmental><experiment><experimental research><experimental study><experiments><feasibility testing><gene expression pattern><gene expression signature><global gene expression><global transcription profile><identification of biomarkers><identification of new biomarkers><knee replacement arthroplasty><marker identification><pain after surgery><parent grant><post-surgical pain><postsurgical pain><programs><resilience><resilient><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><surgery><total knee arthroplasty><transcriptional profile><transcriptional signature><transcriptome><white blood cell><white blood corpuscle>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kristen Lynn Jepsen

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$79,877
FY 2024

Project Title

Administrative Supplement to U54 DA049115: Exploring Immune Transcriptome Signatures in the Development of Chronic Pain

Grant Number:

3U54DA049115-06S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2019

End Date:

7/31/2026

Project Abstract

Summary This Administrative Supplement request aims to perform single nucleus gene expression studies (snGEX) on white blood cells from buffy coat samples collected as part of the Acute to Chronic Pain Signatures (A2CPS) program. snGEX will be assessed at two timepoints per individual: baseline and ...

Research Terms

<Acute><Acute Pain><Administrative Supplement><Blood leukocyte><Cell Body><Cell Nucleus><Cells><Characteristics><Complement><Complement Proteins><Data><Development><Event><Expression Signature><Gene Expression><Gene Expression Profile><Generations><Goals><Immune><Immunes><Individual><Knee arthroplasty><Knee joint replacement operation><Knee replacement><Leukocytes><Leukocytes Reticuloendothelial System><Marrow leukocyte><Nucleus><Operative Procedures><Operative Surgical Procedures><Population><Post-operative Pain><Postoperative Pain><Predisposition><Public Health><Role><Sampling><Surgical><Surgical Interventions><Surgical Procedure><Susceptibility><Total Knee Replacement><White Blood Cells><White Cell><biomarker identification><biosignature><chronic pain><complementation><developmental><experiment><experimental research><experimental study><experiments><feasibility testing><gene expression pattern><gene expression signature><global gene expression><global transcription profile><identification of biomarkers><identification of new biomarkers><knee replacement arthroplasty><marker identification><pain after surgery><parent grant><post-surgical pain><postsurgical pain><programs><resilience><resilient><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><surgery><total knee arthroplasty><transcriptional profile><transcriptional signature><transcriptome><white blood cell><white blood corpuscle>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LOUISE CHANG LAURENT

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$79,877
FY 2024

Project Title

Administrative Supplement to U54 DA049115: Exploring Immune Transcriptome Signatures in the Development of Chronic Pain

Grant Number:

3U54DA049115-06S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2019

End Date:

7/31/2026

Project Abstract

Summary This Administrative Supplement request aims to perform single nucleus gene expression studies (snGEX) on white blood cells from buffy coat samples collected as part of the Acute to Chronic Pain Signatures (A2CPS) program. snGEX will be assessed at two timepoints per individual: baseline and ...

Research Terms

<Acute><Acute Pain><Administrative Supplement><Blood leukocyte><Cell Body><Cell Nucleus><Cells><Characteristics><Complement><Complement Proteins><Data><Development><Event><Expression Signature><Gene Expression><Gene Expression Profile><Generations><Goals><Immune><Immunes><Individual><Knee arthroplasty><Knee joint replacement operation><Knee replacement><Leukocytes><Leukocytes Reticuloendothelial System><Marrow leukocyte><Nucleus><Operative Procedures><Operative Surgical Procedures><Population><Post-operative Pain><Postoperative Pain><Predisposition><Public Health><Role><Sampling><Surgical><Surgical Interventions><Surgical Procedure><Susceptibility><Total Knee Replacement><White Blood Cells><White Cell><biomarker identification><biosignature><chronic pain><complementation><developmental><experiment><experimental research><experimental study><experiments><feasibility testing><gene expression pattern><gene expression signature><global gene expression><global transcription profile><identification of biomarkers><identification of new biomarkers><knee replacement arthroplasty><marker identification><pain after surgery><parent grant><post-surgical pain><postsurgical pain><programs><resilience><resilient><scRNA-seq><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><surgery><total knee arthroplasty><transcriptional profile><transcriptional signature><transcriptome><white blood cell><white blood corpuscle>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Charles Boucher

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 18/100
Active award
Team-scale grant
$50,819
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

3U54HL185005-01S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kenneth N. Olivier

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 18/100
Active award
Team-scale grant
$50,819
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

3U54HL185005-01S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VANDERLEI BAGNATO

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Y. Chiao

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CESALTINA FERREIRA LORENZONI

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca R. Richards-Kortum

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kathleen Schmeler

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

regis kreitchmann

UNIVERSITY OF TX MD ANDERSON CAN CTR, HOUSTON, TX

Exploratory lead · 18/100
Active award
Team-scale grant
$45,360
FY 2025

Project Title

The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Grant Number:

3U54CA277843-03S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2023

End Date:

7/31/2028

Project Abstract

ABSTRACT The overall vision of the AVANÇO Research Consortium is to establish sustainable infrastructure to develop research programs focused on HIV-associated malignancies in Brazil and Mozambique. The research theme chosen for this U54 HIV-Associated Malignancy Research Center (HAMRC) is to develo...

Research Terms

<AIDS><AIDS Associated Opportunistic Infection><AIDS Virus><AIDS associated cancer><AIDS opportunistic infections><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-Related Opportunistic Infections><AIDS-associated malignancies><Acceleration><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome><Acquired Immunodeficiency Syndrome Virus><Address><Advanced Development><Africa><Age><Approaches to prevention><Behavioral Sciences><Biomedical Engineering><Brazil><Cancer Cause><Cancer Etiology><Cancers><Categories><Cervical><Cervical Cancer><Cervical Cancer Screening><Cervical dysplasia><Cervix Cancer><Cervix Dysplasia><Cessation of life><Chronic><Clinical><Collaborations><Colposcopes><Communication><Country><Coupled><Death><Development><Diagnosis><Disease><Disorder><Disparities><Disparity><EXTMR><Economic Income><Economical Income><Epidemic><Epidemiology><Extramural><Extramural Activities><Fostering><Funding><Goals><HIV><HIV Infections><HIV-Associated Cancer><HIV-Related Opportunistic Infections><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HPV Vaccine><HPV infection><HTLV-III Infections><HTLV-III-LAV Infections><Health><Health Sciences><Histologic><Histologically><History><Hospitals><Human Immunodeficiency Viruses><Human Papilloma Virus Vaccine><Human T-Lymphotropic Virus Type III Infections><Human papilloma virus infection><Human papillomavirus Vaccine><Human papillomavirus infection><Image><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Incidence><Income><Infrastructure><Institution><International><Investigators><Joints><LAV-HTLV-III><LMIC><Language><Lymphadenopathy-Associated Virus><MDACC><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Mediating><Medicine><Mentors><Microscope><Morbidity><Morbidity - disease rate><Mozambique><NIH><National Institutes of Health><Optics><Pathology><Persons><Physicians><Pilot Projects><Portuguese><Portuguese East Africa><Prevention><Prevention approach><Public Health><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Research><Research Grants><Research Infrastructure><Research Personnel><Research Project Grants><Research Projects><Research Training><Researchers><Resource Sharing><Rice><Risk><Risk Factors><Scientific Publication><Scientist><Sight><Technology><Testing><Texas><Triage><United States National Institutes of Health><Universities><University of Texas M D Anderson Cancer Center><University of Texas MD Anderson Cancer Center><Uterine Cervix Cancer><Viral><Viral Diseases><Virus Diseases><Virus-HIV><Vision><Woman><Women's mortality><World Health Organization><ages><antiretroviral therapy><antiretroviral treatment><bio-engineered><bio-engineers><bioengineering><biological engineering><career><cervical cancer early detection><cervical screening><co-infection><co-morbid><co-morbidity><coinfection><college><collegiate><colpospectroscope><comorbidity><cost><death among females><death among women><death in females><death in women><death rate among women><death rate in women><developmental><epidemiologic><epidemiological><female death><female mortality><female treatment><girls><histories><imaging><imaging platform><immune suppression><immune suppressive activity><immune suppressive function><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><incomes><low and middle-income countries><malignancy><member><mortality><mortality among females><mortality among women><mortality in females><mortality in women><multi-modality><multimodality><neoplasm/cancer><novel><optical><over-treatment><overtreatment><pandemic><pandemic disease><performance tests><pilot study><point of care><precancer cervical detection><prevent><preventing><programs><research study><screening><screenings><tool><treat females><treat women><treatment among females><treatment among women><treatment in females><treatment in women><viral infection><virus infection><virus-induced disease><visual function><women's death><women's death rate><women's treatment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Susie Annmarie Turkson

VIRGINIA COMMONWEALTH UNIVERSITY, RICHMOND, VA

Exploratory lead · 18/100
Training-friendly
$43,774
FY 2024

Project Title

Women Living with HIV: Cognitive Impact of Estrogen Receptors, Inflammation, and Aging

Grant Number:

5F31AG076375-03

Activity Code:

F31

Mechanism:

Training, Individual

Agency:

NIH

Start Date:

9/10/2022

End Date:

9/9/2025

Why this may be worth a closer look

  • • Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Project Summary/Abstract Cognitive impairment is prevalent in older adults and females carry a disproportionately greater risk for cognitive deficits like dementia and Alzheimer's disease. While estrogen deficiencies have been linked to an increased risk of cognitive decline, the mechanism for this ...

Research Terms

<(TNF)-α><AD dementia><AIDS Virus><Acceleration><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Affect><Age><Aging><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimers Dementia><Amentia><Animal Model><Animal Models and Related Studies><Anti-HIV Positivity><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Aquadiol><Assay><B cell differentiation factor><B cell stimulating factor 2><B-Cell Differentiation Factor><B-Cell Differentiation Factor-2><B-Cell Stimulatory Factor-2><BCDF><BSF-2><BSF2><Beta Proprotein Interleukin 1><Bioassay><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><C-reactive protein><CNS Nervous System><Cachectin><Cell Body><Cells><Cellular biology><Central Nervous System><Clinical><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive aging><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Cohort Studies><Concurrent Studies><Coupled><Cytokine Gene><DNA Molecular Biology><Data><Data Banks><Databanks><Dementia><Development><Dimenformon><Diogyn><Diogynets><Disadvantaged><Disturbance in cognition><Doctor of Philosophy><ER-BETA><ERalpha><ERbeta><ERα><ERβ><ESR-BETA><ESR1><ESR1 gene><ESR2><ESR2 gene><ESRB><ESTRB><Edodekin Alfa><Endocrine Gland Secretion><Estrace><Estradiol><Estradiol Receptor alpha><Estradiol Receptor α><Estradiol-17 beta><Estradiol-17beta><Estraldine><Estrogen Receptor 1><Estrogen Receptor 2><Estrogen Receptor alpha><Estrogen Receptor beta><Estrogen Receptor α><Estrogen Receptor β><Estrogen Receptors><Estrogen decline><Estrogen deficiency><Estrogens><Evaluation><Female><Future><Gene Expression><General Population><General Public><Genes><Goals><HAART><HIV><HIV Positive><HIV Positivity><HIV Seroconversion><HIV Seropositivity><HIV antibody positive><HIV diagnosis><HPGF><HTLV-III Seroconversion><HTLV-III Seropositivity><Health><Hepatocyte-Stimulating Factor><Highly Active Antiretroviral Therapy><History><Hormones><Human><Human Immunodeficiency Viruses><Hybridoma Growth Factor><IFN-Gamma><IFN-beta 2><IFN-g><IFN-γ><IFNB2><IFNG><IFNγ><IL-1 beta><IL-1 β><IL-1-b><IL-12><IL-1β><IL-6><IL1-Beta><IL1-β><IL12><IL1B Protein><IL1F2><IL1β><IL6 Protein><Ig Genes><Immune><Immune Interferon><Immune response><Immune system><Immunes><Immunoblotting><Immunoglobulin Genes><Immunological response><Immunomodulation><Impaired cognition><Inflammaging><Inflammation><Inflammatory><Interferon Gamma><Interferon Type II><Interleukin 1beta><Interleukin-1 beta><Interleukin-12><Interleukin-1β><Interleukin-6><Investigation><LAV-HTLV-III><Link><Lymphadenopathy-Associated Virus><MGI-2><Macrophage-Derived TNF><Mediating><Mediator><Memory><Menopausal Status><Menopause><Mental Health><Mental Hygiene><Modern Man><Molecular><Molecular Biology><Monocyte-Derived TNF><Myeloid Differentiation-Inducing Protein><NKSF><NR3A1><NR3A2><Natural Killer Cell Stimulatory Factor><Nature><Neuraxis><Neuroendocrinology><Outcome><Ovocyclin><Ovocylin><PBMC><Participant><Pathogenesis><Performance><Peripheral Blood Mononuclear Cell><Persons><Ph.D.><PhD><Physicians><Plasmacytoma Growth Factor><Population><Post-Menopause><Post-menopausal Period><Postmenopausal Period><Postmenopause><Pre-Menopause><Pre-menopausal Period><Predisposition><Preinterleukin 1 Beta><Premature Menopause><Premenopausal><Premenopausal Period><Premenopause><Primary Senile Degenerative Dementia><Process><Progynon><Proteins, specific or class, C-reactive><Psychological Health><Receptor Gene><Receptor Protein><Recording of previous events><Research><Risk><Risk Assessment><Risk Reduction><Role><Sampling><Scientist><Single Base Polymorphism><Single Nucleotide Polymorphism><Susceptibility><TLR protein><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Testing><Therapeutic Estradiol><Therapeutic Estrogen><Therapeutic Hormone><Time><Toll-Like Receptor Family Gene><Toll-like receptors><Training><Translating><Treatment Protocols><Treatment Regimen><Treatment Schedule><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Universities><Virginia><Virus-HIV><Western Blotting><Western Immunoblotting><Woman><Women's Interagency HIV Study><after menopause><age-related inflammation><ages><aging process><bio-markers><biologic marker><biological sex><biomarker><biomarker selection><cell biology><cognitive defects><cognitive dysfunction><cognitive function><cognitive loss><cognitive performance><cognitive task><cohort><cytokine><data depository><data repository><data set repository><dataset repository><decline in estrogen><decrease estrogen><decrease in estrogen><deficiency in estrogen><design><designing><developmental><early experience><early menopause><early onset><experience><expression subtypes><following menopause><high risk><histories><host response><immune modulation><immune regulation><immune system response><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><inflamm-ageing><inflamm-aging><insight><interferon beta 2><lFN-Gamma><male><men><model of animal><molecular sub-types><molecular subsets><molecular subtypes><neural inflammation><neuroinflammation><neuroinflammatory><neuroprotection><neuroprotective><older adult><older adulthood><past menopause><post-menopausal><postmenopausal><postmenopausal status><pre-menopausal><premature age of menopause><premenopausal status><primary degenerative dementia><protein blotting><protein expression><receptor><receptor expression><receptor function><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduced estrogen><reduces risk><reduces the risk><reducing risk><reducing the risk><risk-reducing><screening><screenings><senile dementia of the Alzheimer type><single nucleotide variant><skills><social role><substance use><substance using><synapse function><synaptic function><systemic inflammation><systemic inflammatory response>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Charles Boucher

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 18/100
Active award
Team-scale grant
$39,259
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

3U54HL185005-01S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kenneth N. Olivier

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 18/100
Active award
Team-scale grant
$39,259
FY 2025

Project Title

Rare Bronchiectatic Diseases Consortium

Grant Number:

3U54HL185005-01S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

5/31/2030

Project Abstract

ABSTRACT Four rare bronchiectatic diseases (RBDs), including primary ciliary dyskinesia, alpha-1 antitrypsin, humoral immune deficiency, and STAT3-HIES, manifest bronchiectasis (BE) as a severe pulmonary complication. BE, defined by airways dilation/ectasia on chest CT imaging, is associated with co...

Research Terms

<A1PI><AAT deficiency><Acceleration><Acute><Affect><Ancillary Study><Antiproteases><Awareness><Bacteria><Bacterial Infections><Biological Markers><Blood Sample><Blood specimen><Bronchiectasis><CAT scan><CT X Ray><CT Xray><CT imaging><CT scan><Cell Body><Cells><Chronic><Clinical><Clinical Data><Clinical Research><Clinical Study><Clinical Trials><Collaborations><Communication><Complication><Computed Tomography><Coughing><Coupled><DNA mutation><Data><Development><Disease><Disease Progression><Disorder><Dysfunction><Ectasia><Education><Educational aspects><Elements><Endopeptidase Inhibitors><Environment><Epithelium><Esteroproteases><Exhalation><Exhaling><Failure><Family><Feasibility Studies><Fibrosis><Frequencies><Functional disorder><Future><Gene Alteration><Gene Mutation><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><History><Hyper-IgE Syndrome><Hyperimmunoglobulin E Syndrome><Hyperimmunoglobulin E-Recurrent Infection Syndrome><Image Analyses><Image Analysis><Immune><Immunes><In Vitro><Industry><Inflammatory><International><Investigation><Investigators><Kartagener Syndrome><Kartagener Triad><Laboratories><Laboratory Study><Life><Longitudinal Studies><Lung><Lung Diseases><Lung Function Tests><Lung Respiratory System><Measures><Mouth microbiome><Mucous body substance><Mucus><Mutation><NIH><National Institutes of Health><Natural History><Nature><Non-Polyadenylated RNA><Observation research><Observation study><Observational Study><Observational research><Oral><Orphan Disease><Pathogenesis><Pathologic Dilatation><Pathological Dilatation><Patient Outcomes Assessments><Patient Reported Measures><Patient Reported Outcomes><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Peptidase Inhibitors><Peptidases><Peptide Hydrolase Inhibitors><Peptide Hydrolases><Peptide Peptidohydrolase Inhibitors><Phase><Physical condensation><Physicians><Physiopathology><Pilot Projects><Polynesian bronchiectasis><Primary Ciliary Dyskinesias><Procedures><Production><Property><Protease Antagonists><Protease Gene><Protease Inhibitor><Proteases><Proteinase Inhibitors><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Diseases><Pulmonary Disorder><Pulmonary function tests><RNA><RNA Gene Products><Rare Diseases><Rare Disorder><Reading><Recording of previous events><Research Personnel><Research Specimen><Researchers><Resected><Respiratory Disease><Respiratory Epithelium><Respiratory Expiration><Respiratory System Disease><Respiratory System Disorder><Ribonucleic Acid><Role><STAT3><STAT3 gene><Sampling><Scientist><Severities><Site><Source><Specimen><Speed><Sputum><Structure><Structure of respiratory epithelium><Technology><Testing><Therapeutic><Therapeutic Trials><Tomodensitometry><Training><United States National Institutes of Health><Update><Validation><Viral Diseases><Virus Diseases><Voice><Work><X-Ray CAT Scan><X-Ray Computed Tomography><X-Ray Computerized Tomography><Xray CAT scan><Xray Computed Tomography><Xray computerized tomography><a1-antitrypsin deficiency><airway epithelium><airway hypoxia><airway microbiome><alpha 1 Antiprotease><alpha 1-Antiproteinase><alpha 1-Antitrypsin><alpha 1-Antitrypsin Deficiency><alpha 1-Antitrypsin Trypsin Inhibitor><alpha 1-Protease Inhibitor><alpha 1-Proteinase Inhibitor><alpha-1-anti-trypsin deficiency><alpha1-antitrypsin deficiency><aspirate><bacteria infection><bacterial disease><bio-markers><biologic marker><biomarker><biomarker development><career><catscan><chest CT><chest computed tomography><clinical outcome measures><clinical practice><cohort><computed axial tomography><computer tomography><computerized axial tomography><computerized tomography><condensation><design><designing><developmental><disease of the lung><disorder of the lung><drug discovery><gene defect><genome mutation><histories><hypoimmunity><image evaluation><image interpretation><immune deficiency><immunodeficiency><improved><improved outcome><in vivo><industrial partnership><industry partner><industry partnership><infection recurrence><insight><long-term study><longitudinal outcome studies><lung disorder><lung function><metabolism measurement><metabolomics><metabonomics><microbiome><mortality><mucous><mucus clearance><mutant allele><new drug treatments><new drugs><new marker><new pharmacological therapeutic><new therapeutics><new therapy><next generation><next generation therapeutics><non-contrast CT><noncontrast CT><noncontrast computed tomography><novel><novel biomarker><novel drug treatments><novel drugs><novel marker><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbiome><orphan disorder><pathophysiology><patient advocacy group><patient oriented outcomes><pilot study><pulmonary><pulmonary function><rare condition><rare genetic disease><rare genetic disorder><rare syndrome><recurrent infection><recurring infection><respiratory hypoxia><respiratory microbiome><respiratory tract epithelium><respiratory tract microbiome><response><social role><specific biomarkers><therapeutic agent development><therapeutic development><therapeutic target><trait><validations><viral infection><virus infection><virus-induced disease><α-1 anti-trypsin deficiency><α-1-antitrypsin deficiency><α1-Antitrypsin><α1-Antitrypsin Deficiency><α1-Proteinase Inhibitor>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Raegan Winston Durant

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 18/100
Active award
Team-scale grant
$35,226
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54) Travel Supplement

Grant Number:

3U54CA267746-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

8/31/2026

Project Abstract

Introduction This purpose of this proposal is to request supplemental funding for the UAB/Tuskegee FIRST Partnership (U54-CA267746-000538702) to cover costs for travel and lodging expenses for faculty hired under the program (Benjamin-Carver FIRST Scientists) to attend the annual FIRST Grantees Meet...

Research Terms

<African American><Afro American><Afroamerican><Alabama><American><Area><Award><Behavioral><Black><Black race><Budgets><Cancer Cluster><Cancers><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Collaborations><Community Medicine><Diabetes Mellitus><Doctor of Philosophy><Education><Educational aspects><Elements><Ensure><Facebook><Faculty><Family Practice><Female><Funding><Goals><Heart Vascular><Infrastructure><Institution><Interview><Investigators><Journals><Knowledge><Language><Latine><Latinx><Leadership><Letters><LinkedIn><Magazine><Malignant Neoplasms><Malignant Tumor><Medical><Medicine><Minority><Minority Health Research><Minority research><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Neurobiology><Neurosciences><Obesity><Operative Procedures><Operative Surgical Procedures><Ph.D.><PhD><Position><Positioning Attribute><Preventive Medicine><Process><Professional Organizations><Psychiatry><Publications><Recommendation><Recruitment Activity><Research><Research Personnel><Research Resources><Researchers><Resources><Schedule><Scientific Publication><Scientist><Surgical><Surgical Interventions><Surgical Procedure><Travel><United States National Institutes of Health><Universities><Update><Woman><active recruitment><adiposity><candidate selection><cardiovascular disorder><circulatory system><cohort><conference><convention><corpulence><cost><design><designing><diabetes><disparity in health><diversity and inclusion><diversity and inclusivity><expectation><experience><family medicine><health disparity><malignancy><medical college><medical schools><meeting><meetings><member><neoplasm/cancer><neurobiological><preventative medicine><professional association><professional membership><professional society><programs><recruit><research in minorities><research on minorities><research related to minorities><research with minorities><school of medicine><social media><summit><surgery><symposia><symposium><timeline><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MONA N. FOUAD

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 18/100
Active award
Team-scale grant
$35,226
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54) Travel Supplement

Grant Number:

3U54CA267746-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

8/31/2026

Project Abstract

Introduction This purpose of this proposal is to request supplemental funding for the UAB/Tuskegee FIRST Partnership (U54-CA267746-000538702) to cover costs for travel and lodging expenses for faculty hired under the program (Benjamin-Carver FIRST Scientists) to attend the annual FIRST Grantees Meet...

Research Terms

<African American><Afro American><Afroamerican><Alabama><American><Area><Award><Behavioral><Black><Black race><Budgets><Cancer Cluster><Cancers><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Collaborations><Community Medicine><Diabetes Mellitus><Doctor of Philosophy><Education><Educational aspects><Elements><Ensure><Facebook><Faculty><Family Practice><Female><Funding><Goals><Heart Vascular><Infrastructure><Institution><Interview><Investigators><Journals><Knowledge><Language><Latine><Latinx><Leadership><Letters><LinkedIn><Magazine><Malignant Neoplasms><Malignant Tumor><Medical><Medicine><Minority><Minority Health Research><Minority research><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Neurobiology><Neurosciences><Obesity><Operative Procedures><Operative Surgical Procedures><Ph.D.><PhD><Position><Positioning Attribute><Preventive Medicine><Process><Professional Organizations><Psychiatry><Publications><Recommendation><Recruitment Activity><Research><Research Personnel><Research Resources><Researchers><Resources><Schedule><Scientific Publication><Scientist><Surgical><Surgical Interventions><Surgical Procedure><Travel><United States National Institutes of Health><Universities><Update><Woman><active recruitment><adiposity><candidate selection><cardiovascular disorder><circulatory system><cohort><conference><convention><corpulence><cost><design><designing><diabetes><disparity in health><diversity and inclusion><diversity and inclusivity><expectation><experience><family medicine><health disparity><malignancy><medical college><medical schools><meeting><meetings><member><neoplasm/cancer><neurobiological><preventative medicine><professional association><professional membership><professional society><programs><recruit><research in minorities><research on minorities><research related to minorities><research with minorities><school of medicine><social media><summit><surgery><symposia><symposium><timeline><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TIMOTHY TURNER

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Exploratory lead · 18/100
Active award
Team-scale grant
$35,226
FY 2024

Project Title

UAB/Tuskegee Faculty Institutional Recruitment for Sustainable Transformation (UAB/TU FIRST) Partnership (NIH U54) Travel Supplement

Grant Number:

3U54CA267746-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2021

End Date:

8/31/2026

Project Abstract

Introduction This purpose of this proposal is to request supplemental funding for the UAB/Tuskegee FIRST Partnership (U54-CA267746-000538702) to cover costs for travel and lodging expenses for faculty hired under the program (Benjamin-Carver FIRST Scientists) to attend the annual FIRST Grantees Meet...

Research Terms

<African American><Afro American><Afroamerican><Alabama><American><Area><Award><Behavioral><Black><Black race><Budgets><Cancer Cluster><Cancers><Cardiovascular><Cardiovascular Body System><Cardiovascular Diseases><Cardiovascular Organ System><Cardiovascular system><Collaborations><Community Medicine><Diabetes Mellitus><Doctor of Philosophy><Education><Educational aspects><Elements><Ensure><Facebook><Faculty><Family Practice><Female><Funding><Goals><Heart Vascular><Infrastructure><Institution><Interview><Investigators><Journals><Knowledge><Language><Latine><Latinx><Leadership><Letters><LinkedIn><Magazine><Malignant Neoplasms><Malignant Tumor><Medical><Medicine><Minority><Minority Health Research><Minority research><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Neurobiology><Neurosciences><Obesity><Operative Procedures><Operative Surgical Procedures><Ph.D.><PhD><Position><Positioning Attribute><Preventive Medicine><Process><Professional Organizations><Psychiatry><Publications><Recommendation><Recruitment Activity><Research><Research Personnel><Research Resources><Researchers><Resources><Schedule><Scientific Publication><Scientist><Surgical><Surgical Interventions><Surgical Procedure><Travel><United States National Institutes of Health><Universities><Update><Woman><active recruitment><adiposity><candidate selection><cardiovascular disorder><circulatory system><cohort><conference><convention><corpulence><cost><design><designing><diabetes><disparity in health><diversity and inclusion><diversity and inclusivity><expectation><experience><family medicine><health disparity><malignancy><medical college><medical schools><meeting><meetings><member><neoplasm/cancer><neurobiological><preventative medicine><professional association><professional membership><professional society><programs><recruit><research in minorities><research on minorities><research related to minorities><research with minorities><school of medicine><social media><summit><surgery><symposia><symposium><timeline><virtual>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mark Brian Reed

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$32,982
FY 2024

Project Title

SDSU FUERTE: Faculty United towards Excellence in Research and Transformational Engagement

Grant Number:

3U54CA267789-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Project Abstract

U54 ADMINISTRATIVE SUPPLEMENT SUMMARY San Diego State University Faculty Unified towards Excellence in Research and Transformational Engagement (SDSU FUERTE) The FIRST program is funded through the NIH Common Fund and managed in collaboration by the National Cancer Institute. The work that will be ...

Research Terms

<Academy><Address><Administrative Supplement><Air><Area><Budgets><Collaborations><Communities><Environment><Faculty><Faculty Recruitment><Food><Fostering><Foundations><Funding><Funding Opportunities><Goals><Growth and Development><Growth and Development function><Guidelines><Health><Institution><Investigators><Latine><Latinx><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Obesity><Physical activity><Research><Research Personnel><Researchers><Science><Travel><United States National Institutes of Health><Universities><Work><addiction><addictive disorder><adiposity><career><cohort><corpulence><disparity in health><evidence base><health disparity><innovate><innovation><innovative><meeting><meetings><nutrition><programs><recruit><recruit teachers><teacher recruitment><tenure process><tenure track>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maria Luisa Zuniga de Nuncio

SAN DIEGO STATE UNIVERSITY, SAN DIEGO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$32,982
FY 2024

Project Title

SDSU FUERTE: Faculty United towards Excellence in Research and Transformational Engagement

Grant Number:

3U54CA267789-03S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2021

End Date:

8/31/2026

Project Abstract

U54 ADMINISTRATIVE SUPPLEMENT SUMMARY San Diego State University Faculty Unified towards Excellence in Research and Transformational Engagement (SDSU FUERTE) The FIRST program is funded through the NIH Common Fund and managed in collaboration by the National Cancer Institute. The work that will be ...

Research Terms

<Academy><Address><Administrative Supplement><Air><Area><Budgets><Collaborations><Communities><Environment><Faculty><Faculty Recruitment><Food><Fostering><Foundations><Funding><Funding Opportunities><Goals><Growth and Development><Growth and Development function><Guidelines><Health><Institution><Investigators><Latine><Latinx><NCI Organization><NIH><National Cancer Institute><National Institutes of Health><Obesity><Physical activity><Research><Research Personnel><Researchers><Science><Travel><United States National Institutes of Health><Universities><Work><addiction><addictive disorder><adiposity><career><cohort><corpulence><disparity in health><evidence base><health disparity><innovate><innovation><innovative><meeting><meetings><nutrition><programs><recruit><recruit teachers><teacher recruitment><tenure process><tenure track>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Ddungu Kambugu

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$23,375
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY N MARTIN

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$23,375
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gregory Alan Abel

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$20,953
FY 2025

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156732-15S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KASISOMAYAJULA VISWANATH

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 18/100
Active award
Team-scale grant
$20,953
FY 2025

Project Title

2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

Grant Number:

3U54CA156732-15S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/27/2010

End Date:

8/31/2026

Project Abstract

The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research tha...

Research Terms

<Address><Area><Biology><Biotech><Biotechnology><Boston><Cancer Center><Cancer Control><Cancer Control Science><Cancer Research Programs><Cancer Research Project><Cancer Science><Cancers><Charge><Communities><Community Networks><Data Set><Dedications><Development and Research><Discipline><Education><Educational aspects><Ensure><Experimental Designs><Foundations><Funding><Genomics><Goals><Government><Grant><High-Risk Cancer><Incidence><Infrastructure><Institution><Investigators><Joints><Laser Electromagnetic><Laser Radiation><Lasers><Leadership><Malignant Neoplasms><Malignant Tumor><Massachusetts><Mentors><Methodology><Methods><Modeling><Morbidity><Morbidity - disease rate><NIH><National Institutes of Health><Obesity><Phase><Population><Population Group><Population Sciences><Postdoc><Postdoctoral Fellow><R & D><R&D><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Associate><Research Design><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Science><Solid><Source><Students><Study Type><Training><United States National Institutes of Health><Universities><adiposity><anti-cancer research><cancer disparity><cancer health disparity><cancer research><cancer-related health disparity><career><career development><community based organizations><community engagement><community organizations><corpulence><disparity in cancer><early onset><education research><engagement with communities><experience><experiment><experimental research><experimental study><experiments><innovate><innovation><innovative><lack of physical activity><malignancy><member><mortality><neoplasm/cancer><outreach><physical inactivity><post-doc><post-doctoral><post-doctoral trainee><research and development><research associates><research study><student engagement><student motivation><student participation><study design><translational model><translational opportunities><translational potential>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Ddungu Kambugu

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$12,500
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY N MARTIN

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$12,500
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY, SEATTLE, WA

Exploratory lead · 18/100
Active award
Team-scale grant
$12,350
FY 2024

Project Title

Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

Grant Number:

3U54CA274509-02S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/22/2022

End Date:

8/31/2027

Project Abstract

Overall Project Summary The proposed U54 program Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor -- Immunotherapy Combinations (ST-Analytics) is designed to develop the recent conceptual advance that targeted inhibitor + cancer immunotherapy (IT) combination treatments may y...

Research Terms

<Address><Adoptive Cell Transfers><Automobile Driving><Biopsy><Brain Metastasis><Calibration><Clinical Data><Clinical Trials><Combination immunotherapy><Combined Modality Therapy><Communities><Coupled><Data Bases><Databases><Development><Distal><Dose><Education and Outreach><Immune><Immune mediated therapy><Immunes><Immunologic Factors><Immunological Factors><Immunologically Directed Therapy><Immunotherapy><Instruction and Outreach><Kinetics><Lead><MAPK Inhibitors><Malignant Melanoma><Melanoma><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Neoplasm to the Brain><Metastatic Tumor><Metastatic Tumor to the Brain><Metastatic malignant neoplasm to brain><Mitogen-Activated Protein Kinase Inhibitor><Modeling><Multimodal Therapy><Multimodal Treatment><Neoplasm Metastasis><Outcome><Patients><Pb element><Play><Primary Neoplasm><Primary Tumor><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Project Grants><Research Projects><Research Resources><Resistance><Resources><Role><STEM Education><STEM knowledge><Science><Science, Technology, Engineering and Math Education><Science, Technology, Engineering and Mathematics Education><Scientist><Secondary Neoplasm><Secondary Tumor><Structure><System><Therapeutic><Training and Outreach><Tutoring and Outreach><Work><adoptive cell therapy><adoptive cellular therapy><anti-cancer immunotherapy><anticancer immunotherapy><brain micrometastasis><cancer immunotherapy><cancer metastasis><check point blockade><checkpoint blockade><combination therapy><combinatorial><combinatorial immunotherapy><combined modality treatment><combined treatment><data base><design><designing><developmental><disease model><disorder model><driving><dual immunotherapy><heavy metal Pb><heavy metal lead><immune check point blockade><immune checkpoint blockade><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based cancer therapies><immune-based therapies><immune-based treatments><immuno therapy><immunologic substance><immunological substance><immunotherapy for cancer><immunotherapy of cancer><in silico><in vivo><inhibitor><inhibitor drug><inhibitor therapeutic><inhibitor therapy><medical college><medical schools><mouse model><multi-modal therapy><multi-modal treatment><murine model><outreach><outreach program><prevent><preventing><programs><resistant><school of medicine><science, technology, engineering and math knowledge><science, technology, engineering and mathematics knowledge><social role><spatiotemporal><tumor><tumor cell metastasis>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew Ddungu Kambugu

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$10,800
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JEFFREY N MARTIN

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Exploratory lead · 18/100
Active award
Team-scale grant
$10,800
FY 2025

Project Title

United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers

Grant Number:

3U54CA254571-06S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/13/2020

End Date:

6/30/2026

Project Abstract

In the field of HIV-associated malignancies, East Africa faces three intersecting problems common to resource-limited settings. First, East Africa lacks effective primary and secondary prevention strategies for cervical cancer and Kaposi’s sarcoma (KS), two of the most common cancers not only among ...

Research Terms

<AIDS Virus><AIDS associated cancer><AIDS related cancer><AIDS-Related Malignancy><AIDS-Related Malignant Neoplasm><AIDS-associated malignancies><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Africa><Africa South of the Sahara><African><Award><Back><Biometrics><Biometry><Biostatistics><California><Cancers><Career Development Awards><Career Development Awards and Programs><Career Development Programs K-Series><Caring><Cervical Cancer><Cervix Cancer><Clinical><Clinical Research><Clinical Study><Collaborations><Communicable Diseases><Country><Development><Diagnosis><Diagnostic tests><Disease><Disorder><Dorsum><Early Diagnosis><Early treatment><East African><Epidemiologic Research><Epidemiologic Studies><Epidemiological Studies><Epidemiology Research><Face><Foundations><Funding><General Hospitals><General Population><General Public><HIV><HIV Infections><HIV-Associated Cancer><HIV-associated malignancy><HIV-related malignancy><HIV/AIDS-associated malignancy><HIV/AIDS-related cancer><HTLV-III Infections><HTLV-III-LAV Infections><Health><Home><Human Immunodeficiency Viruses><Human T-Lymphotropic Virus Type III Infections><Incidence><Individual><Infectious Diseases><Infectious Disorder><Institution><Investigators><Junior Physician><K-Awards><K-Series Research Career Programs><Kaposi Sarcoma><Kaposi's Sarcoma><Kenya><Knowledge><LAV-HTLV-III><Lead><Leadership><Life Cycle><Life Cycle Stages><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Lymphadenopathy-Associated Virus><Malignant Cervical Neoplasm><Malignant Cervical Tumor><Malignant Neoplasm of the Cervix><Malignant Neoplasms><Malignant Tumor><Malignant Tumor of the Cervix><Malignant Tumor of the Cervix Uteri><Malignant Uterine Cervix Neoplasm><Malignant Uterine Cervix Tumor><Malignant neoplasm of cervix uteri><Massachusetts><Mediating><Medical Research><Mentors><Modeling><Multiple Hemorrhagic Sarcoma><NIH><NLM><National Institutes of Health><National Library of Medicine><National Medical Library><Patients><Pb element><Performance><Persons><Pilot Projects><Preventative strategy><Prevention><Prevention strategy><Preventive strategy><Primary Prevention><Principal Investigator><Prognosis><Program Development><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Career Program><Research Grants><Research Institute><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><San Francisco><Science><Scientist><Screening for cancer><Secondary Prevention><Shoulder><Structure><Sub-Saharan Africa><Subsaharan Africa><Tanzania><Training><Translational Research><Translational Science><Uganda><United States><United States National Institutes of Health><United States National Library of Medicine><Universities><Uterine Cervix Cancer><Viral><Virus-HIV><Virus-Related Malignancy><Virus-Related Malignant Neoplasm><Work><advanced disease><advanced illness><anti-cancer research><cancer research><career development><cervical cancer prevention><clinical relevance><clinically relevant><data management><developmental><early cancer detection><early detection><early therapy><epidemiologic investigation><epidemiology study><experience><faces><facial><heavy metal Pb><heavy metal lead><homes><improved><interest><life course><malignancy><neoplasm/cancer><novel><operation><operations><pilot study><programs><prospective><response><screening><screening cancer patients><screenings><tool><translation research><translational investigation><viral associated cancer><viral associated malignancy><viral associated malignant neoplasm><viral induced cancer><viral induced malignancy><viral induced malignant neoplasm><viral related cancer><viral related malignancy><viral related malignant neoplasm><virus associated cancer><virus associated malignancy><virus associated malignant neoplasm><virus induced cancer><virus induced malignancy><virus induced malignant neoplasm><virus related cancer>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

HADINE JOFFE

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Exploratory lead · 8/100
Team-scale grant
$75,911
FY 2024

Project Title

Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes

Grant Number:

3U54AG062322-04S2

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

5/31/2025

Project Abstract

Summary/abstract Most women experience symptoms and sleep difficulties during perimenopause which can significantly impact their quality of life. The severity and duration of menopausal symptoms are influenced by psychological, biological, behavioral, and demographic factors. However, little is know...

Research Terms

<65 and older><65 or older><65 years of age and older><65 years of age or more><65 years of age or older><65+ years><65+ years old><> 65 years><Aged 65 and Over><Behavioral><Biological><Climate><Data><Demographic Factors><Epidemiologist><Exposure to><Female Health><Frequencies><Goals><Green space><Health><Hot flushes><Investigators><Longitudinal Studies><Menopausal Symptom><Menopause><Mentors><Mentorship><Meteorological Climate><Muellerian inhibiting hormone><Mullerian-inhibiting factor><Outcome><Perimenopausal><Perimenopause><Position><Positioning Attribute><QOL><Quality of life><Research><Research Personnel><Researchers><Severities><Sleep><Stress><Symptoms><Temperature><Training><Woman><Women's Health><above age 65><after age 65><age 65 and greater><age 65 and older><age 65 or older><age > 65><age of 65 years onward><aged 65 and greater><aged 65+><aged ≥65><anti-mullerian factor><anti-mullerian hormone><biologic><climatic><cohort><experience><greenspace><hot flash><human old age (65+)><long-term study><longitudinal outcome studies><longterm study><menopause transition><mullerian inhibiting substance><mullerian regression factor><mullerian-inhibiting hormone><mullerian-inhibitory substance><neural control><neural regulation><neuromodulation><neuromodulatory><neuroregulation><old age><ovarian reserve><over 65 years><parent grant><peri-menopausal><peri-menopause><psychologic><psychological><reproductive><reproductive aging><reproductive cell senescence><reproductive epidemiology><reproductive senescence><skills><sleep difficulty><transition to menopause><transitional menopause><≥65 years>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JILL M GOLDSTEIN

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Exploratory lead · 8/100
Team-scale grant
$13,661
FY 2024

Project Title

Prenatal immune programming of sex differences in depression and CVD risk. Supplement to Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation.

Grant Number:

3U54MH118919-04S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

2/1/2020

End Date:

12/31/2024

Project Abstract

This application is a request for diversity supplemental funding for Ms. Monique Martinez to initiate her graduate studies in the laboratory of Dr. Taben Hale at the University of Arizona. This project examines the fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis, an important syst...

Research Terms

<21+ years old><Adrenal Glands><Adrenals><Adult><Adult Human><Affect><Age><Agonist><Anxiety><Arizona><Autonomic nervous system><Autoregulation><Behavioral><Blood Pressure><Brain><Brain Nervous System><Cardiac><Cardiac Chronotropism><Cardiac development><Cardiometabolic Disease><Cardiometabolic Disorder><Cardiovascular><Cardiovascular Body System><Cardiovascular Organ System><Cardiovascular system><Common Rat Strains><Complex><Data><Developing fetus><Development><Dexamethasone><Differences between sexes><Differs between sexes><Disease><Disorder><Disproportionate number of females><Disproportionate number of women><Disproportionately affects females><Disproportionately affects women><Disproportionately impacts females><Disproportionately impacts women><Disproportionately in females><Disproportionately in women><Education><Educational aspects><Encephalon><Environment><Exposure to><Female><Fetal Development><Foundations><Funding><Gestation><Glucocorticoids><Goals><HPA axis><Health><Heart Rate><Heart Vascular><Homeostasis><Hypothalamic structure><Hypothalamus><Immune><Immunes><Impairment><Inflammation><Laboratories><Lead><Major Depressive Disorder><Mediating><Mental Depression><Minority Graduate Student><Mission><Parasympathetic Nervous System><Pb element><Peripheral><Physiological Homeostasis><Predisposition><Pregnancy><Puberty><Rat><Rats Mammals><Rattus><Reflex><Reflex action><Regulation><Request for Proposals><Research><Risk><Rodent><Rodentia><Rodents Mammals><Sex Differences><Sexual differences><Stress><Susceptibility><Sympathetic Nervous System><System><TLR7><TLR7 gene><Testing><Toll-Like Receptor 7><Training Programs><Universities><Withdrawal><Work><adulthood><ages><cardiogenesis><circulatory system><clinical depression><critical developmental period><critical period><depression><developmental><exposed in utero><female bias><female preponderance><fetal><fetal exposure><fetal programming><fetal stress><heart development><heart formation><heavy metal Pb><heavy metal lead><hypothalamic><hypothalamic-pituitary-adrenal (HPA) axis><hypothalamic-pituitary-adrenal axis><hypothalmus-pituitary-adrenal axis><in utero><in utero exposure><intra-uterine environmental exposure><intrauterine environmental exposure><major depression><major depression disorder><male><member><minority graduate><nervous system development><neural><neuropsychiatric disease><neuropsychiatric disorder><prenatal><prenatal exposure><prenatal stress><prenatally exposed><programs><resiquimod><response><sex based differences><sex-dependent differences><sex-related differences><sex-specific differences><social><stressor><suprarenal gland><unborn><women's preponderance>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

STUART A. TOBET

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Exploratory lead · 8/100
Team-scale grant
$13,661
FY 2024

Project Title

Prenatal immune programming of sex differences in depression and CVD risk. Supplement to Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation.

Grant Number:

3U54MH118919-04S3

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

2/1/2020

End Date:

12/31/2024

Project Abstract

This application is a request for diversity supplemental funding for Ms. Monique Martinez to initiate her graduate studies in the laboratory of Dr. Taben Hale at the University of Arizona. This project examines the fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis, an important syst...

Research Terms

<21+ years old><Adrenal Glands><Adrenals><Adult><Adult Human><Affect><Age><Agonist><Anxiety><Arizona><Autonomic nervous system><Autoregulation><Behavioral><Blood Pressure><Brain><Brain Nervous System><Cardiac><Cardiac Chronotropism><Cardiac development><Cardiometabolic Disease><Cardiometabolic Disorder><Cardiovascular><Cardiovascular Body System><Cardiovascular Organ System><Cardiovascular system><Common Rat Strains><Complex><Data><Developing fetus><Development><Dexamethasone><Differences between sexes><Differs between sexes><Disease><Disorder><Disproportionate number of females><Disproportionate number of women><Disproportionately affects females><Disproportionately affects women><Disproportionately impacts females><Disproportionately impacts women><Disproportionately in females><Disproportionately in women><Education><Educational aspects><Encephalon><Environment><Exposure to><Female><Fetal Development><Foundations><Funding><Gestation><Glucocorticoids><Goals><HPA axis><Health><Heart Rate><Heart Vascular><Homeostasis><Hypothalamic structure><Hypothalamus><Immune><Immunes><Impairment><Inflammation><Laboratories><Lead><Major Depressive Disorder><Mediating><Mental Depression><Minority Graduate Student><Mission><Parasympathetic Nervous System><Pb element><Peripheral><Physiological Homeostasis><Predisposition><Pregnancy><Puberty><Rat><Rats Mammals><Rattus><Reflex><Reflex action><Regulation><Request for Proposals><Research><Risk><Rodent><Rodentia><Rodents Mammals><Sex Differences><Sexual differences><Stress><Susceptibility><Sympathetic Nervous System><System><TLR7><TLR7 gene><Testing><Toll-Like Receptor 7><Training Programs><Universities><Withdrawal><Work><adulthood><ages><cardiogenesis><circulatory system><clinical depression><critical developmental period><critical period><depression><developmental><exposed in utero><female bias><female preponderance><fetal><fetal exposure><fetal programming><fetal stress><heart development><heart formation><heavy metal Pb><heavy metal lead><hypothalamic><hypothalamic-pituitary-adrenal (HPA) axis><hypothalamic-pituitary-adrenal axis><hypothalmus-pituitary-adrenal axis><in utero><in utero exposure><intra-uterine environmental exposure><intrauterine environmental exposure><major depression><major depression disorder><male><member><minority graduate><nervous system development><neural><neuropsychiatric disease><neuropsychiatric disorder><prenatal><prenatal exposure><prenatal stress><prenatally exposed><programs><resiquimod><response><sex based differences><sex-dependent differences><sex-related differences><sex-specific differences><social><stressor><suprarenal gland><unborn><women's preponderance>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jerris Robert Hedges

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 8/100
Team-scale grant
$1
FY 2024

Project Title

The exocyst as an insulin-sensitive regulator of amyloid-beta in neurons

Grant Number:

3U54MD007601-38S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2025

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Alzheimer beta-Protein><Alzheimer's Amyloid beta-Protein><Alzheimer's amyloid><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Area><Aβ><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Humulin R><Inequality><Institution><Insulin><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Novolin R><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Regular Insulin><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><a beta peptide><abeta><access to health care><access to healthcare><accessibility of health care><accessibility to health care><accessibility to healthcare><amyloid beta><amyloid-b protein><aspirate><base><bases><beta amyloid fibril><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><healthcare access><healthcare accessibility><healthcare availability><healthcare policy><healthcare service access><healthcare service availability><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><neuronal><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><soluble amyloid precursor protein><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Noreen Mokuau

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 8/100
Team-scale grant
$1
FY 2024

Project Title

The exocyst as an insulin-sensitive regulator of amyloid-beta in neurons

Grant Number:

3U54MD007601-38S1

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/23/1997

End Date:

5/31/2025

Project Abstract

PROJECT SUMMARY/ABSTRACT With continued support from the National Institute on Minority Health and Health Disparities (NIMHD) through the RCMI U54 RFA-MD-22-002, the goal of Ola HAWAII is to improve minority health and reduce health disparities for those communities in Hawaii which suffer disproport...

Research Terms

<Acceleration><Address><Alzheimer beta-Protein><Alzheimer's Amyloid beta-Protein><Alzheimer's amyloid><Amyloid Alzheimer's Dementia Amyloid Protein><Amyloid Beta-Peptide><Amyloid Protein A4><Amyloid beta-Protein><Amyloid β><Amyloid β-Peptide><Amyloid β-Protein><Area><Aβ><Basic Research><Basic Science><Behavioral Research><Biomedical Research><Burn injury><Burns><COVID-19><CV-19><Cancers><Cardiovascular Diseases><Climacteric><Clinical Research><Clinical Study><Collaborations><Communities><Community Participation><Core Facility><Coronavirus Infectious Disease 2019><Decrease health disparities><Diabetes Mellitus><Disparities><Disparity><Ethnic Group><Ethnic People><Ethnic Population><Ethnic individual><Ethnicity People><Ethnicity Population><Evaluation><Faculty><Filipino><Funding><Goals><Hawaii><Hawaiian><Health><Health Disparities Research><Health Policy><Health disparities related research><Health disparity mitigation><Health disparity reduction><Humulin R><Inequality><Institution><Insulin><Investigators><Island><Lead><Letters><Lower health disparities><Malignant Neoplasms><Malignant Tumor><Measures><Mentors><Minority-Serving Institution><Mitigate health disparities><NCMHD><NIMHD><Names><National Center on Minority Health and Health Disparities><National Institute of Minority Health and Health Disparities><National Institute on Minority Health and Health Disparities><Native Hawaiian and Other Pacific Islander><Native Hawaiian and Pacific Islander><Native Hawaiian or Other Pacific Islander><Native Hawaiian or Pacific Islander><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Novolin R><Outcome><Outcomes Research><P50 Mechanism><P50 Program><Pb element><Pilot Projects><Policies><Policy Developments><Postdoc><Postdoctoral Fellow><Principal Investigator><Process><Productivity><Public Health><Racial Group><Reduce health disparities><Regular Insulin><Research><Research Associate><Research Personnel><Research Resources><Researchers><Resource Allocation><Resource Sharing><Resources><Services><Specialized Center><Translations><Trust><Underserved Population><Universities><Work><a beta peptide><abeta><access to health care><access to healthcare><accessibility of health care><accessibility to health care><accessibility to healthcare><amyloid beta><amyloid-b protein><aspirate><base><bases><beta amyloid fibril><burned><cardiovascular disorder><collaboration with communities><community collaboration><community-based collaboration><coronavirus disease 2019><coronavirus disease-19><coronavirus infectious disease-19><diabetes><disparity in health><ethnic subgroup><ethnicity group><healing><health care access><health care availability><health care policy><health care service access><health care service availability><health disparities science><health disparity><health equity><healthcare access><healthcare accessibility><healthcare availability><healthcare policy><healthcare service access><healthcare service availability><heavy metal Pb><heavy metal lead><improve minority health><improved><improvement of minority health><innovate><innovation><innovative><institutional capacity><life change><malignancy><medical college><medical schools><medically under served><medically underserved><minority health><minority health disparity><minority institution><name><named><naming><neoplasm/cancer><neuronal><new approaches><novel approaches><novel strategies><novel strategy><pilot study><post-doc><post-doctoral><post-doctoral trainee><programs><racial population><racial subgroup><recruit><research associates><research facility><school of medicine><soluble amyloid precursor protein><success><translation><under served community><under served group><under served individual><under served people><under served population><underserved community><underserved group><underserved individual><underserved people>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Zoltan Maliga

HARVARD MEDICAL SCHOOL, BOSTON, MA

Exploratory lead · 0/100
$201,041
FY 2024

Project Title

High dimensional digital pathology to investigate the tumor micro environment and its impact on response to therapy

Grant Number:

5R50CA252138-05

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2020

End Date:

8/31/2025

Project Abstract

Summary Grant: Research Specialist (PAR-19-291) Under the supervision of senior scientist Zoltan Maliga PhD, investigators and staff at the Harvard Medical School Laboratory of Systems Pharmacology (LSP) will contribute to cell and tissue imaging and analysis for U2C and U54 program grants LSP-based...

Research Terms

<Adverse reactions><Antibodies><Atlases><Autoimmune Diseases><Biological Markers><Body Tissues><Cancers><Cell Body><Cells><Collaborations><Cutaneous><Cyclicity><Data Analyses><Data Analysis><Detection><Development><Disease><Disorder><Doctor of Philosophy><Drug Therapy><Environment><Funding><Grant><Human><Image><Immune><Immunes><Immunofluorescence><Immunofluorescence Immunologic><In Situ Hybridization><Inflammation><Investigators><Laboratories><Malignant Melanoma><Malignant Neoplasms><Malignant Tumor><Manuscripts><Melanoma><Methods><Mice><Mice Mammals><Modern Man><Murine><Mus><NIH><National Institutes of Health><Oligo><Oligonucleotides><Pathology><Periodicity><Ph.D.><PhD><Pharmacology><Pharmacotherapy><Process><Reagent><Reporting><Research><Research Personnel><Researchers><Resolution><Rhythmicity><Sampling><Scientist><Senior Scientist><Skin><Skin development><Specialist><Staining method><Stains><Supervision><System><Technology><Tissue imaging><Tissues><United States National Institutes of Health><Work><Writing><autoimmune condition><autoimmune disorder><autoimmunity disease><bio-markers><biologic marker><biomarker><cancer microenvironment><career development><cell imaging><cellular imaging><data interpretation><developmental><digital pathology><drug treatment><high dimensionality><imaging><in situ Hybridization Genetics><in situ Hybridization Staining Method><malignancy><medical college><medical schools><member><multiplexed imaging><neoplasm/cancer><oligos><precancer><precancerous><premalignant><programs><resolutions><response to therapy><response to treatment><school of medicine><skin organogenesis><therapeutic response><therapy response><treatment response><treatment responsiveness><tumor><tumor microenvironment>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Zhong Chen

DUKE UNIVERSITY, DURHAM, NC

Exploratory lead · 0/100
$198,304
FY 2024

Project Title

Systems analysis of the prostate cancer epigenome

Grant Number:

5R50CA251843-05

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/14/2020

End Date:

4/11/2025

Project Abstract

Project Summary/Abstract Although androgen ablation is initially effective for advanced prostate cancer treatment, resistance ultimately develops through various mechanisms, causing patient morbidity. Systems analysis of the prostate cancer epigenome is a genome-scale approach to understanding the u...

Research Terms

<ATAC sequencing><ATAC-seq><ATACseq><Ablation><Algorithms><Androgen Antagonists><Androgen Receptor><Androgenic Agents><Androgenic Compounds><Androgens><Anti-Androgen><Anti-Androgen Agents><Area><Assay><Assay for Transposase-Accessible Chromatin using sequencing><Award><Basal Transcription Factor><Basal transcription factor genes><Binding><Binding Sites><Bioassay><Biological Assay><Body Tissues><CRISPR><CRISPR/Cas system><Cancer Patient><Chromatin><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats><Combining Site><Computer Models><Computerized Models><Data><Data Set><Development><Endocrine Gland Secretion><Endocrine Therapy><Enhancers><Environment><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Event><Funding><General Transcription Factor Gene><General Transcription Factors><Generalized Growth><Genomics><Goals><Growth><Hormonal Therapy><Hormones><Invaded><Laboratories><Learning><MNase-seq><Malignant Cell><Malignant Tumor of the Prostate><Malignant neoplasm of prostate><Malignant prostatic tumor><Micrococcal nuclease digestion of chromatin followed by sequencing><Micrococcal nuclease-sequencing><Mnase-Sequencing><Molecular Interaction><Molecular and Cellular Biology><Morbidity><Morbidity - disease rate><Nucleosomes><Patients><Pattern><Position><Positioning Attribute><Prostate CA><Prostate CA therapy><Prostate Cancer><Prostate Cancer therapy><Prostate malignancy><Prostatic Cancer><Proteomics><RNA Seq><RNA sequencing><RNAseq><Reactive Site><Regulatory Protein><Research><Resistance><Resistance development><Resistant development><Role><Series><Specialist><System><Systems Analyses><Systems Analysis><Techniques><Therapeutic><Therapeutic Androgen><Therapeutic Hormone><Tissue Growth><Tissues><Transcription Factor Proto-Oncogene><Transcription Regulation><Transcription factor genes><Transcriptional Control><Transcriptional Regulation><Translations><Work><advanced prostate cancer><androgen inhibitor><anti-cancer research><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><base editing><cancer cell><cancer research><computational modeling><computational models><computer based models><computerized modeling><design><designing><developing resistance><developmental><epigenetically><epigenome><epigenome editing><epigenomic editing><epigenomics><experiment><experimental research><experimental study><experiments><genetic regulatory protein><genome scale><genome-wide><genomewide><hormone therapy><innovate><innovation><innovative><member><novel><ontogeny><programs><prostate cancer cell><prostate cancer progression><prostate cancer treatment><prostate tumor cell><receptor binding><receptor bound><refractory cancer><regulatory gene product><resistant><resistant cancer><social role><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><tool><transcription factor><transcriptome sequencing><transcriptomic sequencing><translation>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Justin Kwan

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

Exploratory lead · 0/100
$196,525
FY 2025

Project Title

ALLFTD: ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration

Grant Number:

1ZIANS009449-03

Activity Code:

ZIA

Mechanism:

Intramural Research

Agency:

NIH

Project Abstract

ARTFL LEFFTDS Longitudinal FTLD: OVERALL SECTION Frontotemporal Lobar Degeneration (FTLD) is the overarching term for a group of neurodegenerative disorders that are believed to be caused by the accumulation of toxic protein aggregates in the CNS, most commonly comprised of one of two major proteins...

Research Terms

<AD dementia><AD related dementia><ADRD><Active Follow-up><Address><Age><Age of Onset><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimers Dementia><American><Biological><C9ORF72><Clinic><Clinical><Clinical Data><Clinical Trials><Collection><Communities><DNA mutation><DNA-Binding Proteins><Data Collection><Degenerative Neurologic Disorders><Development><Disease><Disorder><Enrollment><Evaluation><FTD dementia><FTLD><Familial disease><Family><Fostering><Frontal Temporal Dementia><Frontal Temporal Lobar Degeneration><Frontotemporal Dementia><Frontotemporal Lobar Degenerations><Frontotemporal variety lobar degeneration><Genes><Genetic Change><Genetic defect><Genetic mutation><Goals><Hereditary><History><Infrastructure><Inherited><Investigators><MAPT gene><MAPT protein><MT-bound tau><MTBT1><Molecular Weight><Mutation><Nervous System Degenerative Diseases><Neural Degenerative Diseases><Neural degenerative Disorders><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Neurologist><PC cell-derived growth factor><PCDGF><PGRN gene><PGRN protein><Participant><Patients><Physicians><Primary Senile Degenerative Dementia><Procedures><Progranulin><Protocol><Protocols documentation><Questionnaires><R-Series Research Projects><R01 Mechanism><R01 Program><Recommendation><Recording of previous events><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Researchers><Sampling><Scanning><Scientist><Series><Study Subject><Symptoms><Syndrome><Testing><Time><active followup><ages><biologic><brain MR imaging><brain MRI><brain magnetic resonance imaging><cerebral MR imaging><cerebral MRI><cerebral magnetic resonance imaging><chromosome 9 open reading frame 72><clinical diagnosis><cognitive assessment><cognitive testing><data sharing><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><effective therapy><effective treatment><enroll><familial disorder><follow up><follow-up><followed up><followup><front temporal dementia><frontal lobe dementia><frontotemporal degeneration><frontotemporal lobar degeneration dementia><frontotemporal lobar dementia><frontotemporal lobe degeneration associated with dementia><genome mutation><granulin precursor><histories><improved><insoluble aggregate><microtubule associated protein tau><microtubule bound tau><microtubule-associated protein tau><microtubule-bound tau><neurodegenerative illness><participant enrollment><patient enrollment><primary degenerative dementia><programs><progranulin gene><progranulin protein><protein aggregate><protein aggregation><recruit><senile dementia of the Alzheimer type><tau><tau Proteins><tau factor><τ Proteins>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Martha Zeiger

DIVISION OF BASIC SCIENCES - NCI

Exploratory lead · 0/100
$154,003
FY 2024

Project Title

Training and Development of Outstanding Surgeon Scientists

Grant Number:

1ZIEBC011992-05

Activity Code:

ZIE

Mechanism:

Intramural Research

Agency:

NIH

Project Abstract

The 5-year pilot program will support a total of 36 early-career surgeon scientist program participants, each of whom will receive three years of funding in three cohorts of 12 Participants per cohort, staggered a year apart. Funding of up to $125,000 in direct costs will be provided annually for ex...

Research Terms

<Academic Medical Centers><Administrative Supplement><Advanced Cancer><Advanced Malignant Neoplasm><Applications Grants><Budgets><CCSG><Cancer Center Support Grant><Cancer health equity><Cancers><Collaborations><Communities><Curriculum><Development><Direct Costs><Disease><Disorder><EXTMR><Education><Educational Curriculum><Educational aspects><Eligibility><Eligibility Determination><Evaluation><Extramural><Extramural Activities><Funding><Goals><Grant><Grant Proposals><Institution><Investigators><Journals><Magazine><Malignant Neoplasms><Malignant Tumor><Manuscripts><Mentors><Methods><NCI-Designated Cancer Center><NIH><NIH Program Announcements><National Institutes of Health><Operative Procedures><Operative Surgical Procedures><Outcome><Participant><Persons><Physicians><Population><Process><Program Announcement><Progress Reports><Protocol Screening><Research Personnel><Research Support><Researchers><Scientist><Societies><Surgeon><Surgical><Surgical Interventions><Surgical Procedure><Survey Instrument><Surveys><Training><Training Activity><Translational Research><Translational Science><Travel><Underrepresented Ethnic Minority><Underrepresented Minority><Underrepresented Students><United States><United States National Institutes of Health><University Medical Centers><Writing><anti-cancer research><cancer research><career><cohort><conference><convention><cost><developmental><diversity, equity, and inclusiveness><equity, diversity, and inclusion><health disparity community><health disparity group><health disparity populations><improved><lesson plans><malignancy><meeting><meetings><neoplasm/cancer><participant interview><programs><recruit><summit><surgery><symposia><symposium><timeline><training module><translation research><translational investigation><under-representation of minorities><under-represented minority><underrepresentation of minorities>
View Full Project Details on NIH Reporter
Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Search NIH grants by PI name

Looking for a specific principal investigator? The keyword search above looks up funded projects by topic. To search NIH grants by PI name (last name, first + last name, or partial name) and see every active and recent NIH award for that researcher, use the dedicated PI Funding Status tool.

How to Use PI Funding Data for Career Decisions

Finding the right principal investigator is one of the most important decisions in an academic career. Whether you are a postdoc looking for a mentor, a graduate student choosing a rotation lab, or a collaborator seeking a co-PI, NIH funding data provides objective signals about which investigators have active research programs and resources to support new team members.

A PI with a recently awarded R01 or equivalent grant is more likely to have budget for new personnel than one whose funding ended two years ago. The activity code tells you the type of grant: R01 and R35 awards typically support multiple lab members, while K-series awards are individual career development grants that may not fund additional positions. Understanding these distinctions helps you interpret search results accurately.

Look beyond the dollar amount. A $500,000 per year R01 at a high-cost institution may support fewer positions than a $300,000 award at a university with lower overhead rates. The project abstract and public health relevance statement reveal whether the PI's research direction aligns with your interests and expertise.

Understanding PI Grant Portfolios

A PI's grant portfolio reveals more than individual awards. Investigators with multiple active grants often run larger labs with more diverse projects, which can mean more opportunities for trainees. However, a PI with a single well-funded grant may offer more focused mentorship and a clearer path to publications.

Multi-PI grants (those with more than one principal investigator listed) indicate collaborative research and may involve trainees from multiple institutions. These can be excellent opportunities for interdisciplinary training but may also mean split attention from any single mentor.

Pay attention to the timing of awards. A PI who just received a new five-year R01 is in a different position than one whose grant ends next year. New awards often correspond to lab expansion and active recruiting, making them ideal targets for job seekers. The start and end dates shown in each result help you assess this timing.

Best Practices for Contacting Funded PIs

Once you identify a promising PI through this tool, the next step is outreach. NIH public records do not include email addresses, but you can usually find contact information through the PI's institutional profile page, lab website, or recent publications. Google Scholar, PubMed, and the PI's department website are reliable starting points.

When reaching out, reference the specific grant that caught your attention. Mentioning the project title and explaining how your skills relate to the funded work shows that you have done your homework. Keep your initial message concise: introduce yourself, explain your interest, attach your CV, and ask whether they anticipate openings.

Timing matters. Contacting a PI within the first year of a new award is ideal, as this is when they are most likely to be recruiting. If you find multiple promising PIs in the same field, prioritize those with the most recent award notices and activity codes that support trainee positions such as R01, U01, or P-series grants.

Frequently Asked Questions About PI Search

What does the opportunity score mean?

The opportunity score is a heuristic that combines award recency, funding amount, activity code type, and project characteristics to estimate how actionable a result might be for job seekers or collaborators. Higher scores suggest stronger signals, but always verify by reading the abstract and checking the PI's current lab page.

Why can't I find a PI I know has funding?

Name variations are the most common cause. Try searching with just the last name, or use different formats like "Smith, John" versus "John Smith." Some PIs also publish under different name variations or may have awards under a previous institutional affiliation.

Does this tool show all NIH-funded PIs?

The tool searches NIH RePORTER data for the keyword and year range you specify. It returns PIs whose funded projects match your search terms. PIs with grants in unrelated areas or whose projects use different terminology will not appear in keyword-filtered results.

What is the difference between "Likely hiring" and "Training-friendly" filters?

"Likely hiring" flags PIs with large new awards or activity codes typically associated with lab expansion. "Training-friendly" identifies awards that include training components or are at institutions known for postdoctoral programs. Both are heuristic filters to help prioritize your outreach.

How to use this well

Start broad, then narrow. Search a field first, then refine by timeframe once you understand who is currently active.

After you find a promising PI, cross-check them in Check PI Funding and review their institution, mechanism type, and project abstracts before reaching out.

What a match means

A result means the keyword appears relevant to the funded project data we searched. It does not guarantee the PI is hiring or that the grant is still active.

Use the abstract, award year, mechanism, and organization context to decide whether the record is strategically relevant.

Data limits

NIH records can lag, institutional names can vary, and some investigators publish or file awards under multiple name formats.

For details on source coverage and refresh cadence, read Data & Methodology.

Related guides

Companion guides for turning a PI search result into useful outreach or a job lead.

Career Guide8 min read

How Postdocs Can Find PIs with New NIH Funding

A tactical job-search guide for identifying recently funded labs, judging fit, and timing outreach to principal investigators.

Read guide
Career Guide7 min read

How to Contact a PI: Finding Emails and Crafting the Perfect Message

Emailing strategies, outreach examples, and a workflow for turning NIH funding signals into focused PI conversations.

Read guide
Career Guide10 min read

How to Read a New NIH Award Like a Hiring Signal

A practical framework for using newly funded NIH awards to judge whether a lab may be expanding, hiring, or worth contacting now.

Read guide
Funding Strategy16 min read

How to Find NIH Funding Opportunities: A Step-by-Step Guide for Researchers

Learn how to find NIH funding opportunities using the NIH Guide, Grants.gov, FOAs, NIH RePORTER, and program officer outreach.

Read guide

Recently Funded Labs in Trending Areas

Principal investigators who received NIH awards in the last 90 days, organized by research area. Use this as a starting point for postdoc searches, collaborator outreach, or competitor scans. Counts and labs refresh daily.

Alzheimer's disease

Neurodegeneration, biomarkers, and disease-modifying therapies.

  • Carlos Cruchaga — WASHINGTON UNIVERSITY, MO
    CONGAS: "Caribbean Omics 'N' Genomics for Alzheimer Study"
    $101,153 · awarded Feb 25, 2026 · 3U01AG084514-01A1S1
  • Carlos Cruchaga — WASHINGTON UNIVERSITY, MO
    CONGAS: "Caribbean Omics 'N' Genomics for Alzheimer Study"
    $3,086,339 · awarded Feb 19, 2026 · 1U01AG084514-01A1
  • HARALD SONTHEIMER — UNIVERSITY OF VIRGINIA, VA
    Extracellular matrix and memory impairments in Alzheimer disease
    $709,066 · awarded Apr 7, 2026 · 5R01AG085359-03
  • Keith Josephs — MAYO CLINIC ROCHESTER, MN
    The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies
    $643,670 · awarded Apr 1, 2026 · 5R01DC014942-09
  • DMITRIY YABLONSKIY — WASHINGTON UNIVERSITY, MO
    Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease
    $661,985 · awarded Mar 3, 2026 · 4R01AG082030-02
Search more PIs in Alzheimer's disease →

CRISPR & gene editing

Therapeutic gene editing, base editing, and prime editing.

  • Changchun Liu — UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT
    Asymmetric CRISPR Approach for Nucleic Acid Quantification
    $643,849 · awarded Mar 30, 2026 · 2R01EB023607-06A1
  • William Pu — BOSTON CHILDREN'S HOSPITAL, MA
    A modular system for murine CRISPR genome and epigenome editing
    $267,000 · awarded Mar 27, 2026 · 5R21OD037909-02
  • Naama Aviram — SLOAN-KETTERING INST CAN RESEARCH, NY
    Molecular mechanisms of memory formation and tolerance in CRISPR-Cas systems
    $249,000 · awarded Apr 2, 2026 · 5R00GM148720-04
  • Mats Ljungman — UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
    Precision targeting of bladder cancer using CRISPR
    $582,849 · awarded Feb 17, 2026 · 5R01CA285730-03
  • Shannon Miller — SCRIPPS RESEARCH INSTITUTE, THE, CA
    Development of potent and safe CRISPR tools for in vivo gene editing using directed evolution
    $230,000 · awarded May 5, 2026 · 5R21EB036298-03
Search more PIs in CRISPR & gene editing →

Cancer immunotherapy

Checkpoint inhibitors, CAR-T, TIL therapy, and beyond.

  • TERRY SHEPPARD — KEYSTONE SYMPOSIA, CO
    Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
    $5,000 · awarded Mar 3, 2026 · 1R13CA310704-01
  • Veronika Fedirko — UNIVERSITY OF TX MD ANDERSON CAN CTR, TX
    Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma
    $927,329 · awarded Mar 3, 2026 · 5R01CA255322-05
  • Yuwen Zhu — UNIVERSITY OF COLORADO DENVER, CO
    The GPR171 pathway in cancer immunotherapy
    $355,706 · awarded Apr 2, 2026 · 5R01CA279398-04
  • ANDREW WIEMER — UNIVERSITY OF CONNECTICUT STORRS, CT
    Synthesis and evaluation of BTN3A1 ligands for cancer immunotherapy
    $374,171 · awarded May 1, 2026 · 5R01CA266138-05
  • Wei Hu — YALE UNIVERSITY, CT
    Novel Treg inactivating approach for cancer immunotherapy via targeted protein degradation
    $482,312 · awarded Apr 6, 2026 · 1R01CA295942-01A1
Search more PIs in Cancer immunotherapy →

GLP-1 & metabolic disease

Diabetes, obesity, and weight-loss therapeutic mechanisms.

  • ZHIPING PANG — RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ
    Synaptic and circuit mechanisms of central GLP-1 signaling in energy balance
    $479,051 · awarded Apr 23, 2026 · 5R01DK131452-05
  • Madhusmita Misra — UNIVERSITY OF VIRGINIA, VA
    Bone metabolism in adolescents undergoing GLP-1 receptor agonist therapy
    $471,776 · awarded Apr 24, 2026 · 5R01HD118635-07
  • STEVEN SCHWENDEMAN — UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
    Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment of Obesity
    $231,000 · awarded Apr 17, 2026 · 1R56DK141545-01A1
  • Jessica Barson — DREXEL UNIVERSITY, PA
    Suppression of ethanol dependence-induced maladaptive appetitive and consummatory behavior by the GLP-1 system
    $564,306 · awarded May 5, 2026 · 1R01AA031732-01A1
  • MICHAEL CAMILLERI — MAYO CLINIC ROCHESTER, MN
    A Randomized, placebo-controlled trial of the effects of Long-Acting GLP-1 or Dual Incretin (GLP-1 and GIP) Modulation on Gastrointestinal Functions and Relationship to Weight Loss
    $322,800 · awarded Apr 9, 2026 · 5R01DK142606-02
Search more PIs in GLP-1 & metabolic disease →

Long COVID

Post-acute sequelae and chronic infection-driven illness.

  • Alexei Tumanov — UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX
    Lymphotoxin-dependent control of long COVID
    $234,715 · awarded Feb 13, 2026 · 1R21AI185790-01A1
  • Amal Amer — OHIO STATE UNIVERSITY, OH
    Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy
    $2,974,582 · awarded Apr 21, 2026 · 5P01AI175399-03
  • Alba Azola — JOHNS HOPKINS UNIVERSITY, MD
    Blood-Brain Barrier Integrity and Immune Dynamics in Neuropsychiatric Sequelae of Post-SARS-CoV-2 onset ME/CFS versus Pre-Pandemic ME/CFS Patients
    $633,378 · awarded Apr 17, 2026 · 1R01NS147100-01
  • DANIELLE REED — MONELL CHEMICAL SENSES CENTER, PA
    Inflammation and chemosensory loss
    $2,654,249 · awarded Feb 26, 2026 · 1P50DC022549-01A1
  • Jarred Younger — UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL
    Low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
    $556,686 · awarded Mar 6, 2026 · 1UG3NS141843-01A1
Search more PIs in Long COVID →